Social disparities and cancer-related stress. by Simon, A.E.H.
REFERENCE ONLY
2809076127
UNIVERSITY OF LONDON THESIS
Degree  ^   P)  year  '2^0 0 (3  Name of Author  O TV j
f\[y(JL  t/v w U i  [A'liaheS
COPYRIGHT
This  is  a  thesis  accepted  for a  Higher Degree of the  University of London.  It is an 
unpublished typescript and the copyright is held by the author.  All persons consulting 
the thesis must read and abide by the Copyright Declaration below.
COPYRIGHT DECLARATION
I recognise that the copyright of the above-described thesis rests with the author and 
that no quotation from it or information derived from  it may be published without the 
prior written consent of the author.
LOAN
Theses may not be lent to individuals,  but the  University Library may lend a copy to 
approved  libraries within the United Kingdom, for consultation solely on the premises 
of those libraries.  Application should be made to: The Theses Section,  University of 
London Library, Senate House, Malet Street, London WC1E THU.
REPRODUCTION
University  of  London  theses  may  not  be  reproduced  without  explicit  written 
permission from the University of London  Library.  Enquiries should be addressed to 
the  Theses  Section  of  the  Library.  Regulations  concerning  reproduction  vary 
according to the date of acceptance of the thesis and are listed below as guidelines.
A.  Before  1962.  Permission  granted only  upon the prior written  consent of the 
author.  (The University Library will provide addresses where possible).
B.  1962 - 1974.  In many cases the author has agreed to permit copying upon
completion of a Copyright Declaration.
C.  1975 - 1988.  Most theses may be copied  upon  completion  of a  Copyright
Declaration.
D.  1989 onwards.  Most theses may be copied.
This thesis comes within category D.
n   \ a  C- I   I   This copy has been deposited in the Library of    L------------
□
This  copy  has  been  deposited  in  the  University  of  London  Library,  Senate 
House, Malet Street, London WC1E 7HU.
Blissett Bookbi 
020 8992 3S1
SOCIAL DISPARITIES AND CANCER-RELATED STRESS
Alice E H Simon
A thesis submitted for the degree of Doctor of Philosophy
University College LondonUMI  Number: U592402
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted.  Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U592402
Published by ProQuest LLC 2013.  Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved.  This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml  48106-1346Acknowledgements  2
ACKNOWLEDGEMENTS
I am very grateful for the help and support that I  have received from Professor 
Jane Wardle and  Professor Andrew Steptoe.  They have both helped to make 
this an enjoyable and  rewarding experience and it has been a privilege to work 
with them.
I would also like to thank other members of the Health  Behaviour Unit who have 
supported me along the way.  My particular thanks go to Dr Katie Robb and Ruth 
Evans for their assistance in carrying out the research interviews and  Dr Anne 
Miles for her invaluable advice.
Many thanks go to all those working at the National Cancer Research Network 
who enabled the research studies to take place.
The financial support from Cancer Research UK is also gratefully acknowledged.
I would  like to thank:  my mother, Maggie Guillebaud, for always encouraging me 
to pursue my education,  my father,  Robin Simon, for his endless editorial help 
and support, and  my husband,  Daniel Jones, for making me stick with it to the 
end.  Last but not least, thanks should go to my as yet unborn baby who provided 
me with a deadline that I simply could not miss.ABSTRACT
Abstract  3
Socioeconomic disparities in health have been demonstrated over a wide 
range of health outcomes.  A differential capacity to cope with stressful life 
events has been proposed as one mechanism contributing to disparities.  SES 
differences in coping with cancer-related stressors are the subject of this thesis.
Study  1   examined SES differences in psychological distress associated 
with cancer screening.  Lower SES groups had lower psychosocial wellbeing 
but were not more vulnerable to adverse psychological consequences.  Study 2 
tested the hypothesis that SES differences in adjustment to a cancer diagnosis 
are greater when the prognosis is poorer.  There was some evidence that lower 
SES groups were more adversely affected by a more advanced disease stage 
diagnosis compared to higher SES groups.  The qualitative interviews in Study 
3 considered the possibility that this was due to differential experience of care, 
but found little evidence that cancer patients’ experiences of medical care 
differed by SES.  Studies 4,  5 and 6 used a large longitudinal sample of cancer 
patients (breast,  prostate and colorectal).  Study 4 explored whether SES 
moderated  psychosocial adjustment related to the types of treatment received, 
presence of co-morbidity or disease stage at diagnosis.  The effect of receiving 
surgery appeared to diminish rather than increase SES differences in 
adjustment.  Study 5 showed that higher SES groups had more psychosocial 
resources to cope with a cancer diagnosis and that resources were related to 
psychosocial wellbeing,  but despite this, Study 6 found  no evidence that lower 
SES groups experienced poorer adjustment to a cancer diagnosis over time.
Overall the studies found little evidence that lower SES gives greater 
vulnerability to serious stressors, and if anything, suggested that a cancerAbstract
diagnosis seemed to minimise the expected SES differences in psychological 
wellbeing.Table of Contents  5
TABLE OF CONTENTS
ABSTRACT...............................................................................................................................................................3
TABLE OF CONTENTS........................................................................................................................................5
LIST OF TA B LE S.................................................................................................................................................. 8
LIST OF FIGURES...............................................................................................................................................10
CHAPTER 1 ...........................................................................................................................................................11
Socio-economic status and psychosocial responses to stress............................................... 11
Transactional Model of Stress................................................................................................................13
SES and  Psychosocial  Resources.......................................................................................................18
Control...................................................................................................................................................... 18
Optimism.................................................................................................................................................22
Social Support....................................................................................................................................... 27
Summary.................................................................................................................................................29
SES and  Exposure to Chronic Stress..................................................................................................29
SES and  Psychosocial Response to New Stressors...................................................................... 32
CHAPTER 2 ...........................................................................................................................................................39
Cancer-related stressors and Psychosocial O u tc o m es........................................................... 39
Cancer-related  Stressors.........................................................................................................................39
Cancer screening................................................................................................................................. 39
Cancer diagnosis.................................................................................................................................. 42
Cancer treatment.................................................................................................................................. 45
Cancer and co-morbidity....................................................................................................................48
Cancer and survivorship.....................................................................................................................49
Cancer and  Psychological Outcomes..................................................................................................50
Prevalence of depression and anxiety...........................................................................................52
Quality of life...........................................................................................................................................55
Benefit finding.........................................................................................................................................58
Cancer and  Social Outcomes................................................................................................................ 60
Social difficulties....................................................................................................................................60
Medical  interactions..............................................................................................................................61
Conclusions.................................................................................................................................................67
CHAPTER 3 ...........................................................................................................................................................68
Measurement of Socio-economic sta tu s............................................................................................68
Measures of Social Position...................................................................................................................69
Occupation............................................................................................................................................. 69
Education.................................................................................................................................................70
Measures of Material  Living Standards.............................................................................................. 71
Income......................................................................................................................................................71
Assets.......................................................................................................................................................71
Area-level Markers of S E S ..................................................................................................................... 73
Subjective S E S ...........................................................................................................................................75
Conclusions................................................................................................................................................. 77
CHAPTER 4 ...........................................................................................................................................................79
Outline of Research Stu d ie s...................................................................................................................79
CHAPTER 5 ...........................................................................................................................................................83
Study 1:  Socioeconomic status differences in adjustment to bowel screening.............83
Introduction...................................................................................................................................................83
Hypotheses..............................................................................................................................................85
Method...........................................................................................................................................................85
Participants..............................................................................................................................................85
Design and  procedure......................................................................................................................... 86
The screening examination................................................................................................................87
Measures..................................................................................................................................................87Table of Contents  6
Analyses.........................................................................................................................................92
Results............................................................................................................................................92
Longitudinal sample..................................................................................................................92
Post-FS sample...................................................................................................................... 100
Discussion.....................................................................................................................................104
CHAPTER 6 ..........................................................................................................................................109
S tu d y 2:  S o c io e c o n o m ic  s ta tu s a n d p s y c h o s o c ia l o u t c o m e s  in  b o w e l c a n c e r p a tie n ts
............................................................................................................................................................109
Introduction.................................................................................................................................. 109
Hypotheses..............................................................................................................................110
Method..........................................................................................................................................111
Participants..............................................................................................................................111
Design and Procedure........................................................................................................... 111
Measures.................................................................................................................................112
Analyses.......................................................................................................................................116
Results..........................................................................................................................................116
Discussion.....................................................................................................................................127
CHAPTER 7 ..........................................................................................................................................131
S t u d y 3:  Q u a l ita tiv e in v e s t ig a t io n o f e d u c a tio n a l d if f e r e n c e s   in c o lo r e c ta l c a n c e r
PATIENTS’  EXPERIENCES OF ONCOLOGY CARE.................................................................................. 131
Introduction.................................................................................................................................. 131
Aims..........................................................................................................................................132
Method..........................................................................................................................................133
Using qualitative and quantitative methods.........................................................................133
Participants..............................................................................................................................135
Design and Procedure........................................................................................................... 136
Analyses.......................................................................................................................................138
Results..........................................................................................................................................139
Respondents...........................................................................................................................139
Positive and Negative Evaluations of Care.........................................................................140
Medical Interaction Themes..................................................................................................143
Comparison of survey items with interview themes.......................................................... 149
Demographic Differences in Perceptions of Care..............................................................151
Socio-economic Differences in Perceptions of Care......................................................... 152
Discussion.....................................................................................................................................154
CHAPTER 8 ..........................................................................................................................................163
S t u d y 4:  S o c io e c o n o m ic  s ta tu s d if f e r e n c e s  in  p s y c h o s o c ia l w e l l b e in g  o f c a n c e r
PATIENTS............................................................................................................................................163
Introduction..................................................................................................................................163
Hypotheses..............................................................................................................................165
Method..........................................................................................................................................165
Participants..............................................................................................................................165
Design and Procedure........................................................................................................... 166
Measures................................................................................................................................. 167
Analyses.......................................................................................................................................172
Results..........................................................................................................................................173
Disease stage, treatment and  psychosocial wellbeing........................................................177
Co-morbidity and psychosocial  wellbeing............................................................................ 180
SES and psychosocial wellbeing..........................................................................................180
Interactions between SES and medical characteristics....................................................184
Discussion.....................................................................................................................................189
CHAPTER 9 ..........................................................................................................................................195
S t u d y 5:  S o c io e c o n o m ic  s ta tu s d if f e r e n c e s in p s y c h o s o c ia l r e s o u r c e s a m o n g s t c a n c e r
PATIENTS.............................................................................................................................................195
Introduction...................................................................................................................................195
Hypotheses..............................................................................................................................197
Method...........................................................................................................................................197
Participants, Design and Procedure.....................................................................................197Measures
Table of Contents  7 
..................................198
Analyses.....................................................................................................................................................201
Results.........................................................................................................................................................202
Discussion.................................................................................................................................................. 209
CHAPTER 1 0 ...................................................................................................................................................... 214
Study 6: Socioeconomic status d ifferences in psychosocial adjustment to cancer over
TIME.....................................................................................................................................................................214
Introduction................................................................................................................................................214
Hypotheses...........................................................................................................................................215
Method.........................................................................................................................................................216
Participants,  Design and  Procedure...............................................................................................216
Analyses.....................................................................................................................................................217
Results.........................................................................................................................................................218
Discussion.................................................................................................................................................. 227
CHAPTER 1 1 ...................................................................................................................................................... 230
Discussion......................................................................................................................................................230
Summary of main findings....................................................................................................................230
Limitations.................................................................................................................................................. 240
Use of different SES markers.........................................................................................................240
Use of multiple psychosocial outcomes......................................................................................241
Samples.................................................................................................................................................242
Design....................................................................................................................................................243
Conclusions and directions  for  future work.....................................................................................245
REFERENCES....................................................................................................................................................253
APPENDICES......................................................................................................................................................291
Appendix I:  Paper submitted for publication:  Socioeconomic disparities in optimism 
Appendix II:  Published  book chapter:  Cancer and  Depression
Appendix III:  Published paper:  Socioeconomic Status differences in coping with a stressful 
medical procedure
Appendix IV:  Longitudinal questionnaire used in Study  1  
Appendix V Post-FS questionnaire used in Study  1
Appendix VI  Paper submitted for publication:  Disease stage and  psychosocial outcomes in 
colorectal cancer
Appendix VII:  Questionnaire used  in Study 2 
Appendix VIII:  Ethical approval for Study 2 
Appendix IX:  Interview Topic Guide for Study 3 
Appendix X:  Questionnaire used in Studies 3, 4,  and 5 
Appendix XI:  Ethical approval for Studies 3, 4,  5 and 6 
Appendix XII:  Codebook used in Study 3 
Appendix Xllll:  Questionnaire used in Study 6List of Tables  8
LIST OF TABLES
CHAPTER 1
Table  1   Explanations for the relationship of social inequality to health from  12
Bartley (2004)
CHAPTER 5
Table  1   Demographic characteristics -  Longitudinal sample  93
Table 2  Area-level deprivation: Change in anxiety and worry about bowel  96
cancer from before to after screening, controlling for screening 
outcome
Table 3  Individual-level deprivation: Change in anxiety and worry about bowel  99
cancer from before to after screening, controlling for screening 
outcome
Table 4  The relationship between SES, screening outcome and psychological  103
well-being at the post-screening assessment, controlling for age and 
gender
CHAPTER 6
Table  1   Demographic and medical characteristics  118
Table 2  The relationships between psychosocial resources, quality of life,  120
psychological distress and disease stage,  controlling for age
Table 3  The relationships between psychosocial resources, quality of life,  121
psychological distress and socio-economic deprivation, controlling for 
age
Table 4  Relationships between socio-economic deprivation, disease stage and  126
psychosocial outcomes, controlling for age
CHAPTER 7
Table  1   Demographic characteristics  141
Table 2  Number of people contributing positive  and negative evaluations  142
Table 3  Content of comments about medical care  147
Table 4  CARES Items  150
Table 5  Positive and negative evaluations of medical care by level of education  153List of Tables  9
CHAPTER 8
Table  1  
Table 2 
Table 3
Table 4
Table 5
CHAPTER 9
Table  1
Table 2
Table 3 
Table 4
CHAPTER 10
Table  1
Table 2 
Table 3
Table 4
Table 5
CHAPTER 11
Table  1  
Table 2
Demographic and medical characteristics of sample 
Socio-economic characteristics of the sample 
Psychosocial wellbeing by disease stage,  controlling for age, gender 
and cancer site
Psychosocial wellbeing by SES, controlling forage, gender and cancer 
site
Differences in psychosocial wellbeing using other SES markers -  
controlling for age, gender and cancer site
Psychosocial resources by individual SES controlling for age, gender 
and cancer site
Differences in psychosocial resources using other SES markers -  
controlling for age, gender and cancer site 
The relationships between psychosocial resources and wellbeing 
Summary of multiple regression analyses showing the associations 
between SES, psychosocial resources and wellbeing
Psychosocial wellbeing by individual SES at Time 2 (9-12 months post­
diagnosis), controlling for age, gender and cancer site 
Psychosocial wellbeing by four different SES markers at Time 2 (9-12 
months post-diagnosis), controlling for age, gender and cancer site 
Overall change in psychosocial wellbeing from Time 1 (1-3 months 
post-diagnosis) to Time 2 (9-12 months post-diagnosis), controlling for 
age, gender and cancer site
Mean change in psychosocial wellbeing from time 1 (1-3 months post­
diagnosis) to time 2 (9-12 months post-diagnosis) by level of individual 
SES, controlling forage, gender, and cancer site 
Change in psychosocial wellbeing by four different SES markers 
controlling for age, gender, and cancer site
Summary of main findings
Comparison of mean psychosocial wellbeing scores across samples
175
176 
179
182
183
203
204
206
207
220
221
223
224
225
231
238LIST OF FIGURES
List of Figures  10
CHAPTER 1
Figure  1   Effects of optimistic engagement and pessimistic disengagement when  24
circumstances are easy or difficult.
Figure 2  The reserve capacity model by Gallo and Matthews (2005)  35
CHAPTER 5
Figure  1   Study design  88
Figure 2  Change in anxiety from before to after screening by quintile of  95
socioeconomic deprivation (Area-level)
Figure 3  Change in bowel cancer worry from before to after screening by quintile  95
of socioeconomic deprivation (Area-level).
Figure 4  Change in anxiety from before to after screening by socioeconomic  98
deprivation (Individual-level)
Figure 5  Change in bowel cancer worry from before to after screening by  98
socioeconomic deprivation (Individual-level)
Figure 6  The relationship between PCQ scores in relation to screening outcome  101
by quintile of socioeconomic deprivation
CHAPTER 6
Figure  1   The relationships between socio-economic deprivation, disease stage  123
and psychosocial outcomes
1A  Anxiety  123
1B  Family Social Support  123
1C  Depression  124
1D  Social Difficulties  124
1E  Quality of Life  125
1F  Medical Interactions  125
CHAPTER 8
Figure  1   Disease stage,  SES and Quality of Life: Social/Family  186
Figure 2  Hormone therapy,  SES and Quality of Life:  Physical  187
Figure 3A  Surgery, SES and Quality of Life: Emotional  187
Figure 3B  Surgery, SES and Quality of Life: Physical  188
Figure 3C  Surgery, SES and Quality of Life: Overall  188
CHAPTER 10
Figure  1  Change in anxiety by income  226
Figure 2  Change in medical interactions by subjective SES  226Chapter 1:  SES and responses to stress  11 
CHAPTER 1
Socio-economic status and psychosocial responses to stress
Socio-economic status (SES) has been a major issue in the public health 
arena for many years.  A strong relationship has been found between SES and 
health such that people with lower SES have consistently worse physical health 
outcomes than those with higher SES at every level of SES (Acheson  1998, 
Marmot & Wilkinson 2005, Marmot et al  1978).  The association between SES 
and health is graded in that there is an incremental rise in good health from the 
bottom of the social spectrum to the top (Marmot 2004).  The relationship is not 
restricted to physical health; people from lower SES backgrounds also 
experience poorer mental health than those from higher SES backgrounds 
(Adler et al  1999,  Lorant et al 2003, Matheson & Summerfield 2001,  Power et al 
2002).
The mechanisms proposed to explain these inequalities in health 
outcomes variously include material, cultural-behavioural,  psycho-social,  life 
course and political influences (see Table 1) (Bartley 2004).  The ‘material’ 
explanation suggests that differences in income affect purchasing power that 
determine, for example, quality of diet or housing, which  have direct effects on 
health.  People from different social backgrounds are also likely to share cultural 
norms that influence behaviours that in turn affect health.  The higher 
prevalence of smoking amongst lower socio-economic groups (Department of 
Health  1998) is often cited in support of the cultural-behavioural explanation of 
inequalities in  health.  The psycho-social model proposes that differences in the 
work and social environment between SES groups may result in different levels 
of exposures to stress and impact on psychosocial resources such as controlChapter 1:  SES and responses to stress  12 
and social support (Taylor & Seeman  1999).  These differences in  resources 
and exposure are thought to impact on bodily functions and subsequent 
physical and mental health.  The life-course approach also seeks to incorporate 
how inequalities in health arise throughout life;  how differences in childhood 
experiences and behaviour can predict adult trajectories in terms of occupation 
and social circumstances that lead to adult differences in morbidity and mortality 
(Kuh et al 2003).  Finally,  macro-social influences could also make a 
contribution to inequalities in health.  For example, the availability of public 
health services,  provision of good quality education to all social groups, and the 
standard and availability of public housing all have the potential to influence 
health outcomes.  All of these diverse explanations are either argued to be, or 
have been shown to be,  part of the process that causes inequalities in  health.
Table  1   Explanations for the relationship of social inequality to health from 
Bartley (2004)________________________________________________________
Explanation type
Material Cultural/
behavioural
Psycho-social Life course Political
economy
Influences  Individual Differences in Status, control, Events and Political
income beliefs, norms social support at processes processes
determines and values mean work or at home, starting before and
diet, housing that individual balance between birth and during distribution of
quality, members of less effort and reward childhood may power affect
polluted advantaged influence health influence both provision of
environment, social groups are through their physical health services,
dangerous less likely to drink impact on body and the ability quality of
work. alcohol functions. to maintain physical
moderately, health.  Health environment
abstain from and social and social
smoking and take circumstances relationships.
exercise in influence each
leisure time. other over time.Chapter 1:  SES and responses to stress  13 
The research in this thesis is concerned particularly with the 
psychosocial model and explores the effects of cancer-related stressors in 
relation to SES and psychosocial wellbeing using observational studies.  The 
subject of the thesis is the relationships between SES, exposure to stress and 
psychosocial outcomes.  To understand these relationships, this chapter will 
review the underlying processes and pathways involved  in stress, specifically 
resources and stressors.  The combination of higher stress exposures and 
poorer coping resources in lower SES groups have been proposed as a 
determinant of what is called ‘allostatic load’ (McEwen & Seeman  1999).  This 
concept alludes to the overall wear and tear on the body which itself further 
compromises the individual’s ability to cope with new stressors.
Transactional Model of Stress 
This thesis focuses on psychological and social responses to stress 
rather than physiological processes and outcomes.  Physiological models define 
stress in terms of a bodily response.  Whilst important for understanding the 
effects of stress on biological systems,  it largely ignores the function of different 
environments in provoking stress and any protective psychosocial factors that 
could contribute to individual differences in the stress response.  Conversely, 
early psychological approaches to the assessment of stress concentrated on 
assessing stressful stimuli rather than responses.  Within this approach, stress 
was measured using checklists of ‘stressors’ based around life events (e.g. 
divorce,  moving house,  illness, death of a relative).  An individual’s level of 
‘stress’ was defined in terms of the number and type of life events experienced. 
The most widely known of these checklists is the Social  Readjustment Rating 
Scale (Holmes & Rahe 1967) which lists 43 events, weighted for averageChapter 1:  SES and responses to stress  14 
stressfulness on a scale of 1   to  100.  The difficulties with this approach are that 
checklists can never be truly comprehensive, and different life events may have 
different meanings for different individuals, and consequently be experienced as 
more or less stressful.
Any psychosocial model of stress needs to take into account the fact that 
individuals react and adapt differently,  both physiologically and  psychologically, 
to the same potentially stressful experience.  The cognitive theory developed by 
Lazarus and  Folkman (1984) that has come to dominate the psychological 
literature on stress and coping,  is a transactional model that addresses this 
issue.  The theory defines stress in terms of a dynamic interaction between the 
person and the environment.  In order for a person to experience stress in any 
given situation they must first realise that there is something harmful or 
threatening occurring.  This process is termed ‘cognitive appraisal’: “The 
process of categorising an encounter, and its various facets, with respect to its 
significance for well-being” (Lazarus & Folkman  1984)(Chapter 2,  p.31). 
Cognitive appraisal is further divided into two types:  primary and secondary 
appraisal.  A primary appraisal of stress requires that the individual’s goals or 
assumptions are challenged in some way.  If the event is appraised as stressful, 
it is further understood to be an event of harm/loss (damage has already been 
sustained), threat (an anticipated harm or loss) or challenge (an adverse event 
that has opportunities for mastery or gain) (Lazarus  1999).  These three 
appraisals of harm, threat and challenge can co-occur in many situations.  For 
example,  in the case of a cancer diagnosis, some harm has already occurred, a 
person may perceive some further future threat in terms of progression or 
recurrence of the disease, and also feel challenged to control themselves or 
their own emotions within the difficult situation.Chapter 1:  SES and responses to stress  15
The type of appraisal that the person makes also depends on available 
resources.  Secondary appraisal is the cognitive-evaluative process of 
focussing on what can be done once a primary appraisal of threat,  harm or 
challenge is recognised.  It involves an evaluation of available resources and 
coping options.  Resources refer to a wide range of factors from demographic 
variables, such as age, gender and SES, through to personality traits such as 
optimism and mastery and other social factors such as social support.  There is 
some evidence that resources influence appraisal and choice of coping 
strategy.  The role of dispositional optimism particularly has been examined in a 
number of studies (Carver et al  1993, Schou et al 2004,  Stanton and Snider).
For example, Stanton and Snider (1993) studied a group of 147 women who 
had been referred for a breast biopsy.  After biopsy 36 patients received a 
cancer diagnosis.  Higher distress prior to receiving biopsy results was 
predicted by being younger and being less optimistic.  People with low 
dispositional optimism were also more likely to use cognitive avoidance as a 
coping strategy and this resulted in greater negative affect.  This finding 
illustrates the idea that personal resources, such as optimism, can have both a 
direct effect on distress as well as an indirect effect via choice of coping 
strategy as proposed by the stress/coping model.
Secondary appraisal is also an evaluation of what coping options are 
actually available and the likelihood that a given strategy will be successful in 
ameliorating the stress and that the strategy can be carried out effectively 
(Folkman & Greer 2000,  Lazarus & Folkman  1984).  Folkman and Greer (2000) 
define coping as: “The thoughts and behaviours a person  uses to regulate 
distress (emotion-focused coping), manage the problem causing distress 
(problem-focused coping) and maintain positive well-being (meaning-basedChapter 1:  SES and responses to stress  16 
coping)” (p. 12).  Within their model, coping is conceived as a process.  Other 
research has focussed on coping as a more stable personality style or trait 
(Burgess et al  1988, e.g. Ong et al 1999).  The trait approach tends to over­
simplify and does not give due reference to characteristics of the situation that 
may influence the choice of coping strategy.
The choice of coping strategy needs to be appropriate to the situation 
because there are no ‘good’ or ‘bad coping strategies per se.  However, during 
more stressful situations more or less collective patterns of coping may be 
observed, although there will still be some individual variability within this and 
different people may also have tendencies to use certain strategies over 
different times and places (Lazarus 1999).  Looking at the literature on coping 
strategies in people with a cancer diagnosis illustrates these points.  Studies in 
cancer patients variously find that the use of fighting spirit (Schnoll et al  1998), 
humour and acceptance (Carver et al  1993), seeking social support, focusing 
on the positive and distancing (Dunkel-Schetter et al  1992) are beneficial in 
terms of psychological wellbeing.  The use of denial, emotional venting or 
cognitive avoidance is related to increased distress (Carver et al  1993,  Deimling 
et al 2005,  Dunkel-Schetter et al  1992,  Hack & Degner 2004).  The studies do 
not always agree on which strategies are beneficial and which lead to 
heightened distress.  For example Carver et al (1993) report that acceptance 
predicts lower distress whereas Hack and  Degner (2004) report that acceptance 
is related to increased distress.  These disagreements may arise because of a 
lack of conceptual clarity concerning each coping strategy (e.g. acceptance as 
facing reality versus acceptance as resignation),  reflected in the many different 
measurement strategies used in coping research.  Additionally the differences 
between samples in terms of type of disease, disease stage, types of treatmentChapter 1:  SES and responses to stress  17 
and time since diagnosis add to the situational variability making direct 
comparisons less valid.  The lack of uniformity may therefore indirectly support 
the tenets of the Lazarus and  Folkman model (1984) which emphasises the 
situational nature of coping.  Because of the nature of coping it is not possible to 
say simply which coping strategies will be advantageous.
At the core of this transactional model is the idea of a balance between 
resources and demands.  A novel situation such as attending cancer screening, 
receiving a cancer diagnosis or undergoing treatment for cancer represents an 
increase in demands.  This could tip the balance so that demands outstrip 
resources, and stress is experienced.  An inadequate coping response could 
then result in negative emotional states (Lazarus  1999).  Coping strategies are 
initiated to change the stressful situation with further iterative appraisal and 
coping responses being carried out until the situation  is resolved.
One of the difficulties with the model is that both appraisals and coping 
are inherently difficult to assess.  Appraisals and  reappraisals are thought to 
occur continually.  As appraisal is conceived as part of a dynamic process,  it is 
hard to distinguish between the appraisal and the stress response.  Also, 
although the appraisal process may at times be fully conscious and deliberative, 
there is also the potential for appraisals to happen at a more subconscious level 
with appraisals happening rapidly within short periods of time (Lazarus 1999). 
These issues make accurate assessment of appraisals difficult to pin down.
The idea of ‘coping strategies’ is also very broad making them difficult to assess 
comprehensively.  Two examples of generic coping measures which are 
currently widely used are the Ways of Coping Checklist (Folkman & Lazarus 
1985) and the COPE (Carver et al  1989).  Both measure different specific 
strategies, which suggest that neither is inclusive in its measurement of coping.Chapter 1:  SES and responses to stress  18 
Another issue is that the model is exclusively within the psychological domain 
and does not include consideration of physical interactions.  However, the 
model clearly moves forward the idea of individual differences in the stress 
process and provides an appropriate framework for the studies in this thesis 
that explore socio-economic differences in psychosocial responses to stress 
using observational studies.
SES and Psychosocial Resources
The discussion of the stress/coping model highlighted the importance of 
psychosocial resources in adaptation to stress.  Although the research studies 
of this thesis focus on psychosocial outcomes such as depression and quality of 
life, psychosocial resources including perceived control, optimism and social 
support,  are also important in the stress-health pathway (Taylor & Seeman 
1999).  If lower SES groups have fewer resources to draw on during times of 
stress, this could result in a less effective coping response and  in turn, to poorer 
outcomes such as greater distress.  Below I  review the evidence that health and 
SES are related to perceived control, optimism and social support.  Other 
resources, for example, self-esteem or neuroticism,  may also be important in 
the relationship between SES and health, but they are not included in the 
research studies of this thesis.
Control
Personal control, also termed ‘mastery’,  has been defined as ‘the extent 
to which one regards one’s life-chances as being under one’s own control in 
contrast to being fatalistically ruled’ (Pearlin & Schooler 1978) (p 5).
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of illnesses and psychological outcomes.  For example, a greater sense of 
control is associated with a reduced risk of coronary heart disease (Marmot et al
1997), better recovery from heart and lung transplants (De Vito et al 2003) and 
better self-reported physical health status (Caputo 2003).  Reduced symptoms 
of depression and anxiety are also related to an increased perception of control 
(Griffin et al 2002).  Penninx et al (1998) explored the effect of personal control 
in chronically ill people (diabetes,  lung disease, cardiac disease, arthritis and 
cancer).  Perceptions of control were related to fewer symptoms of depression 
both in the chronically ill and in the healthy comparison subjects.  The effects for 
high control were stronger in the chronically ill participants, possibly indicating a 
buffer effect.  Increased control has also been shown to relate to decreased 
distress in cancer patients (e.g.Thompson et al  1993).
The mechanisms by which personal control influences physical and 
psychological outcomes are unclear.  Personal control may relate to the use of 
more effective coping strategies, such as decision-making, active planning for 
the future, and information-seeking, whereas low perceived control may lead to 
an  inability to take decisions or make changes resulting  in a feeling of 
helplessness and increased stress and distress.  However, this hypothesis is 
often an assumption within the literature rather than a proposition that has been 
tested extensively.  Hobfoll et al (1994) report an association between more 
prosocial, action coping strategies and a greater sense of mastery and between 
antisocial and passive strategies and lower mastery in a sample of students and 
community residents.  Active coping strategies also related to lower emotional 
distress in this sample.  Similarly Burgess et al (1988) studied control and 
coping styles in newly diagnosed breast cancer and lymphoma patients.  They 
found that people with the belief that they had control over the importantChapter 1:  SES and responses to stress  20 
outcomes in their lives used more positive and confronting coping styles and 
also reported less anxiety and depression than people with  low perceptions of 
control.
There is some evidence that perceived control can affect physiological 
reactivity, thus implying a route to physical health outcomes.  For example, 
Steptoe et al (2003a) examined elevations in plasma fibrinogen as one of the 
pathways through which low control at work could increase cardiovascular 
disease risk.  The study was conducted with 221  men and women drawn from 
the Whitehall II cohort.  Plasma fibrinogen was assessed at baseline, 
immediately after performance of acute stress tasks (colour-word and mirror 
tracing), and 45 minutes later.  Men experiencing low job control had greater 
fibrinogen  responses to acute stress than did those with  high job control.  This 
provided some evidence that low job control could  influence cardiovascular 
disease risk partly through provoking greater fibrinogen stress responses.
Conversely, there is also evidence from the literature on physiological 
reactivity to stressful conditions that suggests that the beneficial effects of high 
perceived control could be reversed in situations where there is an incongruity 
between perceptions of control and the opportunity to exert actual control.
Strong mastery beliefs may promote unrealistic expectations for control 
resulting in patterns of physiological arousal that promote the development of 
atherosclerosis.  For example,  Sieber et al (1992) studied changes in natural 
killer cell (NK) activity in men after exposure to controllable or uncontrollable 
stress (noise).  Men who perceived they had control over the noise showed no 
reduction in  NK activity.  On the other hand, the subjects who perceived that 
they had no control over the stressor did show reduced  NK activity immediately 
after the first 20-minute stress session and up to 72 hours later. The belief inChapter 1:  SES and responses to stress  21 
control enhanced the negative impact of stress on NK activity.  This suggests 
that people who use high control strategies in situations that are inherently 
unchangeable could  lead to adverse outcomes.  Other research has also 
revealed that there are occasions when actual behavioural control (as opposed 
to perceptions of control) can be disadvantageous.  Eitel et al (1995) report that 
patients with end stage renal disease who had control over their treatment (self­
administered treatment) had poorer psychosocial adjustment than those who 
had no control over their treatment (hospital administered treatment).  They 
suggest that,  in patients who are severely ill, the burden of control becomes too 
great.  Both of these studies highlight the possibility that there are occasions 
when the largely beneficial value of control beliefs can be negated.
In terms of the social distribution of personal control, there is clear 
evidence from the Whitehall II study that control at work makes a significant 
contribution to the socio-economic gradient in coronary heart disease incidence 
(Marmot et al  1997).  Those in lower occupational grades report lower job 
control in terms of decision authority and skill discretion and this lack of control 
has an impact on physical health.  Another important study by Lachman and 
Weaver (Lachman & Weaver 1998) examined social class differences in sense 
of control using a survey method in three national probability samples of men 
and women aged 25-75 years (N1  = 1,014;  N2 =  1,195;  N3 = 3,485).
Participants with lower income had lower perceived mastery, as well as poorer 
health.  Higher perceived mastery was related to better health, greater life 
satisfaction, and fewer depressive symptoms.  Hierarchical multiple regression 
analyses were used to explore interactions between control beliefs and income 
on health outcomes.  Importantly, control beliefs worked as a moderator in 
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mastery showed  levels of health and wellbeing comparable to the higher SES 
groups.  However, this was a cross-sectional study and so it was unclear 
whether health outcomes influence control and income rather than vice versa. 
There was also some evidence of social class bias in the responders to the 
survey, and lower income groups were under-represented  in the samples.
Another recent study by Pudrovska et al (2005) using a sample of 1,167 
older adults (65+ years) also suggests a moderating effect of mastery on the 
psychological effects of economic hardship.  The authors report an association 
between economic hardship in later life and increased levels of depression and 
anxiety in people who had  low levels of mastery.  In people with  high mastery 
there was no association between hardship and either depression or anxiety. 
Again this was a cross-sectional survey,  leaving questions of causality 
unanswered,  but these results lend further support to the findings of Lachman 
and Weaver (1998) and the possible role of perceptions of control in the 
association between SES and psychological wellbeing.
The evidence suggests that personal control could act as a coping 
resource in times of serious stress and may be an  important factor in how 
people from different social backgrounds adapt to novel stressors.
Optimism
Optimism has often been defined as a relatively stable personality trait 
under the term ‘dispositional optimism’.  This is a person’s general expectation 
that good outcomes will occur in most circumstances.  The most influential 
researchers in this field have been Charles Carver and Michael Scheier who 
developed the Life Orientation Test (LOT) (Scheier et al  1994)  as a measure of 
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the relationship between optimism and health (Carver et al  1993, Scheier et al 
1986, e.g.  Scheier et al  1999).  The factor structure of the LOT suggests that 
there could be two separate factors, one for positively worded items and one for 
negatively worded items (Scheier et al 1994), which have often been used to 
construct two subscales that are viewed as measuring optimism and pessimism 
respectively.
Optimism is related to engagement in health and social behaviours 
(Carver et al 2003,  Robbins et al  1991, Steptoe et al  1994).  Studies show that 
optimism is related to a wide range of health-promoting behaviours such as 
improved dietary practices,  low-alcohol consumption and non-smoking (Robbins 
et al  1991,  Steptoe et al  1994).  One study has reported that optimism in heart 
patients is associated with improved diet and increased levels of exercise within 
a cardiac rehabilitation programme (Shepperd et al  1996).  Carver et al (2003) 
have also explored disruption of social and  recreational activities in a 
longitudinal study of breast cancer patients.  They showed that pessimism 
related to increased social and recreational disruption up to a year after surgery 
for breast cancer.  This area of research seems to indicate that optimists are 
more likely to engage in activities to ameliorate the effects of ill health whereas 
pessimists are more likely to withdraw.
Research that has focussed on the impact of optimism on physical health 
report mixed  results.  Some studies report better physical outcomes for 
optimists such as decreased mortality in head and  neck cancer patients (Allison 
et al 2003) and higher natural killer cell cytotoxicity in  HIV+ women (Byrnes et al
1998).  Other studies report no association between physical health and 
optimism (e.g. Schofield et al 2004, Tomakowsky et al 2001).  Segerstrom’s 
review (2005) of the effect of optimism on immune response during exposure toChapter 1:  SES and responses to stress  24 
stressors concludes that optimism does have an effect on immune response, 
but that this effect is not always beneficial.  She argues that optimists always 
engage with a stressor, regardless of whether the stressor can be easily 
overcome or ameliorated.  Her research studies have examined the effects of 
optimism and pessimism on immune response (delayed-type hypersensitivity 
[DTH] skin testing with mumps and Candida antigens: larger DTH responses 
indicated stronger cellular immunity) in law students living away at college or at 
home (Segerstrom 2001).  The results have shown that in situations where a 
stressor can be engaged with and resolved, optimists have a beneficial immune 
response, whereas in the situation of an uncontrollable stressor, pessimists 
have the beneficial immune response because they disengage from the task. 
These relationships are illustrate in Figure 1. These results indicate that the 
engagement strategies of optimists may be detrimental, at least in the short­
term but the long-term effect of optimists’ engagement strategies have not been 
explored.  It is possible that the beneficial effect of pessimistic disengagement,.
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Figure 1   Effects of optimistic engagement and pessimistic disengagement when circumstances 
are easy or difficult.  Effects on immunity shown are drawn from effects on delayed-type 
hypersensitivity (DTH) induration in studies of first-year law students (Segerstrom 2005).Chapter 1:  SES and responses to stress  25
at least in terms of immune response, could be short-lived.  The complex 
relationship between optimism and  immune response possibly explains why 
associations between optimism and physical health outcomes are inconsistent 
The relationship between optimism and psychological adjustment is much more 
uniform.  Optimists appear to experience less distress during stressful events, 
even events as extreme as a cancer diagnosis (Carver et al  1993,  Epping- 
Jordan et al  1999, e.g. Schou et al 2004,  Stanton & Snider 1993).
This may be because optimists,  by definition, are those that expect and 
focus on positive outcomes, meaning that they are inherently more cheerful, but 
it has also been argued that optimists use different coping strategies to manage 
the stressful situation  (Carver et al  1993).  In particular,  optimists tend to use 
more problem-focused coping strategies and, when this is not appropriate (e.g. 
when the situation is appraised as uncontrollable), turn to emotional coping 
strategies, that are effective in the particular situation, such as acceptance and 
resignation (Scheier et al  1986).  Other studies also report that optimists use 
more acceptance and  less escapism (King et al  1998),  more fighting spirit and 
less helplessness (Schou et al 2005),  and more problem-focused and less 
emotion-focused strategies (Strutton & Lumpkin  1992).  In each case, the 
coping strategies used by optimists were related to more successful 
psychosocial outcomes.  The studies all use different settings:  recovery from 
coronary artery surgery (King et al  1998),  being diagnosed with breast cancer 
(Schou et al 2005) and the work environment (Strutton & Lumpkin  1992). 
Additionally, different measures of coping strategies, comprising various specific 
strategies, are often used across studies.  The assorted situations themselves 
may make different types of coping strategy more or less appropriate,  in termsChapter 1:  SES and responses to stress  26 
of their effectiveness, and the different measures of coping used  in each study 
make comparisons between studies difficult.  However,  it does appear that the 
use of particular coping strategies is one way in which optimism is related to 
better psychosocial wellbeing.
The relationship of optimism to SES has not been fully explored.  Taylor 
and Seeman (1999) report associations between SES and optimism,  using the 
LOT in four unpublished datasets (recovery from a hurricane,  recovery from 
coronary artery bypass and women at risk for HIV and the natural history of HIV 
in gay men) in their review of psychosocial resources and the SES-health 
relationship.  They used the LOT in the format of two subscales, one for 
optimism and one for pessimism. They describe that the relationship with SES 
is most prominent for pessimism rather than optimism:  higher SES people 
expected fewer negative outcomes than those with  lower SES,  but the 
relationship between the expectation of positive outcomes and SES was not as 
strong.  I have recently worked with colleagues on an analysis of data from two 
community samples of older adults in England (N =5,099) and Scotland (N = 
10,560) that found a strong gradient in optimism across SES groups (Robb et al 
2005) (Appendix I).  When negatively and positively worded  items were 
analyzed separately, the gradient remained significant in both cases, although 
the effect was slightly stronger for the negatively worded items.  Lower SES 
people seem to view the future as containing fewer positive and more negative 
events.  This evidence implies that optimism has a role to play in successful 
adaptation to stressful situations and its possible relationship to SES is worth 
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Social Support
Social resources are both objective states (e.g. social networks - 
counting a person’s number of social ties) and subjective experiences (e.g. self- 
reported perceptions of available emotional and instrumental social support 
from family and friends) (McNally & Newman  1999).  Studies that examine 
social support find stronger relationships with physical health and well-being 
outcomes for perceived support rather than  received support (e.g. Wethington & 
Kessler 1986).  Although social support may have direct effects on health by 
changing health behaviour (e.g. shared common behaviour between members 
of a social network) or by giving people confidence and perceptions of control 
over the environment (Stansfeld  1999), perceived social support also appears 
to act as a coping resource during times of stress.  For example, high levels of 
support are related to increases in quality of life and fewer symptoms of 
depression and anxiety in cancer patients (Alferi et al 2001,  Hann et al 2002, 
Parker et al 2003).  An important finding by Reynolds and  Perrin (Reynolds & 
Perrin 2004) is that the nature of giving and receiving social support needs to be 
appropriate to the situation.  They found in a sample of 79 breast-cancer 
patients that, where support was given, but was unwanted by the patient, it 
could lead to poor psychosocial adjustment.  High levels of social support may 
be particularly important for women and younger cancer patients in terms of 
their psychosocial adjustment (Hann et al 2002).
Another protective social resource, closely related to social support, is 
the ability to communicate within the family.  This may be of particular 
importance during times of stress.  For example, when an individual is 
diagnosed with cancer, family members may have their own fears and concerns 
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cancer patients may not want to discuss the problems they are experiencing 
because it will upset or worry their family.  If families are able to talk openly 
about the illness there are increased opportunities for information exchange and 
the provision of appropriate social support resulting in the patient’s better 
psychosocial wellbeing (Figueiredo et al 2004,  Mesters et al  1997).
Social support also appears to be graded by SES:  people from lower 
socio-economic backgrounds mobilise less social support during times of need 
(Mickelson & Kubzansky 2003, Taylor & Seeman  1999).  Turner and Marino’s 
(1994) study of 1,394 adults aged  18-55 years in Canada found an association 
between  higher occupational status and higher levels of perceived social 
support.  Regression models showed that a small,  but significant proportion 
(15%) of the variation in depressive symptoms by SES was explained by levels 
of social support.  A review of this area by Stansfeld concludes that there is 
stronger evidence for poorer social networks per se than for poorer quality of 
social relationships in low SES groups (Stansfeld  1999).
However, a more recent study by Mickelson and Kubzansky (2003) using 
data from the National Comorbidity Survey in the US (N=8,098), found that 
higher education and  income were related to more perceived emotional support 
and fewer negative social interactions.  They also reported that low SES groups 
experienced greater numbers of chronic and acute life events.  Life events 
mediated the relationship between social support and SES.  Mediation was 
assessed by looking at changes variance associated with SES when the life 
events variables were included in regression and structural equation models. 
They concluded that low SES groups were unable to mobilise support because 
they experienced multiple acute and chronic stressors that led to an erosion of 
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other individuals from the same socio-economic background.  These people are 
therefore experiencing their own chronic and acute stressors and cannot always 
provide extra help to others.  This is consistent with the idea that differential 
exposure to multiple stressors experienced by different SES groups can impact 
available psychosocial resources that are required to meet novel stressors 
(Gallo & Matthews 2003).  However, caution needs to be employed when 
assessing the conclusions of this study because a cross-sectional method was 
used, this meant that the causal directions of these relationships could  not be 
confirmed and arguably testing of mediational models in the absence of 
longitudinal data is somewhat limited (Cole & Maxwell 2003).
Summary
This brief review indicates that psychosocial resources are required to 
secure good physical and mental health but they may vary by SES.  The 
evidence is not always definitive and still lacking in some areas, particularly as 
regards research into the relationship between optimism and SES.  Further 
research still needs to be done to explore these relationships.
SES and Exposure to Chronic Stress
Chronic stress happens either when the stressor occurs repeatedly or 
continuously, or because the stressor is of a nature that cannot be overcome or 
adapted to (Baum et al  1999).  Differential exposure to chronic stress may come 
from work (Marmot et al  1997) or home (Feldman & Steptoe 2004) 
environments as well as through the differential occurrence of adverse life 
events (Mickelson & Kubzansky 2003, Stronks et al  1998).  These chronic 
stressors are also associated with a number of physical and psychological 
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Many background or ambient stressors are embedded into people’s 
living or working conditions.  There is greater over-crowding, crime and noise 
pollution in  lower SES areas (Ellaway & Macintyre  1998).  These are all socio- 
ecological stressors.  Feldman and Steptoe (2004) explored the distribution of 
various aspects of neighbourhood strains in  relation to SES and their effects on 
physical functioning  in a sample of 658 adults.  These included social cohesion 
and control,  neighbourhood problems (e.g.  litter,  noise) and neighbourhood 
vigilance (how much the individual felt that they had to be alert or defensive in 
their area).  Lower SES was related to increased experiences of neighbourhood 
strain and this strain was in turn associated with poorer physical functioning. 
Similarly there is now a large body of work from the Whitehall II study which has 
demonstrated that lower SES is associated with greater work stress (such as 
low control at work and high job demands) that relate to increased risk for 
physical health problems, such as cardiovascular disease (Marmot et al  1997) 
and psychological problems, such as depressive symptoms (Stansfeld et al 
2003).
Lower SES is also associated with experiencing a greater number of 
adverse life events, both acute and chronic e.g. divorce,  illness in the family, 
financial difficulties, being subjected to violence or crime and death of a loved 
one (Mickelson & Kubzansky 2003).  For example, Stronks et al (1998) report 
that lower educational achievement was related to higher exposure to stressors 
including life events (e.g. moving house, divorce, change in employment) on top 
of long-term difficulties (e.g. financial problems,  poor neighbourhood conditions) 
using a Dutch sample of adults (age 17-74,  N = 2,559).  This higher exposure to 
stressors was related to an increased risk of perceived health problems.  There 
was also a difference in perceived health problems by level of education, suchChapter 1:  SES and responses to stress  31 
that those with  less education reported more problems.  They estimated that 
between  10 and  15% of the difference in perceived health problems according 
to educational level was accounted for by the differential exposure to stressors. 
Logistic regression models using cross-sectional data were used to estimate 
this effect and so the causal direction of these associations could not be 
confirmed.
Another study by Turner et al (1995) also explored exposure to both 
chronic stressors and life events in relation to SES (indexed by occupation) and 
depression  in a sample of 1,393 adults aged  18 to 55 years.  Their results lend 
support to the findings of Stronks et al (1998).  Again, Turner et al (1995) report 
that lower SES is related to increased stress exposure and also increased 
depressive symptoms.  Differences in total stress exposure (chronic and life 
events) accounted for 38 per cent of the effect of occupational class on 
depressive symptoms.  Regression models indicated that chronic stress may 
play a stronger role in explaining SES differences in levels of depression 
compared to life events.
One proposed mechanism for how exposure to chronic stress can impact 
on physical health is ‘allostatic load’.  Allostasis refers to the ability of the body 
to maintain stability through change.  It denotes the ability to respond to stress 
by activating adaptive physical systems that lead to behavioural or 
psychological responses that ameliorate the threat.  These physical systems 
return to their resting states once the threat is dealt with.  Adaptive 
physiological responses to stress include increases in blood pressure to enable 
physical and mental exertion, and activation of adrenal steroids to encourage 
food intake or brain activity.  However, continual, or over activation, of these 
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or immunosuppression.  Inappropriate or over-activation of these systems is 
referred to as ‘allostatic load’.  McEwen and Seeman (1999) refer to four types 
of allostatic load:  i) ‘repeated hits’ where there is continual system activation 
because of exposure to multiple stressors;  ii) ‘lack of adaptation’ where there is 
a failure to habituate or adapt to a stressor and the individual does not return to 
‘normal’ or ‘resting’ functioning;  iii) ‘prolonged response’ where there is a slower 
than normal return to pre-stress functioning; and iv) ‘inadequate response’ 
where the stress system is not sufficiently activated  resulting in other 
maladaptive compensatory activity.  These four types of allostatic load 
demonstrate the different ways in which the physiological stress systems can 
become impaired over time.
Differences in biological reactions to stress that support the concept of 
‘allostatic load’ are found in a number of studies that also demonstrate how 
‘load’ is socially distributed by SES.  Work stress has been associated with 
higher ambulatory blood pressures and higher cortisol responses among people 
from lower SES backgrounds (Landsbergis et al 2003,  Pickering  1999,  Steptoe 
et al 2003b).  In the Whitehall II study people from the lower occupational 
grades had larger cortisol awakening responses than those in  higher 
occupational grades (Kunz-Ebrecht et al 2004), suggesting that low SES groups 
experience low level, sustained psychobiological activation.
SES and Psychosocial Response to New Stressors
If people from lower SES backgrounds are exposed to more chronic 
stressors, their relatively fewer psychosocial and material resources may be 
highly taxed on a day-to-day basis.  This could  lead to psychological 
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no reserve capacity to deal with a new threat.  One description of impaired 
ability to respond adequately to novel stressors has been put forward by Taylor 
and is referred to as ‘reactive responding’ (Taylor 1998).  She proposes that the 
lack of resources and exposure to chronic stress associated with lower SES will 
limit the development of effective self-regulatory strategies that are required to 
respond to novel stressors.  Instead,  lower SES groups develop a more limited 
set of psychological responses termed ‘reactive responding’; a concept 
characterized by a state of chronic vigilance, a lack of options, a lack of 
opportunity for learning and skill development, short-term goals and an 
emotionally charged response.  This concept has not yet been effectively tested 
in any systematic research but describes a possible mechanism by which lower 
SES groups may fail to respond adequately to novel stressors.
Another psychological model proposed by Gallo and Matthews (2003), 
which they refer to as the ‘reserve capacity framework’ is shown in Figure  1.2. 
They hypothesise that lower SES environments relate to greater exposure to 
stress which results in more negative and less positive emotion.  The greater 
stress exposure also leads to greater use, and consequently depletion of, 
psychosocial resources that are required to buffer the effects of novel stressors. 
This combination of exposure and resource depletion can result in an impaired 
psychological response to novel stressors including greater distress, as a direct 
result of inadequate resources, but also greater emotional reactivity i.e. an 
inappropriate or over-emotionally charged response to novel threats.  They go 
further in suggesting that this poor psychological response can  influence 
behavioural and physiological factors that result in poor physical health.
A recent test of this model used ecological momentary assessment 
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women to explore the associations between stress,  resources and affect (Gallo 
et al 2005).  Lower SES participants experienced more exposure to stress over 
the two days.  Low SES was also associated with less positive affect, although 
there were no differences between the SES groups in  levels of negative affect. 
This was surprising given that the majority of research findings indicate an 
association between SES and psychological distress.  Regardless of this issue, 
the analyses,  using hierarchical linear modeling, did show that exposure to 
stress contributed to the association between SES and positive affect.
Lower SES participants also reported fewer psychosocial resources (e.g. 
mastery, optimism, self-esteem) that were measured using validated 
questionnaires.  Deficits in these resources predicted  increased stress 
experiences and poorer psychological well-being.  These results support the 
idea that low SES is associated with increased stress exposure and depleted 
psychosocial resources which can lead to poorer psychological well-being.
The tests of emotional vulnerability were inconclusive and contrary to 
expectations.  Women with lower SES, despite reporting lower positive affect 
overall,  reported disproportionate increases in positive affect in  response to 
stimulating or positive experiences over the two-day period.  The authors 
suggest that this may reflect the rarity of positive events.  There were no 
differences in negative affect responses to any types of event or in emotional 
responses (positive or negative) to stressful experiences.  A limitation of this 
study was that the women were a self-selected group who responded to flyers, 
adverts or e-mail requests.  The sample size was small (N =  108) altogether, 
but the recruitment method also resulted in a SES bias in participants resulting 
in a particularly small low SES group (N = 18/108).  This obviously affected the 
ability to carry out rigorous statistical tests.Figure 2 The reserve capacity model by Gallo and Matthews (2005)
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Another larger (N =  1,031) study that examined daily stressors reports 
some conflicting findings.  Grzywacz et al (2004) explored differential 
exposures and vulnerability to stress in relation to SES using data from a 
subsample of participants within the nationally representative Survey of Midlife 
Development in the United States.  Participants (aged 25-74) were 
interviewed on the telephone on eight consecutive evenings.  Unlike the Gallo 
et al (2005) study where lower SES (indexed by education) was associated 
with  increased exposure to stress,  in this sample higher SES participants 
reported more exposure to stressors, but lower SES participants reported 
greater severity of stressors.  Grzywacz et al also report that low SES was 
associated with increased negative affect (positive affect was not assessed) 
that was not found in the study by Gallo et al.  This suggests that the findings 
of Gallo et al in  relation to negative affect may have been anomalous.  In 
terms of vulnerability to stressors, hierarchical linear modeling showed that 
nearly half of the educational differences in negative affect could be attributed 
to increased vulnerability amongst the least educated i.e. people with less 
than a high school degree were more reactive to stressors.  This apparently 
strong association was not found for negative affect in the Gallo et al study. 
Similarly Turner et al’s (Turner et al  1995) study of exposure to chronic stress, 
as opposed to daily stressors, discussed earlier,  looked at interactions 
between SES and stress exposure and found no support for the vulnerability 
hypothesis.  These studies produce somewhat conflicting and contradictory 
results suggesting that further research in the area of SES differences in 
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In summary,  it is not clear whether greater exposure to adversity is 
sufficient explanation for the higher rates of ill health in lower SES groups, or 
whether differential reactions to comparable levels of adversity,  as a 
consequence of limited psychosocial resources for dealing with them,  make a 
contribution.  One way of investigating this issue is to assess emotional and 
physical responses in different SES groups to the same potentially stressful 
situation.
Relatively few studies have explored the hypothesis that SES 
differentially affects psychological reactions to novel stressors.  The 
exceptions to this are a number of studies of severe trauma.  Lower SES 
appears to be a risk factor for developing post-traumatic stress disorder 
(PTSD) (Brewin et al  1999), with evidence coming from responses to a variety 
of traumatic situations including assault (Acierno et al  1999), air disaster 
(Epstein et al  1998) and treatment for breast cancer (Cordova et al 1995). 
Symptoms of PTSD include re-experiencing of the traumatic event (e.g. 
recurrent thoughts or images), avoidance of stimuli associated with the 
trauma, numbing of general responsiveness, a sense of a foreshortened 
future, and symptoms of increased arousal (e.g.  irritability or outbursts of 
anger, difficulty concentrating).  These symptoms cause significant amounts of 
psychological distress and often impair social or occupational functioning. 
Epstein et al (Epstein et al 1998) prospectively studied the development of 
PTSD in 355 health workers who aided victims involved in an air disaster (with 
assessments at 6,  12 and  18 months post-disaster).  People who developed 
PTSD had less education (below university degree), were exposed to more 
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the disaster.  This suggests that the resources, characteristics of the actual 
situation (i.e. differential exposure to burn victims) and chronic stress all 
contributed to the development of PTSD in this sample.
Other studies are needed to replicate these results and explore how 
SES interacts with characteristics of novel stressful situations to influence 
psychological outcomes.  Future research could also examine a wider range 
of stressors, from less to more severe, and more diverse psychological 
processes and outcomes.  Psychological reactions to serious physical 
illnesses, such as cancer, could provide a useful framework to explore this 
topic because all new patients will experience similar threats to their 
psychological wellbeing.  Inequalities in health and  health-care remain an 
important public-health issue,  but the way in which SES impacts psychological 
responses to medical encounters has not yet been fully researched.  The aim 
of this thesis is to explore the relationships between SES, cancer-related 
stressors and psychological wellbeing.  The next chapter will describe the 
range of cancer-related stressors and their impact on psychosocial wellbeing.Chapter 2:  Cancer-related stressors  39 
CHAPTER 2
Cancer-related stressors and Psychosocial Outcomes
Cancer-related Stressors 
There are a number of events on the pathway to a cancer diagnosis 
which have the potential to challenge individuals.  These range from the milder 
stress of going for cancer screening through the greater challenge of other 
diagnostic tests, to the trauma of a cancer diagnosis, treatment and long-term 
survival.
Cancer screening
Screening programmes have been examined in detail in terms of 
evaluating the psychological impact of attending for diagnostic tests because of 
concerns that any psychological harm should be factored  into assessments of 
costs and benefits of the national screening programmes.  Cancer screening is 
potentially stressful due to the possible detection of a grave disease and 
because the screening tests are often uncomfortable (Wardle et al 2005,
Wardle & Pope 1992).  Increased psychological distress is related to a number 
of screening outcomes such as receiving an abnormal result that indicates a 
cancerous or pre-cancerous condition (McCaffery et al 2004,  Steggles et al 
1998, Wardle et al  1995),  receiving false-positive results (Barton et al 2004), or 
having to re-attend for tests where inadequate procedures were used at the 
original screening (French et al 2004).  Distress is also associated with 
uncertainty during the time period that people wait between receiving abnormal 
results and appointments for further investigations and treatment (Essink-Bot et 
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of distress and anxiety among those receiving abnormal results decreases 
within a relatively short period of time, although some longer-term adverse 
consequences have been identified among women recalled for further 
investigations after mammography screening (Brett et al  1998, Olsson et al 
1999).
The usual assumption is that the screening experience causes distress in 
those with abnormal or inconclusive results, but some suggest that the 
differential levels of distress seen in people with abnormal outcomes is due to 
relief experienced in those with normal results rather than increased distress in 
those with abnormal results (Cantor et al 2002,  Essink-Bot et al  1998).  Scaf- 
Klomp et al (1997) compared women who had false-positive mammogram 
results with women who had a negative screening result and an unscreened 
reference group.  They found that although women who received a false- 
positive result showed greater psychological dysfunction 8-10 weeks post­
screening compared to women with negative mammograms, the levels of 
dysfunction reported did not differ from the unscreened group.  Women with 
normal mammograms showed the lowest psychological dysfunction scores both 
8-10 weeks and 6 months post-screening. The majority of women who had 
received a false-positive result reported experiencing it as a stressful event, but 
it appears that the event is not so stressful as to heighten their psychological 
dysfunction.  This gives some support to the idea that differences in 
psychological functioning are as likely due to feelings of relief in the negative 
group than to raised anxiety and distress in the false positive group.  Other 
studies have found similar results.  For example,  a large scale trial of prostate 
cancer screening measured anxiety three weeks before screening,  in the 
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they received a negative result compared to when they were waiting for the test. 
In the men requiring biopsies, scores were also taken during the two week wait 
for the result and  1   week after receiving a negative outcome.  These men were 
the most anxious whilst they were waiting for their results compared to their 
scores one week after receiving the negative biopsy (Essink-Bot et al  1998). 
Similar work looking at referral for colonoscopy following a positive FOBT found 
that anxiety was highest after notification of a positive FOBT and before 
investigation by colonoscopy.  In participants who had a negative colonoscopy 
(i.e. an original false-positive result) anxiety scores fell the day after 
colonoscopy and remained low 1   month later (Parker et al 2002).  Negative 
results may lead to short-term decreases in distress making it appear that 
abnormal results increase distress and the false conclusion that screening is 
stressful.
The impact of the threat from screening, either in terms of increased 
distress or relief, could differ depending on individual characteristics and 
resources, but there is little research in this area.  The majority of screening 
studies have focused on cervical or breast cancer screening as these are the 
most well established programmes.  This has meant that there is only a small 
amount of data on men’s reactions to screening and very few studies that are 
able to compare male and female reactions.  Low SES individuals are known to 
be less likely to attend for screening (McCaffery et al 2002).  However, there is 
no research which explores how SES may affect psychological reactions to the 
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Cancer diagnosis
The psychological impact of receiving a cancer diagnosis depends on a 
number of factors including disease characteristics (site of the disease, severity 
of the disease), communication about the disease, and the individual’s situation 
and coping styles.  The British government’s commitment, as set out in the 
Cancer Plan (Department of Health 2000), to cut the time from receiving a 
diagnosis to receiving treatment to only 1   month,  has meant that cancer 
patients must quickly comprehend information about their illness and then 
experience radical treatment over a relatively short period of time.  Patients 
have more psychological difficulties around the time of diagnosis than later in 
the course of their illness (Burgess et al 2005,  Norton et al 2004, Schroevers et 
al 2003, Steginga et al 2004).  Being diagnosed with cancer affects multiple 
psychosocial outcomes in addition to psychological distress.  Cancer can have 
an impact on relationships with family and friends (Northouse et al 2000) and 
consequently on the levels of social support the person receives during their 
illness (Reynolds & Perrin 2004).  New relationships with medical staff have to 
be formed and the quality of these relationships is likely to be a significant factor 
in coping with the disease (Ong et al 2000).  Cancer and its treatments can also 
impose a range of physical and functional disabilities which will increase the 
number of social problems encountered, from the ability to work with ensuing 
financial difficulties, to problems maintaining independence and the ability to 
care for oneself (Wright et al 2002).
Disease site
Cancer patients are not, of course, a homogeneous group in terms of the 
cancers they have and so for this reason alone there are likely to be differences 
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5000 cancer patients, of whom 58% had received a diagnosis within the last 90 
days.  The highest prevalence of distress was found  in lung cancer patients, 
where 43.4% of the sample showed high levels of distress.  Patients with brain, 
liver,  pancreatic and head and neck cancer experienced similarly high levels of 
distress.  Significantly lower levels of distress were experienced  in patients with 
gynaecological, breast, colon and prostate cancers. This may be because of the 
better prognosis for these cancer sites.  For example, the five-year survival rate 
for breast cancer in the 1996 to  1999 period was 77% compared to only 3% for 
women with pancreatic cancer or 12% for men with  brain cancer over the same 
period (Cancer Research  UK Cancer Statistics 2005).  Other studies report 
similar findings, for example, Stommel et al (2004) found higher levels of 
depression in  lung cancer patients compared to breast,  colon or prostate 
patients in their sample of 860 older (65 years+) patients.
There may also be site-specific psychological issues.  Female cancers, 
such as breast cancer, may raise issues related to body image, sexuality and 
feminity (Kunkel & Chen 2003).  Similar issues surrounding masculinity may 
face men who present with testicular or prostate cancer as they confront 
possible fertility and sexual function limitations (Gurevich et al 2004, Moore & 
Estey 1999).  Other cancers, such as bowel cancer, can be sources of 
embarrassment because of the detailed discussions of bodily functions, 
invasive testing procedures and possible long-term loss of bowel control 
(Rozmovits & Ziebland 2004).
In terms of the relationships between socio-economic status and cancer 
incidence and mortality, these also differ by disease site.  Cancers of the lung, 
cervix and larynx show a strong positive gradient in both incidence and 
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mortality.  For lung cancer, the relationship is such that the lowest SES groups 
have a rate of incidence and mortality at around twice those of the highest SES. 
For other cancer sites, such as the colon,  rectum,  myeloma and uterus there is 
practically no relationship between SES and either incidence or mortality 
(Coleman et al  1999, Quinn et al 2001).  Cancers of the brain,  breast, and 
prostate, show a slight gradient in incidence, such that the highest SES groups 
have higher incidence, yet there is no gradient in mortality.  This is because the 
highest SES groups have better survival rates (Coleman et al  1999).  The 
causal explanation for the relationship between SES and cancer will include 
both site specific causal factors (such as the relationship between smoking in 
low SES groups and  lung cancer) as well as more general factors across sites.
The research studies in this thesis focus on breast,  prostate and 
colorectal cancer patients.  These patients are likely to experience overall lower 
levels of distress than some of the other cancer sites, as discussed.  These 
sites were chosen because they are all relatively common cancers that are both 
mixed-gender and gender specific.  Additionally the relationship between SES 
and incidence in these sites is either non-existent or slightly negative (i.e.  higher 
incidence in higher SES) meaning that any SES vulnerabilities in psychosocial 
adjustment will not be confounded by a greater overall cancer burden amongst 
the lower SES groups.
Disease stage
Disease stage at diagnosis is one factor that may affect psychological 
adjustment.  Being diagnosed with more advanced disease implies a poorer 
prognosis that could be expected to pose a greater threat to psychological well­
being.  A number of studies show that more advanced disease is associated 
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2003,  Shimozuma et al 1999)) although other studies find little or no relationship 
between stage and psychological outcomes (Bleiker et al 2000,  Kissane et al
2004,  Norum  1997).  One problem with these latter studies was either not 
including patients in the most advanced disease stage (e.g.  (Bleiker et al 2000)) 
or making a comparison between early and advanced stage patients in widely 
different time frames since diagnosis (e.g.  (Kissane et al 2004)).  The majority 
of studies examining disease stage and psychological outcomes are with breast 
cancer patients and the findings may not be applicable to other types of cancer 
where disease stages may have subtly different meanings.  There are few 
studies that examine this issue in colorectal cancer patients.  One study did not 
find any difference between patients with  Dukes B and  Dukes C diagnoses in 
terms of psychological distress (Norum  1997).  However, this study had a small 
sample size (n = 64) and did not distinguish between C1  and C2 diagnoses. 
There is a need to explore this issue further.  These varied responses may also 
reflect the fact that patients are often poor at understanding the precise 
implication of their diagnosis (Chow et al 2001, Gattellari et al  1999, Quirt et al 
1997, Weeks etal  1998).
Cancer treatment
Due to the nature of the treatments that are commonly available for 
cancer (e.g. surgery, chemotherapy, radiotherapy and hormone therapy), 
patients often find that treatment has a major impact on their everyday lifestyle, 
self-perception,  physical abilities and psychological well-being.  For 
asymptomatic patients, being treated for cancer may be the first time that they 
feel physically ill and are confronted directly by problems associated with having 
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processes and the majority of patients also express a desire to do so (Bruera et 
al 2002) but this can be a difficult experience involving collating and 
understanding complex information and feeling responsible for making the right 
choices.
Some cancer treatments are also associated with  increased  levels of 
depression.  Immunotherapeutic agents, such as interferon-alpha and 
interleukin,  used to treat some cancers (e.g. kidney,  melanoma), induce 
depressed mood as a direct side-effect (Capuron et al 2001, Musselman et al 
2001,  Paterson et al 2005). Other more extreme treatments such as bone- 
marrow or stem-cell transplants appear to result in higher levels of distress than 
cancers with other treatment modalities indirectly because of the more severe 
trauma to the body and isolation of the patient (Holzner et al 2004,  lllescas-Rico 
et al 2002,  Neitzert et al  1998).
More widespread treatments such as chemotherapy,  radiotherapy or 
surgery commonly cause symptoms of illness including fatigue,  pain and 
sickness. These symptoms experienced at chronic levels are debilitating and 
are connected to psychological distress (Bennett et al 2004,  Hopwood & 
Stephens 2000,  Portenoy et al 1994, Stommel et al 2004). The studies cited 
here find that different treatments can increase levels of distress.  Patients 
currently undergoing treatment may differ in terms of distress compared to 
those who have completed or who are still awaiting treatment.  After surgery, 
patients can be severely physically debilitated and experience a range of side- 
effects or novel complications such as lymphodema, impaired sexual 
functioning and incontinence, or having a colostomy, as well as psychosocial 
problems such as body image, family functioning and adjusting to new social 
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such as nausea and loss of hair that can produce similar psychosocial problems 
(Carelle et al 2002).  Apart from these obvious side-effects chemotherapy is 
also associated with  longer term cognitive dysfunction (Ahles & Saykin 2002). 
Radiotherapy is another long term treatment requiring considerable time 
commitment and also causing a number of side effects (e.g. chronic fatigue) 
which can have an impact on a person’s ability to function at levels equivalent to 
pre-treatment (Tavio et al 2002).  Chemotherapy and radiotherapy both prolong 
the length of time patients feel physically ill and also consequently prolong the 
length of disruptions to their normal life.
Hormone therapy is often used in the treatment of endocrine sensitive 
cancers including many cancers of the breast and prostate.  Up to 70% of all 
breast cancers are hormone-sensitive and there are a number of hormonal 
therapies for both pre- and post-menopausal women with early or advanced 
disease.  Hormonal treatments can have adverse side-effects such as vaginal 
dryness and hot flushes.  But there is some evidence to suggest that patients 
prefer hormonal treatments over chemotherapy when there is a choice to be 
made (Fallowfield et al 2004).  Women cite the avoidance of hair-loss, the 
convenience of the treatment (i.e.  less disruption to everyday life) and an overall 
perception of fewer side-effects as the reasons for preference of hormonal 
therapy (Fallowfield et al 2004).  This illustrates the value placed on quality of 
life during treatment.
There are also other studies which conclude that type of treatment, or 
other disease-related variables are not associated with distress (e.g.  Burgess et 
al 2005,  Norum  1997, Stommel et al 2004)).  Burgess et al’s (Burgess et al 
2005) study of depression and anxiety in 222 women with breast cancer 
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lack of social support, are more important risk factors for depression than 
cancer-related variables.  These variables are risk-factors for depression  in 
general population samples.
Although there is little research that has examined the impact of SES in 
relation to different treatments, one recent cross-sectional study using a sample 
of breast cancer patients (N = 1,357) (Janz et al 2005) does report on the 
interaction between education and treatment modalities.  Receiving 
chemotherapy was associated with lower quality of life for all patients,  but had a 
disproportionately worse impact on women with lower levels of education.  The 
study shows that the impact of treatments may vary depending on patients’ 
socio-economic backgrounds.  Clearly these results not to be confirmed in 
further studies, and it would also be useful to explore if this type of effect could 
also occur when comparing those with different prognoses, disease sites or 
time since diagnosis.
Cancer and co-morbidity
Cancer incidence increases with age and consequently many people will 
be already be diagnosed with co-morbid conditions prior to their cancer 
diagnosis.  As might be expected, the presence of a co-morbid illness in 
addition to a cancer diagnosis can have long-term adverse effects in terms of 
health status and disability that are not experienced by cancer patients without 
co-morbid problems (Hewitt et al 2003).  Research  in this area is surprisingly 
sparse but some studies do report that co-morbidity in cancer patients can 
predict increased depressive symptoms (Kurtz et al 2002) and poorer quality of 
life (Sarna et al 2005).  Kurtz et al (2002) studied  158 older (65+ years) 
colorectal cancer patients.  60% of the sample had two or more co-morbidChapter 2:  Cancer-related stressors  49 
conditions,  indicating that this is a widespread problem.  Patients with co-morbid 
illness reported more depressive symptoms across four waves of assessment. 
This suggests that co-morbidity may be an important factor in understanding 
psychosocial adjustment in cancer patients.
One study that examined co-morbidity in relation to SES in a mixed- 
sample of cancer patients (breast,  lung, colorectal,  prostate, stomach) found an 
association between  lower SES and increased co-morbidity,  particularly for 
heart or vascular disease (Schrijvers et al  1997).  This is perhaps unsurprising 
given the higher rates of ill health amongst lower SES groups in general.  The 
authors of this study suggested that some of the SES differences in the survival 
of cancer patients may be due to the presence of co-morbid  illness but did  not 
examine this hypothesis systematically.  As there appears to be a relationship 
between co-morbidity and wellbeing, the increased  levels of co-morbidity 
amongst low SES groups could also impact on psychosocial adjustment.
Cancer and survivorship
The term ‘cancer survivor’ has multiple meanings (Twombly 2004).  Here 
the term refers to people who are cured of their disease or in remission and are 
no longer undergoing any treatment.  The increase in  incidence and survival 
from cancer, together with an overall aging population and an increase in 
population size, means that the term ‘cancer survivor’ applies to an increasing 
number of people.  A number of issues related to having had cancer continue to 
affect ‘survivors’ despite their disease free status.  Having had cancer can 
cause an increase in  long-term health limitations compared to people who have 
never had cancer for more than a decade (Yabroff et al 2004).  Long-term side 
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menopause in breast cancer patients (Ernst et al 2002,  Hoda et al 2003) and 
loss of fertility in testicular cancer patients (Huyghe et al 2004).  Cancer 
survivors often continue to express anxiety related to disease recurrence 
(Mehta et al 2003, Thomas et al 1997b).  Survivors frequently continue to attend 
outpatient clinics many years after the doctor has recommended discharge, in 
order to receive reassurance about their disease free status (Thomas et al 
1997a).  Having had a cancer diagnosis can seriously affect a person’s social 
identity and role through loss of employment or change in status within the 
family (Zebrack 2000).  Receiving a cancer diagnosis can  represent a key social 
transition or change in a person’s expected life trajectory leading to a process of 
long-term reorganisation and a search for meaning in the illness experience 
(Utley 1999).  Appraisals of the meaning of the cancer experience can change 
over time and may not be evident until a long time after treatment is completed. 
Cancer is often appraised as an extremely stressful experience during the 
diagnosis and treatment phase.  This appraisal may change to either an 
irrelevant or neutral experience in the years after treatment has been completed 
(Bowman et al 2003).  Alternatively, many survivors come to appraise their 
experience as one that is positively trained e.g.  in terms of an opportunity for 
personal growth (Manne et al 2004).
Cancer and Psychological Outcomes1  
Thus far, this chapter has focussed on describing situational factors 
related to cancer that could effect psychosocial wellbeing.  The next section will 
explore in more detail the psychosocial outcomes associated with having
' A version of this was published in  D e p re s s io n   a n d  P h y s ic a l Illn e s s Steptoe, A (ed), Cambridge 
University Press,  a copy of the chapter is included in Appendix II.Chapter 2:  Cancer-related stressors  51 
received a cancer diagnosis that are explored within the research studies of this 
thesis.
The importance of psychosocial care for cancer patients rises in 
prominence as the number of people surviving cancer increases. Coleman et al 
(1999) report the overall 5-year survival rate for all cancer cases during the 
1986-1990 period as 31% in men and 43% in women.  This represents a 
dramatic increase in survival compared to the rates for the  1971-1975 which 
were  19% in men and 31% in women.  This increase in survival is due to 
detection of cancer at an early stage leading to improved prognoses (Stockton 
et al 1997).  There have also been improvements in the effectiveness of the 
treatments for cancer (McArdle & Hole 2002).  As a result of this lengthened life 
expectancy, greater attention is now being paid to quality of life and 
psychosocial care for cancer patients.  In the short term, psychosocial care 
means ensuring that patients maintain a decent quality of life during the 
diagnostic and treatment phase.  In the longer term, the aims are to ensure that 
any lasting psychological problems are prevented so that the cancer patient can 
rehabilitate and return to 'normal' life.
The word ‘cancer’ is linked with fears about illness, dying and death in 
many people’s minds.  McMenamin et al (2005) assessed knowledge and 
awareness of breast cancer in a large general population survey (N = 2,355) 
and found that 66% of women overestimate their risk of developing breast 
cancer and 56% underestimated 5-year survival rates.  Women believe that 
they are more likely to get cancer and that they will die from it than  is actually 
the case.  Other types of cancer also inspire this fearful response, for example, 
70% of people taking part in a survey of attitudes to bowel cancer screening 
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Not surprisingly, a diagnosis of cancer can lead to raised levels of psychological 
distress.
Prevalence of depression and anxiety
Estimates vary as to the number of people with cancer who will develop 
symptoms of anxiety (2%-25%) (Stark & House 2000) or depression (20%-50%) 
(Bottomley 1998, McDaniel et al 1995), depending on the definition of cases 
and the types of measurement used.  Taking the prevalence of depression as 
an example,  Massie’s (2004) review of papers published up to 2002 cites a 
range of 0-38% for major depression and 0-58% for depression spectrum 
disorders (including more mild and moderate symptom reporting of depression. 
In studies published since 2002 this variability is still common.  At the lower end, 
one study of a breast cancer waiting-room sample found that 29% of patients 
were in the distressed range.  Follow-up interviews found that approximately 9% 
met criteria for major depression, 7% met criteria for minor depression, and 6% 
met criteria for generalised anxiety disorder (Coyne et al 2004).  This is 
consistent with other recent estimates (Harter et al 2001,  Kissane et al  1998, 
Sharpe et al 2004).  At the higher end,  Burgess et al (2005) reported that 48% 
of breast cancer patients experienced “clinically significant” depression or 
anxiety in the first year after diagnosis.  However, this figure grouped individuals 
meeting full diagnostic criteria for major depressive disorder and generalized 
anxiety disorders with “borderline” cases of depression and anxiety.  Burgess 
and colleagues note that a year after diagnosis, the prevalence of “clinically 
significant” depression and anxiety was only 15%, and thereafter the risk of 
anxiety and depression was no greater than in the general population, 
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limiting and not an enduring clinical disorder.
There are a number of factors which contribute to the wide variation in 
reporting of depression and anxiety in cancer patients.  Levels of anxiety and 
depression are likely to vary according to the length of time that has elapsed 
since diagnosis (Burgess et al 2005).  Higher estimates may also reflect use of 
symptom reporting recorded with the use of self-report questionnaires rather 
than diagnostic interviews (Hotopf et al 2002).  Higher frequencies may also be 
seen in in-patients who have more severe symptoms or advanced stages of 
disease (Lynch  1995).
Given that there is little agreement over the prevalence of depression 
and anxiety in cancer patients,  it is hard to compare prevalence rates with those 
of the general population or other medical patient groups.  In  UK older adults 
(60-74) (the group most likely to experience a cancer diagnosis) the 1-month 
prevalence is 7% for mixed anxiety and depressive disorder,  3% for general 
anxiety disorder and  1% for depressive episodes (Evans O et al 2003).  Using a 
broader definition of depression and a wider age range,  10% of all adults (16- 
74) in the UK experience important symptoms of depression  (also  1-month) 
(Singleton  N et al 2001).  In the US,  Kessler et al (Kessler et al 2003) find  16.6% 
lifetime prevalence of depression and 6.6%  12-month prevalence.  Some 
studies of the prevalence of depression and anxiety in cancer patient samples 
report comparable or lower levels to these, suggesting that there are no excess 
distress disorders in these patients.  This idea was systematically assessed  in a 
meta-analysis of 58 studies comparing levels of anxiety and depression in 
cancer patients to the general population.  This showed that levels of 
depression were higher in cancer patients than in the general population but 
levels of anxiety and general psychological distress were not (van't Spijker et alChapter 2:  Cancer-related stressors  54 
1997).  Other reviews also conclude that depression  is more common in cancer 
patients than among the general population (Hotopf et al 2002,  Pirl 2004,
Raison & Miller 2003).
Another useful comparison to place cancer patients in context is in 
relation to levels of depression and anxiety in other patient groups.  Rates in 
patients with  neurological disorders appear to be more consistently higher (30- 
50%) than in those with cancer or other medical illnesses (Massie 2004).
Results from a recent longitudinal study of depressive symptoms in a sample of 
8387 adults (aged 51  to 61  years) report that cancer patients have more 
depressive symptoms than those with hypertension, arthritis,  heart disease, 
diabetes or stroke in the first two years after diagnosis.  Levels of depressive 
symptoms in cancer patients were comparable to levels found in those with 
chronic lung disease (Polsky et al 2005).  However, estimates of the prevalence 
of major depressive disorder among cancer patients,  based on semi-structured 
diagnostic interviews with representative samples, overlap with the 5% to 13% 
range found  in primary care patients (Barrett et al  1988,  Coyne 1994,  Katon 
1987,  Kessler et al  1985, Schulberg et al  1987).  The best estimates of the 
prevalence of depression and anxiety in cancer patients suggest that the 
disorder is more common than in the general population,  but perhaps only as 
common as, or little more common than, general medical patients,  including 
primary care patients.
Measurement issues
Research studies involving cancer patients continues to use a wide 
range of self-report measures from a simple distress thermometer (Jacobsen et 
al, 2005) to the full range of longer standardized measures developed  in other 
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(CES-D;  Radloff,  1977) and Brief Symptom Inventory (Derogatis & Melisaratos, 
1983).  Concerns that self-reported distress among cancer patients is 
confounded with cancer symptoms (such as fatigue,  loss of appetite and 
cognitive impairment) have also led to interest in developing measures that are 
cleansed of somatic complaints. The most notable self-report instrument in this 
category is the widely used Hospital Anxiety and  Depression Scale (HADS) 
(Zigmond & Snaith  1983).  The HADS excludes insomnia, anergia and fatigue, 
as well as symptoms of more severe psychiatric disorder.
Self-report measures are valid as general measures of distress, as 
measures of severity of depression or anxiety among patients who have a 
clinical diagnosis of depression or anxiety, or as a first stage screening of 
patients for follow up with a diagnostic interview to determine if they are actually 
depressed.  In research studies, self-report measures are often  used to 
compare groups who have more or less distress rather than identifying 
psychiatric ‘cases’.  This avoids the problem of using cut-off scores on self- 
report measures that must always strike a balance between sensitivity and 
specificity.  I will be using self-report measures of distress to compare 
differences between groups and not for the purpose of identifying ‘cases’.
Quality of life
A cancer diagnosis also has the potential to impact on psychological 
wellbeing in a wider sense including social,  physical and functional abilities as 
well as emotional wellbeing.  There is a large literature which looks at these 
broader quality of life concerns in cancer patients.  There are two main research 
survey systems that measure quality-of-life in cancer patients:  European 
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Questionnaire (EORTC-QLQC30) (Aaronson et al  1993) and  Functional 
Assessment of Cancer Therapy -  General (FACT-G) (Celia et al  1993).  Both 
systems comprise a core questionnaire with cancer specific subscales that can 
be varied according to the patient group.
A number of studies have examined levels of quality of life in cancer 
patients and compare it to population controls.  Studies using the EORTC scale 
show that cancer patients have worse quality of life compared to population 
controls (Hjermstad et al  1998), particularly in areas of social functioning, 
physical symptoms (such as fatigue and appetite loss) and financial difficulties 
(Hjermstad et al 1999).  These effects are evident up to a year after diagnosis 
(Arndt et al 2004b, Arndt et al 2004a) but there is evidence that many domains 
return to normal or remain equivalent to population controls throughout the 
illness (Kopp et al 2004).  Data using the FACT-G is not as extensive and there 
are some mixed results.  Two studies found little or no differences between 
quality-of-life scores in cancer patients compared to general population samples 
(Holzner et al 2004,  Miller et al 2002) and one study showed that cancer 
patients had lower scores (i.e. worse quality of life) (Celia et al 2003).  Finding 
small differences between cancer patients and controls could  be due to 
response shift in patients or that the outcome for most patients is generally 
good.  Importantly the studies finding only small differences do show that type 
of cancer or treatment type can affect quality-of-life scores with bone marrow 
transplant patients having lower scores than either other patients or controls in 
one study (Holzner et al 2004) and ovarian patients having the lowest scores in 
the other study (Miller et al 2002).  The controls in one study were inadequate 
as they were people attending for cervical screening and who may be 
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FACT scales were designed for use with cancer patients and comparisons with 
general population samples could be misleading for this reason.  It seems likely 
that, as with levels of anxiety and depression, some cancer patients will be 
more adversely affected than others and a proportion of patients will have 
considerably lower quality of life compared to that of healthy populations.
At first glance, the content of the core modules of the EORTC-QLQC30 
and the FACT-G appear similar.  Both measures have physical, social and 
emotional subscales.  However, systematic and statistical evaluations of their 
content reveal poor agreement.  Kemmler et al (1999) compared responses on 
the two measures in a sample of 244 breast cancer and  Hodgkin’s disease 
patients.  They found that only the physical domains were satisfactorily 
correlated (r = 0.66).  The least correspondence was found for the social 
domain (r = 0.14).  The two instruments cover different aspects of quality of life. 
The items of the EORTC-QLQC30 concentrate largely on the physical domain 
and its consequences.  For example,  its social functioning subscale addresses 
the social role implications of physical limitations whereas the FACT-G social 
and family subscale concentrates on social support and emotional attachments. 
The FACT-G consequently seems to have a broader coverage of the possible 
dimensions of quality of life that could be affected by a cancer diagnosis whilst 
the EORTC-QLQC30 may be more appealing to clinicians interested in physical 
impairment.  For the purpose of my research,  I am interested  in the effects of a 
cancer diagnosis across a number of quality-of-life domains and the FACT-G is 
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Benefit finding
Previous research has shown that individuals may feel both negative and 
positive emotions (Schroevers et al 2000, Watson & Clark 1997).  Although 
cancer is likely to cause distress and disruption, there is also the possibility that 
aspects of the experience can be viewed as beneficial.  For example, cancer 
patients have reported that their personal relationships have been strengthened 
by the experience, that they have made positive changes to future plans, 
activities or priorities, and that they have an enhanced sense of purpose 
(Cordova et al 2001,  Curbow et al 1993, Gritz et al  1990).  These positive 
changes in response to cancer have sometimes been labeled ‘benefit finding’ 
(Antoni et al 2001).
The relationship between benefit finding and distress is unclear.  Sears, 
Stanton  and Danoff-Burg (2003) report that there is no relationship between 
benefit finding and distress a year after diagnosis in a sample of 92 early-stage 
(Stages I and  II) breast cancer patients.  Tomich and  Hegelson (2004) used a 
larger sample (N = 364) and included breast cancer patients with more 
advanced disease (Stages I,  II and III).  They found that initial benefit finding 
(assessed four months post-diagnosis) predicted increased distress nine 
months later.  Carver and Antoni (2004) contradict this finding by showing that 
benefit finding related to decreased distress and depression four to seven years 
after surgery in a sample of 96 breast cancer patients (Stages I and  II only).
These inconsistent findings could be due to differences in the 
characteristics of the samples.  Particularly, stage of disease appears to interact 
with benefit finding.  Lechner et al (2003) used a mixed-cancer sample (N = 83), 
representing all four disease stages, to explore the relationship between stage 
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Stage II had significantly higher benefit finding scores than either those with 
Stage I or Stage IV disease.  They hypothesise that early stage disease may 
not be sufficiently stressful to provoke the type of life re-examination associated 
with benefit-finding, and that also very high levels of threat associated with very 
advanced disease would preclude benefit-finding.  In the study by Tomich and 
Hegelson (2004) they also report that women with Stage II disease experience 
more benefits than those with Stage I.  Stage III patients had a higher mean 
benefit finding than either Stage I or II patients,  but this did  not reach statistical 
significance.  Importantly there was also an interaction between disease stage 
and benefit finding on negative affect.  Patients with higher benefit finding and 
advanced disease stage at the initial assessment (four months post-surgery) 
had worse negative affect and mental functioning at subsequent assessments 
(3 months and 9 months after T1) compared to those with  lower disease stage. 
These findings indicate that studies that exclude advanced disease stages (as 
in the studies by Sears et al and Carver and Antoni) will find different 
relationships between benefit-finding and distress than those studies that 
include these patients.
There is some emerging evidence regarding the relationship between 
SES and benefit-finding.  Carver and Antoni (2004) report that lower education 
is associated with increased benefit-finding.  The study by Tomich and 
Hegelson (2004) also reports an association between  lower SES (education, 
occupation and income) and increased benefit finding.  They argued that lower 
SES groups may typically experience more hardships in their lives and thus 
have more experience of trying to find something positive from a negative 
situation.  Supporting evidence for this is that individuals who experience more 
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fewer traumas (Cordova et al 2001, McFarland & Alvaro 2000).  Although more 
work is needed to replicate these results, if we consider benefit finding as a 
psychological outcome in its own right,  regardless of its possible association 
with distress, then this could be one area in which  lower SES groups have an 
advantage over high SES groups.
Cancer and Social Outcomes
Social difficulties
In addition to the impact of a cancer diagnosis on psychological 
outcomes, it can also lead to functional impairments that have a profound 
impact on social activities, from ability to work and participate in leisure and 
community activities, to carrying out basic domestic chores (Malone et al 1994). 
Cancer patients also report worrying about money and experience problems 
within the family (Macleod et al 2004).  Some level of functional impairment can 
remain for a number of years after diagnosis and treatment.  One study by 
Chirikos et al (2002) of the economic consequences of functional impairment in 
breast cancer survivors reports that survivors were more impaired than controls 
even five years after diagnosis.  Breast cancer survivors were also more likely 
to work less and experienced reduced earning capacity.  Another study has 
shown that the difference in employment status between cancer patients and 
age and gender-matched referents is small,  but significant (50% employment 
amongst cancer patients compared to 55% in  referents).  The difference is 
largely due to many cancer patients opting to take early retirement (Taskila- 
Abrandt et al 2005).
Recent work in this area by Wright and colleagues (Wright et al 2001, 
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types of social difficulties encountered by cancer patients and led to the 
development of a questionnaire measure to assess these problems (Wright et al 
2005).  They initially carried out focus group discussions with  96 cancer 
patients.  Eight areas of concern were identified by patients:  i) difficulties 
managing in the home,  ii) difficulties with health and welfare services,  iii) 
financial problems,  iv) employment issues, v) legal problems, vi) relationship 
difficulties, vii) sexuality and body image problems, and viii) difficulties 
participating in leisure activities.  The most frequently endorsed problems were 
those to do with  relationships and communication,  but problems with finances, 
employment and domestic chores were also widely reported.  Being female, 
younger and receiving palliative care was related to increased reporting of 
problems (Wright et al 2002).  This demonstrates that a diagnosis of cancer can 
have far-reaching consequences for patients’ financial situation, ability to 
maintain independence, and capacity for participation in the social world at a 
level prior to diagnosis.
Medical interactions
Quality of medical interactions is likely to affect patients’ ability to 
maintain psychological health across the spectrum of cancer-related stressors 
from screening, through diagnosis, treatment and survival.  Satisfaction with 
care in oncology is related to the communication and interpersonal skills of 
physicians,  information provision, and organisation of services (Davidson &
Mills 2005).  The Calman-Hine report (Caiman & Hine 1995) proposed that the 
best practice in oncology services would include a patient-centred approach 
with physicians providing clear information and assistance about treatment 
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towards a ‘concordance’ model of patient care (Ferner 2003).  This replaces the 
authoritarian or compliance model where there is a passive patient receiving 
treatment from a paternalistic doctor.  The concordance model proposes a 
partnership between  health professionals and patients, allowing the patient to 
become more active in decisions relating to their care.
In studies of patient satisfaction with oncology staff, patients tend to 
express high levels of satisfaction with their interactions with medical staff 
(Shilling et al 2003) and with the information that they have received (Sapir et al 
2000).  Despite expressing these high levels of satisfaction and comprehension, 
many patients continue to have an inaccurate understanding of their disease 
status, the types of tests they have undergone and the treatment they have 
received (Gattellari et al  1999, Mackillop et al  1988, McGregor 2003,  Sapir et al 
2000).  This discrepancy may arise because of the type of language used in 
consultations, particularly the use of ambiguous terms such as ‘seedlings’,
‘spots’ and ‘growths’ and medical jargon such as ‘benign’ ‘metastasis’ and 
‘tumour’, which are not terms readily understood by the lay public (Chapman et 
al 2003, Sapir et al 2000).  New patients may be unable to take in new 
information about the disease, selectively remember only optimistic information, 
or selectively fail to attend to the word ‘cancer’ when  it is used because of the 
stressful nature or receiving a cancer diagnosis (Moore & Estey 1999,
Purandare 1997).  These sorts of comprehension problems are related to the 
use of ‘denial’ coping strategies where patients seek to minimize or ignore the 
impact of having the disease (Gattellari et al  1999).  Their have been a number 
of studies that  examine good practice in breaking ‘bad  news’ to cancer patients 
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speak in simple terms using unambiguous language and to be honest, 
compassionate and supportive (Fallowfield & Jenkins 2004).
Patient assessments of clinician communication skills and their 
experience of receiving a cancer diagnosis are related to subsequent levels of 
anxiety and depression (Schofield et al 2003).  In a survey of 60 women with 
early stage breast cancer, three aspects of care related to psychological 
adjustment: caring (interpersonal skills), competence (technical expertise) and 
understanding (communication skills) (Mager & Andrykowski 2002).  Overall 
levels of satisfaction were unrelated to levels of distress or anxiety in this study, 
although other studies show that satisfaction scores relate to these aspects of 
care as well as to organisation of health services such as waiting times and 
provider-delay (Davidson & Mills 2005).
Oncologists recognise that their communication skills may be lacking due 
to inadequate training and that this contributes to their own experience of stress 
and satisfaction (Ramirez et al  1996).  Fallowfield and colleagues have been 
testing and running communication skills training for clinicians over a number of 
years and have run a randomised control trial of the effectiveness of the training 
course.  Their training programme improves the use of empathy, open rather 
than closed questioning, checking understanding,  responding to patient cues, 
and encouraging fewer interruptions (Fallowfield et al 2002).  This training is 
successfully integrated into oncologists’ normal practice with improvements 
showing persistence when measured up to 15 months after the training course 
(Fallowfield et al 2003).  These studies show that health care professionals are 
receptive to training and that significant improvements can be achieved.  These 
improvements in communication skills have only a small, statistically non­
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areas, such as service delivery (e.g. waiting times and administration) are as 
important for patient satisfaction as communication skills (Shilling et al 2003).
Patient satisfaction surveys are highly variable in terms of quality.  Sitzia 
(Sitzia  1999) reviewed the reliability and validity of patient satisfaction data.  He 
found that only 6% of the  181  studies reviewed reported either criterion or 
construct validity together with content validity and reliability.  80% of studies 
produced new satisfaction instruments with a further 10% modifying existing 
instruments.  This is because most studies are context specific and 
consequently need a variety of different measures.  This issue is being 
addressed  in the area of cancer patient satisfaction.  For example the EORTC- 
QLQ SAT32 is in the process of validation (Bredart et al 2004).  This is a 
measure of patient satisfaction in oncology that is undergoing extensive testing. 
The areas measured include technical skill,  information giving and interpersonal 
qualities for both doctors and nurses.  There is also a section on organisation of 
care including waiting time, accessibility and comfort.  This addresses the areas 
related to satisfaction identified in the literature and should prove a useful tool 
when it becomes available.  An issue with patient satisfaction surveys is that 
high levels of satisfaction are often reported (Sitzia  1999) despite contradictory 
observations of unmet care needs (Sanson-Fisher et al 2000).
Sitzia (Sitzia  1999) comments that only a low proportion of studies use 
qualitative methods to observe patient satisfaction and that this could be 
valuable for descriptive use and theory development.  Qualitative interviews 
may be more effective at revealing dissatisfaction than quantitative surveys as 
they allow patients to answer in an open-ended manner in their own terms. 
There are some recent qualitative papers that explore aspects of doctor-patient 
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Wright et al 2004)).  Freedman (Freedman 2003) observed 25 breast cancer 
patients with  12 different physicians during their medical encounters and found 
that patients made decisions regarding their treatment depending on their 
personal and emotional reaction to the physician.  This meant that they followed 
the advice of the physicians that they felt they ‘got on with’ best.  Patients also 
place importance on creating a good friendship or positive social environment 
with their physicians.  This was one way of establishing a form of control in that 
a trusting relationship would result in them receiving better treatment from their 
physician.  A limitation of this study was that the majority of the participants had 
relatively high SES (completed high school with private medical insurance).
Low SES patients may have different experiences and different methods for 
evaluating their care.
Wright et al (2004) also found that the social and interpersonal aspects of 
medical interactions were more important to breast cancer patients than the 
actual quality of the information that they received.  They audiotaped 
consultations between patients and physicians and then interviewed both again 
1-5 days later.  Patients emphasised the importance of being seen as an 
individual rather than ‘just another patient’.  They felt that establishing a 
relationship by talking about issues unrelated to their disease would mean that 
their physician would remember them and attend to their needs better.  This 
also highlighted the attachment needs patients had with their doctors during a 
time of threat.  Patients made judgements about trust and level of expertise 
based on their physicians interpersonal skills, such as showing respect and 
care by talking at eye level, giving patients the option to choose treatments and 
taking the time to provide the patient with reassurance.  Both of these 
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means of conveying trust and expertise rather than the content or type of 
information that they give to their patients.  These papers were both 
observations of interactions with breast cancer patients.  Male cancer patients 
or patients with a different cancer site may reveal different attitudes.  Future 
research would benefit from using a mixed-gender sample and by targeting 
recruitment according to socio-economic group so that views from a wide range 
of social backgrounds can be observed.
A recent review of the literature by Willems et al (2005) found that lower 
SES patients received less positive emotional reassurance, a more directive 
consulting style and less diagnostic and treatment information from their 
physicians.  Lower SES patients also experienced  less control over their 
communication with their physicians.  This review assessed papers from  1965 
to 2002 and included  12 papers in the review.  The majority of the papers in this 
area were published some time ago with only 2 papers dating from 2000 and 
none more recently than that.  Research in the area is still sparse and more up- 
to-date data is required.  Two more recent papers (Macleod et al 2004, van Ryn 
& Fu 2003) show that socio-economically deprived breast cancer patients 
receive less information from hospital specialists than more affluent women 
(Macleod et al 2004) and that doctors communicate better with people they 
perceive to be of the same social class as themselves (van  Ryn & Fu 2003). 
Qualitative interviews to explore this issue will also help to provide a stronger 
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Conclusions
In Chapter 1  I explored the relationship of SES to psychosocial 
responses to stressors.  I concluded that there was still a scarcity of research 
that examined differential vulnerability of SES groups in response to real-life 
stressors.  In this chapter I have demonstrated that there are a number of 
cancer-related stressors from screening through diagnosis, treatment and 
survival that have the potential to impact on psychosocial wellbeing and reason 
to believe that SES may be an important moderating variable.  The research 
studies in this thesis will use the framework of cancer-related stressors to 
examine the relationships between SES and psychosocial outcomes in 
response to stress.Chapter 3:  Measurement of SES  68
CHAPTER 3 
Measurement of socio-economic status
The term, ‘socio-economic status’,  refers to people’s positions within the 
social and economic structure of society.  It encompasses ideas of social class, 
social status or prestige, and material living conditions (Bartley 2004). 
Hierarchies are an integral part of society.  One aspect of this stratification 
arises from ownership, production and exchange of economic resources. 
Material living standards can be reflected in measures of income, or wealth, 
including various assets, that affect the individual’s purchasing power and ability 
to access resources.  Social class has largely been defined in terms of people’s 
occupation.  Occupation can be used as an indicator of social relations in the 
settings of employer-employee relationships, ownership of property, types of 
labour contract and cultural norms within different occupational sectors (Rose & 
O'Reilly  1998).  Occupation is clearly linked with ideas of status, prestige or 
community ranking.  Status within society is not necessarily linked to material 
assets.  Occupation determines income, but status can be obtained 
independently of material advantages.  There are high  prestige occupations that 
are relatively poorly paid and lower status occupations that are highly paid (e.g. 
research scientist vs advertising executive).  Another important indicator of 
social and economic position is level of education.  Educational achievements 
can reflect both class and material conditions because wealth is required to 
secure a high  level of education and a high  level of education  is also required to 
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Measures of Social Position
Occupation
In the UK, social position has most often been measured using 
occupational class systems.  The Registrar General's classification system 
(RGSC) of occupational status was developed for the  1921  census data 
(Stevenson  1928) and was widely used.  It classified people into 6 categories (3 
manual and 3 non-manual) according to skills and community status.  The 
RGSC is criticised for lacking theoretical content and explanatory power and for 
not being applicable to people out of work, young people,  retired people, or to 
women (Chandola  1998,  Rose & O'Reilly 1998, Szreter 1984).  This system 
classifies housewives as 'unoccupied' and it is difficult to assign them a class, 
although there is better success when classifying women according to a 
husband's occupation.
The Registrar General's classification system, and its various updated 
versions,  have been replaced by the UK National Statistics Socio-Economic 
Classification (NS-SEC) (Rose & O'Reilly 1998) as the official UK government 
measure of social class.  The NS-SEC is explicit about its theoretical basis.  It 
measures social class based on the differences between employment relations 
and conditions.  The focus is on occupational relationships and it divides people 
into: those that are employers and buy labour and have some degree of control 
and authority over it, employees who sell labour and are under control of 
employers, and the self-employed who do neither.  These categories are then 
further subdivided depending on 'service relationship' which takes into account 
degree of autonomy, authority, salary increments, benefits and opportunities.
One of the problems with occupational measures of social class has 
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outside of work include not only the unemployed, but also students, home­
makers and retired populations.  It may not always be appropriate to classify 
people based on their past employment.  Women may work intermittently 
between periods of increased domestic responsibility and their jobs may not 
reflect their household circumstances.  Classifying women on the basis of their 
partner’s occupation is also problematic and not always appropriate or possible. 
Similarly,  retired people’s current material circumstances may be greatly 
reduced compared to what it was during periods of paid employment.  These 
problems have not been successfully addressed under the new NS-SEC 
classification system.  Drever et al (2004) classified adults aged 25-64 into 
socio-economic groups as defined by the NS-SEC using data from the 2001 
census.  They report that twice the proportion of women aged 25-64 were 
unclassified compared with men of the same age (13.7% and 6.3% 
respectively).  This disparity was apparent across all age groups.  Drever et al’s 
analysis was restricted to those under the age of 65 and over the age of 25 
because the retired and student populations could not be usefully classified. 
Among women aged 60 to 65 years nearly 40% of women were unclassifiable. 
The NS-SEC may not be appropriate to use in research studies which focus on 
these populations.
Education
Years of education has the advantage of being a continuous measure, 
with meaningful cut points (e.g.  in the UK, completion of GCSE's, A-levels, 
University) that is applicable to the whole population,  including women and 
minority groups (Berkman & Macintyre  1997).  Education is also linked to 
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entail.  If psychosocial resources are important links for explaining the 
relationship between SES and health, then measuring education may be more 
important because of its links to cognitive development and behaviours. 
However,  because educational achievement is generally stable over the course 
of a lifetime it cannot reflect fluctuations in social and economic circumstances. 
Additionally, access to education has changed dramatically over the past couple 
of generations making comparisons between older and younger populations 
difficult.
Measures of Material Living Standards
Income
Income provides information about an  individual's purchasing power and 
potential access to resources.  Measuring income has appeal because it can be 
used as a continuous measure with a broad range.  However,  it cannot fully 
reflect a person's economic status as it fails to take into account, for example, 
inherited wealth, material assets and savings (Berkman & Macintyre 1997). 
Additionally,  any measure of income needs to be supplemented by information 
concerning the number of people that the income is used to support.  Finally, 
income is often poorly reported in surveys because people consider it to be 
sensitive information that they would rather not divulge (Berkman & Macintyre 
1997).
Assets
A relatively novel way of measuring SES has been to assess various 
material assets of the individual.  In particular housing tenure and car ownership 
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used in conjunction with other measures such as occupation (Filakti & Fox 
1995, Wannamethee & Shaper 1997).  These measures are also equally 
applicable to men and women, to those beyond working age (Filakti & Fox 
1995) and to the younger population such as adolescents (Wardle et al 2002).
Resources are not simply markers for income and wealth, although both 
car and home ownership are highly correlated with  income and occupation 
(Rickards et al 2004).  Home ownership may reflect higher standards of living in 
terms of the fabric of the dwelling including protection from noise, damp and 
cold as well as quality of the area, such as vandalism and access to local 
amenities when compared to homes that are rented from local authorities or 
private landlords (Ellaway & Macintyre 1998).  Car ownership may improve 
access to employment and local facilities such as health services and open 
spaces.
Both car and home ownership have increased in the UK over recent 
years.  In  1971, 49% of households were owner-occupied, this had  increased to 
69% by 2002 (Rickards et al 2004), possibly reflecting such policies as the 
‘right-to-buy’ that was introduced in the 1980s.  73% of households had access 
to a car in 2002 compared with 52% in  1972 (Rickards et al 2004).  This breaks 
down into 44% of households with one car and 29% of households with two 
cars or more (Summerfield & Babb 2004).  The high  levels of car and home 
ownership imply that those without these items are amongst the most deprived 
in the UK.  However, these figures vary widely between  urban (low ownership) 
and rural (high ownership) locations with nine London boroughs and Glasgow 
city reporting levels of car ownership below 50% (Summerfield & Babb 2004).
Asset-based indicators of SES are useful because respondents are 
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to questions about levels of income.  For example, Macintyre et al (1998) report 
that in their sample of 1710 individuals involved in the West of Scotland Twenty- 
07 Study,  148 (8.7%) respondents failed to answer questions about income 
compared to only 2 (0.1%) people with missing data on car ownership and 
another 2 missing for home ownership.  Measuring car and  home ownership 
consequently have a number of benefits in terms of accurately assessing SES.
Area-level Markers of SES
There are also measures which catalogue SES at an area level.  This 
involves linking individual postcode data to an area-level, composite score 
based on census information.  This type of measure can be useful because 
postcode data maybe more readily available or easier to collect than other more 
intrusive questions about a person’s socio-economic background.  Individual- 
level data may be more likely to be either missing or unreliable in some way.
On theoretical grounds the relationship between SES and health may be 
in part due to the material environment of the area that the individual lives in 
(Yen & Syme  1999).  Some studies suggest that area-level measures make an 
independent contribution to the link between SES and health over and above 
individual factors (Robert et al 2004, Shohaimi et al 2003).  Other studies 
suggest that appropriate adjustment for individual level markers of SES reduces 
the magnitude of the associations between neighbourhood SES and  health 
(Reijneveld & Schene 1998).  A review by Pickett and  Pearl (2001) found that 
23 out of 25 studies reported statistically significant area-level effects on health 
outcomes after controlling for individual-level SES.  However, they noted that 
studies which included multiple individual-level markers reported weaker area- 
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implies that area-level effects could be proxies for unmeasured individual-level 
effects.
Studies that compare the relationship between area-level and individual- 
level markers of SES sometimes find poor agreement.  For example,  Demissie 
et al (2000) report that in their study of 943 children within  155 small 
enumeration areas in Quebec,  individual and area level markers of SES 
corresponded exactly only 28.7%.  Similarly Wardle et al (2002) report a 
correlation of 0.42 between  individual and area level markers that, although a 
relatively high and significant correlation, still indicates a large proportion of 
misclassification.  This lack of correspondence could suggest that individual and 
area level markers capture markedly different aspects of SES or alternatively 
that one or the other measure is inaccurate.  It remains unclear whether area- 
level effects of SES on health reflect access to health-promoting local resources 
or are surrogates for unmeasured aspects of individual SES.
Regardless of this issue, another problem with area-level markers relates 
to the choice of the size of area that is measured.  In  England and Wales, the 
most well known area-level score is the Townsend  Index  (Townsend et al 
1988).  This is a measure of deprivation based on access to cars,  percentage 
unemployed,  percentage owner occupiers and degree of overcrowding.  In the 
1991  census, a score was produced for each enumeration district in England 
and Wales. There were approximately 130,000 enumeration districts with 
roughly 200 households per district.  Individual’s postcode information can be 
linked to their enumeration district and consequently every individual can be 
assigned a Townsend score.  Measuring SES at a neighbourhood or area level 
implies that the population within that area is relatively homogenous and, at the 
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increased.  However, efforts to protect confidentiality have meant that the 2001 
census no longer produces information at this small-area level.  The 2001 
census data does hold information at ‘output area’ level (approximately 125 
households) rather than enumeration districts,  but detailed information at this 
level is withheld.  The Townsend Index is still calculated at ward level, of which 
there are only 8850 (with approximately 5000 residents in each) within England 
and Wales.  This increases the likelihood of socio-economic heterogeneity, thus 
reducing the accuracy and relevance of the measure.  Other studies and 
reviews also support the use of area-level measures that are based on the 
smallest and most homogeneous census-defined  region that is feasible 
(Hyndman et al  1995, Krieger et al 1997) in order to improve validity.  As a 
result, the Townsend  Index using the 1991  census data may be more effective 
than the information produced using the 2001  data.  Data collected prior to 2001 
can confidently employ the Townsend  Index using the  1991  census data.  As 
the time lag between the  1991  census data collection and the data collection 
period of new research studies’ increases, the Townsend score based on the 
1991  data becomes more unreliable.  Studies with data collection since 2001 
should cease to employ the 1991  data as a source for calculating Townsend 
scores.  The dilemma is that the new scores from the 2001  data will also be less 
accurate because they are based on larger areas.  This cautionary note will also 
apply to other area-level measures such as the more modern Index of Multiple 
Deprivation (Department of the Environment 2000).
Subjective SES
An alternative approach to measuring SES using the objective markers 
discussed so far is to assess individual’s perceptions of their own socio-Chapter 3:  Measurement of SES  76 
economic position.  Wilkinson (1999) has argued that the social comparisons 
that people make in relation to their own position within society’s hierarchies 
compared to others could be more important for determining health rather than 
absolute level of SES.  It may be that subjective SES is more accurate than 
objective SES as it allows the individual to take into account the special 
circumstances of their own lives that the broader categories of the objective 
measures cannot include.
A one-item measure that assesses subjective SES has been developed 
recently by Adler et al (2000).  It takes the form of a drawing of a ladder on 
which individuals place themselves.  The ladder has ten rungs with those who 
are the best off in terms of income, education, and occupation at the top and 
those who are worst off at the bottom.  Adler et al (2000) tested this measure in 
a sample of 157 women.  Subjective SES was more strongly and consistently 
related to psychological and physical health outcomes than objective SES 
markers.  The associations between subjective SES and health remained after 
controlling for objective SES and negative affect.
A potential problem with this type of marker is that there may be overlap 
with psychological functioning.  People who have depression or low self­
esteem could be inclined to assess their social position as somewhat lower than 
is actually the case.  Singh-Manoux et al (2003) explored how people made 
decisions about their subjective SES using regression models with participants 
from the Whitehall II study.  They found that the most important predictors of 
subjective SES were employment grade,  household income, education, 
satisfaction with standard of living and feeling of financial security.
Psychological functioning (hopelessness, control,  mental health, vigilance, 
hostility,  and optimism) although correlated with subjective SES were notChapter 3:  Measurement of SES  77 
independent predictors of subjective SES.  This suggests that the subjective 
SES measure is a measure of SES and not a proxy for psychological 
functioning.  However, this one study cannot be taken as conclusive because 
other unmeasured aspects of psychological functioning,  particularly self­
esteem, may have an impact on subjective assessments of SES.  Nevertheless, 
one of the potential benefits of using this kind of measure is that it should be 
equally applicable to all sections of the population -  young and old, male and 
female.  It therefore overcomes some of the problems associated with objective 
markers that are based on either occupation or income.
Conclusions
The view of SES implicit in these measures is that its relationship to 
health is based around social position as well as material well-being.  SES 
represents access to resources in terms of money,  knowledge and people.  The 
indicators described here are used either individually or in a combined format to 
access the various different aspects of SES.  Each of the methods has merits 
and difficulties.  The large-scale epidemiological studies which first bought to 
light the relationship between SES and health did not have a sound a priori 
theory regarding how this link is established.  This makes it hard to choose an 
appropriate measure.
Additionally, there are clearly problems with accurately assessing SES 
amongst older age and retired populations,  (the majority of cancer patients) that 
are studied in this thesis.  One study that examined the use of seven different 
socio-economic indicators (occupation, education, income, housing tenure, 
household resources, Townsend indicators, and car affordability) in a sample of 
3543 older adults (age 55-75 years) reported that all indicators were associatedChapter 3:  Measurement of SES  78 
with differences in self-reported health, but that combination measures,  rather 
than single indicators, were more effective.  They concluded that best 
measurement approach is to use a combined score based around either 
occupation or education paired with household  resources (Grundy & Holt 2001).
I  have decided that the best strategy may be to take multiple 
measurements,  using separate markers (including income, Townsend  Index 
and subjective SES) and also by forming a composite score.  The composite 
score is based on car and home ownership as well as level of educational 
achievement.  This measure has a number of advantages.  Level of education, 
as discussed,  is a relatively stable trait that applies to people who are not 
currently employed (retired,  homemakers and unemployed) thus by-passing 
many of the difficulties encountered using occupational measures.  Educational 
achievement is sensitive to age and birth cohort,  but the studies included in this 
thesis concentrate on populations with relatively narrow age ranges.  Education 
is also clearly linked to social prestige or status, as discussed.  Car and home 
ownership measure aspects of material deprivation,  rather than social 
deprivation.  Both of these items should be more sensitive to changes in 
circumstances and are more acceptable measures of material assets than 
questions directed about income, which are often poorly completed.  Combining 
these items produces a measure of socio-economic status based on actual 
resources and status or prestige.  This measure has successfully been used in 
other research studies (Wardle et al 1999, Wardle et al 2004).  All of the SES 
markers used in this thesis are based around the proposal that there will be an 
incremental gradient in wellbeing from lower to higher SES rather than 
categorical differences between ‘classes’ or between extremes of  ‘rich’ and 
‘poor’ (Marmot 2004).Chapter 4:  Outline of Studies  79
CHAPTER 4 
Outline of Research Studies
From the literature review,  it is apparent that it would be valuable to 
understand more about how SES moderates reactions to real-life stressors. 
This is both because it will make a contribution to understanding the SES- 
health relationship, and because it will be useful for understanding the needs 
of lower and higher SES people when faced with particular stressors.  I am 
using cancer-related stressors as a framework for examining this issue 
because cancer is a major stressor that can strike people from any SES 
group, and cancer clinicians could find it useful to know more about how SES 
influences responses to the disease.  The research studies in this thesis will 
specifically investigate the following topics:
Study 1:  Examines SES differences in psychological reactions to colorectal 
cancer screening in a population-based survey of older adults.  I propose that 
cancer screening represents only a moderately stressful situation,  but that 
different screening outcomes will be more or less stressful depending on their 
prognostic significance.  The study examines SES differences in reactions to 
different screening outcomes and investigates whether SES affects 
psychological adjustment over time.  The results will demonstrate whether or 
not this moderate type of stressor exacerbates SES differences in 
psychological wellbeing and can be compared to the results for the effect of 
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Study 2: Examines SES differences in psychological reactions to receiving 
different disease stage diagnoses in a sample of colorectal cancer patients. 
Receiving a diagnosis of cancer represents a more severe stressor than 
undergoing cancer screening, explored in the previous study.  This may be a 
situation more likely to exacerbate any SES differences in psychological 
adjustment.  Again, differences in disease stage at diagnosis have prognostic 
significance (as in the case of different screening outcomes in the previous 
study) and could be experienced as more or less stressful.  SES may interact 
with characteristics of stressful situations (here represented by disease stage) 
to differentially affect psychosocial outcomes.
Study 3:  Uses a qualitative methodology to investigate the relationships 
between patients and medical staff and explore whether experiences of 
medical care differ according to patients’ SES.  The literature review indicated 
that interactions with medical staff were important for psychological 
adjustment and that experiences may differ by SES,  but this has remained an 
under-researched topic.  Medical interactions are studied quantitatively in 
Studies 2, 4 and 6,  but the qualitative analysis used in this study complements 
the quantitative approach by providing a richer and fuller account of patients’ 
experiences.
Study 4:  Examines SES differences in psychosocial outcomes according to 
different disease stage diagnoses and different treatment regimens in a 
mixed-cancer patient sample (breast, prostate, and colorectal).  This study 
aims to replicate and confirm any results seen in Study 2 using a larger,Chapter 4:  Outline of Studies  81
mixed-cancer patient sample and additionally explore any SES interactions 
with different treatment regimens, and the presence of co-morbid illnesses on 
psychosocial outcomes.  Undergoing certain treatments changes the amount 
of stress experienced by cancer patients e.g. patients who receive surgery will 
be more physically debilitated than those that do not.  Similarly the presence 
of a co-morbid illness in addition to cancer would be expected to more 
stressful.  This widens the assessment of SES interactions with different 
cancer-related stressors on psychosocial outcomes.
Study 5:  Examines the association between SES and psychosocial resources 
in a mixed-cancer patient sample and the relationship between psychosocial 
resources and psychosocial wellbeing.  The literature review suggested that 
psychosocial resources, such as optimism, control, and social support could 
be related to SES and psychosocial wellbeing.  This study uses the same 
dataset as Study 4 to explore these relationships.
Study 6:  Examines the relationships between SES and psychosocial 
adjustment to a cancer diagnosis over time.  It may be that different SES 
groups are able to psychological adapt to a cancer diagnosis more efficiently. 
Cancer patients are followed up at 1-3 months post-diagnosis and 9-12 
months post-diagnosis to examine this topic.  The same sample as that used 
in Studies 4 and 6 are used in these analyses.
The studies cover a wide-range of cancer-related stressors from  less to 
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these different situations.  The analytic strategy involves i) comparing SES 
groups cross-sectionally ii) an examination of interactions between SES and 
the characteristics of the cancer-related stressor (e.g. disease stage or 
treatment type) and iii) SES differences in psychological health over time.
More than one level of cancer stress is explored in the studies, such as 
different disease stages, different screening outcomes or adjustment over time 
so that reactions to the situation are examined in relation to SES rather than 
population level differences in wellbeing by SES.  This will improve the 
understanding of individual differences in reactions to cancer-related stressors 
which can serve to inform supportive care strategies.  This will also further the 
knowledge of how SES can affect reactions to stress leading to better 
awareness of the ways in which inequalities in psychological health arise.Chapter 5:  Study 1   83
CHAPTER 5.
Study 1:  Socioeconomic status differences in adjustment to bowel screening2
Introduction
The present study tests the idea that lower SES groups will have a 
more emotionally charged response than higher SES groups to a moderately 
stressful medical encounter.  The study uses emotional reactions to a cancer 
screening examination to test this hypothesis.
The stressor investigated in this study is a screening examination for 
early detection of colorectal cancer.  Colorectal screening is not currently 
included in the national screening programme in the UK, but a randomized 
controlled trial of the efficacy of flexible sigmoidoscopy (FS) is in progress (UK 
Flexible Sigmoidoscopy Screening Trial Investigators 2002).  This study uses 
data from this trial.  FS screening involves endoscopic examination of the 
distal colon to identify precancerous changes (polyps) and early, 
asymptomatic lesions.  FS is followed up with colonoscopy if there are 
indications of disease in the proximal colon.  The bowel preparation for the FS 
examination (a self-administered enema) is a novel procedure for most adults 
and the endoscopy itself can be embarrassing and  uncomfortable.  In this 
study,  people who were found to have polyps waited another two weeks 
before being given the ‘all-clear’, whilst those needing colonoscopy waited an 
average of six weeks for the appointment, then endured another more 
invasive and uncomfortable procedure.  The worry associated with the 
possible detection of cancer also added to the potential stress.
2 A version of this chapter was published in P s y c h o s o m a tic   M e d ic in e (2005) and a copy is included in 
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Previous research into the psychological impact of cancer screening 
suggests there is increased distress both in anticipation of attending 
screening, and while waiting for follow-up tests (Steggles et al  1998, Wardle & 
Pope  1992).  Longer-term adverse consequences have been  identified among 
women who are recalled for further investigations after mammography 
screening (Brett et al  1998, Olsson et al  1999).  I judged that the FS screening 
procedure would be mildly stressful and that the experience of people recalled 
for colonoscopy would be moderately stressful, thus providing an appropriate 
setting to look for SES differences.
The data available from the trial included measures of anxiety and 
cancer worry before and after the screening examination(s) in a subset of trial 
participants (the longitudinal sample).  This meant that it was possible to 
compare changes in emotional wellbeing over time between SES groups.  I 
expected that the lower SES groups would be more anxious beforehand and 
would find the examination procedure more threatening,  resulting in more 
adverse emotional outcomes in these groups.  The longitudinal data also 
included both an area-level (Townsend  Index) and an individual level (based 
on level of education, car and home ownership) index of SES.  This allowed 
comparison of the results using two different socio-economic markers.
Data on psychological well-being 3 months after screening were 
available for the whole screening group (the post-FS sample).  This permitted 
an examination of SES (Townsend index only available for this sample) 
differences in well-being in people who received negative (clear) results 
compared with those who had polyps detected and  removed during FS and 
those who were referred for colonoscopy.  I hypothesized that the screeningChapter 5:  Study 1   85
experience would be most stressful for those who were referred for 
colonoscopy, and predicted that there would be an interaction between SES 
and screening outcome in post-screening well-being.
Hypotheses
1.  There will be SES differences in psychological adjustment to flexible 
sigmoidoscopy screening such that lower SES groups will be more 
adversely affected.
2.  There will be SES differences in psychological adjustment to different 
screening outcomes, such that lower SES groups will experience 
greater distress than higher SES groups when being referred for 
colonoscopy.
Method
Participants
Data for these analyses come from the UK Flexible Sigmoidoscopy 
Trial; a randomized controlled trial of the efficacy of a single FS examination in 
older adults (Atkin et al 2001,  UK Flexible Sigmoidoscopy Screening Trial 
Investigators 2002).  Fourteen geographical centres throughout the UK were 
included in the trial.  There was at least one centre in each  Regional Health 
Authority in England, two in Wales and one in Scotland.  The trial involved a 
general population sample of 354,262 men and women age 55-64 years old, 
identified from 505 General Practices.  Exclusion criteria included:  inability to 
provide informed consent, history of colorectal cancer, adenomas or 
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less than five years, and having received a colonoscopy or sigmoidoscopy in 
the previous three years. Those who were considered eligible for the trial by 
their GP were mailed information about FS screening.  People who responded 
to the information letter and expressed an interest in attending (194,726) were 
randomized either to screening or usual care (no screening) in a ratio of 1:2.
In total 57,254 respondents were randomized to screening, of whom 40,674 
(71%) attended.  Local research ethics approval was given for each of the 
participating centres.
Design and procedure
Background questionnaires had been sent to a randomly selected sub­
set of participants (N = 5,942/57,254, approximately 10% of the randomized 
sample) around 5-6 months before they came for the screening examination in 
three centres: Portsmouth, Oxford, and Swansea.  The questionnaire was 
seven pages long and consisted of items regarding demographics, health 
behaviours, attitudes to cancer and cancer screening,  psychological well­
being bowel symptoms and family history of bowel cancer (Appendix IV).  This 
group comprised the smaller sample used to examine changes in emotional 
well-being from before to after the examination (the longitudinal sample). 
Follow-up questionnaires were sent to all screening participants, except those 
diagnosed with cancer (N =  140), 3 months after the first examination (N = 
40,534, the post-FS sample).  This questionnaire was also seven pages long 
(Appendix V) and measured satisfaction with the screening experience, 
psychological well-being, bowel symptoms and health behaviours.Chapter 5:  Study 1   87
The screening examination
The examination was carried out in a dedicated unit in the local hospital 
by a medical endoscopist.  The procedure took around 5 minutes and the 
participants could watch the progress of the scope and any polyp removal on 
a screen.  The design of the study is shown in Figure 1.  72% (N = 29,406) 
had no polyps detected and were given a letter confirming the negative result 
at the end of the examination.  9,607 (23.6%) had small polyps detected and 
removed at FS.  2,131  (5.3%) were referred for colonoscopy either at the time 
of the FS screen or because the polyps that were removed at FS showed 
high-risk pathology.  The average time from FS to completion of colonoscopy 
was 6 weeks.  All screened participants, except those diagnosed with cancer, 
were mailed a follow-up questionnaire 3 months after the FS exam to assess 
the psychological impact.
Measures
Socioeconomic status 
Area-level indicator
SES was indexed using an area-level measure of socioeconomic 
deprivation that could be derived from postcode information within  England 
and Wales.  The Townsend Index (Townsend et al  1988) is based on  levels of 
car ownership,  housing tenure,  unemployment, and overcrowded  living 
conditions as recorded in the  census across enumeration districts (onFigure 1   Study design
29 804 eligible and complete 
post-screening questionnaire
40 674 attend 
screening
2051  receive colonoscopy
80 do not attend
3789 complete pre-screening 
questionnaire
9607 polyp removal 1643 referred for colonoscopy
18 referred for surgery with 
no further investigations
29 406 FS negative (FSN)
2131 total 
referred for colonoscopy 
(FSC)
488 high risk polyps
9119 no pathology 
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average about 200 households).  Each enumeration district receives a score 
based on its relative levels of deprivation.  A score of zero represents the 
national average with  negative values representing less deprivation (higher 
SES) and positive values representing more deprivation.  Postcode 
information was collected for each individual and linked to enumeration 
districts; the Townsend score for the district was assigned to the individual.
For the purposes of analyses, the scores were grouped into quintiles to form 
five categories with ‘1’ indicating lower socioeconomic deprivation and ‘5’ 
signifying higher deprivation.  This classification results in five roughly, equal 
groups and consequently provides information about the relative deprivation of 
participants within the sample. This measure of deprivation was available for 
both the longitudinal and the post-FS sample.  The data collection period for 
this study was between  1994 and  1999 and the Townsend index score was 
based on the data from the 1991  census.
Individual-level indicator
The longitudinal sample also recorded self-report indicators of SES.  An 
individual-level indicator of socio-economic deprivation was measured  using a 
score composed of three items: car ownership (yes/no),  home ownership 
(yes/no),  higher educational qualifications (some/none).  Car and home 
ownership were selected because they are frequently used markers of 
deprivation and also correspond to items on the Townsend  Index.  Education 
is another widely used measure of SES and has the advantages of remaining 
stable over time and being applicable to members of society outside of the 
work force.  A composite score was created with a range from 0-3.  A score of 
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qualifications) while a score of ‘3’ represents the most deprived (no car,  not 
home owners and no qualifications).  This marker provides information about 
each individual’s circumstances and is consequently a measure of that 
individual’s actual or absolute level of deprivation.  This individual data was 
not available for the post-FS sample.
Screening outcome
The three possible screening outcomes were:  i) flexible sigmoidoscopy 
with a negative (clear) result (FSN),  ii) flexible sigmoidoscopy in which small 
polyps were found and removed (FSP), and iii) flexible sigmoidoscopy 
followed by colonoscopy to examine the proximal bowel and  remove large and 
numerous polyps (FSC). The small number of participants (0.34%, N =  140) 
who received a cancer diagnosis were not included in these analyses.
Bowel cancer worry
Worry about bowel cancer was assessed with the single item: “How 
worried are you about getting bowel cancer?” (Sutton et al  1994).  Response 
options were:  ‘not at all worried’, ‘a bit worried’,  ‘quite worried’ and ‘very 
worried’.
Psychological Well-being
The shortened (6 item) state version (Marteau & Bekker 1992) of the 
State-Trait Anxiety Inventory (STAI; (Spielberger et al  1983)) was included in 
both the pre-screening and post-screening questionnaire.  The short form has 
good concurrent validity compared with the full form and good internal 
reliability (a = 0.82) (Marteau & Bekker 1992).  Item scores were summed to 
produce a scale from 6 to 24 with higher scores indicating greater anxiety.Chapter 5:  Study 1   91
At follow-up, participants were additionally sent the 12-item General 
Health Questionnaire (GHQ-12; (Goldberg et al  1997)).  The GHQ is designed 
as a self-administered test to assess psychological distress in primary care 
patients (Goldberg  1978).  It assesses present state in relation to usual state 
e.g. “in the last three months have you been able to face up to your 
problems?”.  The items have 4 response options: ‘Better/more than usual’, 
‘same as usual’,  ‘less than usual’, and ‘worse/much less than usual’.  The 
GHQ-12, which has good reliability and validity (Goldberg et al 1997), 
producing scores from 0 to 24 with higher scores indicating greater distress.
Positive consequences of screening were also measured at follow-up 
using six items from the Psychological Consequences of screening 
Questionnaire (PCQ; (Cockburn et al  1992)).  All items started with the stem: 
“do you think that your experience of having the Flexi-Scope test has...?”  
followed by: “given you a sense of reassurance that you do not have bowel 
cancer”, “made you feel more able to do the things that you normally do”, 
“made you feel more hopeful about the future”, “made you feel less anxious 
about bowel cancer”, “made you get on better with those around you”, “given 
you a greater sense of well-being”.  Response options were:  ‘not at all’,  ‘a little 
bit’, ‘quite a bit’,  ‘a great deal’.  Items were scored  1-4 and scores were 
summed to produce a scale from 4-30 with higher scores indicating more 
positive consequences.  The scale had good internal reliability (Cronbach’s a 
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Analyses
In the longitudinal sample, repeated measures analysis of variance with 
deprivation quintiles as the between-subjects factor, time (pre to post 
screening) as the within-subjects variable, and screening outcome included as 
a control variable, was used to test for the hypothesized SES by time 
interactions for state anxiety and bowel cancer worry.  For the analyses of 
SES differences in response to the different screening outcomes, we used the 
larger post-FS sample.  Results were analyzed using analysis of variance with 
SES and screening outcome as the independent variables and age and 
gender included as control variables.  Family history was not used in the 
analyses as a control variable because it was unrelated to SES and did not 
alter the results when included in the analyses.  If, as we hypothesized, a 
positive FS test followed by colonoscopy is experienced as more stressful for 
lower SES participants, then we would expect to find an outcome by SES 
interaction for anxiety (STAI), psychological distress (GHQ) and positive 
consequences (PCQ).
Results
Longitudinal sample
3789/5,942 (64%) both attended screening and  returned the pre­
screening questionnaire.  3,535/3,789 (93.3%) also returned the post­
screening questionnaire and therefore contributed data for the longitudinal 
analyses.  The participants were 50.6% male (N =  1789) and 49.4% female (N 
= 1746).  97.5% were white (see Table  1).  Their mean age was 60.74 (SD = 
2.91) years.  The mean Townsend score was -1.47 (SD = 2.66) (i.e. moreChapter 5:  Study 1
Table 1   Demographic characteristics -  Longitudinal sample
N (N = 3,535)  %
Gender Male 1789 50.6
Female 1746 49.4
Ethnicity White British 3447 97.5
Black 6 0.2
Asian 17 0.5
Other 10 0.3
Do not wish to answer 22 0.6
Missing 33 0.9
Education No formal qualifications 1550 43.8
Some formal qualifications 1806 51.1
Missing 179 5.1
Car owner None 327 9.3
One 1948 55.1
More than one 1214 34.3
Missing 46 1.3
Home owner Own 3146 89.0
Rent 284 8.0
Other 54 1.5
Missing 51 1.4Chapter 5:  Study 1   94
affluent than the national average) with a range from -6.03 to 8.11.  Area-level 
deprivation did not relate to age (F [4, 3460] = 2.09,  NS) or gender (x2  = 0.42, 
df =  1,  NS). The individual-level index of SES was related to age (F [3,3331] = 
4.27, p<0.01) such that older age was associated with increased deprivation. 
Gender was also associated with individual-level SES (x2  (1) = 28.4, p<0.001) 
with more women represented in the most deprived category. The area-level 
and individual-level measures both included indicators of car and home 
ownership and were consequently highly correlated (spearman’s rho = 0.32, 
p<0.01).  However, this is lower than might be expected and suggests that 
there were a number of people who were designated affluent using the 
Townsend  index but were deprived using the individual-level measure, and 
vice versa.
The overall mean level of anxiety at baseline was 9.83 (SD = 3.49). 
Univariate ANOVAs, controlling for age, gender and screening outcome, 
showed that there were significant differences in  levels of anxiety and bowel 
cancer worry depending on area-level SES,  both before (anxiety: F [3,3432] = 
10.15, p<0.001,  partial eta squared = 0.012, worry: F [3,3434] = 8.35, 
p<0.001, partial eta squared = 0.010) and after (anxiety:  F [3,3420] =  12.00, 
p<0.001, partial eta squared = 0.014, worry:  F [3,3414] = 7.49, p<0.001, 
partial eta squared = 0.009) screening.  More deprived groups were more 
anxious and more worried about developing bowel cancer both before and 
after screening (see Figures 2 and 3).  The partial eta squared indicated small 
effect sizes.  Anxiety was reduced (F (1,3389) = 27.85, p<0.001, partial eta 
squared = 0.001) from before (STAI mean = 9.83; SE, 0.06) to after screening 
(STAI mean =  9.49; SE, 0.06), but there was no evidence for a differentialChapter 5:  Study 1   95
Figure 2 -  Change in anxiety from before to after screening by quintile of 
socioeconomic deprivation (Area-level).
10.60
10.40 -
10.2 0 -
10.00  -
(A
C
03 a >
E
TJ
aj
C O
3
9.80 -
9.60 -
9.40 -
x c
<
9.20 -
9.00
Post-screening Pre-screening
Deprivation
quintile
▲  1  - affluent
*   2
o  3
X  4
■  5 - deprived
Time
Figure 3 -  Change in bowel cancer worry from before to after screening by 
quintile of socioeconomic deprivation (Area-level).
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Table 2 Area-level deprivation: Change in anxiety and worry about bowel 
cancer from before to after screening, controlling for screening outcome.
Anxiety Bowel cancer worry
Area-level
deprivation
(Townsend) Mean change  95% Cl Mean change  95% Cl
Affluent  1 -0.29  -0.57 to  -0.00 -0.11  -0.16 to  -0.05
2 -0.32  -0.60 to  -0.02 -0.08  -0.14 to  -0.02
3 -0.58  -0.86 to  -0.29 -0.10  -0.16 to  -0.04
4 -0.37  -0.66 to  -0.09 -0.13  -0.19 to  -0.07
Deprived  5 -0.16  -0.45 to  -0.13 -0.10  -0.15 to  -0.04
effect across levels of SES.  Bowel cancer worry also decreased significantly 
over the period of screening (F [1, 3383] = 55.96 p<0.001,  partial eta squared 
= 0.001) (pre-screening worry mean = 1.97; SE,  0.01,  post-screening worry 
mean = 1.87; SE, 0.01) but again the interaction with deprivation was not 
significant.  Table 2 displays the mean change across each level of 
deprivation, showing that the reductions in both anxiety and bowel cancer 
worry were small.
The individual-level marker of deprivation revealed more about the 
socio-economic distribution of the sample.  Table 1  gives details of the 
demographic characteristics of the sample.  As can be seen, although there is 
a roughly equal distribution of those with (51.1%) and without (43.8) 
educational qualifications, very few people did not own a car (9.3%) or theirChapter 5:  Study 1   97
own home (9.5%).  This indicated that the sample had relatively low levels of 
deprivation.  Consequently the individual-level deprivation index had very few 
participants (N = 86, 2.4%) in the highest deprivation category and a 
disproportionate number in the most affluent category (N =  1653, 49.6%).
Similar results were obtained using the individual-level marker of SES 
as to those found using the area-level indicator.  There was a significant effect 
for anxiety and bowel cancer worry, with more deprived groups reporting more 
anxiety worry before (anxiety: F [3, 3324] = 20.16, p<0.001,  partial eta 
squared = 0.018; worry: F[3, 3308] = 29.85, p<0.001, partial eta squared = 
0.026 ) and after screening (anxiety: F [3,3292] =  18.36, p<0.001, partial eta 
squared = 0.016, worry: F [3,3289 =  15.85, p<0.001,  partial eta squared = 
0.014) (see Figures 4 and 5).  Anxiety (F (1,3276) =  10.04, p<0.01, partial eta 
squared = 0.002) and worry (F [1, 3255] =  17.70 p<0.001, partial eta squared 
= 0.001) reduced from before (STAI mean =  10.33; SE,  0.16; worry mean = 
2.08; SE, 0.04) to after screening (STAI mean = 9.78;  SE, 0.17; worry mean = 
1.93; SE,  0.04), but again the interactions with deprivation were not significant 
(see Figures 4 and 5).  Again, all significant results had small effect sizes and 
the mean change in anxiety and worry from before to after screening was 
small across all levels of deprivation (see Table 3).3
3  A series of further analyses collapsing both the Townsend index and the individual level-marker to 
three category systems were carried out and did not reveal any further significant associations.Chapter 5:  Study 1   98
Figure 4 - Change in anxiety from before to after screening by socioeconomic 
deprivation (Individual-level).
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Figure 5 - Change in bowel cancer worry from before to after screening by 
socioeconomic deprivation (Individual-level).
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Table 3 Individual-level deprivation: Change in anxiety and worry about bowel 
cancer from before to after screening, controlling for screening outcome.
Anxiety Bowel cancer worry
Individual-level
deprivation
Mean change 95% Cl Mean change 95% Cl
Affluent 0 -0.56 -0.88 to -0.24 -0.07 -0.14 to  -0.01
1 -0.55 -0.89 to -0.22 -0.16 -0.23 to  -0.09
2 0.11 -0.57 to -0.79 -0.15 -0.29 to  -0.01
Deprived 3 -1.21 -2.30 to -0.11 -0.22 -0.45 to  0.00Chapter 5:  Study 1   100
Post-FS sample
There were  140 cases of cancer identified via screening.  These people 
were not asked to complete a 3-month post-FS questionnaire and were 
followed up separately.  All other participants who attended screening (N = 
40,534) were asked to complete a questionnaire.  In these analyses, data 
from 2,897 Scottish participants and 358 participants from England and 
Wales, for whom the Townsend index scores were not available, were 
excluded.  In addition, the data from the trial’s two pilot centers:  Leicester (N = 
3,893) and Welwyn Garden City (N = 532) were excluded, since the clinical 
procedure was slightly different in these centres.  The possible final sample 
size was therefore 32,854 of whom 29,804 (90.7%) completed a post-FS 
questionnaire.  The FSC group were somewhat less likely to complete the 
questionnaire than the other two outcome groups (x2  = 63.58, df= 2, p<0.001) 
(86.2% vs 95.2%).  Questionnaire completers were more affluent than non­
completers as measured by the Townsend score (F [1, 32853] =  139.16, 
p<0.001).  Men were slightly less likely to complete the questionnaire than 
women (x2  =  16.60, df = 1, p<0.001) (90.0% vs 91.3%) but there was no 
association with age.
The average age of participants was 60.5 years, with  14,876 women 
(49.9%) and  14,928 men (50.1%).  Men were more likely than women to have 
a positive result (x2  = 697.95, df-2,  p<0.001) as expected from their higher 
incidence of bowel cancer.  Participants who had polyp removal (FSP) or 
colonoscopy (FSC) were slightly older (60.60 vs 60.42 years) than those with 
an initially clear result (F[2, 32214] = 16.71, p<0.001).  SES (Townsend 
Index) was also significantly related to screening outcome (x2  =  15.85, df=  1,Chapter 5:  Study 1   101
p<0.01).  21.8% of the most deprived group were referred for colonoscopy 
compared to only 19.6% in the most affluent group.
Scores on the STAI, GHQ and PCQ by SES and screening outcome 
are shown in Table 4.  Overall, the levels of distress (GHQ) and anxiety (STAI) 
in this sample were low compared to other community and population samples 
(e.g. (Evans et al 2004, Marteau & Bekker 1992,  Pevalin & Goldberg 2003)). 
Distress was not associated with SES,  but there was a graded association 
between SES and anxiety (F [4, 28951] = 68.40 p<0.001, partial eta squared = 
0.009).  Ratings of positive consequences of screening (PCQ) were also 
linked to deprivation (F[4, 28997] =  195.91  p<0.001,  partial eta squared =
0.026); but lower SES groups reported more positive consequences of 
screening (Figure 6).
Figure 6 -  The relationship between PCQ scores in relation to screening 
outcome by quintile of socioeconomic deprivation.
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Screening outcome was related to psychological well-being,  but contrary to 
expectation,  psychological well-being was highest in those who had the 
colonoscopy.  This group had the lowest scores for anxiety (F [2, 28239]
=10.38 p<0.001, partial eta squared = 0.001) and distress (F [2, 28239] =
10.38 p<0.001,  partial eta squared = 0.001).  There were no differences in 
positive consequences scores (F [2, 29311] =2.39,  NS) between the outcome 
groups.
Interactions between SES and outcome group were not significant for 
any of the psychological variables: (STAI F [8, 28952] =  1.35, p = 0.21,  PCQ F 
[8, 28998] = 1.50, p = 0.15, GHQ F [8, 27940] =  1.42, p = 0.18).Table 4 The relationship between SES, screening outcome and psychological well-being at the post-screening assessment, controlling for 
age and gender.
Mean (95% Cl)
Screening outcome 
group
Area-level
Deprivation
(Townsend) GHQ PCQ Anxiety
FSN 1 8.82 (8.72-8.92) 14.72 14.58-14.85) 9.41  (9.29-9.52)
(Negative) 2 8.75 (8.65-8.85) 14.99 14.85-15.12) 9.58 (9.46-9.69)
3 8.83 (8.73-8.93) 15.30 15.16-15.43) 9.71  (9.59-9.82)
4 8.75 (8.63-8.84) 15.89 15.76-16.03) 9.95 (9.84-10.07)
5 8.81 (8.70-8.91) 16.76 16.62-16.89) 10.57 (10.45-10.68)
FSP 1 8.67 (8.47-8.86) 14.57 14.32-14.82) 9.42 (9.20-9.63)
(Lower risk polyps) 2 8.71 (8.52-8.90) 14.76 14.52-15.01) 9.69 (9.48-9.60)
3 8.81 (8.62-9.00) 15.50 15.25-15.74) 9.89 (9.68-10.10)
4 8.74 (8.55-8.93) 15.66 15.42-15.90) 10.16(9.95-10.37)
5 7.96 (7.56-8.36) 16.58 16.33-16.84) 10.38 (10.17-10.60)
FSC 1 8.44 (8.02-8.85) 14.51 13.98-15.04) 9.09 (9.63-9.54)
(Colonoscopy) 2 8.42 (8.01-8.84) 14.99 14.44-15.53) 9.13(8.66-9.60)
3 8.20 (7.77-8.62) 15.39 14.84-15.95) 9.33 (8.85-9.81)
4 8.75 (8.36-9.15) 16.08 15.56-16.60) 9.29 (8.84-9.73)
5 7.96 (7.56-8.36) 17.42 16.90-17.94) 9.61  (9.16-10.05)Chapter 5:  Study 1104
Discussion
This aim of this study was to test the hypothesis that there would be an 
association between SES and emotional reactions to a novel stressful 
experience, bowel cancer screening.  Anxiety was higher in lower SES groups 
both before and after screening,  reflecting established differences in 
psychological well-being found in general population studies (Hollingshead & 
Redlich  1958, Lorant et al 2003).  Worry about cancer was also higher, which 
was reported in the Glasgow centre of the FS Trial (Wardle et al 2004), but this 
is not an  issue that has been examined widely. The sample sizes for both the 
longitudinal data and the post-FS sample were large meaning that there was 
adequate power to detect small effect sizes.  All of the significant effects were 
small, but these results were important because there is still a general 
assumption in the screening literature that people will experience increased 
distress as a result of screening.  These results challenge this assumption by 
showing that people can experience small, but significant,  reductions in anxiety 
and worry about cancer after screening has taken place.  The participants in 
this trial clearly did not find the screening experience distressing.
There was little evidence that lower SES groups had more negative 
reactions to screening.  The hypothesis that lower SES groups would have 
additional emotional vulnerability in response to a moderately stressful medical 
procedure did not appear to be supported.  This finding was consistent using 
both the area-level and individual-level indicators of SES.  The Townsend index 
was divided into quintiles and was a measure of relative deprivation within the 
sample whereas the individual-level indicator measured absolute levels of 
deprivation.  There were no differences in  reporting either of significant results 
or of the magnitude of the effect using the two different markers.Chapter 5:  Study 1105
Similar to the findings from other research studies, the two deprivation 
measures were significantly correlated, but at a lower level than might be 
expected.  This implies either that the two measures assess different aspects of 
SES or that one measure is more accurate than the other.  It is not possible to 
come to a definitive conclusion about this,  but given the similarlity of the results 
using the two measures,  I think that either could be useful.  The Townsend 
Index could be used in this study based on data from the  1991  census as the 
data collection period was between  1994 and  1999.  The remaining studies in 
this thesis use new data with collection since 2001, and therefore since the new 
census data has become available.  Problems with using the new census data, 
as discussed in Chapter 4, mean the Townsend  Index may be less relevant as it 
is now based on larger area statistics.
Returning to the results from this study,  I anticipated that the sub-set of 
participants referred for colonoscopic examination would experience greater 
stress because of the additional medical investigation and the greater delay 
before receiving a clear result, and expected that this would create relatively 
more distress in the lower SES groups.  The post-FS sample provided an 
adequate sample size to explore SES differences by screening outcome.
Overall the levels of distress and anxiety were low post-screening.  More 
importantly, they were lower for the two outcome groups who had more 
pathology detected (FSP and FSC outcomes).  People referred for colonoscopy 
also reported the most positive consequences of taking the test.  One possible 
explanation is that people who had a colonoscopy experienced the greatest 
‘relief when the results were received.  If relief is positively valued, then it might, 
at least transiently, give the best outcome.  Results from other screening 
studies have also shown that on receipt of a negative test there can be anChapter 5:  Study 1106 
immediate decrease in distress, again defined in terms of relief because the 
threatening situation is positively resolved (Essink-Bot et al 1998,  Parker et al 
2002, Scaf-Klomp et al 1997).  Contrary to my prediction,  lower SES groups 
were not any more adversely affected by being referred for colonoscopy.  This 
gives no support to the idea that low SES groups have an impaired capacity to 
respond to new difficulties (Kristenson et al 2004), at least in terms of their 
psychological health.  It is possible that lower SES participants benefited to a 
greater extent from the additional attention and health information provided at 
the time of colonoscopy than did others.
Across the groups as a whole,  lower SES was associated with identifying 
more positive psychological consequences of taking the test, despite having 
higher levels of anxiety and worry about cancer.  Previous research has shown 
that individuals may simultaneously feel distress and well-being (Schroevers et 
al 2000, Watson & Clark 1997) but the extent to which demographic and health 
status outcomes relate to levels of positive experiences has not been fully 
explored.  One recent study found that ‘benefit-finding’ increased with more 
severe disease stage,  lower SES and higher negative affect in women with 
breast cancer (Tomich & Helgeson 2004).  The authors argued that the more 
severe the threat, the greater the need to mobilize resources to minimize its 
impact, and finding benefit in the experience is one way of doing this.  If lower 
SES groups typically experience higher levels of life stress, they may have 
more experience of using this strategy to minimize impact.  Supporting evidence 
for this is that individuals who experience more traumatic life events report more 
benefits than those who experience fewer traumas (Cordova et al 2001, 
McFarland & Alvaro 2000).Chapter 5:  Study 1107
The results did not appear to support my original hypotheses regarding 
psychological reactions to stress in low SES groups raising the possibility that 
the conditions in which the hypotheses were tested were not satisfactory.  A 
limitation of the study design was that only people who had expressed an 
interest in the test were subsequently invited to take part in the trial.  This 
introduced a bias in the selection of the participants according to SES.  Higher 
SES participants were more likely to express an interest in taking the FS test 
and so were more likely to be invited to take part (McCaffery et al 2001) and 
also more likely to attend (Sutton et al 2000).  This same bias is seen in all 
national screening programmes as well as in countries that use opportunistic 
screening (Fong Chiu 2003, Schootman et al 2003).  However, it’s not clear that 
this SES gradient in participation should explain why the lower SES groups had 
a more positive reaction to the test.
A second limitation is that the timing of the post-FS survey may have 
been too long after the screening took place and any transient differences in 
reactions to the test may have subsided during the 3 months after the test.  But 
in the colonoscopy group, follow-up was only 4-6 weeks after the result on 
average, and less in some groups.  In addition, all participants in the study had 
low levels of distress at follow-up.  This could be because trial situations 
introduce a “Hawthorne effect” whereby clinic staff provide greater reassurance 
and information than would be usual outside of a trial setting.  A review of this 
effect found only limited evidence in support of this idea (Braunholtz et al 2001). 
The low levels of distress also suggest that the stress experienced by people 
was not severe enough to allow any differences by SES to be displayed.  There 
is increasing evidence that a clear screening test, even if more than one 
investigation is required before the all-clear,  is a positive experience for someChapter 5:  Study 1108 
people;  perhaps as a reprieve from persistent worry, or in terms of relief after 
the stress of the procedure, as previously discussed.  Future studies should 
address these limitations by choosing a situation that is both non-voluntary and 
highly stressful.
This research is important despite these limitations.  It shows that, of the 
people who do come to take these tests, low SES participants experience a 
reduction in distress similar in magnitude to high SES participants, and may 
even perceive more positive consequences of participating in screening.  There 
is no reason to think that the same would not be true for similar routine 
screening situations.  This study demonstrates that despite expectations,  lower 
SES groups were able to gain as much, if not more,  psychological benefit from 
undergoing screening as more privileged groups.  Few studies have examined 
SES differences in psychological reactions to stressors.  These results suggest 
that low SES groups may be more resilient to novel stressors than previously 
expected (Taylor 1998).  The subsequent studies of this thesis aim to pursue 
this idea and discover whether these findings are consistent across different 
situations.Chapter 6:  Study 2109
CHAPTER 6
Study 2:  Socioeconomic status and psychosocial outcomes in bowel cancer
patients4
Introduction
The results from Study 1   indicated that there were no SES differences in 
psychological adjustment to bowel cancer screening.  The screening did not 
appear to be a particularly stressful experience for the majority of participants. 
Psychological differences by SES in adjustment to medical stressors may only 
occur during more extremely stressful encounters.  This study will explore 
reactions to a much more serious stressor, i.e.  being diagnosed with colorectal 
cancer.
As discussed in Chapter 2,  receiving a cancer diagnosis represents a 
major psychological challenge that can lead to increased symptoms of 
depression and anxiety and impaired quality of life.  Being diagnosed with 
cancer also impacts on relationships with family and friends and consequently 
on the levels of social support the person receives during their illness.  New 
relationships with medical staff have to be formed and the quality of these 
relationships is likely to be another significant factor in coping with the disease. 
Cancer and its treatments can also impose a variety of physical and functional 
disabilities which in turn can affect the patient’s ability to work or to maintain 
independence.
As in the previous study,  I will test the hypothesis that SES will interact 
with characteristics of the stressful situation and result in more adverse
4 Parts of this chapter have been submitted for publication to P s y c h o o n c o lo g y and a copy is included in 
Appendix VI.Chapter 6:  Study 2110 
psychosocial outcomes for those from more deprived backgrounds.  Study 1  
examined differences in psychological adjustment over time and interactions 
with screening outcomes.  In this study,  I propose to cross-sectionally examine 
SES interactions with characteristics of the cancer diagnosis.  I propose that 
disease stage at diagnosis is a factor that might affect psychological 
adjustment, although research findings have been inconsistent (also discussed 
in Chapter 2).
The present study examines the impact of disease stage and SES on 
emotional, social, physical and functional outcomes in colorectal cancer 
patients.  A recent systematic review of research into social disparities in 
colorectal cancer patients concluded that there is still a lack of studies that 
explore the links between disparities and quality-of-life outcomes (Palmer & 
Schneider 2005).  I hypothesized that people with lower SES and more 
advanced disease would experience more psychosocial problems, and that the 
greater threat of an advanced stage diagnosis would widen the difference in 
adjustment between low and high SES patients.
Hypotheses
1.  Lower SES patients with a diagnosis of colorectal cancer will have worse 
emotional, social, physical and functional outcomes.
2.  Patients with a diagnosis of more advanced colorectal cancer disease stage 
will have worse emotional, social,  physical and functional outcomes.
3.  There will be an interaction between SES and disease stage on 
psychosocial outcomes such that low SES patients with advanced disease will 
have worse emotional, social, physical and functional outcomes than higher 
SES patients with equivalent disease stage.Chapter 6:  Study 2111
Method
Participants
This was a survey of all patients who had received a diagnosis of colorectal 
cancer at a single hospital in Southern England over a one-year period (July 
2002-July 2003).  290 patients with colorectal cancer attended the participating 
hospital over the trial period, of which 231  were alive at the time of the survey. 
Patients’ GPs were contacted one month prior to the survey so that they could 
exclude their patients if they were too ill to participate; this resulted in  19 
exclusions.  212 patients were therefore sent a postal questionnaire.  95 (45%) 
initially returned a completed questionnaire.  A further 11  patients declined 
participation, citing reasons ranging from feeling too unwell to feeling too well 
and not wanting to be reminded about cancer.  After one month non-responders 
were contacted again and a further 33 patients sent back a completed 
questionnaire.  In total 128/212 (60.4%) people completed and returned the 
questionnaire.
Design and Procedure
This was a cross-sectional survey sampling all new cases of colorectal 
cancer seen at the participating hospital during the trial period.  Potential 
participants were identified via the hospital database.  Patients were sent an 
introductory letter,  patient information sheet, questionnaire and freepost 
envelope.  The patient information sheet and questionnaire contained the 
contact details of a researcher.  Potential participants were invited to contact the 
researcher with any questions regarding the study.  Hospital staff sent out 
questionnaire packs which were returned anonymously to the research staff.Chapter 6:  Study 2112
Questionnaires were numbered and linked to details in the hospital database to 
allow the hospital staff to send a reminder to non-responders after a month. 
Return of the questionnaire was taken as an indication of consent to participate 
in the questionnaire phase of the research. Additional formal consent was 
sought for access to the patient’s medical records.  Returned questionnaires 
were numbered and not named so that data returned to UCL was anonymous. 
Participants completed a self-report questionnaire on quality of life, social 
problems, experience of medical care, social support, anxiety and depression. 
Demographic information included ethnicity, gender,  and socio-economic status 
(SES) (see Appendix VII).
Ethical approval was obtained from the Isle of Wight,  Portsmouth and 
South East Hampshire Local Research Ethics Committee (see Appendix VIII).
Measures
Socio-economic status
Socio-economic status (SES) was indexed using the same individual- 
level indicator described in Study 1.  Three items reflecting material 
circumstances and education were assessed: car-ownership or not (score 0/1), 
home-ownership or not, and some higher education versus none.  This resulted 
in a composite score from 0 to 3, with ‘3’ representing the highest deprivation. 
There were very few participants in the most deprived category (N = 8), so, for 
the purpose of analyses, this category was combined with the next level of 
deprivation.  This resulted in three categories of socio-economic deprivation: 
affluent (score 0), medium (score 1) and high deprivation (score 2-3) (car- 
owner,  home-owner and higher education).
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Disease stage was measured using the Duke’s classification system with 
data taken from patient’s medical records.  A: the tumour penetrates the 
mucosa of the bowel wall but no further.  B: the tumour penetrates into and/or 
through the muscular layer of the bowel wall.  C1: the tumour penetrates into, 
but not through, the muscular layer of the bowel wall and there is evidence of 
colon cancer in the lymph nodes.  C2: the tumour penetrates through the 
muscular layer of the bowel wall and there is evidence of colon cancer in the 
lymph nodes.  D: the cancer has spread throughout the body and there are 
distant metastases e.g.  in the liver or lung.
Quality of Life
Quality of life was assessed using the Functional Assessment of Cancer 
Therapy Colorectal version (FACT-C) (Ward et al  1999).  This has five 
subscales:  physical (7 items, e.g. ‘I have pain’), functional (7 items, e.g.  ‘  I am 
able to enjoy the things I  usually do for fun’), social/family (7 items, e.g.  ‘I get 
emotional support from my family), emotional well-being (6 items e.g.  ‘I feel 
nervous’) and a colorectal-specific subscale (7 items e.g.  ‘I have control of my 
bowels’).  Participants indicate how true each statement is for them during the 
past seven days.  There are five response options from ‘not at all’ to ‘very 
much’.  The scale range is 0 to 24 for the 6-item scale and 0 to 28 for the 7-item 
scales, with higher scores indicating better quality of life.  A total score is 
computed from the sum of the physical, functional, social/family and emotional 
subscales, with a range from 0 to 108.  The FACT-C has good internal 
reliability (overall: a = 0.91, subscales: a range = 0.71-0.88) and an ability to 
distinguish between groups based on their functional status and extent of 
disease (Ward et al  1999).
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Social support was measured using the Multidimensional Scale of 
Perceived Social Support (MSPSS) (Zimet et al  1988).  The MSPSS is a 
measure of the subjective assessment of social support adequacy.  It is a  12- 
item scale with three subscales (4 items each) examining support from family 
(e.g.  ‘my family really tries to help me’), friends (e.g. ‘I can count on my friends 
when things go wrong’), and significant other (e.g.  There is a special person 
who is around when  I am in need’).  Participants are asked how much they 
agree or disagree with each statement.  A five-point response rating scale was 
used from ‘strongly disagree’ to ‘strongly agree’.  The scale range is 1  to 60 with 
higher scores indicating better support.
Social Difficulties
The Social Difficulties Inventory (SPI) (Wright et al 2005) is a 21-item 
questionnaire designed for use in oncology care.  It covers problems in 
managing personal care, domestic chores and responsibilities, finances and 
benefits, employment, relationships, sexuality and body image, mobility and 
leisure activities.  Participants rate whether they have experienced any 
difficulties over the past month.  There are four response options with a range 
from ‘no difficulty’ to ‘very much’.  Participants mark the ‘no difficulty’ box if the 
question does not apply to them.  The scale range is 0 to 63 with higher scores 
indicating more social problems.
Medical Interactions
Communication with medical staff was assessed using the 4-item 
subscale from the Cancer Evaluation and Rehabilitation System -  Short Form 
(CARES-SF) (Schag CA & Heinrich RL 1988).  The items refer to levels of 
information provided, understanding the information provided,  levels of control 
over treatment, and difficulty asking questions.  Participants are asked howChapter 6:  Study 2115 
much each statement applies to them during the past month (Schag CA & 
Heinrich RL 1988).  For example: ‘I find that the medical team withholds 
information from me about the cancer’.  There are five response options from 
‘not at all’ to ‘very much’.  Items are summed and divided by the number of 
items answered,  resulting in a scale from 0 to 4.  Higher scores indicate poorer 
communication with medical staff.
Psychological Well-being
Depression was measured with the Centre for Epidemiological Studies 
Depression Scale (CES-D) (Radloff LS  1977).  This scale asks about feelings 
over the past week and the number of days that they felt that way.  For 
example:  “I was bothered by things that don’t usually bother me” with response 
options from ‘rarely,  none of the time (less than one day)’, to ‘most or all of the 
time (5-7 days)’.  The shorter 10-item version (Kohout et al  1993) was used, 
but retained the original response options.  The CES-D is scored 0-3.  Items are 
summed to form a scale that ranges from 0 to 30 with higher scores indicating 
more depression.
Anxiety was assessed using the Hospital Anxiety and  Depression Scale 
(HADS) anxiety scale (HADS-A, 7 items) (Zigmond & Snaith  1983).
Participants rate how they have usually felt over the past week.  For example 
‘worrying thoughts go through my mind’ with the response options ‘a great deal 
of the time,  ‘a lot of the time’, ‘from time to time but not too often’ and ‘only 
occasionally’.  Each item has four response options that vary slightly according 
to the statement.  Positively worded statements (e.g.  ‘I can sit at ease and feel 
relaxed) are reversed scored.  Items are scored 0 to 3 and summed to form a 
scale ranging from 0 to 21, with higher scores indicating more anxiety.Chapter 6:  Study 2116
Analyses
Data were analyzed using analysis of variance with SES group and 
disease stage as the independent variables, and age as a control variable. 
Missing data on individual items were replaced using the subject mean for each 
subscale if at least half of the items had been completed (Fairclough DL & Celia 
1996).
I hypothesized that lower SES and more advanced disease would be 
associated with poorer outcomes.  I also hypothesized that the worst prognoses 
(Dukes stage C2,  D and those receiving palliative care) would be particularly 
stressful for lower SES participants, and so I predicted a disease stage by SES 
interaction.
Results
128/212 (60.4%) questionnaires were returned.  Table  1   shows the 
demographic and medical characteristics of the sample.  Participants were 52% 
male (N = 65) and 48% female (N = 60) (missing:  n = 3).  100% were white. 
Their mean age was 70.2 (SD = 10.7), with a range from 36 to 89.  The 
breakdown of the socio-economic markers showed that there was a roughly 
equal distribution of participants with (42.2%) and without (46.1%) educational 
qualifications.  74.2% of the sample were car owners, which was slightly lower 
than the national ownership figures (77% (Rickards et al 2004)) whereas home 
ownership (75% of the sample) was somewhat higher than national figures 
(69% (Rickards et al 2004)).  There were no differences between  responders 
and non-responders in terms of either age, gender or residential area 
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Disease stage was indexed using the Duke’s classification system with 
data taken from patient’s medical records.  Disease stage information was 
available for 86% (N = 110) of participants.  10 participants did not give consent 
for their medical records to be examined.  A further 8 patients were excluded 
from the analyses.  Staging information was not obtained for two patients that 
declined treatment and one patient who did not have surgery due to the 
presence of another co-morbid condition.  A further four patients were excluded 
because they had anal squamous cancers and one patient was excluded 
because the diagnosis was appendiceal cancer.  The majority of participants 
(54.7%) had a Dukes stage B or C1  diagnosis (Table  1).  11  (8.6%) participants 
had a Dukes D stage or were receiving palliative care and  12 (9.4%) 
participants had a Dukes C2 diagnosis; these two categories were combined to 
form one advanced stage category in the subsequent analyses.  Neither age nor 
gender were related to disease stage.
Lower SES participants were older (F (1,103) =  12.34 p<0.001) and more 
were female (%2 = 4.24, df= 1, p<0.05).  The average time between diagnosis 
and completing the questionnaire was 257 days (SD =112 days).  Time since 
diagnosis was not related to either disease stage or SES.
Patients with more advanced disease had poorer quality of life for all 
except one of the FACT-C subscales (see Table 2).  They had worse physical 
well-being (F (1,108) = 3.74 p <0.01), functional well-being (F (1,109) = 3.67 
p<0.01), emotional well-being (F (1,109) = 3.73 p<0.01), and colorectal 
symptoms (F (1,110) = 2.67 p<0.01), and a much  lower overall score (F (1,108) 
= 5.71  p<0.001).  The only scale that did not show differences was theChapter 6:  Study 2118
Table 1   Demographic and medical characteristics
N (N = 128) %
Disease A 17 13.3
stage B 41 32.0
C1 29 22.7
C2 12 9.4
D and palliative 11 8.6
Exclusions and refusals 18 14.1
Gender Male 65 50.8
Female 60 46.9
Missing 3 2.3
Education No formal qualifications 59 46.1
Some formal qualifications 54 42.2
Missing 15 11.7
Car owner None 29 22.7
One 70 54.7
More than one 25 19.5
Missing 4 3.1
Home owner Own 96 75.0
Rent 20 15.6
Other 9 7.1
Missing 3 2.3Chapter 6:  Study 2119 
social/family subscale.  More advanced disease stage was related to the 
perception of receiving less social support (overall MSPSS score: F (1,107) = 
2.57 p <0.05) particularly from ‘significant others’ (F (1,106) = 2.86 p<0.01) but 
there was no difference in support received from friends.  Patients with more 
advanced disease were also more anxious (F (1,108) = 3.32 p<0.01) and 
depressed (F (1,108) = 6.92 p<0.001) and experienced more social problems (F 
(1,109) = 2.674 p<0.05).  Quality of medical interactions did not significantly 
differ by disease stage.  The partial eta squared statistic (Table 2) indicated that 
the effect sizes ranged from small (from 0.01  to 0.08) to medium (from 0.09 to 
0.24) derived by squaring Cohen’s r criteria for small,  medium and large effect 
sizes (Cohen  1988).
SES was related to the overall quality of life score (F (1,101) = 3.58 
p<0.01) and the physical well-being subscale (F (1,101) = 2.99 p<0.05) with the 
lower SES participants having less physical ability and worse overall quality of 
life (Table 3).  Low SES participants also perceived that they had less social 
support (MSPSS total score: F (1,01) = 2.48 p<0.05),  particularly from family 
members (F (1,100) = 2.86 p<0.05) and significant others (F (1,100) = 2.92 
p<0.05), although there was no difference in support from friends.  Lower SES 
was also associated with higher anxiety (F (1,102) = 3.88 p<0.01) and 
depression (F (1,102) = 4.03 p<0.01).  Low SES groups reported the least 
satisfaction with medical staff interactions (F (1,103) = 5.13 p<0.01), and the 
highest level of social problems (F (1,102) = 4.24 p<0.01).  Again the partial eta 
squared statistic showed effect sizes in the small to medium range (Table 3).
There were significant interactions between SES and disease stage for 
anxiety (Figure 1  A) (F (6,102) = 2.63, p<0.05), and perceived social support 
from families (Figure  1B) (F (6,100) = 2.63, p<0.05) (See Table 4 for Means andTable 2 The relationships between psychosocial resources, quality of life, psychological distress and disease stage, controlling for
age
Dependent Variables Disease Stage - U ean (95% Cl)
Linear Univariate 
ANOVA P-value
Partial eta 
squared
A
(n = 17)
B
(n = 41)
C1
(n = 29)
C2/D/Palliative 
(n = 23)
Quality of Life
Physical 24.9 (22.6-27.2) 24.7 (23.3-26.2) 22.9(21.1-24.8) 20.9(18.9-23.0) P = 0.005 0.039
Functional 22.0(19.1-25.0) 21.3(19.4-23.2) 19.6(16.7-21.4) 16.7(14.1-19.2) P = 0.003 0.088
Emotional 20.2(17.9-22.4) 20.4(19.0-21.9) 18.8(17.1-20.6) 16.5(14.6-18.5) P = 0.008 0.063
Social/Family 21.3(18.7-23.9) 23.2 (21.5-24.8) 19.9(17.8-21.9) 20.7(18.5-22.9) P = 0.367 0.097
Colorectal 22.2(19.6-24.8) 21.2(19.5-22.9) 20.0(18.0-22.1) 17.8(15.5-20.1) P = 0.009 0.126
Overall 88.3(81.1-95.6) 89.6 (84.9-94.2) 80.4 (74.6-86.2) 74.8(68.5-81.0) P = 0.001 0.124
Social Support
Family 18.5(16.8-20.1) 18.4(17.4-19.4) 16.7 (15.7-18.0) 17.2(15.9-18.5) P = 0.104 0.059
Friends 17.3(15.7-18.8) 17.6(16.6-18.5) 16.3(15.1-17.5) 16.0(14.7-17.4) P = 0.108 0.052
Significant Other 19.1  (17.6-20.6) 18.8^17.9-19.8) 17.8(16.7-18.9) 16.8(15.6-18.1) P = 0.011 0.126
Overall 54.8 (50.8-58.8) 54.7 (52.2-57.2) 50.9 (47.8-53.9) 50.0 (46.7-53.3) P = 0.026 0.092
Psychological Distress
Anxiety 2.8 (0.9-4.7) 3.2 (2.0-4.4) 4.1  (2.7-5.6) 6.1  (4.5-7.6) P = 0.007 0.052
Depression 2.7 (0.3-5.1) 4.7 (3.2-6.2) 6.4 (4.6-8.2) 9.4 (7.3-11.4) P = 0.000 0.163
Medical Interactions 0.3 (0.0-0.6) 0.2 (0.0-0.4) 0.3 (0.1-0.6) 0.6 (0.3-0.8) P = 0.189 0.036
Social Difficulties 5.3 (2.0-8.8) 5.4 (3.2-7.6) 9.0(6.4-11.7) 9.4 (6.5-12.3) P = 0.026 0.065Table 3 The relationships between psychosocial resources, quality of life, psychological distress and socio-economic deprivation,
controlling for age
Dependent Variables Socio-economic deprivation - Mean (95% Cl)
Linear Univariate 
ANOVA P-value
Partial eta 
squared
Affluent 
(n = 42)
Medium 
(n = 46)
Deprived 
(n = 28)
Quality of Life
Physical 25.0 (23.2-26.7) 23.4 (21.7-25.0) 21.6(19.5-23.7) P = 0.017 0.071
Functional 20.7(18.4-23.1) 20.3(18.0-22.5) 17.1  (14.2-20.0) P = 0.060 0.101
Emotional 19.8(18.2-21.3) 19.5(18.1-21.0) 17.9(16.1-19.8) P = 0.132 0.030
Social/Family 22.3 (20.3-24.4) 20.6(18.6-22.6) 19.6(17.0-22.1) P = 0.104 0.056
Colorectal 21.8(19.8-23.8) 20.6 (18.7-22.5) 18.9(16.5-21.3) P = 0.068 0.056
Overall 87.7 (82.4-93.1) 83.6 (78.3-88.8) 76.2 (69.6-82.8) P = 0.009 0.128
Social Support
Family 18.0(17.0-19.0) 18.0(17.0-19.0) 16.1  (14.8-17.5) P = 0.036 0.059
Friends 16.8(15.6-18.0) 16.7 (15.5-17.8) 16.2(14.6-17.9) P = 0.605 0.039
Significant Other 18.1  (17.0-19.1) 18.3(17.3-19.3) 16.4(15.1-17.7) P = 0.050 0.035
Overall 52.8 (50.0-55.6) 53.0 (50.3-55.7) 48.4(45.0-51.9) P = 0.054 0.055
Psychological Distress
Anxiety 2.7(1.5-3.9) 4.3(3.1-5.4) 5.2 (3.7-6.6) P = 0.010 0.092
Depression 5.1  (3.3-6.9) 5.2 (3.5-6.9) 8.9(6.6-11.1) P = 0.011 0.113
Medical Interactions 0.1  (-0.1-0.3) 0.5 (0.3-0.7) 0.6 (0.3-0.8) P = 0.004 0.135
Social Difficulties 5.0 (2.3-7.7) 6.4 (3.8-9.0) 11.1  (7.8-14.4) P = 0.005 0.119Chapter 6:  Study 2
95% Cl).  Among high SES patients, anxiety remained low across all disease 
stages whereas lower SES participants with advanced disease had much higher 
levels of anxiety.  Specifically, the significant difference lay between the deprived 
and affluent groups with a C2 or D diagnosis (Deprived group anxiety:  M = 6.71, 
95% Cl = 4.47-8.96, vs Affluent group anxiety:  M = 1.61, 95% Cl = -0.99 -  4.20). 
For social support, the low SES participants with a C2 or D diagnosis experienced 
much less support, particularly from their families (Deprived group family social 
support:  M =  13.86, 95% Cl = 11.82-15.90 vs Medium group:  M =  19.09, 95% Cl = 
17.07-21.12 and Affluent group:  M = 18.65 95% Cl =  16.23-21.01).  Both 
interactions had effect sizes in the medium range (partial eta squared, anxiety =
0.123, familial social support = 0.116).
The interactions for the other psychosocial outcomes did not reach 
statistical significance,  but the patterns were similar.  Examples of these 
relationships are shown in Figures 1C to 1F.  For example, the graph showing the 
relationship between SES, disease stage and medical interactions (Figure 1F) is 
comparable to the distribution seen in the anxiety graph in that it is the high SES 
participants who maintain good levels of communication across the disease stages 
while lower SES participants experience worse communication with higher disease 
stage.  Although some of these graphs indicate a possible interaction between 
SES and disease stage in terms of psychosocial outcomes, the overlapping 
confidence intervals seen in Table 4 demonstrate that these relationships were not 
statistically significant.Chapter 6:  Study 2
Figure 1  -  The relationships between socio-economic deprivation, disease stage 
and psychosocial outcomes
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Figure 1F -  Medical Interactions
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Duke's stageTable 4 Relationships between socio-economic deprivation, disease stage and psychosocial outcomes, controlling for age
Disease
stage
Socio­
economic
deprivation
Dependent Variables - Mean (95%CI)
Anxiety Familial Social 
Support
Depression Social Difficulties Quality of Life Medical
Interactions
A Affluent 3.69(1.44-5.93) 18.52(16.49-20.56) 2.76 (-0.53-6.06) 3.58 (-1.28-0.84) 91.39 (81.29-101.50) 0.20 (-0.17-0.57)
Medium 2.30 (-0.56-5.14) 17.83(15.24-20.42) 2.32 (-1.87-6.50) 5.08 (-1.08-11.25) 86.99 (74.15-99.82) 0.62 (0.15-1.09)
Deprived 1.15 (-2.51-4.81) 20.10(16.04-24.15) 2.75 (-2.63-8.13) 7.96 (0.04-15.88) 91.28 (74.80-107.76) 0.16 (-0.44-0.77)
B Affluent 2.73 (0.98-4.48) 17.73(16.14-19.32) 3.67(1.10-6.25) 8.91 (3.22-14.60) 91.44 (83.55-99.33) 0.04 (-0.25-0.33)
Medium 3.27(1.78-4.76) 19.05(17.70-20.41) 4.40 (2.20-6.59) 4.76 (1.53-7.98) 90.44 (83.73-97.16) 0.16 (-0.09-0.40)
Deprived 4.01  (1.38-6.64) 17.40(15.01-19.79) 6.67 (2.80-10.53) 4.46 (0.67-8.25) 83.87 (72.03-95.71) 0.24 (-0.20-0.67)
C1 Affluent 3.26(1.46-5.06) 18.06(16.43-19.69) 5.30 (2.67-7.94) 8.06 (4.18-11.95) 84.00 (73.94-94.05) 0.11 (-0.19-0.41)
Medium 2.68 (0.57-4.79) 15.71 (13.68-17.73) 5.37 (2.27-8.46) 7.29 (2.46-12.12) 84.29 (76.19-92.38) 0.24 (-0.11-0.59)
Deprived 6.63 (3.79-9.47) 16.95 (14.37-19.53) 8.78 (4.98-12.58) 11.93 (6.33-17.53) 72.11  (59.32-84.90) 0.73 (0.30-1.15)
C2IDI
Palliative
Affluent 1.61 (-0.99-4.20) 18.65(16.29-21.01) 6.08 (2.26-9.89) 5.07  (-0.56-10.69) 85.71  (74.02-97.41) 0.16 (-0.27-0.59)
Medium 7.41 (5.18-8.64) 19.09 (17.07-21.12) 8.86 (5.59-12.14) 10.06 (5.24-14.89) 72.20 (62.15-82.24) 0.61 (0.24-0.98)
Deprived 6.71 (4.47-8.96) 13.86(11.82-15.90) 11.90 (8.39-15.41) 12.83 (7.97-17.68) 70.71 (60.60-80.82) 0.87 (0.50-1.24)Chapter 6:  Study 2 127
Discussion
The aim of this study was to explore the relationships between disease 
stage, SES and psychosocial outcomes.  I hypothesized that patients with low 
SES and more advanced disease would be at high-risk for poor psychosocial 
adjustment.  I proposed that the increased stress of a more advanced cancer 
diagnosis would have a greater adverse impact on people with a low SES 
background compared to those with a high SES background.
The results of this study showed that more advanced disease was related 
to worse outcomes on almost every measure.  The existing literature in this area 
focuses mainly on breast cancer patients and the conclusions are inconsistent; 
perhaps because patients with advanced disease are often examined separately 
(Pinder et al  1993) and not compared to patients with other diagnoses.  It is also 
more difficult to recruit and retain patients with advanced disease (Bleiker et al 
2000).  In our study,  patients with a C2 or D diagnosis had an incrementally larger 
difference in adjustment compared with the differences between the other stages. 
This highlights the importance of including patients with advanced disease in 
comparative research studies, where possible, and indicates that there are 
significant unmet psychosocial needs in this group of patients.  Including patients 
with very advanced disease in research studies is not always feasible or 
appropriate, either for the patients or in terms of efficient research design.  If those 
with more advanced disease stage are experiencing high levels of distress then 
involvement in psychological research may be too intrusive.  Equally, within the 
context of smaller longitudinal studies, the high mortality associated with advanced 
disease could compromise the effectiveness of statistical analyses.Chapter 6:  Study 2 128
Lower SES was also associated with worse psychosocial outcomes across 
the board, with poorer psychological well-being,  less social support, poorer quality- 
of-life, more social difficulties and less satisfaction with medical interactions.  A 
relationship between SES and psychological well-being in cancer patients has 
been found in other studies (Dean 1987, Macleod et al 2004) but  there is little 
literature that examines SES differences in the quality of communications with 
medical staff.  Socio-economically deprived women reported receiving less 
information from a hospital specialist than more affluent women in a study of 177 
breast cancer patients (Macleod et al 2004).  Doctors have also been found to 
communicate better with people they perceive to be of the same social class as 
themselves (van Ryn & Fu 2003).  Our data also show that low SES patients are 
less satisfied with their interactions with medical staff.  The differences in ratings 
between SES groups although small represented a medium effect size.  Training 
medical staff to communicate well with their patients is important (Fallowfield & 
Jenkins 2004) and one focus of this training should be on patients who are 
culturally, socially or economically different from the doctors or nurses themselves.
Lower SES patients also experienced more social problems across work, 
finances,  relationship and physical functioning/mobility.  A number of studies have 
reported increased social difficulties amongst cancer patients (Malone et al  1994, 
Taskila-Abrandt et al 2005), but few have also examined the impact of SES.  One 
other study has shown that lower SES patients worry more about money and have 
more family problems (Macleod et al 2004), but this area is under-explored.  The 
higher level of social problems in lower SES patients means that there is a greater 
challenge to psychological health.Chapter 6:  Study 2 129
Analyzing the interactions between SES and disease stage provided some 
evidence that the gap in adjustment between higher and lower SES groups widens 
with increasing disease stage.  Higher SES patients reported lower levels of 
anxiety regardless of their disease stage, whereas lower SES patients with higher 
disease stage had higher anxiety.  This interaction suggests a protective effect of 
being in a high SES group.  For social support, the low SES patients experienced 
far less support,  particularly from their family, when they had a C2/D diagnosis 
compared to higher SES patients.  Levels of social support for other disease 
stages were comparable across SES groups.  Although levels of both anxiety and 
social support are socially distributed throughout the general population 
(Mickelson & Kubzansky 2003, Office for National Statistics 2000) these findings 
demonstrate that these SES differences are exacerbated in a situation of severe 
stress, in this case, by being diagnosed with advanced stage cancer.
These findings complement the study by Janz et al (2005) which showed 
that treatments (particularly chemotherapy) can also have a substantially worse 
impact,  in terms of quality of life,  in patients with less education.  These results 
support the hypotheses of this study and are in contrast to the null findings of 
Study 1.  This suggests that SES differentials in adjustment to medical stressors 
may only be important during the most stressful circumstances.  A detailed 
comparison between the results of Study 1  and this study cannot be achieved 
because different measures of psychological adjustment were used in each case.
This study contributes to an initial picture of how lower SES can adversely 
affect psychological reactions to different medical stressors, but there are 
limitations to the study.  The sample size was relatively small, and like otherChapter 6:  Study 2130
studies, there were difficulties recruiting participants with advanced disease (C2:  n 
=12;  D or palliative:  n =  11).  The response rate was only moderate (60.4%), 
although there were no differences between responders and non-responders in 
terms of age, gender or residential area deprivation.  These results must be 
considered preliminary and there is a need to replicate the results.  A longitudinal 
research design would also give better data on SES differences in adjustment over 
time.  However, the message from these results is that the psychosocial burden of 
colorectal cancer is significantly greater in those with more advanced disease and 
greatest among patients whose material and educational backgrounds make it 
more difficult to cope with this additional stress.  Fortunately, there is some 
evidence that low SES groups with cancer respond well to interventions to improve 
quality of life (McEvoy & McCorkle 1990, Taylor et al 2003), suggesting that 
provision of extra support services could have a beneficial effect.  This study also 
contributes to our understanding of individual differences in reactions to cancer- 
related stressors.  These results further our knowledge of how SES can affect 
reactions to stress leading to better awareness of the ways in which inequalities in 
psychological health arise.Chapter 6:  Study 2131
CHAPTER 7
Study 3:  Qualitative investigation of educational differences in colorectal cancer
patients’ experiences of oncology care
Introduction
Satisfaction with care in oncology is a key goal in terms of delivery of 
services and an important area of research.  Medical staff can be trained to 
improve their performance (Fallowfield et al 2003) and understanding the factors 
that influence patient satisfaction can help to target these training interventions. 
This topic is discussed in more detail in Chapter 2.  In Study 2,  I assessed 
satisfaction with care in a sample of 128 colorectal cancer patients and found that 
lower SES was related to slightly less satisfaction with interactions with medical 
staff and there was a medium effect size.  However, the survey method employed 
in Study 2 did not explore this issue fully.  Lower SES participants could have 
found it harder to complete the survey because of lower health literacy (Davis et al 
2002), and important dimensions of (dis)satisfaction could have been missed 
using the survey method.  Qualitative interviews to explore these issues will help 
to provide a basis for developing appropriate research tools and identifying issues 
for future quantitative studies.
Arguably, qualitative interviews could be more effective at revealing 
dissatisfaction than quantitative surveys because they set no limits to the domains 
of dissatisfaction and allow patients to answer in their own terms.  Qualitative 
research may also have particular clinical relevance because its descriptive ability 
imparts greater awareness of the social dynamics of medical encounters to theChapter 7:  Study 3 132 
reader.  Physicians who read qualitative research studies can identify with the 
situations described and use the results to negotiate similar social settings 
(Giacomini & Cook 2000).
None of the qualitative studies looking at patient satisfaction discussed in 
Chapter 2 have specifically addressed socio-economic status (SES) differences in 
satisfaction.  The current study uses a qualitative approach to explore cancer 
patients’ experiences with medical care.  Supplementary quantitative information 
was also obtained to examine the correspondence between the two methods. 
Colorectal cancer patients provided a mixed-gender sample, and purposive 
sampling according to neighbourhood characteristics ensured inclusion of 
participants from a wide range of social backgrounds.
Aims
This is an exploratory qualitative study and, as such, there are no set hypotheses. 
The aims of the study are:
1.  To examine colorectal cancer patients’ experiences and satisfaction with 
medical care.
2.  To examine the reasons given for patient (dis)satisfaction.
3.  To compare levels of satisfaction between patients with high and low levels of 
further education.
4.  To compare survey and interview methods as a means of collecting information 
about patient (dis)satisfaction.Chapter 7:  Study 3 133
Method
Using qualitative and quantitative methods
Qualitative and quantitative research have traditionally been considered 
mutually exclusive methodologies due to their differing epistemological stances i.e. 
constructivist versus realist.  This boundary has become considerably blurred in 
recent years with researchers from both traditions acknowledging the utility of 
different research methods (Foss & Ellefsen 2002, Malterud 2001, Sandelowski 
2000).  I am using a qualitative method in addition to a quantitative method in this 
study in order to gain a better understanding of the meaning and implications of 
the findings as well as to expand the knowledge gained from the prior survey 
(Study 2).  Using mixed methods may increase the power of analytic studies as 
the complexity of interactions demand more complex research designs to 
understand them (Sandelowski 2000).
The majority of my thesis is based around quantitative analyses of survey 
data and as such I can be considered to have taken a ‘realist’ approach.  In this 
study,  I have chosen a qualitative method that lends itself to the realist approach: 
content analysis.  Content analysis counts and measures interview statements, 
implying that there is a measurable, objective ‘truth’.  As such, any content 
analysis needs to be more overtly replicable than other forms of qualitative 
research as it purports to be as close to an objective analysis as possible.  This 
means that there needs to be a clear ‘paper trail’,  including measures of reliability 
(e.g. inter-rater reliability) which can be easily understood by independent people. 
Boyatzis (Boyatzis 1998) proposes that this kind of thematic analysis with reliabilityChapter 7:  Study 3 134 
testing provides a ‘conceptual bridge’ between quantitative and qualitative 
methodologies.
Content analysis
Content analysis is a form of thematic analysis.  It is semi-qualitative in 
nature in that interview data is transformed  into numeric data that can be 
quantitatively analysed.  Content analysis involves assigning numeric codes to 
segments of texts according to predefined coding rules.  Codes can be determined 
inductively, from the raw data, and deductively,  based on prior theory or research. 
Coding units can be a single word, sentence or paragraph representing a theme 
(Weber 1990).  Codes can be both manifest (explicit in the text) and latent 
(inferred meaning from the text) (Boyatzis  1998).  Codes are used to group 
together segments of text that contain similar material or themes.  These codes 
can be counted for each individual, resulting in data that can be analysed 
quantitatively using frequencies and chi-square analyses of group differences.
This method should permit inferences to be made by systematically identifying 
features of the text (Krippendorf 1980).
There are some potential problems and  limitations with this method.  Some 
of the advantages of qualitative methods lie in their ability to provide participant- 
centred information that is rich in context and meaning.  Content analysis can lead 
to the meaning being removed from the context.  The frequent occurrence of a 
word or topic within an interview can simply reflect the interviewee’s willingness to 
talk about the topic and not the importance of the topic to the person or the 
intensity with which it is experienced (Joffe & Yardley 2004).  This problem can be 
addressed by scoring using a ‘presence/absence’ method where the presence of aChapter 7:  Study 3 135 
theme is coded only once rather than an ‘intensity’ method where instances of a 
theme are counted within each interview.  Using larger coding units to capture 
meaningful themes can also address this problem.  However,  larger coding units 
can mean that multiple codes will apply to the same segment of text.  This can 
affect subsequent analyses by causing spurious correlations to occur.  The main 
advantage of this method is that it produces quantifiable data permitting easy 
comparison with other survey datasets.  Some of the same strictures regarding 
reliability and validity that are used in quantitative data collection can be applied 
and so the results can be generalised beyond the sampling frame in the usual 
manner.  For example,  inter-rater reliability can be calculated by having two or 
more researchers coding the same interview data.  Arguably this is simply training 
researchers to code in the same way, but this reliability testing results in 
consistency of judgement (Boyatzis 1998) and means that codes must be openly 
explicit and replicable in order to be taught to other people.
I am using this method to allow easier comparison between the interview 
method and the survey method.  The epistemological stances of the two methods 
are sufficiently close to enable this mixed-method approach yet sufficiently 
different to allow additional knowledge to be obtained.
Participants
24 patients with a new colorectal cancer diagnosis were recruited to the 
study through the outpatient oncology clinics at four hospitals in Middlesex and 
Essex.Chapter 7:  Study 3 136
Design and Procedure
A purposive sampling approach was used to recruit similar numbers of low
and high SES participants.  Potential participants were invited to join the study 
either directly at an outpatient oncology clinic or by being given a questionnaire 
pack with a consent form to indicate if they were willing to be contacted for an 
interview either at the clinic or at their home.  Nine of the twelve patients (75%) 
approached directly at the hospital took part in the interview study.  46 colorectal 
patients returned the survey, of whom  18 (39%) patients indicated that they did not 
wish to take part in the interview study, 2 (4%) initially indicated willingness to be 
interviewed, but later declined, and one patient was excluded because of having 
recurrent disease rather than a new diagnosis.
This left 25 potential participants whose postcodes were linked to census 
data (Townsend et al 1988) to select those living in high or low SES 
neighbourhoods to achieve maximum variability in the sampling.  15 (60.0%) 
patients were selected for interview.  The 10 patients not interviewed included  1  
whose SES could not be established from the information provided, 7 patients who 
had closer to ‘average’ SES and 2 patients who were approached but who were 
not available when contacted by phone.  This resulted in 24 interviewees in total 
who were divided into two SES groups on the basis of their educational 
attainment.  Participants were categorised as high SES if they had any further 
educational qualifications (O-level/school certificate and above i.e. age 16+ years, 
N =12) and low SES if they had no formal qualifications (N =  12).  Education was 
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to knowledge,  literacy, and ability to comprehend and critique information.  These 
are all skills that could be relevant for interactions with medical staff.
Three experienced researchers carried out the interviews which took 
between 30 and 90 minutes.  The interviews were semi-structured using a topic 
guide (Appendix IX).  They began with an invitation for the participant to give an 
account of their experiences:  “Could you start by describing when you first 
realised that you might have cancer?”  This usually resulted in a discussion of the 
patient’s understanding of their illness, their medical treatment (particularly 
surgery) and the medical care they had received.  Additional prompts included: 
“What has your experience been like with the medical care at this hospital?”  and 
“Could you tell me something about the doctors and nurses that you’ve come 
across?”  Answers to these questions formed the basis for the main analysis.
All participants agreed to be audio-taped and the interviews were 
transcribed verbatim except for one case where the tape recorder failed for part of 
the interview and detailed notes were written instead by one of the researchers 
(RE).  Tapes were numbered and not named to ensure participant confidentiality. 
The corresponding number/name list is kept in a locked filing cabinet and the 
tapes will be destroyed on completion of the study.
23 of the 24 (95.8%) interviewees also completed a survey (Appendix X) 
using items from the CARES-SF medical interactions subscale (Schag & Heinrich 
1988). The 31  patients that returned the questionnaire survey,  but who were not 
interviewed, also completed this subscale.  Permission was obtained from 
participants to establish medical details on stage of cancer and types of treatment.Chapter 7:  Study 3 138 
Ethical approval for this study was obtained from the London Multi-centre 
Research Ethics Committee (see Appendix XI).
Analyses
Transcripts were analysed using content analysis, a form of thematic 
analysis that assigns numeric codes to segments of texts according to predefined 
coding rules.  Codes for the content analysis were developed by reading through 
the interviews and loosely organising the topics of the interview into key themes 
using the Atlas.ti software.  Higher-level categories were coded first and then 
progressively sub-divided into finer grained discriminations (Joffe & Yardley 2004). 
For example, any statements referring to ‘medical care’ were coded first.  These 
were then coded into statements that were either positively or negatively valued. 
These statements were then further divided according to the type of interaction 
they referred to e.g.  personality of doctors, administrative issues,  levels of medical 
expertise.  The unit of analysis was defined as an expression which conveyed a 
complete meaning.  This could take the form of a single word, a complete 
sentence or total statement.  Units of text were coded more than once if they 
conveyed more than one meaning.  Codes could be both manifest and latent.  A 
presence versus absence coding method was used;  i.e. the presence of a theme 
is coded only once per interview.
A codebook (Appendix XII) was written and  refined by studying five (20.8%) 
of the transcripts in detail and a coding manual was written.  The manual was 
discussed by two researchers (AS and KR) to clarify the meaning of the coding 
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independently by 2 researchers (AS and KR).  Overall inter-rater reliability was 
calculated using Cohen’s Kappa, a measure of percentage agreement.  The 
average kappa percentage agreement across the three transcripts was 76%
(range 72% to 82%),  indicating a substantial strength of agreement (Landis &
Koch 1977).  The remaining transcripts were then coded by one researcher (AS).
Data from the content analysis were analysed using chi-square to examine 
SES group differences in the frequency of satisfaction and dissatisfaction with 
medical interaction.  The survey data were analysed using analysis of variance 
(ANOVA) to examine SES group differences or trends (recognising the possibility 
of low power and type II error -  see discussion) in satisfaction with medical care 
as measured by the CARES.  The results from the interviews and survey were 
compared to gauge the value of each method for collecting the desired 
information.
Results
Respondents
Of the 58 total eligible participants, there were no differences between 
those interviewed (N = 24) and those not interviewed (N = 34) in terms of age, 
gender or education.  The demographic characteristics of the sample are shown in 
Table 1.  The majority of interviewees were patients from 2 hospitals (hospital A:  N 
=  11, 45.8%,  hospital B:  N = 9, 37.5%), with another two (8.3%) patients each from 
two other hospitals.  There were  14 men and  11  women aged between 38 and 80 
years old (M = 62.59, SD = 11.09).  22 people (91.7%) described their ethnicity as 
White British with 2 people identifying themselves as White Irish.  The majority ofChapter 7:  Study 3 140 
respondents were married (69.6%).  41.7% of the sample were retired with a 
further three (12.5%) participants reporting that they were too ill to work .  As 
intended, there was variability in SES, with half of the participants without any 
educational qualifications and half with a household income of £20,000 or less.
The average time from diagnosis to interview date was 92 (SD = 65) days.
22 (91.7%) people had had surgery to remove their tumour; the other two 
received a combination of radiotherapy and chemotherapy in advance of a bowel 
operation and were waiting for surgery at the time of the interview.  In total 7 
patients had started chemotherapy and a further 8 were expecting to receive it in 
the future.  Only four participants received radiotherapy,  and this was in 
conjunction with chemotherapy.  11  (45.8%) patients had a colostomy present as a 
result of the bowel surgery.  Six were temporary (reversible) colostomies, 2 were 
permanent and 3 patients were waiting for a final decision from their medical team 
regarding the possibility of a reversal.  The majority of the patients (N = 15, 62.5%) 
had either a Duke’s A or B stage at diagnosis.  The remaining 9 patients all had 
lymph node involvement and 2 had liver metastases.  13 (54.2%) patients had 
another co-morbid illness present.
Positive and Negative Evaluations of Care
Participants described the events leading up to their diagnosis and 
subsequent treatment and commented on their experience with their medical care. 
Responses were coded as positive or negative comments and people could 
contribute both.  The comments were also coded according to the type of medical 
care they referred to:  ‘specialist doctors’ (e.g. surgeon, oncologist), ‘specialistTable 1   Demographic characteristics
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N (N = 24) %
Gender Male 14 58.3
Female 11 41.7
Ethnicity White British 22 91.7
White Irish 2 8.3
Marital Married 16 69.6
status
Single 1 4.3
Divorced 4 17.4
Widowed 2 8.7
Employment Retired 10 41.7
Too ill to work 3 12.5
Full-time homemaker 1 4.2
Student 1 4.2
Employed full-time 5 20.8
Employed part-time 4 16.7
Education No formal qualifications 12 50.0
0  level or equivalent (16 years of age) 2 8.3
A level or equivalent (18 years of age) 1 4.2
Bachelor degree 3 12.5
Masters/PhD/PGCE 3 12.5
Other vocational 3 12.5
Income Less than £10,000 4 16.7
£10-20,000 8 33.3
£20-30,000 5 22.7
£30,000 and above 5 22.7
Missing 2 8.3Chapter 7:  Study 3 142
nurses’ (e.g. stoma nurse,  research nurse),  ‘other doctors’ and ‘other nurses’ 
(general, non-specific statements about doctors, the medical team, ward doctors 
or nurses), and ‘GPs’.
Participants made slightly more comments about doctors than nurses 
overall (Table 2).  Statements about ‘other doctors’ were mentioned by the highest 
number of people (N = 22, 91.7%).  Very few people reported entirely  negative 
experiences with care.  There were more positive than negative experiences 
reported in every category, except for GPs.  GPs were talked about less during the 
interviews compared to other types of health professional, but were the only 
category where more people made negative (N = 6) than positive comments (N = 
3).  Specialist nursing was the least likely to be criticised, with only 3 people 
relating negative encounters.
Table 2 Number of people contributing positive and negative evaluations
Evaluation N  (%) N =24
Positive only Negative only Both positive No
Medical care and negative evaluations
Dr specialist 7(29.1) 1   (4.2) 10(41.7) 6 (25.0)
Nurse specialist 13(54.2) 3(12.5) 0 (0.0) 8 (33.3)
Dr other 7 (29.1) 3(12.5) 12 (50.0) 2 (8.3)
Nurse other 7 (29.1) 5 (20.8) 7 (29.1) 5 (20.8)
GP 2 (8.3) 5 (20.8) 1   (4.2) 16(66.7)
People often related both positive and negative medical interactions, 
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This may be partly because people who made negative comments tried to balance 
their statement by reporting something that was positive about their experience as 
well.  Reading through the statements, we identified  10/15 patients who made 
negative comments and then tried to say something that would reduce the impact 
of the criticism they were making.  The following quote illustrates this effect where 
the respondent says Tm not saying ...’ to distance himself from being overly 
critical:
1 1  We went in there and we were told ‘ask any question you like’.  As 
soon as you started asking questions, he’s a bloody academic, he 
didn’t like it.  He had,  I’m not saying he’s not brilliant,  I’m not saying 
that." (ID 617)
Nobody made only negative statements across all of the care categories.  5 
people had entirely positive experiences and  19 people described both.  Overall, 
this suggested a fairly high level of satisfaction with medical interactions.
Medical Interaction  Themes
The content of the evaluative statements was also explored (see Table 3) 
and five themes were identified:
•  Interpersonal Relationships -  the quality of the relationship between the 
patient and the medical team and the perceived personality of the physician 
(Box 1)
o  Positive:  is a caring person, takes time to listen or do extras, 
provides reassurance, is positive,  is attentive or helpful, shares 
jokes,  is hard working.Chapter 7:  Study 3 144 
o  Negative: has an uncaring attitude,  is rough or blunt, is rushed, 
doesn’t provide emotional/supportive care or has a poor bedside 
manner,  is paternalistic,  is lazy,  ignores patients.
Expertise -  the level of expertise possessed by the physician, perceptions 
of trust and confidence (Box 2)
o  Positive: care provider knows what they are doing and is a
professional person.  The patient perceives they are getting the best 
care available, wants to do what they are told by doctors, feels 
grateful for care.
o  Negative: care provider does not know what they are doing, does not 
have adequate skills or knowledge, does not look at notes properly, 
tells you things that are incorrect or gives conflicting information, 
does something wrong.  Patient does not believe what the physician 
is saying.
Communication and disclosure -  ability to convey meaning about cancer 
and treatments (Box 3)
o  Positive: tells you everything, talks clearly, explains technical things, 
answers questions, provides information, 
o  Negative: doesn’t tell everything,  is too technical, doesn’t answer 
questions, gives information at the wrong time,  is not explicit, doesn’t 
provide enough information.
System -  experiences of the NHS/care system (Box 4)
o  Positive: seen quickly,  NHS better than expected, support services 
readily available.Chapter 7:  Study 3 145 
o  Negative: delays or long waiting times,  notes or scans not available 
during consultations,  lazy or sloppy administration, support services 
inadequate, didn’t see right doctor,  not enough staff available.
•  General  (Box 5)
o  Positive: overall care has been good, general favourable comments 
o  Negative: overall care has been bad, general critical comments
Table 3 shows the distribution of the comments amongst these themes. 
Patients most frequently talked about the personalities of their medical team and 
the nature of the relationship they had with them.  The most positive comments 
were in this category, suggesting it is an area valued by patients. The positive 
personality/relationship theme occurred most frequently in the ‘specialist doctor’ 
category, with  12 of the 17 people who contributed positive statements making 
comments in this theme.  Many patients specifically reported that their doctor’s 
personality demonstrated that he or she was a caring and trustworthy person. 
Making a judgement in this area appeared to be one way that patients assessed 
the quality of the care they were receiving:
1 1   He (consultant) was a really nice man.  He come out and he examined me 
and he said ‘look, everything went really well for you’.  He said ‘we’ve taken 
away the whole cancer from your body’... And I was very relaxed for a guy 
that was never in a hospital because the team and M rX  (consultant) was so 
confident.” (ID 552)
Patients may find it more difficult to form opinions about either medical expertise or 
the quality of the information they received as these are novel. They are moreChapter 7:  Study 3 146 
confident about evaluating personal relationships because this is something they 
do regularly in their everyday lives.
Most negative comments were in the ‘system’ category showing that 
there were levels of frustration around the organisation of care.  The negative 
‘system’ theme occurred most frequently in the ‘nurses other’ category.  9 of the 
12 people making negative remarks about ‘nurses other’ made them in this area. 
These comments were often about the nurses on the hospital wards being under­
trained or over-stretched resulting in poor quality care.  Again, organisational or 
administrative ability may be areas that patients are confident about criticising 
because it is a part of most people’s everyday lives, whereas ‘expertise’ and 
‘disclosure/communication’ themes required the ability to judge novel medical 
information.  For example,  people often used non-medical analogies to illustrate 
the problems they had with the care system:
This quote (ID 559) is from a man who is a store controller and runs a goods 
department for a large American company.  He is talking about waiting for a scan 
and compares it to running a production line.
“Well I was due through the machine at three o’clock.  At twenty to three they gave 
me the liquid.  So I had to force that down and instead of going through the 
machine at three o’clock I went through at twenty past three,  so once you get a 
backlog it escalates in this case. No one gave an apology... And if you like,  I know 
the NHS has got its problems, but these sorts of problems, if you like,  are localised 
ones.  It’s not a case like you’re running a production line or something like that. 
And at the end of the day we are the end users.  Ok,  I know, you see it on theTable 3 -  Content of comments about medical care
Medical care Content of evaluations -  Number of people making comments (%) Total number 
of comments Relationship Expertise Disclosure System General
Drs specialist Positive N = 17 12 (70.6) 9 (52.9) 3(17.6) 3(17.6) 2(11.8) 29
Negative N = 11 7 (63.6) 3 (27.3) 4 (36.4) 2(18.2) 0 (0.0) 16
Nurses
specialist
Positive N =  13 9 (69.2) 4 (30.8) 6 (46.2) 1   (7.7) 1   (7.7) 21
Negative N = 3 1   (33.3) 0 (0.0) 0 (0.0) 2 (18.2) 0 (0.0) 3
Drs other Positive N =  19 4 (21.1) 4(21.1) 6(31.6) 2(10.5) 10 (52.6) 26
Negative N =  15 3 (20.0) 6 (40.0) 9 (60.0) 7 (46.7) 0 (0.0) 25
Nurses other Positive N = 14 10(71.4) 2 (14.3) 1   (7.1) 0 (0.0) 4 (28.6) 17
Negative N =  12 4 (33.3) 3 (25.0) 2 (16.7) 9 (75.0) 2 (16.7) 21
GP Positive N = 3 3(100.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 3
Negative N = 6 0 (0.0) 6(100.0) 1   (16.7) 1   (16.7) 0 (0.0) 8
Total number of 
comments
Positive N = 66 38 19 16 6 17
Negative N = 47 15 18 16 21 2
Both N =   113 53 37 32 27 19Chapter 7:  Study 3 148
television, NHS is having problems,  but everybody has problems,  but at the 
same time it’s up to the people, if you like,  who are employee infantry, if you 
like, basically they can resolve them before it happens.”
This next quote is from a policeman (ID 627) who is describing the delay he 
experienced in receiving his diagnosis which he compares to leaving someone 
bleeding in a street without helping them.
1 1  Why did it take from that point to this point to be told about it,  why was 
there this big gap you know?... because its four and half months down the 
road,  these things (liver metastases) might have been just minute... I said 
‘in fact if I find out any more you’ll be up for manslaughter’. ..which is 
causing the death of somebody by negligence it is,  isn’t it? It’s like me 
seeing you in the street, if I just put that pad over your head I’m going to 
stop some of the blood coming out,  to let him bleed you know,  .. .but it’s 
that annoying fact that you think that maybe somebody had really let you 
down and why?.”
These two quotes show how people assess system failures in terms of their own 
experiences.
Overall the positive comments most frequently referred to relationships with 
physicians, whereas negative comments were most frequently about system 
failures.  Notably there were also far more positive comments in the ‘general’ 
category whereas negative comments were about specific incidences.  These bad 
experiences were important because they could result in adverse health 
consequences.  For example, one patient discussed his delayed diagnosis (four 
and half months) despite visiting the hospital for appropriate tests.  He believed 
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instance, one hospital experienced a disruption in the Macmillan nursing service
(one nurse had left, one nurse was on maternity leave and they were unable to
provide usual care).  The Macmillan nurses were largely responsible for
distribution of disease information and providing patient support.  When the
service was not operating fully, patients said that the lack of information led to
increased worry and distress.  These cases illustrate the impact that poor care
experiences can make to cancer patient’s lives.
Comparison of survey items with interview themes
Supplementary quantitative information about communication with medical 
staff using 6 items from the Medical Interactions subscale of the CARES (Schag et 
al.,  1988) was also collected.  23 of the 24 people taking part in the interviews 
completed it.  Non-interviewees (N = 31) had higher CARES scores (M = 3.21,  SD 
= 4.44) than interviewees (M =  1.43, SD = 1.70), this was not statistically 
significant (F [1,54] = 3.00 p = 0.09),  but the p-value suggests the presence of a 
trend towards non-interviewees being more dissatisfied with their care.
The survey data were compared with the interview data in a number of 
ways.  Firstly, the content of the survey items was compared with the content of 
the negative interview comments.  Secondly,  negative interview scores were 
calculated and compared with CARES scores on a case by case basis to see how 
well they corresponded.
Four of the six items from the CARES fall within the communication/ 
disclosure theme identified in the interviews (withholds information, don’t explain 
what they are doing, difficulty asking questions, difficulty understanding).  11  of the 
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items.  16 people made negative comments about communication/ disclosure
during the interviews.  The item about expressing feelings to care providers
seemed to be more closely related to the personality/relationship theme.  The final
item concerned control (’I would like to have more control over what the doctors do
to me’) and this theme did not appear in the interviews at all, despite being the
items with the highest frequency of people indicating any dissatisfaction (N = 8).
Table 4 -  CARES items
Response options N (%)
CARES items N = 23 Not at all A little A fair 
amount
Much Very
Much
Medical team withholds 
information
18(78.3) 5(21.7) 0 (0.0) 0 (0.0) 0 (0.0)
Doctors don’t explain what 
they are doing
18(78.3) 4(17.4) 1   (4.3) 0 (0.0) 0 (0.0)
Difficulty asking doctors 
questions
19(82.6) 4 (17.4) 0 (0.0) 0 (0.0) 0 (0.0)
Difficulty expressing my 
feelings to doctors/nurses
19(82.6) 3(13.0) 1   (4.3) 0 (0.0) 0 (0.0)
Difficulty understanding 
doctors
20 (87.0) 3(13.0) 0 (0.0) 0 (0.0) 0 (0.0)
Like to have more control 
over doctors
15(65.2) 6(26.1) 2 (8.7) 0 (0.0) 0 (0.0)
Table 4 shows the distribution of the responses to the CARES items.  Only 
12 people indicated any dissatisfaction across any of the items, and these were at 
the lower ends of the scale.  In contrast,  15 people made negative comments in 
the interviews, suggesting that interviews might pick up a greater number of 
instances of dissatisfaction because it allowed people to relate specific incidents.
A ‘negative score’ for the interviews was calculated by adding together the 
presence of negative comments across the five medical care categories (specialist 
doctor, specialist nurse, other doctor, other nurse and GP).  This resulted in aChapter 7:  Study 3 151 
score from  1   to 5 with a higher score indicating negative comments in more areas
i.e. more negative experiences.  There was a non-significant positive correlation
indicating some correspondence between reporting negative experiences during
the interview and CARES scores (r = 0.24,  NS).  There appeared to be two cases
(both high SES and male) who did not report negative experiences in the interview
but had relatively high CARES scores and four cases (one high and three low
SES, all male) who made a number of negative comments in the interviews but
had low CARES scores.
Demographic Differences in Perceptions of Care
Patients with disease stages Dukes A or B were compared with those with 
more advanced disease (Dukes C1  and above) in terms of their medical 
interactions.  There were no differences between the two groups in any aspects of 
the interview data or in ratings on the CARES subscale.  Responses from patients 
at different hospitals could be examined comparing patients from two hospitals 
where there were sufficient numbers to perform these analyses.  These analyses 
showed no difference between these two hospitals in responses in any category. 
There were also no differences between men and women in any of the ratings.
Age was unrelated to the 5 medical interaction themes overall or the CARES 
subscale, but younger patients reported more negative care experiences with 
specialist doctors (r = 0.58, p<0.01,  N = 20) and specialist nurses (r = 0.69, 
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Socio-economic Differences in Perceptions of Care
Chi-square analyses,  using Fisher’s exact test where appropriate, 
examined SES differences in medical interactions.  Fisher’s exact test can be used 
for 2 x 2 chi square tables where the expected cell frequencies fall below five.  It 
calculates the exact probability rather than a critical value.
There were equal numbers of men and women in the low SES group (i.e. 6 
men and 6 women) and slightly more men in the high SES group (8 men and 4 
women) but this was not significantly different.  The mean age in the low SES 
group was 64.58 (SD = 10.1) years and 60.1  (SD = 11.4) in the high SES group, 
but this was not a significant difference.  Of the nine people who had lymph node 
involvement, 6 were in the low SES group and 3 in the high SES group, but this 
difference was not statistically significant.
There were significant differences between the education groups when 
talking about ‘specialist doctors’ in both positive (x2  (1) = 5.04 p<0.05) and 
negative (x2  (1) = 4.20 p<0.04) categories.  Table 5 shows the distribution of 
positive and negative comments by education within each of the care provider 
categories.  Patients with less education were less likely to contribute any positive 
or negative comments in the care provider category ‘specialist doctor’.  Half of the 
less educated participants made no comments in this care category compared 
with all  12 of the more educated participants.  This may indicate a reluctance of 
less educated participants to make evaluations about the specialist care they are 
receiving.  There were no significant differences between the two groups in any of 
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terms of the distribution of the five evaluation themes: personality/relationship,
expertise, communication/disclosure, system or general.
Table 5 Positive and negative evaluations of medical care by level of education
Medical care
Further Education N (%)
No (N =  12)  Yes(N =  12)
Drs specialist Positive 6 (50.0) 11  (91.7)
Negative 3 (25.0) 8 (66.7)
Nurses specialist Positive 6 (50.0) 6 (50.0)
Negative 1  (8.3) 2(16.7)
Drs other Positive 9 (75.0) 10(83.3)
Negative 10(83.7) 5 (33.3)
Nurses other Positive 9 (75.0) 5 (41.7)
Negative 5(41.7) 7 (58.3)
GPs Positive 1   (8.3) 2 (16.7)
Negative 4 (33.3) 3 (25.0)
There was a difference between the two educational groups in the CARES 
scores, but the low education group had slightly higher satisfaction (F(1,22) = 4.76 
p = 0.04), although this was a relatively small effect (effect size = 0.4) indicating a 
high level of overlap between the two groups.  However, of the four people with 
high negative interview scores and low CARES scores, 3 were low SES, possibly 
indicating that low SES participants were better able to communicate their 
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Discussion
Patients in this study predominantly expressed high levels of satisfaction 
with their care, particularly care from specialist nurses.  Some people also 
expressed extreme dissatisfaction, but often in one specific area, with positive 
experiences in other fields.  The tone of interviews suggested that patients are 
reluctant to be critical of their medical care, particularly care from specialist 
professionals, perhaps because they feel less able to judge expertise in this area. 
Only GPs received more negative than positive comments overall, although the 
total numbers of comments about GPs were lower than in other categories.  In 
contrast to the comments about specialist care, the majority of the criticisms about 
GPs concerned their expertise.  Patients may feel that GPs display a lack of 
knowledge about cancer, or at least less than they expect.  Specialist nurses 
received the most ‘positive only’ ratings with no criticisms at all.  These comments 
often referred to aspects of their interpersonal skills and their ability to disclose 
and communicate information about cancer.  This suggests that specialist nurses 
are extremely skilled in managing all aspects of patient communications.
The themes identified from the qualitative interviews (i.e.  relationship, 
expertise, disclosure, system and general) were similar to those from other studies 
(Freedman 2003, Wright et al 2004).  The most frequently commented themes 
(both positive and negative) were in the area of personal relationships or 
interpersonal skills, and this also had the highest numbers of positive comments. 
There was some support for the idea that people judge the quality of their care 
based on their physicians’ personality,  highlighting the importance of presenting a 
‘caring personality’ in terms of patient satisfaction.  The most negative comments 
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times for tests, administration of appointments and training and supply of nurses.
Perhaps patients feel comfortable criticising this area because organisational skills
are a part of most people’s lives.  Patient satisfaction cannot be achieved only by
improving the communication skills of medical care professionals because poor
service organisation can eclipse improvements in these areas (Shilling et al 2003).
This research also offered new insights.  Other qualitative studies have not 
coded the direction (i.e. positive vs. negative) of people’s experiences.  The 
present study identified areas of good and bad practice as well as illustrating areas 
that patients value.  The majority of patients reported both positive and negative 
experiences, sometimes in the same area of care.  For some people this probably 
reflects a desire to balance criticism with positive statements but for most it 
appeared to represent their mixed experience of care.
The quantitative (CARES questionnaire) data revealed one area that was 
not discussed in the interviews.  Over a third of the patients indicated that they 
would like more control over what the doctors did to them.  The content analysis 
failed to pick up this issue perhaps because the coding was at a more ‘explicit’ 
level and issues surrounding control are more abstract and only inferred implicitly 
from the interview statements.  It could be argued that control issues underlie 
many problems of dissatisfaction.  For example, this person complains about the 
timing of visits from the district nurse:
“We were very sort of confined.  You know, they’re short staffed and they don’t tell 
you when they’re coming.  They say morning probably and then it might get into 
the afternoon, you see, so you’re sort of stuck all day.” (ID 397).
They do not refer specifically to lack of control,  but this shows how control of their 
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because of the physical limitations imposed and the necessity of having to rely on
care providers.  It is possible that asking most people in this situation if they would
like more control will result in an affirmative answer.  This demonstrates that
interview and survey methods may draw out different aspects of satisfaction.
However, comparing the interview and survey data showed that some people
showed more dissatisfaction on the survey and some in the interviews, with no
clear pattern of differences.  Interviews can elicit more specific examples of poor
care whereas surveys can uncover more general concerns.
There was little evidence of differences in care experiences depending on 
the patient’s SES.  Study 2 found that lower SES patients reported slightly more 
dissatisfaction with medical services on the CARES medical interactions subscale 
and that had provided the impetus for the present study.  However the quantitative 
difference was not confirmed in this new sample and the qualitative data were in 
the opposite direction.  Less educated patients provided fewer evaluative 
statements overall in the interviews and tended to list events without expressing 
whether the care was good or bad.  The only significant difference was that lower 
SES patients were less critical of medical care from specialist doctors.  This could 
be because of reluctance to criticise the care they receive,  but the other categories 
showed no differences and the effect was weak, suggesting that it might be a 
chance finding.  Another difference between Study 2 and this study was the length 
of time from diagnosis to assessment of patient satisfaction.  Study 2 included 
patients up to one year after diagnosis (M = 257, SD =  112 days post-diagnosis) 
whereas this study interviewed patients generally within the first three months after 
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affected the results in that differences in satisfaction with care by SES may only
arise over time.  Longitudinal data is needed to test this hypothesis.
Previous research has found differences in the way that physicians 
communicate with lower SES participants by providing less information and using 
a more directive consulting style (Macleod et al 2004, Willems et al 2005).  I aimed 
to explore patients’ reporting of their medical experiences and so doctors were not 
observed.  Differences may exist in consulting styles between patients,  but if so,  it 
is not having striking implications for patient dissatisfaction.
This study could have failed to detect SES differences because it was 
underpowered.  The results from Study 2 could have disguised a much larger 
effect that would be revealed during the interview process.  Post-hoc power 
analysis, using g-power software, showed that the power of the study to detect a 
large effect size was 0.69.  Good power in a study is usually rated at 0.80.  Two 
additional participants were required to reach a power of 0.80.  However, there 
should be enough power to show any trends in the data, even if they do not reach 
statistical significance.  No trends were seen and the addition of two extra 
participants is unlikely to have changed the results in a dramatic manner.  Another 
reason for failing to detect SES differences could be because of a mis-match 
between the educational levels of the interviewers (all of whom had a number of 
years of further education) and the SES of the interviewees.  This could result in 
difficulties with establishing rapport.  However,  interviewers successfully elicited 
more negative comments from the less educated interviewees than the survey 
method suggesting that this was not a real limitation.  The interviewees were also 
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higher levels of dissatisfaction on the CARES items.  Low SES patients with higher 
dissatisfaction may have chosen not to be contacted for an interview.
There were a number of strengths to this study.  It provided a mixed-gender 
sample with slightly more male (58%) than female (42%) participants.  Previous 
qualitative studies have been restricted to women’s experiences with breast 
cancer.  Recruiting men to qualitative interviews is often more difficult.  This study 
found no gender differences in experiences with care.  In terms of other 
demographic factors, younger age was associated with increased criticism of 
specialist care from both doctors and nurses, which has also been reported in 
another study  that had a high proportion of lower SES participants (62% left 
school <16 years) (Davidson & Mills 2005).  Other studies have been dominated 
by high SES participants and may not provide a balanced view (e.g.  Freedman 
2003)).
This study showed that although there are SES differences in satisfaction 
with medical interactions, these are likely to be small.  There are still some 
unanswered questions concerning the impact of different hospital centres on these 
differences and a further multi-centre study could enhance the understanding of 
this topic.  In addition,  longitudinal data could show if differences in satisfaction 
with medical interactions emerge over time, and whether this could affect 
psychological adjustment in the longer-term.  The qualitative data collection 
provided a fuller picture of the care experience of colorectal cancer patients and 
emphasised the importance of physician’s interpersonal skills and difficulties with 
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Box 1   -  Interpersonal Relationship 
Positive
“The girls (nurses) at the Unit are so helpful and everything like that,  I mean they’re 
so nice, you can’t ask for a better team.” (ID 586)
“Mr X, even though he’s now registrar to someone else,  he came by my bed several 
times to ask how I was getting on. And Miss X, the new registrar, she’s been very 
kind and very gentle, you know.  Everybody’s been very considerate to me.”  (ID 574)
“Professor X was brilliant, he’s such a, he’s just,  I can see in his eyes.  I mean they 
are all there for that type of job but sometimes it can be a career thing and sometimes 
it can be loyalty to people and that man is definitely loyalty to people. “(ID 311)
Negative:
“He was bit sharp, urn, don’t know his name but,  I mean at the end I did say to him 
urn, I said when you do meet patients can you just at least smile a bit because you 
make, you made me very uneased.”  (ID 311)
“He (surgeon) tended to talk down to them a bit, he tried to be paternalistic to me 
and I blew him right out of the water.”  (ID 371)
“The registrar [was] very poor, very poor manner, very poor his way of dealing with 
the whole situation...  it was just the way he came across,  I mean he walked in the 
room he said...  ‘hello Mrs Smith’ he said ‘well you know you’ve got cancer’ just like 
that, it just came out and I thought, and it was just the way he said it...  it was just 
awful I thought,  I hadn’t even sat down in the chair before he’d sort of said it you 
know and I don’t think he was very experienced at the way you go about these 
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Box 2 -  Expertise 
Positive:
“Everything on the specialist side is fine, it’s good, it’s acknowledgeable, they know 
what they’re talking about, they gave suitable, appropriate advice.”  (ID 1095)
“I’ve got faith and strength in the surgeon because I was very impressed by what he 
said to me and erm very professional.  And so that gave me a lot of confidence.  And 
I think that was one of the best things to do is to actually talk to your surgeon and you 
think yep that’s ok and well I’ve got the best person on the job that I can possibly get.”  
(ID 384)
Negative:
“The health care assistants, the only thing I can say about them is that they’re totally 
incompetent...  They don’t know the significance of any of the things they are doing, 
don’t know the significance of a moderately high temperature.” (ID 1095)
“My GP doesn’t know anything much about, he knows a very limited amount about 
bowel cancer, he knows what it is and what they do for it,  but he didn’t understand 
how you are afterwards, that’s physically more than mentally.” (ID 368)Chapter 7:  Study 3 161
Box 3 -  Communication/Disclosure 
Positive:
“The nurses were actually very good, they sort of told me everything they were going 
to do and explained everything and told me what I should be doing if, you know, which 
I tried to follow.”  (ID 950)
“All of the doctors that I’ve come across have tried not to use long words and I think, if 
you like, this, if you like, is a good thing.”  (ID 559)
“I am one of these people that have to know everything.  Everything I asked they gave 
me the answers to.  I found the treatment very good, before I came into hospital, 
during hospital, the doctors were very good, and anything I asked.”  (ID 352)
Negative:
“I was just prepared to listen to everything that was said and I still don’t think I heard 
the word cancer...  I asked my husband again after that ‘what was said?’ and I needed 
him to say the word, but nobody would use the word.” (ID 343)
“When they’re using technical terms and things you know you get a bit confused 
sometimes.”  (ID 1112)Chapter 7:  Study 3 162
Box 4 -  System 
Positive:
“There’s all these people saying the NHS is no good and I say well from what I’ve 
seen it’s excellent.”  (ID 384)
“Once they discovered it (cancer), they acted so quickly at [hospital name], and I 
know people complain about [hospital name], but they complain about all hospitals, 
but as far as I’m concerned, it couldn’t have been better.”  (ID 368)
Negative:
“He didn’t have the scan with him.  Now that was the bit that pushed me.  I’m not 
saying his notes weren’t right, I’m not saying any of that,  but when you had a scan 
six months ago that nobody’s bothered to look at, you’ve had another one in 
hospital, you really want it there don’t you?”  (ID 627)
“I feel I’m delicate inside still which is only natural like, but there was no 24 hour 
contact number and there was no backup for relatives of anything”  (ID 552)
Box 5 -  General 
Positive:
“The medical care at the hospital was absolutely marvellous.”  (ID 560)
“They seemed all right to me, no fault to find in them at all.  Er the doctor was very 
good, the nurses done their best.”  (ID 587)
“All the doctors and nurses that I’ve come across have been great.”  (ID 372) 
Negative:
“I had a couple of nasty experiences,  but that was just bad luck basically.”  (ID 559)
“There again, I haven’t had that much contact with that many nurses.  I’m not so 
keen on nurses really.”  (ID 372).Chapter 8:  Study 4  163
CHAPTER 8
Study 4: Socioeconomic status differences in psychosocial wellbeing of cancer
patients
Introduction
The results from Study 2 suggested that SES might moderate the extent of 
anxiety associated with a stressful situation.  Higher SES cancer patients reported 
relatively lower levels of anxiety across all disease stages, whereas lower SES 
patients had increasingly higher anxiety with more advanced disease stage.
These results were from a comparatively small sample of colorectal cancer 
patients and clearly they need to be replicated.  A larger sample comprising more 
diverse disease sites and assessing other potentially stressful characteristics of 
the medical situation in addition to disease stage, would be useful for confirming 
these findings.
Potential cancer-related stressors were described in Chapter 2,  including 
characteristics of different treatments and co-morbid illness that could affect 
psychosocial wellbeing.  Treatments such as chemotherapy,  radiotherapy or 
surgery commonly cause symptoms of illness including fatigue,  pain and sickness. 
These symptoms experienced at chronic levels are debilitating and connected to 
psychological distress.  Cancers tend to be diagnosed at later ages and 
consequently many people will already be diagnosed with co-morbid conditions 
prior to their cancer diagnosis.  Patients with co-morbid illness may also be likely 
to report increased depressive symptoms.Chapter 8:  Study 4  164
The present study examines the relationships between disease stage and 
SES taking account of treatment and co-morbid illness on psychosocial wellbeing 
in a sample of cancer patients.  The sample used in this study differed in a number 
of ways from that used in Study 2:  it comprised a mixed sample of breast, 
prostate and colorectal cancer patients,  it was larger (N = 352),  patients came 
from multiple hospital sites and all patients were assessed within a specific time­
frame post-diagnosis (up to three months).  The larger sample is beneficial in 
terms of additional power to detect SES differences.  The mixed-cancer population 
from multiple hospital sites enables a broader, more wide-ranging overview of 
cancer patient experiences so that any effects will be more generalisable. 
Additionally, as all of the patients were observed within a similar time frame since 
diagnosis they should be more likely to be experiencing the same kind of 
psychological challenges than those in Study 2 where there was a difference of up 
to a year in the timing.  The assessment of SES in this sample was also more 
comprehensive and included markers of income, education, material assets, 
subjective SES and an area-level indicator.  Comparing the outcomes using the 
different markers could help identify the most appropriate measure for this type of 
population and the ability of the different SES markers to detect differences in 
psychosocial wellbeing could reveal information about the mechanisms of any 
SES effects.
As in Study 2,  I will test the hypothesis that SES interacts with 
characteristics of the stressful situation to result in adverse psychosocial outcomes 
for those from more deprived backgrounds.Chapter 8:  Study 4  165
Hypotheses
1.  Lower SES patients will have poorer psychosocial wellbeing than higher SES 
patients.
2. Cancer-related stressors will affect psychosocial wellbeing.  Patients receiving 
chemotherapy, or being diagnosed with invasive disease will have worse 
psychosocial wellbeing.
3.  Patients with a co-morbid illness will experience poorer psychosocial well­
being.
4.  There will be an interaction between SES and cancer-related stressors 
(disease stage, treatment, co-morbidity) on psychosocial wellbeing.
Method
Participants
This was a longitudinal survey of patients who had received a diagnosis of 
breast,  prostate or colorectal cancer.  Patients were recruited from nine hospital 
sites in and around  North London,  Middlesex and Essex.  There was a two year 
recruitment period (February 2003-January 2005).  352 patients were recruited 
during this period.  Potential participants were identified by oncology and research 
nurses in each hospital.  Patients presenting with severely advanced disease were 
excluded from the study due to its longitudinal nature.  The research or oncology 
nurses who recruited participants were responsible for making an assessment of 
the suitability of each patient for inclusion in the study.  Not all of the hospitals 
maintained  records of which patients were approached compared to those that 
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sites) revealed that 187 patients were approached by a research nurse to 
participate in the study, of who 125 agreed to participate,  representing a response 
rate of 67%.
Design and Procedure
New breast,  prostate and colorectal cancer patients seen at participating 
hospitals during the trial period were invited to join the study by research or 
oncology nurses at outpatient oncology clinics.  They were given a questionnaire 
pack with an information sheet and consent form which included the contact 
details of a researcher.  Potential participants were invited to contact the 
researcher with any questions regarding the study.  Questionnaire packs were 
returned via freepost mail to UCL.  Participants were invited to provide address 
information so that the longitudinal aspect of the survey could be completed from 
UCL.  Address information was kept separately from the questionnaires. 
Questionnaires were numbered and not named to maintain anonymity.  Hospital 
staff were given feedback regarding which participants (by number) had returned 
completed questionnaires and non-responders were sent a second survey after a 
one month period had elapsed.  Formal consent was also sought from each 
patient for access to their medical records.  Ethical approval was obtained from the 
London Multi-centre Research Ethics Committee (see Appendix XI).
Participants completed a self-report questionnaire covering a range of 
psychosocial wellbeing outcomes and resources: quality of life, social problems, 
experience of medical care, social support, anxiety, depression, benefit finding, 
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included ethnicity, gender, and socio-economic status (SES) (see Appendix X). 
Surveys were completed at two time points: first at 1-3 months post-diagnosis and 
then again 9-12 months post diagnosis.  Data for this chapter were taken from the 
first survey.
Measures
Markers of Socio-economic status
Socio-economic status (SES) was indexed using the same individual-level 
indicator described in Studies 1   and 2.  Three items reflecting material 
circumstances and education were assessed: car-ownership or not (score 0/1), 
home-ownership or not, and some higher education versus none.  This resulted in 
a composite score from 0 to 3, with ‘3’ representing high SES (as opposed to high 
deprivation i.e.  reverse scored compared to its use in Studies 1  and 2). Again the 
two most deprived categories were combined resulting in a three category marker 
of socio-economic status:  high (score 3) (car-owner,  home-owner and higher 
education), medium (score 2), and low (score 0-1).
The Townsend Index (Townsend et al  1988) is an area-level indicator of 
deprivation based on levels of car ownership, housing tenure,  unemployment, and 
overcrowded living conditions as recorded in the  census across enumeration 
districts (on average about 200 households).  This Index was also used  in Study 1.
A score of zero represents the national average with negative values representing 
less deprivation (higher SES) and positive values representing more deprivation. 
Postcode information was collected for each individual giving address information 
and was linked to enumeration districts; the Townsend score for the district wasChapter 8:  Study 4  168
assigned to the individual.  The Townsend index score was based on the data 
from the 1991  census.
Income was assessed with a single item question: “Think about your 
family’s income, which category would describe the total annual household 
income? (including your own and partner’s salary and any benefits)”.  There were 
8 response categories ranging from less than £10,000 per year to more than 
£70,000 per year.
Subjective SES was assessed using a pictorial,  10-rung ladder (Adler et al 
2000).  Participants were shown the ladder together with the following instructions: 
“Think of this ladder as representing where people stand in the UK.  At the top of 
the ladder are the people who are the best off, those with the most money,  most 
education and most respected jobs.  Those at the bottom are the people who are 
worst off with the least money,  least education and least respected jobs or no job. 
The higher up you are on the ladder, the closer you are to the people at the top, 
the lower you are the closer you are to the people at the bottom.  Please place a 
large ‘X’ on the rung where you think you stand at this time in your life relative to 
other people in the UK.”  This results in a ten category measure of subjective SES 
with ‘1’ representing low SES and ‘10’ representing high SES. The subjective SES 
measure was only assessed at the second round of data collection and 
consequently was only available for 235/352 (67%) of participants.
Medical characteristics
Information on medical characteristics was obtained by accessing 
individual’s medical records.  Information from medical records were obtained for 
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records for the remaining patients, but participating hospitals failed to provide the 
required information mainly due to lack of staff time and resources.
Information regarding disease stage, treatment and presence of co-morbid 
illnesses were collected.  Patients were classified into two disease stage groups: 
invasive and non-invasive.  Those with ‘invasive’ disease were patients who had 
lymph node involvement or distant metastases.  There were four main treatment 
types: surgery,  radiotherapy, chemotherapy, and hormone therapy.  For cases 
where information from medical records were lacking, self-report items on the 
survey regarding disease stage (“Has your cancer spread to any other part of your 
body?”) and treatment (“Have you already received any of the following 
treatments?”) were used. The questionnaire did not contain an item about co­
morbidity and so this information was only available for the patients whose medical 
records were accessed.
Psychosocial wellbeing
Psychosocial wellbeing was assessed with a number of scales previously 
used Study 2: quality of life, social difficulties, anxiety, depression and medical 
interactions.  Additionally, one measure of positive psychological wellbeing 
assessing ‘benefit finding’ was included.
Quality of Life
Quality of life was assessed using the Functional Assessment of Cancer 
Therapy (FACT-G) (Celia et al  1993) with the appropriate cancer specific 
subscales for breast,  prostate or colorectal cancer.  There are five subscales: 
physical (7 items, e.g.  ‘I have pain’), functional (7 items, e.g.  ‘  I am able to enjoy 
the things I  usually do for fun’), social/family (7 items, e.g.  ‘I get emotional supportChapter 8:  Study 4  170
from my family), emotional well-being (6 items e.g.  ‘I feel nervous’) and a cancer- 
specific subscale.  Participants indicate how true each statement is for them during 
the past seven days.  There are five response options from ‘not at all’ to ‘very 
much’.  The scale range is 0 to 24 for the 6-item scale and 0 to 28 for the 7-item 
scales, with higher scores indicating better quality of life.  A total score is 
computed from the sum of the physical, functional, social/family and emotional 
subscales, with a range from 0 to 108.
Social Difficulties
The Social Difficulties Inventory (SDI) (Wright et al 2005) is a 21-item 
questionnaire designed for use in oncology care.  It covers problems in managing 
personal care, domestic chores and responsibilities, finances and benefits, 
employment,  relationships, sexuality and body image,  mobility and  leisure 
activities.  Participants rate whether they have experienced any difficulties over the 
past month.  There are four response options with a range from ‘no difficulty’ to 
‘very much’.  Participants mark the ‘no difficulty’ box if the question does not apply 
to them.  The scale range is 0 to 63 with higher scores indicating more social 
problems.
Anxiety
Anxiety was assessed using the anxiety subscale from the Hospital Anxiety 
and Depression Scale (HADS) anxiety scale (HADS-A, 7 items) (Zigmond &
Snaith 1983).  Participants rate how they have usually felt over the past week.  For 
example ‘worrying thoughts go through my mind’ with the response options ‘a 
great deal of the time,  ‘a lot of the time’, ‘from time to time but not too often’ and 
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according to the statement.  Positively worded statements (e.g.  ‘I can sit at ease 
and feel relaxed) are reversed scored.  Items are scored 0 to 3 and summed to 
form a scale ranging from 0 to 21, with higher scores indicating more anxiety. 
Depression
Depression was measured with the Centre for Epidemiological Studies 
Depression Scale (CES-D) (Radloff LS 1977).  This scale asks about feelings over 
the past week and the number of days that they felt that way.  For example:  “I was 
bothered by things that don’t usually bother me” with response options from 
‘rarely,  none of the time (less than one day)’, to ‘most or all of the time (5-7 days)’. 
The shorter 10-item version (Kohout et al  1993) was used,  but retained the 
original response options.  The CES-D is scored 0-3.  Items are summed to form a 
scale that ranges from 0 to 30 with higher scores indicating more depression.
Benefit Finding
This is a measure of the perceived benefits that may arise from the 
experience of having cancer.  This scale was originally developed for use with 
breast cancer patients (Antoni et al 2001).  It is a  17-item unidimensional scale.  In 
this study the item set was reduced from  17 to  11  and excluded items that referred 
to social support and the role of other people because of their overlap with items 
on the perceived social support scale that was also used  in this survey.  The 
remaining items assess benefits such as acceptance of life’s imperfections and 
developing a sense of purpose in life.  In this sample, the reduced scale had good 
internal reliability (a=0.95).  The stem for each item is “Having had cancer has....”, 
followed by a possible benefit of having had cancer, for example “contributed to 
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at all’,  ‘a little’, ‘moderately’, ‘quite a bit’ and ‘extremely’, scored  1-5.  Items are 
summed to form a scale scored  11 to 55.
Medical Interactions
Communication with medical staff was assessed using the 4-item subscale 
from the Cancer Evaluation and Rehabilitation System -  Short Form (CARES-SF) 
(Schag & Heinrich  1988).  The items refer to levels of information provided, 
understanding the information provided,  levels of control over treatment, and 
difficulty asking questions.  Participants are asked how much each statement 
applies to them during the past month.  For example: ‘I find that the medical team 
withholds information from me about the cancer’.  There are five response options 
from ‘not at all’ to ‘very much’.  Items are summed and divided by the number of 
items answered,  resulting in a scale from 0 to 4.  Higher scores indicate poorer 
communication with medical staff.
Analyses
Data were analyzed using analysis of variance with SES group and medical 
characteristics as the independent variables, and age, gender and cancer sites as 
control variables.  Psychosocial wellbeing: quality of life, social difficulties, anxiety, 
depression, benefit finding, and medical interactions, were the dependent 
variables.  The analyses were carried out using four different SES markers 
(individual SES [car/home/education], Townsend score,  income and subjective 
SES).
The psychosocial variables had small amounts of missing data.  In cases 
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greater than 5% (the depression and social difficulties variables only), the 
analyses were re-run using imputed values based on the subject mean for each 
scale if at least half of the items had been completed, and any changes in the 
outcomes were noted.
The effect of clustering due to the different hospital sites was considered 
and intracluster correlation coefficients were calculated for all of the dependent 
variables.  Most of the dependent variables had small intracluster correlations 
(range: 0.02-0.04), only the social difficulties variable indicated a medium effect 
(0.1) (Hox 2002).  Any analyses involving this variable included adjustment for 
clustering due to hospital site.
Lower SES,  more advanced disease, receiving chemotherapy and the 
presence of a co-morbid illness were hypothesized to be associated with poorer 
outcomes.  Having more advanced disease,  receiving chemotherapy or having a 
co-morbid illness were hypothesized to be particularly stressful for lower SES 
participants, and an interaction between these medical characteristics and SES 
was predicted.
Results
There were 352 participants.  Nine hospital sites took part in recruitment to 
the study.  Recruitment levels varied widely between each hospital site.  For 
example, two hospitals recruited  100 patients each, accounting for 56.8%
(200/352) of the full sample, whereas one hospital only recruited 2 participants.
Table 1  shows the demographic and medical characteristics of the sample. There 
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proportion of breast cancer patients (204/352, 58.0%) recruited to the study.  Ages 
ranged from 29 to 89 years of age,  but just over half of the patients (51.8%) were 
over 65 years of age.  The sample is also predominantly white (84.9%) and 
married (68.8%).  A third of the patients had lymph node involvement or distant 
metastases (33.5%).  The majority had received surgery (81.5%),  half had been 
given radiotherapy (47.2%) and a third received chemotherapy (33.8%).  60% 
(160/268) of the breast and prostate patients were continuing with some form of 
hormone therapy.  Just under half of the patients had at least one co-morbid 
condition (45.5%), but information on the presence of co-morbidity was only 
available for N = 275/352 (78%).  The average time since receiving a cancer 
diagnosis until recruitment to the study was 66 days (SD = 45 days).
Table 2 shows the socio-economic characteristics of the sample.  57.4% 
had some educational qualifications.  79.5% of the sample were car owners and 
80.1% were home owners.  These figures were slightly higher than the national 
ownership figures,  particularly for home-ownership (car: 77%,  home: 69%
(Rickards et al 2004)),  but levels of home-ownership vary across age groups and 
the figures in this sample more closely reflect levels of ownership amongst older 
adults (home owners: age 60-64 years = 81%, age 65-69 = 73% (Rickards et al
2004).  The Townsend score showed that just under half lived in above average 
deprivation areas (scoring ‘0’ and above).  This was also a low earning sample 
with 52.3% reporting a household income of £20K and under.  This could reflect 
the fact that this was also a largely retired population.Chapter 8:  Study 4  175
Table 1   -  Demographic and medical characteristics of sample
N ( N = 352) %
Gender Male 114 32.4
Female 238 67.6
Age (range 29-89) 65 years and over 145 41.2
Under 65 years 135 38.4
Missing 72 20.4
Ethnicity White 299 84.9
Black 15 4.3
Indian/Pakistani 20 5.7
Chinese 1 0.3
Other 13 3.7
Missing 4 1.1
Employment status Full & part-time 116 33.0
Homemaker 26 7.4
Unemployed 13 3.7
Student 3 0.9
Disabled/too ill 12 3.4
Retired 176 50.0
Missing 6 1.7
Marital status Married/living with partner 242 68.8
Widowed 51 14.5
Divorce/separated 27 7.7
Single 32 9.1
Cancer site Breast 204 58.0
Colorectal 84 23.9
Prostate 64 18.2
Disease stage Invasive 118 33.5
Non-invasive 209 59.4
Missing 25 7.1
Treatments Surgery Yes 287 81.6
received No 55 15.6
Missing 10 2.8
Chemotherapy Yes 119 33.8
No 226 64.2
Missing 7 2.0
Radiotherapy Yes 166 47.1
No 179 50.9
Missing 7 2.0
Hormone Yes 160 45.5
therapy No 185 52.5
Missing 7 2.0
Co-morbid illness Yes 160 45.5
No 115 32.7
Missing 77 21.9Chapter 8:  Study 4
Table 2 Socio-economic characteristics of the sample
N (N = 352) %
Educational Some 193 54.8
qualifications None 143 40.6
Missing 16 4.5
Car owner Yes 280 79.5
No 70 19.9
Missing 2 0.6
Home owner Yes 282 80.1
No 68 19.3
Missing 2 0.6
Townsend score Deprived (>0) 156 44.3
Affluent (<0) 187 53.1
Missing 9 2.6
Income <10K 72 20.5
10-20K 112 31.8
20-30K 57 16.2
30-40K 31 8.8
40-50K 16 4.5
50-60K 13 3.7
60-70K 3 0.9
>70K 7 2.0
Missing 41 11.6
Subjective SES 1   low SES 6 1.7
2 9 2.6
3 21 6.0
4 28 8.0
5 57 16.2
6 58 16.5
7 35 9.9
8 10 2.8
9 9 2.6
10 high SES 2 0.6
Missing 117 33.2Chapter 8:  Study 4  177
The main SES analyses used a composite marker based on educational 
qualifications, car and home ownership, as previously described in Chapter 3.
This resulted in three SES groups:  low (N = 62), medium (N =  133) and high (N = 
141).  There were no differences in the SES distribution of the sample according to 
hospital site (x2  = 2.17, df=  1,  NS).  There were no gender differences between 
the SES groups (x2  = 0.14, d f-  1,  NS).  Lower SES was associated with older age 
(F [1,269] = 6.03, p<0.001).  There were no differences by disease site (x2  = 0.07, 
df= 1,  NS), but more ‘high’ (55.4%) and ‘medium’ (52.7%) SES than low SES 
(29.5%) participants had  received  radiotherapy (%2 = 9.10, df=  1, p<0.01).  There 
were no differences between SES groups in terms of the other treatments 
(surgery, chemotherapy,  hormone therapy) or disease stage at diagnosis.
However, 76.7% of low SES participants had a co-morbid illness compared to 
47.3% of high SES participants (x2  = 11.49, df=  1, p<0.001).
Disease stage,  treatment and psychosocial wellbeing
Patients with invasive disease reported worse overall quality-of-life (F 
[1,318] = 4.48, p<0.05) (Table 3).  These patients particularly had worse emotional 
quality-of-life (F [1,324] = 8.64, p<0.01) and a trend for poorer functional quality-of- 
life (F [1,322] = 3.51, p = 0.062).  Advanced disease status was also associated 
with increased anxiety (F [1,320] = 4.66, p<0.05), with a similar trend being seen 
for depression (F [1,300] = 3.43, p = 0.065).  When the analyses were re-run using 
imputed data in the depression variable, this association became significant (F 
[1,325] = 5.14, p = 0.022, partial eta squared = 0.017) such that those with moreChapter 8:  Study 4  178
advanced disease had higher levels of depression (Mean = 7.66,  95% Cl = 8.37- 
8.95) than those with non-invasive disease (Mean = 6.02,  95% Cl = 5.04-7.00).
Social difficulties were higher in those with metastases (F [7, 288] =  12.75, p<0.01) 
but there were no differences between the two groups for benefit finding (F [1,316]
= 0.005,  NS) or medical interactions (F [1,320] = 2.09,  NS).  The effect sizes were 
all small.
Receiving a particular treatment or not (e.g. surgery or not, chemotherapy or not) 
and their associations with psychosocial wellbeing were explored using univariate 
ANOVAs controlling for age, gender and disease site.  There were no differences 
in any of the psychosocial wellbeing variables depending on having radiotherapy 
or hormone therapy (NB using just breast and prostate patients for the analyses 
with hormone therapy).  Receiving surgery (M = 8.16,  SE = 0.64) was associated 
with slightly decreased social difficulties compared to those who did not receive 
surgery (M = 9.46,  SE = 0.32) (F [7,300] = 6.19, p<0.05), although this association 
becomes non-significant when using a variable that includes imputed values for 
missing data.  Those who had received chemotherapy reported worse functional 
quality-of-life (M =  15.21,  SE =  1.57) (F [1,339] = 4.14, p<0.05) and more 
dissatisfaction with their medical interactions (M = 0.32,  SE = 0.06) (F [1,336] =
13.57, p<0.001) than those who did not (functional:  M =  18.86, SE = 0.57, medical 
interactions:  M = 0.99, SE = 0.17).  There was also an association between having 
chemotherapy and increased social difficulties (using a variable including imputed 
missing values only) (F [7,344] = 5.95, p<0.05) (M =  10.45, SE = 0.76 versus M = 
7.89, SE = 0.59).Table 3 Psychosocial wellbeing by disease stage, controlling for age, gender and cancer site.
Disease stage Mean (95% Cl) P Partial eta2
Psychosocial wellbeing No metastases N = 209 Metastases N =  118
Quality of  Physical 
life  Social/family 
Emotional 
Functional 
Total
22.62 (21.84-23.40) 
21.92 (20.92-22.92)
18.62 (17.81-19.43) 
18.67 (17.53-19.80) 
81.80 (79.11-84.50)
22.03 (21.00-23.06) 
21.48 (20.17-22.80) 
16.61  (15.55-17.68) 
16.84 (15.34-18.34)
77.04 (73.50-80.59)
0.212
0.718
0.004
0.062
0.035
0.005
0.000
0.027
0.011
0.014
Social difficulties 7.17(6.40-7.95) 10.92 (8.71-13.14) 0.009 0.037
Anxiety 5.00 (4.17-5.82) 6.38 (5.31-7.45) 0.032 0.015
Depression 5.74 (4.71-6.77) 7.32 (5.92-8.71) 0.065 0.012
Benefit finding 35.71  (33.47-37.96) 35.36 (32.37-38.34) 0.184 0.006
Medical interactions 0.33 (0.21-0.45) 0.49 (0.33-0.65) 0.149 0.007Chapter 8:  Study 4 180
Co-morbidity and psychosocial wellbeing
The presence of a co-morbid condition was associated with poorer 
emotional quality-of-life (F [1,273] = 4.55, p<0.05) (M =  17.15, SE = 0.44 vs.  M = 
18.82, SE = 0.54).  There was also a trend for patients with co-morbid illness to 
report worse social/family (F [1,272] = 2.79, p = 0.096) and overall quality of life (F 
[1,268] = 3.39, p = 0.067).
SES and psychosocial wellbeing
Table 4 shows the relationship between individual SES 
(car/home/education) and psychosocial wellbeing.  There were significant linear 
relationships between SES and social/family quality-of-life (F [1,330] = 2.24, 
p<0.05), depression (F [1,310] = 6.71, p<0.05) and social difficulties (F [7,298] = 
8.71, p<0.05).  Those with higher SES had better quality of life, were less 
depressed and had fewer social difficulties.  The high SES group had consistently 
better outcomes across many of the psychosocial wellbeing variables, as can be 
seen by looking at the means and confidence intervals reported in Table 4. 
However, there was no gradient in the SES differences across the three groups, 
and the ‘medium’ SES group did not seem distinct from either the low or high SES 
groups.
These analyses were repeated using the three other SES markers 
(Townsend index,  income, and subjective SES) for comparison (Table 5).  For the 
purpose of the ANOVA analyses, the Townsend index was divided into three equalChapter 8:  Study 4181 
groups.  For income, the top four groups ( £40K+, see Table 2) were collapsed 
into one category because of  small numbers in the higher income groups.  This 
resulted in a five category variable for income.  Finally, the bottom three 
subjective SES groups and the top three subjective SES groups were also 
collapsed into single categories because of small numbers (see Table 2).  This 
resulted in a six category subjective SES variable.
The analyses using the Townsend index also found a significant difference 
across levels of deprivation in terms of depression (although this association 
became non-significant when using imputed values to take account of missing 
data), but no other significant differences were found.  There were no significant 
differences in any of the psychosocial wellbeing variables according to level of 
income.  The subjective SES score revealed a number of significant differences. 
The higher SES groups had better social/family, functional and overall quality of 
life, less anxiety and more satisfaction with medical interactions.  There appeared 
to also be a trend for the higher SES groups to report less depression.  The 
analyses using this marker were re-run with missing values imputed from an  EM 
algorithm based on the other SES indicators (car,  home, education,  income and 
Townsend score).  This method did not significantly alter the results.  The partial 
eta squared statistic indicated small effect sizes for all of the significant results 
using any of the four SES markers.Table 4 Psychosocial wellbeing by SES, controlling for age, gender and cancer site.
SES Mean (95% Cl) P Partial
eta2
Psychosocial wellbeing Low N = 62 Medium N = 133 High N = 141
Quality of  Physical 
life  Social/family 
Emotional 
Functional 
Total
22.04 (20.67-23.42)
20.55 (18.84-22.25)
18.55 (17.17-19.93) 
17.99 (15.97-20.00) 
79.53 (74.91-84.15)
21.82 (20.80-22.85) 
21.30 (20.07-22.53) 
16.40 (15.37-17.43) 
16.78 (15.33-18.23) 
76.22 (72.90-79.55)
23.23 (22.31-24.15) 
22.64 (21.54-23.73) 
18.41  (17.49-19.32) 
18.93 (17.64-20.22) 
83.27 (80.29-86.24)
0.593
0.042
0.866
0.438
0.180
0.018
0.014
0.030
0.019
0.036
Social difficulties 9.01  (6.66-11.36) 9.45 (7.61-11.29) 7.25 (6.74-7.76) 0.017 0.009
Anxiety 5.61  (4.17-7.06) 6.29 (5.23-7.34) 4.66 (3.72-5.60) 0.278 0.022
Depression 7.08 (5.27-8.90) 7.75 (6.50-9.00) 4.79 (3.64-5.95) 0.036 0.043
Benefit finding 37.60 (33.58-41.63) 33.96 (31.09-36.82) 34.94 (32.39-37.50) 0.272 0.006
Medical interactions 0.40 (0.20-0.61) 0.39 (0.24-0.54) 0.37(0.23-0.50) 0.780 0.001Table 5 Differences in psychosocial wellbeing using other SES markers -  controlling for age, gender and cancer site.5
SES markers
Individual Townsend ,   Income Subjective SES
Psychosocial wellbeing P Partial P Partial P Partial P Partial
eta2 eta2 eta2 eta2
Quality of life  Physical 0.593 0.018 0.230 0.013 0.497 0.011 0.748 0.013
Social/family 0.042 0.014 0.259 0.011 0.733 0.011 0.016 0.063
Emotional 0.866 0.030 0.395 0.004 0.482 0.006 0.235 0.024
Functional 0.438 0.019 0.442 0.008 0.136 0.020 0.031 0.062
Total 0.180 0.036 0.519 0.013 0.657 0.005 0.032 0.049
Social difficulties 0.017 0.009 0.060 0.000 0.812 0.002 0.363 0.015
Anxiety 0.278 0.022 0.348 0.012 0.582 0.004 0.018 0.053
Depression 0.036 0.043 0.053 0.010 0.180 0.012 0.074 0.036
Benefit finding 0.272 0.006 0.435 0.004 0.402 0.007 0.901 0.012
Medical interactions 0.780 0.001 0.453 0.022 0.294 0.012 0.049 0.035
5  Analyses run with income as a three category variable (<10K, 10-20K, >20K) did not result in any significant associations.  There did not appear to be a 
meaningful way in which to alter the subjective SES scores into a three category system, but running a system with four roughly equal sized groups (score 1-4=1 
5=2, 6=3, 7-10 = 4) reduced the number associations found (Social Family F (1,233) = 2.23, P = 0.226, Total quality of life F(l,229) = 1.70, P = 0.268, Medical 
interactions F(l,232) = 1.81, P=0.236).  These changes in SES categories were considered less sensitive and were not pursued in the subsequent studies.Chapter 8:  Study 4  184
Interactions between SES and medical characteristics
There was a significant interaction between disease stage and individual 
SES for social/family quality of life (F [2,310) = 4.94,  p<0.01) (partial eta squared 
= 0.032 i.e. small effect).  High SES patients with invasive disease (M = 22.83,
95% Cl = 20.91-24.76) had better quality of life than low SES patients with 
invasive disease (M = 17.09, 95% Cl = 14.43-19.74).  Figure 1   shows this 
relationship.
Interactions between SES and treatment types on psychosocial wellbeing 
were also examined.  No significant interactions were found for chemotherapy or 
radiotherapy.  SES interacted with receiving hormonal therapy on physical quality- 
of-life (F [2,250] = 3.96 p<0.05, partial eta squared = 0.031).  Low SES patients 
had lower physical quality-of-life if they did not receive hormonal therapy 
compared to higher SES patients.  The significant difference lay between the low 
(M = 19.13, 95% Cl = 16.83-21.44) and middle SES groups (M = 22.90, 95% Cl =
21.48-24.31)) who did not receive hormone therapy.  Figure 2 displays this 
relationship and indicates that the high SES group without hormone therapy (M = 
21.85, 95% Cl = 20.42 -  23.28) also had higher quality of life than the lowest SES 
group, although comparing the confidence intervals shows that this was not a 
significant difference.  All patients receiving hormone therapy had improved 
physical quality-of-life and there was no difference in physical quality-of-life 
between the SES groups in those receiving hormonal therapy.  This suggests that 
the effect of receiving hormone treatment negated any SES differential in quality of 
life.Chapter 8:  Study 4  185
There were also a number of interactions between surgery and SES on 
psychosocial wellbeing, although it should be noted that only a small proportion of 
patients did not receive surgery (N = 51), meaning that, for example, only 7 
patients had both low SES and did not have surgery.  The interaction analyses 
showed that high SES patients without surgery had higher emotional quality-of-life 
than lower SES patients without surgery (F [2,323] = 3.10, p<0.05,  partial eta 
squared = 0.019) (Figure 3A).  The significant difference was between the high (M 
= 20.58,  95% Cl =  18.67-22.59) and medium SES groups (M =  16.92, 95% Cl = 
15.17-18.67) although the same pattern was observed for the low SES groups as 
well (M =  17.43, 95% Cl =  14.12-20.74).  Patients in the ‘low’ and ‘medium’ SES 
groups and who had surgery seemed to show a slight improvement in emotional 
quality-of-life compared to those who did not have surgery, whereas high SES 
patients who had surgery had lower quality-of-life than high SES patients who did 
have surgery.  This interaction meant that low and high SES patients who had 
surgery had comparable levels of emotional quality-of-life.
A slightly different interaction was seen for physical and overall quality-of- 
life: high SES patients who do not have surgery have better physical (F [2,321] = 
4.16, p<0.05, partial eta squared = 0.026) (M = 25.90,  95% Cl = 23.89-27.90)
(Figure 3B) and overall (F [2,318] = 3.59, p<0.05, partial eta squared = 0.023)
(Figure 3C) quality-of-life than patients with lower SES.  In each case the 
significant difference lay between the ‘high’ and ‘medium’ SES groups (Medium 
SES and no surgery: physical M = 21.92, 95% Cl = 20.17-23.68, overall M =
78.08, 95% Cl = 72.43-83.72).  However the graphs also demonstrate a similar 
trend for the low SES group, but this group had greater variation resulting in widerChapter 8:  Study 4
confidence intervals (low SES and no surgery:  physical M = 23.00,  95% Cl = 
19.69-26.31, overall M = 82.55, 85% Cl = 71.03-94.08).  All patients who have 
surgery experienced reduced physical and overall quality-of-life, compared to 
patients that do not have surgery,  but the difference according to SES group 
disappears.
There were no significant interactions between SES and co-morbidity on 
psychosocial wellbeing.
Figure 1   Disease stage, SES and Quality of Life: 
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Figure 2 Hormone therapy, SES and Quality of Life: 
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Figure 3B  Surgery, SES and Quality of Life: Physical
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Discussion
This study explored relationships between cancer-related stressors 
(disease stage, treatment type, and co-morbidity), SES and psychosocial 
wellbeing.  I hypothesised that the presence of invasive disease,  receiving 
chemotherapy or the presence of a co-morbid illness would be particularly 
stressful for lower SES patients resulting in poorer psychosocial wellbeing.
The relationship between advanced disease stage and poorer psychosocial 
wellbeing seen in the sample of colorectal cancer patients in Study 2 was 
replicated in this study.  Patients with invasive disease had poorer quality of life, 
increased anxiety and experienced more social difficulties.
In terms of treatment type, only chemotherapy was associated with worse 
functional quality of life,  increased dissatisfaction with medical interactions and 
social difficulties.  Other reports have also found an association between quality of 
life and receiving chemotherapy (Janz et al 2005,  Schover et al  1995) and one 
study found increased distress and dysfunction in those treated with 
chemotherapy that persists up to four years after diagnosis (Schover et al  1995). 
Surgery, radiotherapy and hormone therapy did not relate to any of the 
psychosocial wellbeing variables.
The analyses also showed that the presence of a co-morbid illness could 
have some impact on emotional, and possibly functional, quality-of-life, although 
the other psychosocial wellbeing variables remained unaffected. This is not a well- 
researched area, although one other study also reports that co-morbidity is 
associated with increased depressive symptoms amongst cancer patients (Kurtz 
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Four different markers of SES were used in this study.  Only subjective SES 
showed associations with a wide range of psychosocial wellbeing variables,  such 
that lower subjective SES related to decrease social/family, functional and overall 
quality of life as well as increased anxiety and dissatisfaction with medical 
interactions.  Subjective SES could be more accurate than objective SES as it 
allows the individual to take into account the special circumstances of their own 
lives.  A problem with the measure of subjective SES is that it may overlap with the 
psychosocial wellbeing variables e.g. depressed individuals may rate themselves 
lower on the subjective measure.  Singh-Manoux et al (2003) used regression 
models with participants from the Whitehall II study and  reported that the most 
important predictors of subjective SES were other objective SES markers 
(employment grade,  household  income, education) and although psychological 
functioning (hopelessness, control, mental health, vigilance,  hostility, and 
optimism) was correlated with subjective SES it was not an independent predictor 
of it.  This suggests that subjective SES is not a proxy for psychological 
functioning.  However, a difficulty with using this measure in this study was that 
subjective SES was only assessed at the second round of data collection, 
meaning that it was not available for the full baseline sample which impacts the 
reliability of the results.
The lack of association between the Townsend index and psychosocial 
wellbeing variables may be because the index is based on data from the 1991 
census and area characteristics could have changed.  Similarly,  household income 
may not be an accurate marker for SES in this population because a large 
proportion were retired,  resulting in decreased  income that may not truly reflectChapter 8:  Study 4  191 
their socio-economic position.  Problems with using these two markers of SES are 
discussed in more detail in Chapter 3.
Individual SES was used as the primary marker because it had shown a 
good ability to detect SES differences in wellbeing in the sample used in Study 2. 
Associations between this marker and anxiety, medical interactions, physical and 
overall quality-of-life found in Study 2 were not replicated in this sample, although 
associations with social difficulties and depression were replicated.  Overall, this 
indicates a general lack of association between the individual SES measure and 
psychosocial wellbeing variables in this sample.  This could either be because of 
problems using this marker in the current sample or because there really are no 
effects.  Only 17% of the current sample were classified  in the lowest SES group. 
Specifically, the sample over-represented car (79.5%) and home (80.1%) owners 
compared to national figures (car: 77%, home: 69% (Rickards et al 2004).  Nurses 
were responsible for recruiting to this study and were in some sense 
‘gatekeepers’.  It is possible that this may have biased recruitment to the study 
with higher SES participants being over-represented.  Additionally the sample is 
likely to include only those patients that nurses felt would be either more 
cognitively able to complete the questionnaire or who were generally more 
interested in research.
Higher SES patients were less likely to have the additional stress of a co- 
morbid illness.  Although this may seem obvious given the higher rates of ill health 
amongst lower SES groups, there is little literature that has explored this topic.
One study that examined this topic in a mixed-sample of cancer patients (breast, 
lung, colorectal, prostate, stomach) also found an association between lower SESChapter 8:  Study 4  192 
and increased co-morbidity,  particularly for heart or vascular disease (Schrijvers et 
al 1997).  Apart from the possible implications for survival, the additional stress of 
a co-morbid illness might be expected to decrease psychosocial wellbeing.
However, the evidence from this study showed only weak associations between 
co-morbidity and lower quality of life.
Higher SES patients were also more likely to have had radiotherapy.  Two 
studies looking at the use of palliative (Huang et al 2001) and adjuvant (Paszat et 
al 1998) radiotherapy in Canadian breast cancer patients also report that high SES 
patients are more likely to receive these treatments.  Other studies find no such 
association,  including one study of breast cancer patients in Scotland (Macleod et 
al 2000) and one study with prostate patients in the US (Krupski et al 2005).
These conflicting results imply variation in the implementation of treatment 
strategies that could reflect both geographic and provider differences that in turn 
influence the accessibility of radiotherapy for patients from different socio­
economic backgrounds.  One suggestion is that patients from higher SES 
backgrounds are more likely to demand radiotherapy (Huang et al 2001), possibly 
related to an overall higher level of participation in treatment decisions also seen in 
the higher rates of high SES participants enrolled in clinical trials (Gross et al
2005).
These differences in exposure to cancer-related stressors did not affect the 
wellbeing of different SES groups as no significant interactions between SES and 
radiotherapy or co-morbidity on psychosocial wellbeing were found.  There was a 
significant interaction between SES and disease stage on social/family quality-of- 
life in this sample.  High SES patients with invasive disease had better quality ofChapter 8:  Study 4  193
life than low SES patients with invasive disease.  The interaction found in the 
previous study regarding the effect of SES and disease stage on anxiety was not 
replicated.  The interaction effects with disease stage may not be consistent and 
the effects are small.
There were interactions between surgery and SES on quality of life.  The 
effect of treatment appeared to flatten the SES disparities in quality of life.
Although differences in quality of life may exist prior to treatment, the effect of 
having surgery for cancer is equally good or bad regardless of SES.  However, 
because only small numbers of patients did not receive surgery, (for example, only 
7 patients had both low SES and did not have surgery) this limits the strength of 
the conclusions that can be drawn.  The evidence from the interaction analyses 
suggests that the hypothesis that differences in psychosocial wellbeing according 
to level of SES would widen in situations of severe stress, such as an invasive 
cancer diagnosis, or when undergoing different treatments,  is not demonstrated.
On the contrary, the evidence from the interactions between SES and surgery on 
psychosocial wellbeing indicates that undergoing treatment for cancer may lessen 
the differences in psychosocial wellbeing according to SES.
There were a number of limitations to this study.  The first was the 
recruitment strategy that may have introduced a source of bias, as discussed.  It 
also meant that information regarding non-responders could  not be accessed in 
order to assess the extent of the bias.  Another issue was that the collection of 
information regarding medical characteristics from patient’s medical files could not 
be completed due to lack of co-operation from participating hospitals.  Reasons 
cited for not allowing access to records were largely due to limited time resourcesChapter 8:  Study 4  194
for staff to complete research protocols.  Medical record data could be 
supplemented by self-report measures for a number of variables,  but a large 
proportion of missing data regarding co-morbidity still remained.
A more fundamental problem was that the study was underpowered to 
detect small effect sizes.  Post-hoc power analyses using g-power software 
revealed that the power to detect a small effect size (0.10), with 3 groups of SES, 
an alpha of 0.05 and sample size of 352,  is only 0.4.  Good power of 0.8 is only 
maintained for effect sizes of 0.17 and above.  The majority of the analyses in this 
study also included elements of missing data.  Although the missing data in the 
psychosocial wellbeing variables was unrelated to SES,  it did further reduce the 
sample size and consequently weaken the power.  Particularly, the interaction 
analyses were probably not sufficiently powered to detect any small effects.  This 
means that a definite conclusion that there were no interaction effects cannot be 
reached.
The results did confirm that the presence of invasive disease was an added 
psychosocial burden and that to some extent both co-morbidity and chemotherapy 
could also lead to worse psychosocial adjustment.  But the results also showed 
that these differences in adjustment according to medical characteristics did not 
increase greatly with lower SES and any differences in exposure to cancer-related 
stressors did not have a significant impact on psychosocial wellbeing.  Further 
analyses of the longitudinal aspect of this dataset will reveal if SES has an impact 
on psychosocial adjustment to cancer over time.Chapter 9:  Study 5  195
CHAPTER 9
Study 5: Socioeconomic status differences in psychosocial resources amongst
cancer patients
Introduction
In Study 4, the relationship between SES and psychosocial wellbeing in 
cancer patients was explored.  The results showed some evidence of poorer 
wellbeing in lower SES groups and patients with more invasive disease, but no 
evidence that lower SES groups were especially vulnerable to invasive disease.
In Chapter 1,  I had proposed that SES would relate to the distribution of 
psychosocial resources that are required to adapt successfully to a stressful 
situation.  In this Chapter I will explore this idea using the same dataset as used in 
Study 4.
A number of individual psychological characteristics have been 
hypothesised to influence reactions to stress.  As discussed in Chapter 1, a sense 
of personal control and higher levels of optimism relate to better psychosocial 
adjustment during times of stress, such as experiencing a physical illness.  Levels 
of perceived social support and the closely related resource of disclosure, or the 
ability to communicate openly about difficulties within the family also play a role. 
Finally, choice and use of different coping strategies may influence subsequent 
psychological wellbeing.
These resources have also been implicated in the relationship between 
SES and wellbeing.  Whilst there is an established  link between personal control 
and SES, the relationships between SES and optimism or social support andChapter 9:  Study 5  196
disclosure are less clear (see Chapter 1).  The relationships between coping 
strategies and SES have never been explored in any great detail.  Taylor and 
Seeman (1999) propose coping strategies as a potential candidate in the 
mediational chain between SES and psychosocial wellbeing.  They cite a personal 
communication from Charles Carver that avoidant coping strategies may be higher 
in lower SES groups, but report no examples of published research in this area.
The action of coping strategies on SES may be via their relationship to other 
resources such as control, optimism and social support, as discussed in Chapter 
1, or because of a more direct relationship to SES.  This study will explore whether 
coping strategies are directly associated with SES.
The aim of this study was to look at the distribution of psychosocial 
resources (control, optimism, social support, disclosure and coping strategies) 
according to SES.  The relationships between psychosocial resources and 
wellbeing will also be examined.  Finally, the combined influence of SES and 
resources on wellbeing will be explored.  I hypothesised that lower SES would 
relate to lower levels of psychosocial resources and that lower resources would 
relate to poorer psychosocial wellbeing.Chapter 9:  Study 5  197
Hypotheses
1.  High SES will be associated with greater mastery,  optimism and social 
support.  Coping strategies might differ by SES.
2.  Psychosocial resources (mastery, optimism, social support, and use of 
effective coping strategies) will be associated with psychosocial wellbeing 
(quality of life, depression, anxiety, social difficulties, benefit finding, and 
medical interactions).
3.  SES and resources will predict psychosocial wellbeing.
Method
Participants,  Design and Procedure
The methods used  in the present study are identical to those described in 
Study 4 and so are not repeated here.  The sample consisted of 352 colorectal, 
breast and prostate cancer patients.  Participants completed a self-report 
questionnaire covering a range of psychosocial wellbeing outcomes and 
resources: quality of life, social problems, experience of medical care, anxiety, 
depression, benefit finding, social support, disclosure, mastery, optimism and 
coping strategies.  Demographic information included ethnicity, gender, and socio­
economic status (SES).  Surveys were completed at two time points:  1-3 months 
post-diagnosis and 9-12 months post diagnosis.  Data for this report were taken 
from the baseline of the study.Chapter 9:  Study 5  198
Measures
Psychosocial Resources 
Personal Control
Control was assessed using the Pearlin Mastery Scale (Pearlin & Schooler 
1978).  Mastery is the extent to which a person perceives themselves to be in 
control of events or ongoing situations and reflects the perception of the ability to 
manage them.  The scale consists of 7 items.  An example item is: “I can do just 
about anything  I really set my mind to do.”   There are five response categories 
ranging from ‘strongly disagree’ to ‘strongly agree’.  Participants are asked to 
respond according to how they generally feel.  Items are scored one to five, with 
appropriate items reversed scored.  This results in a scale with a range from 7 to 
35.  Higher scores indicate more feelings of mastery.
Optimism
Optimism was assessed using the Life Orientation Test-Revised (LOT-R) 
(Scheier et al  1994).  This is a measure of dispositional optimism i.e. a personality 
variable,  used to assess individual differences in generalised optimism.
Participants were asked to respond according to how they generally feel.  There 
are six items in the scale, with five response options from ‘strongly disagree’ to 
‘strongly agree’.  An example item is: “Overall,  I expect more good things to 
happen to me than bad”.  Responses are scored one to five so that high values 
relate to increased optimism.  The scale range is from 6 to 30.Chapter 9:  Study 5  199
Social Support
Social support was measured using the Multidimensional Scale of 
Perceived Social Support (MSPSS) (Zimet et al  1988).  The MSPSS is a measure 
of the subjective assessment of social support adequacy.  It is a 12-item scale with 
three subscales (4 items each) examining support from family (e.g. ‘my family 
really tries to help me’), friends (e.g.  ‘I can count on my friends when things go 
wrong’), and significant other (e.g.  There is a special person who is around when I 
am in need’).  Participants are asked how much they agree or disagree with each 
statement.  A five-point response rating scale was used from ‘strongly disagree’ to 
‘strongly agree’.  The scale range is 1   to 60 with higher scores indicating better 
support.
Disclosure
Disclosure was measured using the Openess to Discuss Cancer in the 
Family scale (ODCF) (Mesters et al  1997).  This scale assessed the amount of 
open communication about cancer in the family.  This was originally a nine-item 
scale.  A modified five-item version of this scale was used in this study.  Four items 
that referred specifically to a partner or child were excluded because they did not 
apply to all participants.  Participants are asked to indicate for each item how 
much they agree or disagree with the statement.  There are four response options: 
‘strongly agree’, ‘agree’, ‘disagree’,  ‘strongly disagree’.  Items are scored  1-4 with 
a higher score indicating greater openness. The items in the scale refer to both 
self-disclosure of the disease (e.g.  I talk as little as possible about my illness 
because I don’t want to make my family uneasy) and the family’s ability to talk 
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family).  The scale in this study had reasonable internal reliability (a=0.67), that 
was not improved by deleting any one item from the scale.
Coping strategies
Coping was measured using items from the Brief Cope (Carver 1997).  The 
Brief COPE is a 28 item scale consisting of 14, two-item subscales that measure 
different ways of coping: self-distraction, active coping, denial, substance use,  use 
of emotional support,  use of instrumental support,  behavioural disengagement, 
venting,  positive reframing,  planning,  humour, acceptance, religion, and self­
blame.  In this study, sub-scales referring to social support (both emotional and 
instrumental) were removed as similar constructs were measured elsewhere in the 
questionnaire.  This resulted in a 24-item scale.  Participants are asked to rate 
how much they have been using each coping strategy on a four-point scale.  For 
example: “I’ve been turning to work or other activities to take my mind off things” 
(active coping) with the response options:  ‘I haven’t been doing this at all’,  ‘I’ve 
been doing this a little bit’,  ‘I’ve been doing this a medium amount’,  ‘I’ve been 
doing this a lot’.  Items are scored  1   to 4 and sub-scale scores are calculated by 
summing the two items that form the scale.  Therefore each sub-scale has a score 
from 1   to 8.  The subscales of the Brief COPE have good internal reliability (Carver 
1997).
Socio-economic status
There were four markers of socio-economic status: individual SES (3 
categories), Townsend Index (3 categories),  income (5 categories) and subjective 
SES (6 categories), described in detail in the previous chapter.Chapter 9:  Study 5  201
Psychosocial wellbeing
Psychosocial wellbeing was assessed using a number of questionnaire 
scales described in the previous chapter: quality of life, social difficulties, anxiety, 
depression and medical interactions and benefit finding.
Analyses
Data were analyzed using analysis of variance with SES as the 
independent variable, and age, gender and cancer sites as control variables. 
Psychosocial resources: control, optimism, social support, disclosure, and coping 
strategies were the dependent variables.  The analyses were carried out using 
four different SES markers (individual SES [car/home/education], Townsend 
score,  income and subjective SES).  The relationships between psychosocial 
resources and psychosocial wellbeing were examined using pearson correlations. 
Finally, a series of hierarchical regression analyses were run to examine the 
contribution of both SES and resources on psychosocial wellbeing.
Intracluster correlation coefficients for the effect of hospital sites were 
calculated for all of the dependent variables.  Most of the dependent variables had 
small intracluster correlations (range: 0.001-0.05) (Hox 2002).  The coping 
strategy ‘venting’ was approaching a medium-sized correlation (0.09) and any 
analyses involving this variable included adjustment for clustering due to hospital 
site.
I hypothesized that lower SES would be associated with lower control, 
optimism and social support.  I expected that control, optimism, social support, 
disclosure and coping strategies would be correlated with better psychosocial 
wellbeing.Chapter 9:  Study 5  202
Results
Table 1   shows the relationships between psychosocial resources and the 
individual SES marker.  Higher SES was associated with increased control (F 
[1,322] = 3.34, p<0.05) with a clear gradient in control across the three SES 
groups.  A similar pattern was seen for optimism with increasing optimism 
associated with higher levels of SES (F [1,317] = 5.67, p<0.01).  The association 
between individual SES and control and optimism was also found using the 
measures of income and subjective SES (see Table 2).  This suggests a robust 
relationship.
There was no association between social support and disclosure and SES. 
The means in Table  1   do show that the low SES group had consistently lower 
social support and the high SES group reported more openness to discuss cancer 
in the family (disclosure),  but these differences were not significant and the effect 
sizes were small.
Two coping strategies were also associated with SES: substance use (F [1,328] = 
7.18, p<0.05) and planning (F [1,323] = 2.74, p<0.05).  Lower SES groups were 
more likely to use alcohol or drugs to help them cope with their illness.  Higher 
SES groups were more likely to think about what steps needed to be taken to cope 
with the illness.  The association between individual SES and substance use was 
not found using any of the other SES markers,  but income was also associated 
with the use of ‘planning’ coping strategies.  The Townsend  index was not 
associated with any of the psychosocial resources.203
Table  1   Psychosocial resources by individual SES controlling for age, gender and cancer site
SES P value Partial
eta2
Psychosocial resources Low N = 62 Medium N = 133 High N = 141
Mastery 23.45 (21.31-25.60) 24.38 (22.92-25.84) 26.04 (24.77-27.31) 0.041 0.022
Optimism 19.75(18.06-21.43) 20.82(19.57-22.06) 22.59 (21.53-23.66) 0.005 0.035
Social  Significant other 
support  Family 
Friends 
Total
16.67(15.42-17.92) 
17.22(16.27-18.17) 
16.39 (15.29-17.49) 
50.09 (47.31-52.86)
18.14(17.27-19.01) 
18.00(17.33-18.67) 
16.69 (15.92-17.47) 
52.98 (51.14-54.83)
17.84(17.07-18.61) 
17.91  (17.31-18.50) 
16.95(16.27-17.63) 
52.71  (51.09-54.34)
0.115
0.225
0.389
0.108
0.008
0.004
0.001
0.007
Disclosure  Openness within family 12.71  (11.44-13.99) 12.65(11.89-13.41) 13.69(12.99-14.40) 0.184 0.015
Coping  Self-distraction 
strategies  Denial
Substance use
Behavioural disengagement
Venting
Self-blame
Active
Positive reframing
Planning
Humour
Acceptance
Religion
4.09 (3.46-4.72)
2.71  (2.18-3.25) 
4.85 (4.53-5.17) 
2.38 (2.08-2.67) 
3.22 (2.45-3.99) 
2.61  (2.22-3.00)
4.71  (4.06-5.36) 
4.36 (3.74-4.99) 
4.07 (3.43-4.72) 
4.05 (3.36-4.74) 
7.26 (6.64-7.66) 
4.48 (3.76-5.19)
4.25 (3.80-4.70) 
3.38 (3.01-3.76) 
4.13(3.89-4.36)
2.48 (2.27-2.68) 
3.21  (2.98-3.44)
2.49 (2.20-2.77) 
4.48 (3.99-4.97) 
3.84 (3.40-4.28) 
4.31  (3.87-4.76) 
4.04 (3.54-4.53)
6.26 (5.89-6.62) 
3.33 (2.82-3.85)
4.62 (4.22-5.02)
2.83 (2.49-3.17) 
4.44 (4.23-4.65) 
2.11  (1.93-2.29) 
3.26 (3.07-3.46) 
2.52 (2.26-2.77) 
5.17(4.76-5.59)
4.62 (4.22-5.01)
4.84 (4.44-5.24) 
3.86 (3.41-4.31) 
6.66 (6.33-6.98) 
4.22 (3.75-4.68)
0.167
0.722
0.035
0.129
0.895
0.679
0.239
0.506
0.046
0.640
0.107
0.545
0.005
0.027
0.044
0.024
0.000
0.002
0.015
0.016
0.017
0.003
0.026
0.021204
Table 2 Differences in psychosocial resources using other SES markers -  controlling for age, gender and cancer site.
SES markers
Individual Townsend Income Subjective
Psychosocial resources P Partial
eta2
P Partial
eta2
P Partial
eta2
P Partial
eta2
Mastery 0.041 0.022 0.230 0.007 0.009 0.034 0.036 0.090
Optimism 0.005 0.035 0.125 0.009 0.008 0.041 0.015 0.087
Social Significant other 0.115 0.008 0.813 0.003 0.695 0.007 0.164 0.023
support Family 0.225 0.004 0.437 0.002 0.282 0.005 0.153 0.048
Friends 0.389 0.001 0.906 0.000 0.764 0.009 0.061 0.018
Total 0.108 0.007 0.797 0.000 0.963 0.008 0.128 0.012
Disclosure Openness within family 0.184 0.015 0.471 0.003 0.104 0.030 0.202 0.024
Coping Self-distraction 0.167 0.005 0.834 0.003 0.490 0.021 0.122 0.060
strategies Denial 0.722 0.027 0.344 0.019 0.326 0.011 0.084 0.045
Substance use 0.035 0.044 0.605 0.007 0.260 0.039 0.567 0.017
Behavioural disengagement 0.129 0.024 0.755 0.001 0.346 0.007 0.539 0.020
Venting 0.895 0.000 0.411 0.005 0.339 0.016 0.411 0.026
Self-blame 0.679 0.002 0.332 0.006 0.226 0.020 0.342 0.015
Active 0.239 0.015 0.611 0.003 0.110 0.013 0.068 0.030
Positive reframing 0.506 0.016 0.876 0.004 0.433 0.008 0.460 0.039
Planning 0.046 0.017 0.959 0.000 0.017 0.033 0.220 0.056
Humour 0.640 0.003 0.602 0.009 0.344 0.008 0.213 0.028
Acceptance 0.107 0.026 0.158 0.011 0.535 0.016 0.470 0.031
Religion 0.545 0.021 0.286 0.006 0.083 0.010 0.844 0.020Chapter 9:  Study 5
Disclosure was a poorly completed scale with  N = 50 having missing data. 
The missing data for optimism and control, although small amounts, were related 
to SES such that low SES groups were less likely to complete these items.
Missing data in this sample was also important because the study was 
underpowered, as discussed in the previous chapter.  However,  imputing missing 
values for each variable,  using the subject mean for each subscale if at least half 
of the items had been completed, did not alter the results in any meaningful way.
The relationship between psychosocial resources and psychosocial 
wellbeing was explored using pearson correlations (Table 3).  Increased control 
and optimism related to better quality of life (control: r=  0.38, df  = 317, p<0.001, 
optimism: r= 0.43, df = 321, p<0.001), less anxiety (control: r -  -0.44, df -  319, 
p<0.001, optimism: r= -0.47, df= 322, p<0.001), less depression (control: r=  - 
0.46, df= 305, p<0.001, optimism: r= -0.43, cff = 308, p<0.001), and fewer social 
difficulties (control: r= -0.18, df = 291, p<0.05, optimism: r=  -0.18, d f- 293, 
p<0.05).  Control was also correlated with medical interactions such that increased 
control related to less dissatisfaction with medical care (r= -0.19, df -  319, 
pO.01).
205206  Chapter 9:  Study 5
Table 3 The relationships between psychosocial resources and wellbeing
Psychosocial wellbeing -  Pearson r
Psychosocial Resources
Quality of Life
Social
Difficulties Anxiety Depression
Benefit
Finding
Medical
Interactions Emotional Functional  Physical
Social/
family Total
Mastery 0.30*** 0.33*** 0.24*** 0.21** 0.38*** -0.18* -0.44*** -0.46*** 0.11 -0.19**
Optimism 0.36*** 0.32*** 0.22** 0.36*** 0.43*** -0.18* -0.47*** -0.43*** 0.09 -0.03
Social Family 0.12 0.21** 0.18* 0.53*** 0.38*** -0.26*** -0.23*** -0.27*** 0.24*** 0.01
Support Friends 0.06 0.12 0.02 0.43*** 0.24*** -0.01 -0.12 -0.19** 0.24*** -0.10
Significant other 0.07 0.12 -0.07 0.28*** 0.15* -0.00 -0.16* -0.21** 0.19** -0.01
Total 0.10 0.17* 0.03 0.49*** 0.29*** -0.09 -0.20** -0.26*** 0.26*** -0.05
Disclosure Openness 0.10 0.24** 0.11 0.35*** 0.30*** -0.13 -0.36*** -0.33*** 0.02 -0.14
Coping Self-distraction -0.22*** -0.12* -0.14** -0.01 -0.16** 0.17** 0.25*** 0.18*** 0.25*** 0.09
strategies Denial -0.29*** -0.17** -0.12* -0.06 -0.21*** 0.06 0.36*** 0.26*** 0.14* 0.15**
Substance use .021 0.04 -0.09 0.10 0.03 -0.02 -0.09 0.01 0.25*** -0.04
Behavioural Disengagement -0.28*** -0.12* -0.12* -0.10 -0.19*** 0.18** 0.27*** 0.27*** -0.05 0.24***
Venting -.035*** -0.29*** -0.35*** -0.15** -0.38*** 0.40*** 0.40*** 0.43*** 0.17** 0.13*
Self-blame -0.27*** -0.23*** -0.17** -0.05 -0.25*** 0.29*** 0.29*** 0.31*** -0.03 0.19***
Acceptance 0.12* 0.11* -0.11* 0.16** 0.11* 0.01 -0.13* -0.04 0.26*** -0.15**
Active -0.12* 0.03 -0.12* 0.05 -0.05 0.13* 0.13* 0.03 0.35*** 0.03
Positive reframing -0.06 0.03 -0.18*** 0.15** -0.01 0.16** 0.12* 0.05 0.51*** 0.05
Planning -0.22*** -0.11* -0.17** -0.05 -0.20*** 0.19*** 0.19*** 0.19*** 0.21*** 0.09
Humour -0.07 0.01 -0.14* 0.09 -0.03 0.19*** 0.04 -0.02 0.15** -0.03
Religious -0.10 -0.01 -0.13* 0.08 -0.04 0.10 0.11 0.08 0.40*** 0.06
*** Correlations is significant at the 0.001  level (2-tailed). 
**  Correlation is significant at the 0.01  level (2-tailed).
*  Correlation is significant at the 0.05 level (2-tailed).Chapter 9:  Study 5  207
Table 4 Summary of multiple regression analyses showing the associations
between SES, psychosocial resources and wellbeing (a)
Quality of life B (SE) Beta t P(t)
Model 1   SES 1.833(1.061) 0.092 1.728 0.085
R = 0.230  R2  = 0.053  Adi R2  = 0.008  F(4,347) = 4.85,  P<0.001
Model 2  Mastery 0.397 (0.138) 0.161 2.870 0.004
Optimism 0.488 (0.164) 0.168 2.987 0.003
Social Support 0.311  (0.089) 0.166 3.507 0.001
Disclosure 0.556 (0.248) 0.110 2.244 0.026
Coping Venting  -6.612(1.669) -0.224 3.962 0.001
Planning  -6.246(1.952) -0.174 3.200 0.002
R = 0.595  R2  = 0.354  Adj R2  = 0.315  F (20,331) = 9.06, P<0.001
Social Difficulties B (SE) Beta t P(t)
Model 1   SES -10.21  (0.552) -0.95 1.903 0.058
R = 0.408 R2  = 0.166 Adi R2  = 0.157 F(4,347) = 17.32 P<0.001
Model 2()  Mastery -0.252 (0.079) -0.184 3.172 0.002
Social Support -0.145 (0.051) -0.140 2.859 0.005
Coping Venting  2.378 (0.958) 0.145 2.482 0.014
Self-blame  2.161  (0.900) 0.125 2.401 0.017
R = 0.555  R2  = 0.308  Adj R2  = 0.266  F(20,331) = 7.360, P<0.001
Anxiety B (SE) Beta t P(t)
Model 1   SES -0.659 (0.325) -0.108 2.030 0.043
R = 0.255  R2  = 0.065  Adj R2  = 0.054  F(4,347) = 6.023, P<0.001
Model 2(}  Mastery -0.144 (0.041) -0.190 3.491 0.001
Optimism -0.149 (0.049) -0.166 3.041 0.003
Disclosure -0.249 (0.074) -0.159 3.362 0.001
Coping Denial  0.955 (0.423) 0.108 2.259 0.025
Venting  1.761  (0.499) 0.194 3.532 0.001
R = 0.625  R2  = 0.391  Adj R2  = 0.354  F(20,331) = 10.632,  P<0.001
Depression B (SE) Beta t P(t)
Model 1   SES -0.838 (0.372) -0.121 2.249 0.025
R = 0.206  R2  = 0.043  Adj R2  = 0.032  F(4,347) = 3.861, P<0.01
Model 2(  ’   Mastery -0.172 (0.048) -0.199 3.584 0.001
Optimism -0.165 (0.057) -0.162 2.913 0.004
Social support -0.074 (0.031) -0.114 2.424 0.016
Disclosure -0.232 (0.086) -0.131 2.706 0.007
Coping Venting  2.512 (0.577) 0.244 4.353 0.001
R = 0.605  R2 = 0.366  Adj R2  = 0.327  F(20,331) = 9.538, P<0.001
Benefit Finding B (SE) Beta t P(t)
Model 1   SES -0.840 (0.888) -0.052 0.947 0.344
R = 0.121  R2  = 0.015  Adj R2  = 0.003  F(4,347) = 1.284, NS
Model T ’   Social Support 0.263 (0.079) 0.172 3.331 0.001
Coping Religion  4.331  (1.295) 0.181 3.345 0.001
Positive reframing  7.615 (1.697) 0.269 4.487 0.001
R = 0.488  R2 = 0.238  Adj R2  = 0.192  F(20,331) = 5.171, P<0.001
Medical Interactions
Model 1   SES -0.71  (0.047) -0.082 1.492 0.136
R = 0.089  R2  = 0.008  Adj R2  = 0.004  F(4,347) = 0.689, NS
Model 2{  ’   Mastery -0.19 (0.007) -0.179 2.736 0.007
Coping Behav. Disengage.  0.221  (0.091) 0.137 2.428 0.016
R = 0.350  R2 = 0.123  Adj R2 = 0.070  F(20,331) = 2.311  P<0.001
(a) Age, gender and cancer type are included as control variables in all models
(b) Only variables where P(t)<0.05 are reported in the tableChapter 9:  Study 5  208
Higher levels of social support were related to increased quality of life (r =
0.29, df= 314, p<0.001) and particularly to increased social/family quality-of-life (r 
= 0.49, d f- 318, p<0.001).  More perceived social support was also correlated 
with decreased anxiety (r= -0.20, df -  316, p<0.01) and depression (r= -0.26, df 
= 303, p<0.001) and higher levels of benefit finding (r= 0.26, df -  314, p<0.001). 
The associations between disclosure and the psychosocial wellbeing variables 
were largely similar to those found for social support, except there was no 
relationship between disclosure and benefit finding.
Many of the coping strategies were related to poorer quality of life and 
higher anxiety, depression or social difficulties.  Particularly self-distraction, 
behavioural disengagement, venting, self-blame and planning were associated 
with each of these wellbeing variables such that use of the strategy related to 
poorer wellbeing.  However, these same coping strategies were also related to 
increased benefit finding.  Only acceptance was related to better psychosocial 
wellbeing.  Acceptance was related to increased quality of life (r= 0.11, df= 333, 
p<0.05),  less dissatisfaction with medical interactions (r= -0.15, df= 335, p<0.01) 
and decreased anxiety (r= -0.13,  df -  335, p<0.01).
Hierarchical regression analyses explored the contribution of both SES 
and resources on wellbeing.  SES was entered in a first block (model  1) and 
resources added in a second block (model 2).  The results of these analyses are 
displayed in Table 4.  The F values indicate that there were significant 
relationships between SES and quality of life, social difficulties, anxiety and 
depression.  However,  in each case the adjusted R2 for the models that includedChapter 9:  Study 5  209
only SES were low (range:  1-16%), demonstrating a poor fit.  The models that 
included psychosocial resources were significantly associated with all of the 
wellbeing variables.  In each case there was an increase in the adjusted  R2  
values compared to the first step of the regression which only included SES, but 
the proportion of variance explained was still relatively low (range:  7-35%).
The relationships between SES,  resources and wellbeing were in the 
directions expected based on the univariate analyses.  The beta weights gave 
some indication of which variables had the greatest effect on wellbeing.  ‘Venting’ 
had the strongest association with quality of life, anxiety and depression, while 
‘mastery’ had the highest beta weights in analyses predicting social difficulties 
and medical interactions.  ‘Benefit finding’ was most highly associated with 
positive reframing.
Discussion
This study explored the relationships between SES and psychosocial 
resources, between psychosocial resources and psychosocial wellbeing and the 
combined contribution of SES and resources on wellbeing.  I hypothesised that 
lower SES would be associated with decreased mastery, optimism, social 
support and disclosure.  I also proposed that there could be an association 
between SES and choice of coping strategies.  I expected that psychosocial 
resources would be related to levels of psychosocial wellbeing and that the 
combination of SES and resources would successfully predict wellbeing.Chapter 9:  Study 5  210
The literature consistently reports an association between personal control 
and SES (Lachman & Weaver 1998, Marmot et al  1997,  Pudrovska et al 2005).
This effect was replicated in this sample with higher SES patients reporting 
increased control.  An association between optimism and SES, such that high 
SES was associated with increased optimism, was also found in this study.
Taylor and Seeman (1999) discuss four unpublished datasets that find similar 
relationships between SES and optimism that are confirmed by the results of this 
study.
The evidence reviewed in Chapter 1   suggested that there would also be 
an association between social support and SES, with lower SES groups reporting 
less social support.  Additionally,  I proposed that disclosure and open 
communication within the family, a construct closely related to social support, 
may also have been related to SES.  The results of this study found no 
relationship between either social support or disclosure and SES, although the 
results from Study 2 did show a significant association between SES and social 
support.  Looking at the mean values for social support and disclosure in relation 
to SES in this sample suggests that a significant association between SES and 
social support may have gone undetected due to low power, as discussed in the 
previous chapter.  The mean values implied that lower SES could be associated 
with less social support and disclosure.  The partial eta squared values implied 
that any undetected effect was likely to be small.  Alternatively, there may be no 
association between perceived social support and SES,  rather other aspects ofChapter 9:  Study 5  211
social resources, such as size of social networks, could be more important in 
relation to SES (Stansfeld  1999).
There was also little evidence that coping strategies were directly related 
to SES.  The most likely candidates were substance use and planning.  The 
association with substance use may reflect the behavioural association of 
increased alcohol or cigarette consumption among lower SES groups rather than 
any cognitive aspect relating to coping and SES.  As regards ‘planning’, one 
characteristic of Taylor’s (1998) construct of ‘reactive responding’ (see Chapter 1) 
in lower SES groups is that it will be characterised by ‘On-Line Responding/On- 
Line Planning’.  She suggests that low SES groups may have little opportunity for 
anticipatory planning and that what planning occurs may be ‘on-line’ in response 
to environmental demands.  The results here seem to support this idea as only 
the higher SES participants reported planning what steps to take in response to 
their illness.
There was some evidence, therefore, that psychosocial resources were 
distributed according to SES.  The importance of psychosocial resources for 
psychosocial wellbeing was also confirmed by the correlation analyses.  The 
associations between control and optimism and psychosocial wellbeing were 
particularly strong and consistent.  Notably these were also the resources that 
were related to SES.
The correlational analyses also showed that many of the coping strategies 
were related to poorer psychosocial wellbeing in terms of quality of life, 
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strategies appeared to be positively related to benefit finding, although these 
associations were not present in the multivariate regression analyses, where only 
‘positive reframing’ and ‘religious’ coping were associated with benefit finding.
The regression analyses also revealed that ‘venting’ was important for 
determining wellbeing.  ‘Venting’ referred to allowing negative feelings and 
emotions to be expressed.  In this study,  increased  use of ‘venting’ led to 
decreased wellbeing.  The existing literature also implies that venting may have 
adverse effects on psychosocial adjustment amongst cancer patients (Compas et 
al  1999,  Deimling et al 2005).  Other studies also support the beneficial effect of 
some coping strategies (e.g. humour and focusing on the positive) (Carver et al 
1993, Dunkel-Schetter et al 1992) that was not confirmed in these analyses.  The 
finding that approach or positively-valence strategies (active,  planning,  humour, 
religion) were related to more distress in the correlation analyses is perhaps 
surprising.  One possible explanation is that approach or problem-solving 
strategies were not beneficial in these circumstances because the cancer 
diagnosis was inherently uncontrollable or unchangeable.  The finding that 
‘acceptance’ (characterised as facing reality and learning to live with the illness, 
rather than trying to change the situation) was the strategy associated with 
wellbeing in the correlation analyses supports this view.  Alternatively it may be 
that the relationship works in the opposite direction,  i.e. decreased psychosocial 
wellbeing elicits increased use of a number of coping strategies to try to improve 
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The regression analyses showed that including resources in the model 
increased the proportion of variance explained  in wellbeing considerably 
compared to models that only included SES.  However, the adjusted R2 figures 
were still relatively low, leading to the conclusion that other unmeasured factors 
must play a major role in determining psychosocial wellbeing.  There are a 
number of variables that were not assessed within the scope of this study, but 
which could be considered as candidates for influencing wellbeing.  These 
include personality traits such as neuroticism (de Jonge et al 2004) and self­
esteem (Penninx et al  1998), past history of mental illness (Burgess et al 2005) 
and other physical symptoms or side-effects, such as cancer-related fatigue 
(Barsevick et al 2006).
Obviously the limitations of the study were the same as those discussed in 
Study 4,  i.e. the recruitment strategy,  resulting in possible bias in the types of 
people included in the sample, and the relatively low power, affecting the ability to 
draw definite conclusions.  However, two of the main hypotheses: that 
psychosocial resources would relate to SES, and that resources would  relate to 
psychosocial wellbeing were largely supported.  Particularly control and optimism 
were lower among lower SES groups and these resources were also significantly 
and consistently related to a number of psychosocial wellbeing outcomes.  The 
final hypothesis, that the combination of SES and resources would successfully 
predict psychosocial wellbeing, was also supported,  although the proportion of 
variance explained in wellbeing was not high.Chapter 10:  Study 6  214
CHAPTER 10
Study 6: Socioeconomic status differences in psychosocial adjustment to cancer
over time
Introduction
Study 1   explored psychological adjustment to bowel cancer screening over 
time (from pre to post-screening) and found no evidence of differential adjustment 
by level of SES.  The stressor explored in Study 1, that of cancer screening, was 
relatively minor compared to the experience of receiving a cancer diagnosis.  It 
would be useful to explore whether the findings from Study 1  are consistent 
across other situations or if increases in the level of stress experienced resulted 
in differential psychosocial adjustment over time according to SES.  The dataset 
described in Studies 4 and 5 had a longitudinal component and provided an 
opportunity to explore psychosocial adjustment to receiving a cancer diagnosis 
by level of SES over time.
The cross-sectional results in Study 4 had also shown that there were very 
few SES differences in psychosocial wellbeing at 1-3 months post-cancer 
diagnosis.  In some ways this was contradictory to evidence from general 
population samples that show that low SES groups experience poorer 
psychosocial wellbeing overall compared to high SES groups.  It is possible that 
the initial shock of receiving a cancer diagnosis diminishes SES differences in 
psychosocial wellbeing rather than increasing the differences.  If this is the case, 
then SES differences in wellbeing may re-emerge over time as treatment isChapter 10:  Study 6  215
completed and patients adjust to their new situation.  The results from Study 2, 
where SES differences in psychosocial wellbeing amongst bowel cancer patients 
were found,  lent some support to this hypothesis.  The cancer patients in Study 2 
were on average 257 days post-diagnosis when they completed a research 
survey, whereas patients in Study 4 were only 66 days post-diagnosis on 
average.  However,  patients in Study 2 were not selected according to a fixed- 
point post-diagnosis, but rather were sampled at any time from one month to one 
year post-diagnosis.
The aim of the present study was to examine if there are SES differences 
in psychosocial wellbeing at 9-12 months after receiving a cancer diagnosis.  In 
general, cancer patients appear to experience more psychosocial difficulties 
around the time of diagnosis compared to later in the course of their illness, as 
discussed in Chapter 2.  Therefore,  I expected that there would be an increase in 
psychosocial wellbeing over time and that higher SES groups would experience 
greater improvements in psychosocial wellbeing compared to lower SES groups.
Hypotheses
1.  SES will be associated with psychosocial wellbeing in cancer patients 9-12 
months post-diagnosis.  Lower SES groups will experience poorer 
psychosocial wellbeing than higher SES groups.
2.  There will be an increase in psychosocial wellbeing amongst cancer 
patients over time (from  1-3 months diagnosis to 9-12 months diagnosis).Chapter 10:  Study 6  216
3.  Increases in psychosocial wellbeing over time will differ according to SES. 
Higher SES groups will experience greater improvements in wellbeing 
compared to lower SES groups.
Method
Participants,  Design and Procedure
Data for these analyses are taken from the longitudinal survey,  previously 
described in Studies 4 and 5.  Patients had received a diagnosis of breast, 
prostate or colorectal cancer and were recruited from nine hospital sites in and 
around  North London,  Middlesex and Essex.  Participants completed a self-report 
questionnaire covering a range of psychosocial wellbeing outcomes and 
resources: quality of life, social problems, experience of medical care, anxiety, 
depression,  benefit finding, social support, disclosure,  mastery, optimism and 
coping strategies.  Demographic information included ethnicity, gender, and 
socio-economic status (SES).  352 patients were recruited  1-3 months post­
diagnosis (Time 1) (M = 66 days,  SD = 45 days) and completed a research 
survey.
There was a second round of data collection at 9-12 months post-diagnosis 
(Time 2) (M = 362 days, SD = 45 days) (a copy of the second  round research 
survey is shown in Appendix XIII).  A total of 14 patients were excluded from the 
research study at the second round of data collection.  Eight patients were 
withdrawn from the study by themselves or by the research nurses, either 
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again.  A further six patients had died since the initial assessment.  All other 
patients (N = 338) were followed up, of whom 279/338 (82.5%) completed the 
second research survey.  Longitudinal data were analysed  in this report.
Measures
Socio-economic status
There were four markers of socio-economic status:  individual SES (3 
categories), Townsend  Index (3 categories),  income (5 categories) and subjective 
SES (6 categories), described in detail in Chapter 8.
Psychosocial wellbeing
Psychosocial wellbeing was assessed using a number of questionnaire 
scales also described in Chapter 8: quality of life, social difficulties, anxiety, 
depression, benefit finding, and medical interactions.
Analyses
The associations between psychosocial wellbeing and SES at Time 2 
were analysed using ANOVAs with SES as the independent variable, and age, 
gender and cancer sites as control variables.  Psychosocial wellbeing: quality of 
life, social difficulties, anxiety, depression, benefit finding,  and medical 
interactions were the dependent variables.  The analyses were carried out using 
four different SES markers (individual SES [car/home/education], Townsend 
score,  income and subjective SES).  Changes in psychosocial wellbeing, andChapter 10:  Study 6  218
change in wellbeing in relation to level of SES, were assessed using repeated 
measures analyses.
An analysis was made of the missing data in both the baseline and the 12- 
month follow-up data.  In cases where the missing data were related to SES or 
the proportion of missing data was greater than 5% (the depression and social 
difficulties variables only), the analyses were re-run using imputed values based 
on the subject mean for each scale if at least half of the items had been 
completed,  and any changes in the outcomes were noted.
Intracluster correlation coefficients for the effect of hospital sites were 
calculated for all of the dependent variables.  Most of the dependent variables 
had small intracluster correlations (range: 0.001-0.05) (Hox 2002).  Again, the 
social difficulties variable had a large correlation at the second round of data 
collection (0.16) as well as at the first (discussed in Chapter 8) and any analyses 
involving this variable included adjustment for clustering due to hospital site.
Results
279 of a possible 338 patients completed the second survey,  representing 
a response rate of 82.5%.  There were no differences between responders and 
non-responders in terms of age, gender, cancer site or disease stage.  There was 
an association between SES and response to the second round questionnaire.
The lowest SES groups (using the individual SES marker) were more likely to be 
non-responders than those in the highest SES groups (27.4% vs  12.1% non­
responders) (x2  = 8.25, df=  1, p<0.01).Chapter 10:  Study 6  219
Table  1   shows the associations between individual SES and psychosocial 
wellbeing at Time 2.  There were no significant associations between individual 
SES and wellbeing at Time 2.  Using a social difficulties variable that included 
imputed missing data resulted in a significant association between difficulties and 
individual SES (F [7,214] =  13.03 p<0.01).  The ‘medium’ SES group experienced 
higher difficulties compared to the other two groups.
The results of the analyses using the other three SES markers are shown 
in Table 2.  Higher income related to decreased benefit finding (F [1,244 = 2.19, 
p<0.05).  Higher subjective SES was related to increase social/family (F [1,234] = 
1.56, p<0.05), emotional (F [1,235] = 2.33, p<0.05), functional (F [1,235] = 2.59, 
p<0.05) and overall quality-of-life (F [1,234] = 2.27, p<0.01).  Additionally, there 
was a trend for higher subjective SES groups to report decreased anxiety (F 
[1,229] =2.02, p=0.056).  The partial eta squared statistic indicated that these 
were all small effects.
Overall change in psychosocial wellbeing from Time 1  to Time 2 was 
assessed with repeated measures ANOVAs and the results are shown in Table
3.  There were significant changes in emotional quality-of-life (F [1,253] = 4.45, 
p<0.05), and benefit finding (F [1,239] = 6.36,  p<0.01).  Again, the partial eta 
squared statistic indicated small effects.  The means in Table 3 show that 
emotional quality-of-life and benefit finding increased from Time 1   to Time 2, and 
social difficulties decreased.  Table 4 shows the mean change over time forTable 1   Psychosocial wellbeing by individual SES at Time 2 (9-12 months post-diagnosis), controlling for age, gender
and cancer site.
SES Mean (95% Cl) P Partial
eta2
Psychosocial wellbeing Low N = 45 Medium N = 101 High N =  124
Quality of  Physical 
life  Social/family 
Emotional 
Functional 
Total
24.00 (22.47-25.53) 
20.46 (18.48-22.45) 
20.38 (18.89-21.88) 
21.58 (19.61-23.56) 
86.34 (80.97-91.74)
23.70 (22.54-24.85) 
21.81  (20.39-23.24) 
19.18 (18.06-20.31) 
19.60 (18.15-21.04) 
84.27 (80.41-88.14)
24.12 (23.15-25.09) 
21.92 (20.72-23.13) 
19.62 (18.67-20.57) 
21.42 (20.20-22.63) 
87.07 (83.81-90.33)
0.889
0.214
0.396
0.883
0.823
0.003
0.006
0.005
0.018
0.008
Social difficulties 4.72 (2.10-7.34) 6.32 (5.06-7.59) 4.59 (3.26-5.91) 0.109 0.011
Anxiety 3.88 (2.35-5.40) 5.16 (4.08-6.25) 4.59 (3.66-5.53) 0.638 0.006
Depression 5.29 (3.27-7.31) 6.23 (4.78-7.68) 5.57 (4.41-6.73) 0.810 0.003
Benefit finding 36.49 (32.10-40.89) 32.80 (29.57-36.02) 36.26 (33.48-39.04) 0.929 0.009
Medical interactions 0.44 (0.22-0.66) 0.37 (0.22-0.52) 0.37 (0.24-0.500 0.594 0.003Table 2 Psychosocial wellbeing by four different SES markers at Time 2 (9-12 months post-diagnosis), controlling for age,
gender and cancer site.
SES markers
Individual Townsend Income Subjective SES
Psychosocial wellbeing P Partial P Partial P Partial P Partial
eta2 eta2 eta2 eta2
Quality of life  Physical 0.889 0.003 0.612 0.003 0.331 0.010 0.361 0.021
Social/family 0.214 0.006 0.778 0.003 0.099 0.028 0.043 0.037
Emotional 0.396 0.005 0.479 0.004 0.610 0.011 0.046 0.053
Functional 0.883 0.018 0.769 0.001 0.139 0.025 0.023 0.058
Total 0.823 0.008 0.513 0.003 0.938 0.007 0.014 0.051
Social difficulties 0.109 0.011 0.764 0.008 0.604 0.020 0.458 0.058
Anxiety 0.638 0.006 0.936 0.001 0.525 0.041 0.056 0.047
Depression 0.810 0.003 0.105 0.011 0.257 0.016 0.141 0.043
Benefit finding 0.929 0.009 0.809 0.003 0.045 0.038 0.836 0.019
Medical interactions 0.594 0.003 0.369 0.005 0.930 0.016 0.040 0.070Chapter 10:  Study 6
levels of the individual SES marker.  The increases in emotional quality-of-life 
and decreases in social difficulties did not significantly differ across levels of SES. 
Although there appeared to be some differences in the change of benefit finding 
according to level of SES,  in that the ‘low’ and ‘medium’ SES group experienced 
a reduction in benefit finding and the ‘high’ SES group had a mean increase in 
benefit finding, this was not a significant interaction (see Table 5).
Analyses using the other SES markers yielded two significant time by SES 
interactions.  The change in anxiety from Time  1   to Time 2 differed by level of 
income (F [4,222] = 2.86, p<0.05) and the change in satisfaction with medical 
interactions differed by level of subjective SES (F [5,196] = 2.50, p<0.05).  These 
interactions are shown in Figures 1   and 2.  The interactions were difficult to 
interpret.  The highest income group appeared to experience some increase in 
anxiety from Time 1   to Time 2 whereas all other income groups showed no 
change or some reduction in anxiety.  The interaction in  Figure 2 did not have a 
discernible pattern according to level of subjective SES.Table 3  Overall change in psychosocial wellbeing from Time 1   (1-3 months post-diagnosis) to Time 2 (9-12 months post­
diagnosis), controlling for age, gender and cancer site.
Time 1
Time 
Time 2 P Partial eta2
Quality of life  Physical 22.81 (22.10-23.53) 24.03 (23.31-24.74) 0.080 0.012
Social/Family 22.24 (21.33-23.16) 21.63 (20.71-22.55) 0.567 0.001
Emotional 18.02 (17.31-18.73) 19.72 (19.00-20.43) 0.036 0.017
Functional 18.46 (17.40-19.51) 20.94 (20.02-21.87) 0.073 0.013
Total 81.77 (79.34-84.19) 86.18 (83.67-88.68) 0.084 0.012
Social difficulties 8.79 (2.67-14.92) 6.47 (3.27-9.67) 0.077 0.021
Anxiety 5.21 (4.45-5.96) 4.59 (3.88-5.31) 0.181 0.007
Depression 5.96 (5.03-6.92) 5.61 (4.62-6.59) 0.863 0.001
Benefit finding 34.99 (32.77-37.23) 35.25 (33.07-37.43) 0.012 0.026
Medical interactions 0.36 (0.26-0.46) 0.40 (0.29-0.50) 0.718 0.001Table 4 Mean change in psychosocial wellbeing from time 1   (1-3 months post-diagnosis) to time 2 (9-12 months post­
diagnosis) by level of individual SES, controlling for age, gender, and cancer site
Low
SES Mean change (95% Cl) 
Medium High
Quality of life  Physical 1.27 (-0.34 - 2.88) 1.60 (0.40 - 2.80) 0.77 (-0.26-1.81)
Social/Family -1.14 (-3.16-0.88) 0.14 (-1.27- 1.56) -0.84 (-2.04 - 0.36)
Emotional 1.68 (0.22-3.14) 2.03 (0.94-3.13) 1.39 (0.45 - 2.32)
Functional 2.57 (0.30-4.84) 2.41 (0.80-4.03) 2.48 (1.10-3.85)
Total 3.30 (-1.90-8.49) 6.27 (2.64 - 9.90) 3.66 (0.56 - 6.76)
Social difficulties -1.29 (-3.96- 1.38) -2.89 (-5.09 - -0.70) -2.90 (-4.59--1.21)
Anxiety -1.12 (-2.55 - 0.32) -0.60 (-1.61  -0.41) -0.13 (-1.00-0.73)
Depression -0.99 (-3.17-1.18) -0.80 (-2.30 - 0.70) 0.69 (-0.57- 1.95)
Benefit finding -1.03 (-4.70 - 2.64) -0.04 (-2.57 - 2.49) 1.83 (-0.38 - 4.04)
Medical interactions 0.08 (-0.11  -0.27) 0.03 (-0.11  -0.15) -0.01 (-0.12-0.11)Table 5 Change in psychosocial wellbeing by four different SES markers controlling for age, gender, and cancer site
SES markers
Time x individual  Time x Townsend  Time x Income  Time x subjective
P Partial
eta2
P Partial
eta2
P Partial
eta2
P Partial
eta2
Quality of  Physical 0.707 0.003 0.859 0.001 0.770 0.008 0.652 0.016
life  Social/family 0.374 0.008 0.649 0.003 0.289 0.022 0.591 0.018
Emotional 0.762 0.002 0.548 0.005 0.757 0.008 0.409 0.024
Functional 0.999 0.000 0.332 0.009 0.268 0.023 0.354 0.026
Total 0.459 0.006 0.473 0.006 0.648 0.011 0.977 0.004
Social difficulties 0.536 0.006 0.598 0.008 0.205 0.006 0.132 0.019
Anxiety 0.367 0.008 0.409 0.007 0.024 0.049 0.947 0.006
Depression 0.692 0.003 0.778 0.002 0.134 0.035 0.719 0.016
Benefit finding 0.355 0.009 0.665 0.003 0.423 0.018 0.480 0.023
Medical interactions 0.692 0.003 0.096 0.019 0.070 0.039 0.032 0.060M
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Figure 1  - Change in Anxiety by Income
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Figure 2 - Change in Medical Interactions by Subjective SES
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Discussion
This study explored relationships between SES and psychosocial 
adjustment to a cancer diagnosis.  I hypothesised that lower SES groups would 
experience poorer psychosocial wellbeing 9-12 months after receiving a cancer 
diagnosis compared to higher SES groups.  I expected that all cancer patients 
would experience an increase in psychosocial wellbeing over the course of the 
year from when they first received their diagnosis (i.e. from Time 1:1-3 months 
post-diagnosis to Time 2: 9-12 months post-diagnosis),  but that this improvement 
would differ according to SES.  I proposed that lower SES groups would 
experience less improvement in psychosocial wellbeing than higher SES groups.
Study 4 had found an association between subjective SES and quality of 
life and anxiety in cancer patients who were 1-3 months post-diagnosis.  Similar 
associations were found in the cancer patients 9-12 months post-diagnosis.  The 
relationship between subjective SES and medical interactions that was seen  1-3 
months post-diagnosis was not replicated at the 9-12 month assessment. 
Associations between the marker of individual SES and depression and social 
difficulties found  1-3 months post-diagnosis were also not found at the 9-12 month 
assessment.  Overall it appeared that SES did not emerge as an important 
predictor of psychosocial wellbeing in cancer patients who were 9-12 months post­
diagnosis.  This was surprising given the relationship seen between SES and 
psychosocial wellbeing in general population studies (e.g. Adler et al  1999,  Lorant 
et al 2003,  Power et al 2002).  These findings also differed from those in Study 2 
where associations between individual SES and anxiety, depression, social 
difficulties, medical interactions and quality of life were seen.Chapter 10:  Study 6  228
There were some improvements in psychosocial wellbeing over time: 
emotional quality-of-life and benefit finding increased.  However, other studies 
have also reported decreases in levels of anxiety and depression (e.g.  Burgess et 
al 2005,  Nordin et al 2001, Stommel et al 2004) over the year after diagnosis that 
were not found in this sample.  The lack of association between SES and 
psychosocial wellbeing and the fact that there were overall few significant changes 
in psychosocial wellbeing over time suggests that there may be a problem with the 
sample.  One possibility is that the initial sample did not contain patients who were 
experiencing high levels of distress, either because patients experiencing distress 
did not want to take part or because the nurses responsible for recruitment to the 
study did not approach patients who were highly distressed.  Comparing the mean 
score of the HADS-Anxiety scale in the present sample to data from another 
similar published sample does not seem to support this idea.  Nordin et al (2001) 
studied levels of anxiety using the HADS-A in 522 breast,  prostate, colorectal and 
gastric patients at the time of their diagnosis and six months later.  The mean 
anxiety score in their sample at baseline was 5.3 and 3.6 six months later.  This 
constituted a significant reduction in anxiety.  The mean anxiety score at baseline 
in the present sample was 5.2 and 4.6  12 months later.  Although the scores were 
similar at baseline, the cancer patients in the present sample did not experience a 
significant overall reduction in anxiety as seen in Nordin et al’s sample.  If 
anything, the present sample experience continuously higher levels of anxiety, 
although it is not clear why this should be the case.
Any changes in psychosocial wellbeing over time did not differ by level of 
SES.  The significant interactions between time and income on anxiety andChapter 10:  Study 6  229 
between time and subjective SES on satisfaction with medical interactions were 
ambiguous and did not amount to clear evidence of SES differences in 
adjustment.  The longitudinal results from Study 1   examining psychological 
adjustment to bowel cancer screening (pre to post-screening) also did not find any 
evidence of differential adjustment by level of SES.  Taken together, these results 
imply that SES does not affect psychosocial adjustment over time to novel 
stressors.
A limitation of this study is that there was a bias in  response to the second 
round questionnaire by level of SES.  Lower SES patients were less likely to 
complete the second round questionnaire.  This may have introduced bias into the 
longitudinal results if the lower SES patients who did  not complete the second 
round questionnaire differed  in some way from those that did, although it is 
obviously not possible to check for this type of bias.  Other limitations of the study 
design included the recruitment strategy and problems with power previously 
discussed in Chapter 8.
The results from this study suggested that the effect of a cancer diagnosis 
could serve to diminish rather than enhance SES differences in psychosocial 
wellbeing.  The threat and stress of the diagnosis may serve to worsen the 
wellbeing of high SES groups so that the levels of wellbeing they experience 
become comparable to that of the lower SES groups -  resulting in there being little 
or no SES differences in wellbeing.  These findings must be treated tentatively, 
especially in the light of somewhat contradictory evidence seen in Study 2.
Sampling issues resulting in bias could have skewed the results.  The differences 
between the two samples are discussed  in more detail in the following chapter.Chapter 11:  Discussion  230
CHAPTER 11 
Discussion
The aim of the present series of studies was to explore how people from 
different socio-economic backgrounds react to novel stressors in terms of their 
psychosocial wellbeing.  A review of the literature suggested that people from 
lower socio-economic groups could be more vulnerable to adverse psychosocial 
outcomes in the face of new stressors, but there was still a scarcity of research in 
this area.  The strategy used to examine this issue was to explore psychosocial 
reactions to a range of new,  ‘real life’, stressful situations,  ranging from less to 
more severe experiences.  Cancer-related stressors provided a framework within 
which to research this topic.  Specific characteristics of each stressful situation 
were looked at in terms of their interactions with SES and adjustments to 
stressors over time by level of SES were also investigated.
Summary of main findings 
A summary of the main findings from each research study is provided in 
Table  1.  Firstly, a moderate stressor, that of bowel cancer screening was 
examined.  There were three different screening outcomes (negative,  polyps 
detected, additional colonoscopy required) that posed progressively greater 
threats.  SES differences in reactions to these screening outcomes were explored 
as well SES differences in adjustment (pre-post screening) to the screeningTable 1   Summary of main findings
Stressor Sample Psychosocial
Outcomes
SES
indicators
Results Conclusion
Study 1 Bowel cancer 
screening:
Adjustment 
over time
Different
screening
outcomes
Longitudinal 
pre to post 
screening 
(N = 3535)
Cross- 
sectional 
post­
screening 
(N =29,804)
Anxiety
Bowel cancer 
worry
Distress
Positive 
consequences 
of screening
Individual
SES
Townsend
Anxiety and worry higher in lower SES 
groups.
Lower SES report more positive 
consequences of screening.
Anxiety and worry reduce pre-post 
screening.
More pathology (polyps/colonoscopy) 
associated with lower anxiety and 
worry post-screening.
Change over time not different by 
SES.
No differential effect of SES 
depending on screening outcome
Differences in psychological well­
being by SES typical of the 
general population.
No interaction between SES and 
time or level of stressor 
(screening outcome).
Lower SES groups not more 
vulnerable to effects of the 
stressor.Stressor Sample Psychosocial
Outcomes
SES
indicators
Results Conclusion
Study 2 Bowel cancer 
diagnosis
Stage of 
disease
Cross- 
sectional 
(N = 128)
Quality of Life
Depression
Anxiety
Social
Difficulties
Medical
Interactions
Social Support
Individual
SES
Lower SES associated with worse 
psychosocial outcomes (quality of life, 
anxiety, depression, medical 
interactions, social difficulties and 
social support)
Advanced disease stage associated 
with worse psychosocial outcomes 
(quality of life, anxiety, depression, 
social difficulties, social support)
SES interacts with disease stage for 
anxiety and social support.  High SES 
have lower anxiety across all disease 
stages, lower SES show increases in 
anxiety across disease stage.  Low 
SES had less social support with 
advancing disease stage than high 
SES.
Differences in wellbeing by level 
of SES typical of the general 
population.
Level of stressor (disease stage) 
affected wellbeing.
Some evidence lower SES 
moderated reactions to the 
diagnosis.
Study 3 Bowel cancer 
diagnosis
Qualitative 
(N = 24)
Satisfaction 
with medical 
interactions
Education Patients most often discussed their 
interpersonal relationships with care 
providers.
Most negative comments related to 
organisational aspects of the service.
Specialist nurses received the most 
positive comments.
Low SES less likely to comment about 
their experience of specialist oncology 
services, either positively or negatively
Little evidence that the 
experience of care differed by 
SES.
Lower SES may be less likely to 
evaluate or be critical of care.
If there are differences in the way 
care providers interact with low 
SES patients they do not 
translate into dissatisfaction.Stressor Sample Psychosocial
Outcomes
SES
indicators
Results Conclusion
Study 4 Mixed-cancer 
patients 
(bowel, breast, 
prostate)
Stage of 
disease
Treatment
type
Co-morbidity
Cross- 
sectional 
(N = 352)
Quality of Life Individual
SES
Anxiety
Townsend
Depression
Income
Social
difficulties Subjective
SES
Medical
interactions
Benefit finding
Lower individual SES associated with 
worse social difficulties, depression 
and family quality-of-life.
Lower subjective SES associated with 
worse quality of life, anxiety and 
dissatisfaction with medical 
interactions.
Advanced disease associated with 
worse quality of life, increased anxiety, 
depression, social difficulties.
Having chemotherapy associated with 
worse functional quality-of-life, more 
social difficulties and dissatisfaction 
with medical interactions.
Co-morbidity associated with worse 
quality of life.
High SES patients with advanced 
disease have better family quality of 
life than low SES patients with 
advanced disease.
There are SES differences in quality of 
life in those who do not have surgery 
or who do not have hormone therapy, 
but these differences disappear once 
patients receive the treatment.
Not as consistent findings of 
general population differences in 
wellbeing by SES as that seen in 
Study 2.
Level of stressor (disease stage) 
affects psychosocial wellbeing. 
Inconsistent effects of treatment 
and co-morbidity on wellbeing.
Some interactions between 
stressors and SES on 
psychosocial wellbeing.  Unlike 
Study 2, effect of having 
treatment diminished SES 
differences in wellbeing rather 
than increased them.
Interactions between SES and 
disease stage on anxiety not 
replicated.  There was an 
interaction between family quality- 
of-life that differed from the 
‘treatment’ interactions in that the 
SES difference in wellbeing 
widened rather than diminished.
Raises the possibility that 
differences in wellbeing by SES 
are levelled out or diminished (not 
increased) by the stress of 
receiving a cancer diagnosis and 
treatment for it.Stressor Sample Psychosocial
Outcomes
SES
indicators
Results Conclusion
Study 5 Mixed-cancer 
patients 
(bowel, breast, 
prostate)
Cross- 
sectional 
(N = 352)
Personal
control
Optimism
Social support
Coping
Strategies
Individual
SES
Townsend
Income
Subjective
SES
Higher SES had more personal control 
and optimism.
Increase control and optimism were 
related to better psychosocial 
wellbeing.
SES and resources predicted 
wellbeing in a regression model, but 
the variance explained was relatively 
low.
Psychosocial resources are 
related to SES.
Psychosocial resources are 
related to wellbeing.
Weak associations between SES 
and psychosocial wellbeing in 
Study 5 precluded a mediational 
analysis of the effects of 
psychosocial resources 
explaining SES differences in 
wellbeing.
Study 6 Mixed-cancer 
patients 
(bowel, breast, 
prostate)
Adjustment 
over time
Longitudinal 
(N = 278)
Quality of Life
Anxiety
Depression
Social
difficulties
Medical
interactions
Benefit finding
Individual
SES
Townsend
Income
Subjective
SES
No SES differences in psychosocial 
wellbeing 9-12 months diagnosis using 
individual SES.
Subjective SES differences in 
wellbeing 9-12 months diagnosis for 
quality of life.
Some improvements in psychosocial 
wellbeing over time, for emotional 
quality-of-life, benefit-finding.
Interaction analyses did not yield any 
interpretable patterns of differences in 
adjustment by SES.
Fewer SES differences in 
wellbeing 9-12 months post­
diagnosis than at 1-3 months 
post-diagnosis (Study 4).
Lends further support to the idea 
that differences in wellbeing by 
SES may be diminished rather 
than increased by the stress of 
being diagnosed with cancer.Chapter 11:  Discussion  235 
process.  Although lower SES groups experienced higher anxiety and worry about 
bowel cancer overall, SES did not moderate psychological adjustment over time.
This study provided no support for the hypothesis that lower SES groups would be 
more vulnerable to adverse psychosocial outcomes in the face of a novel stressor.
The subsequent research studies in the thesis concentrated on the more 
severe stress of receiving a cancer diagnosis.  Although this thesis is primarily 
concerned with SES and psychosocial outcomes and does not focus on the 
processes by which SES and outcomes are linked, Study 5 did make a preliminary 
exploration into this area.  A mediational analysis of the effects of psychosocial 
resources in explaining SES differences in wellbeing was not possible because 
there were only weak associations between SES and psychosocial wellbeing 
(Baron & Kenny 1986).  However, the hierarchical regression analyses did 
investigate the combined contribution of SES and  resources on psychosocial 
wellbeing,  but the results indicated that the proportion of variance explained was 
relatively low.  Other unmeasured factors must have a part to play in predicting 
wellbeing and could include: personality traits (de Jonge et al 2004,  Penninx et al 
1998), past history of mental illness (Burgess et al 2005) and other physical 
symptoms or side-effects, such as cancer-related fatigue (Barsevick et al 2006).
Interactions between SES and characteristics of the cancer experience on 
psychosocial wellbeing were examined in Studies 2, 4 and 6.  Reactions to more 
or less advanced disease stage diagnoses, undergoing different types of cancer 
treatments, and the effect of having a co-morbid  illness were investigated.
Study 2 found some evidence greater vulnerability for lower SES groups in 
the face of a cancer diagnosis.  Higher SES groups maintained  lower levels ofChapter 11:  Discussion  236 
anxiety regardless of disease stage, whereas lower SES groups experienced 
increasing anxiety with increasing disease stage.  However, this effect was not 
replicated in Study 4.  The findings from Study 4 suggested that SES differences 
in wellbeing may be diminished by the effects of undergoing treatment for cancer. 
Specifically it appeared that there were small SES differences in wellbeing 
amongst those that did not receive surgery, but that these differences disappeared 
amongst those who did receive surgery.  The findings from Study 6 lent further 
support to the idea that experiencing a cancer diagnosis could reduce SES 
differences in wellbeing rather than increase them.  There was little evidence of 
any SES differences in wellbeing at the 9-12 month post-diagnosis assessment.
This is contrary to findings from general population studies which consistently 
report that SES differences in psychological wellbeing (Lorant et al 2003,  Power et 
al 2002).  The findings from Study 6 thus imply that experiencing cancer can 
diminish these SES differences.
The differences in the findings from Study 2 (colorectal sample) versus 
Studies 4 and 6 (mixed sample) could have a variety of explanations.  One 
possibility is that there were fundamental differences between the two samples in 
terms of psychosocial wellbeing -  one or other sample may not have been 
representative because of the different sampling frames and recruitment strategies 
resulting in one sample containing patients that were more or less distressed.
This could  in turn have had an impact on analyses of SES differences.  The mean 
scores for each psychosocial outcome for the different samples are shown in 
Table 2.  There were a few significant differences between the scores in the Study 
2 sample compared to the sample in Studies 4-6.  The Study 2 sample wereChapter 11:  Discussion  237 
slightly less anxious (F (1,462) = 7.09, p<0.01) and had better emotional quality-of- 
life (F [1,467] = 1.42, p<0.05) than the baseline assessment of the longitudinal 
study.  But the Study 2 sample had slightly worse functional quality-of-life (F 
[1,398] = 6.82, p<0.01) and more social difficulties (F [1,362] = 5.23, p<0.05) than 
the follow-up (Time 2) assessment in the sample used in Studies 4-6.
The overall picture suggested that psychosocial wellbeing may be affected 
by time since diagnosis.  The Time 1   assessment of the longitudinal sample had 
the worst psychosocial wellbeing (Mean = 66 days post-diagnosis), the Study 2 
sample (Mean = 257 days post-diagnosis) had slightly better wellbeing, and the 
Time 2 assessment of the longitudinal sample (Mean = 362 days post-diagnosis) 
had the best psychosocial wellbeing.  However, any difference in wellbeing 
depending on time since diagnosis does not seem to be a plausible explanation of 
the differences in results between the samples as Study 2’s timing is between the 
first and second assessment of the longitudinal sample.
Given that fundamental differences between the two samples were small, 
this may not be an explanation of the different results and another explanation 
must be sought.  The results may not necessarily be as inconsistent as they first 
appear.  As regards the interaction effects, the effect of prognostic factors such as 
disease stage, compared to the effect of treatments for cancer in relation to SES 
may be different.  Being diagnosed and treated for cancer may serve to diminish 
SES differences in psychosocial wellbeing,  but this effect could be reversed in the 
face of a palliative diagnosis.Chapter 11:  Discussion  238
Table 2 Comparison of mean psychosocial wellbeing scores across samples
Average time since diagnosis
Studies 4-6 -  
Time 1  
N = 352 
66 days
Sample - Mean (SD)
Study 2  Studies 4-6 -  
Time 2
N =  128  N = 279 
257 days  362 days
Quality of 
Life
Physical
Emotional
Functional
Social/Family
Total
22.48 (4.55) 
17.92 (4.50) 
18.37 (6.24) 
22.25 (5.40) 
81.07(14.64)
23.28 (5.07) 
19.06 (4.83) 
19.20 (6.71) 
21.57 (5.46) 
83.09 (16.34)
23.65 (4.37) 
19.30 (4.36) 
20.86 (5.45) 
21.93 (5.31) 
85.68 (14.52)
Depression 6.38 (5.27) 6.14 (5.47) 5.85 (5.06)
Anxiety 5.53 (4.50) 4.28 (4.24) 4.96 (4.17)
Social difficulties 7.67 (7.21) 8.72 (8.58) 5.82 (7.31)
Medical interactions 0.40 (0.74) 0.39 (0.64) 0.40 (0.58)
That there were fewer main effect SES differences in psychosocial 
wellbeing in the longitudinal sample compared to the Study 2 sample is not due to 
the socio-economic distributions of the samples.  There were no differences 
between the two samples in terms of their socio-economic distribution (individual 
SES marker: x2  = 2.01, df=  1,  NS, townsend thirds: % 2  = 0.01, df =  1,  NS).  One 
possibility is that the findings in Study 2 were affected by the hospital setting.
Study 2 was a single site study and procedures or medical interactions particular 
to that hospital could have affected the results.
Although the different studies reported some interaction between severity of 
stressor and SES, overall there was not compelling evidence that SES moderates 
psychosocial wellbeing in response to novel stressors.  However, the research 
studies did have other important findings that related to the particular situationsChapter 11:  Discussion  239 
that were investigated.  Study 1   examined psychological reactions to a bowel 
screening test and importantly found that anxiety was reduced after screening, 
rather than increased.  Also people who received additional tests experienced the 
greatest reductions in anxiety.  This is an important finding within the literature on 
screening tests for cancer where there is a concern that screening for cancer will 
increase anxiety and worry (Wardle & Pope 1992).
Studies 2 and 4 showed a consistent relationship between disease stage 
and psychosocial wellbeing.  This has been an area of research fraught with a 
number of difficulties and inconsistent findings.  Some studies show that more 
advanced disease is associated with poorer psychological well-being (Gallagher et 
al 2002, e.g.  Osborne et al 2003, Shimozuma et al  1999) whilst others studies find 
little or no relationship (Bleiker et al 2000,  Kissane et al 2004,  Norum  1997).  One 
problem is that studies do not always include patients in the most advanced 
disease stage (e.g.  Bleiker et al 2000).  Another difficulty is when comparisons 
between early and advanced stage patients are made in widely different time 
frames since diagnosis (e.g.  Kissane et al 2004).  Study 2 included a proportion of 
patients with advanced disease and those who were receiving palliative care.
Study 4 used a tight frame of time since diagnosis.  Both studies found an 
association between increasing disease stage and poorer psychosocial wellbeing 
and consequently make a useful contribution to this research area.
Finally, Study 5 explored the relationships between a number of 
psychosocial resources and SES.  The relationship between SES and optimism in 
particular has not been researched in any great detail previously.  The research 
study in this thesis together with data I have analysed and submitted forChapter 11:  Discussion  240 
publication from the Flexible-Sigmoidoscopy trial (discussed in Chapter 1, see 
Appendix I) show that lower SES is associated with decreased optimism.  This 
may be important in so far as optimism is implicated in psychosocial adjustment 
and physical wellbeing (Schou et al 2004,  Segerstrom 2005).
Limitations
Use of different SES markers
There were many limitations to the research describe in this thesis.  Most 
serious was that I could not come to a conclusion about the most appropriate SES 
indicator, which resulted in multiple testing.  No one marker seemed more or less 
appropriate and the measurement of SES was more uncertain than  I had initially 
expected.
The most effective SES indicators (in terms of detecting any differences in 
wellbeing) in the samples used in this thesis appeared to be the composite, 
individual SES score and the subjective SES scale.  The composite score was 
useful in Study 2 and to a lesser extent in Studies 4-6.  This method was based on 
a recommendation from another study examining the effectiveness of SES 
indicators in older adults (Grundy & Holt 2001).
The use of subjective SES as indicator in older age samples had not been 
considered in any detail and the subjective SES marker used  in this thesis is 
relatively new (Adler et al 2000).  One study that looked at cortisol response to 
awakening (CAR) in older adults (age 65-80 years) in relation to SES found that 
subjective SES was more robustly related to CAR than objective measures ofChapter 11:  Discussion  241 
education or financial strain (Wright & Steptoe 2005).  This finding also suggests 
that subjective social status could be a useful marker in older populations.
The Townsend  Index was also useful in the analyses of the Flexible- 
Sigmoidoscopy dataset in Study 1,  but appeared to lose its sensitivity in the 
subsequent samples.  This was probably due to the fact that the Index was based 
on  1991  census data.  The sample in Study 1   had a data collection period starting 
in  1994, whereas the subsequent studies collected data from 2002 onwards.  The 
accuracy of the Index was probably better for the earlier periods of data collection.
This topic clearly needs further research which specifically focuses on the 
measurement of SES in elderly populations.  This was not within the remit of the 
current thesis and no definite conclusions could be reached.
Use of multiple psychosocial outcomes
A related issue was the use of multiple psychosocial outcomes, which could 
have increased the probability of Type I error (i.e. finding a significant result that 
does not really exist).  The cancer literature often uses this strategy because many 
areas of life are affected by receiving a diagnosis.  It is really not appropriate to 
use single measures of wellbeing e.g. just assessing depression whilst ignoring 
the impact of cancer on other areas of life.  I did not adjust p-values to 
compensate for this problem because this can have the effect of increasing Type II 
errors (i.e. finding a non-significant result when an effect really does exist) and this 
also has implications for power and sample size.  Larger sample sizes would have 
been needed in order to adjust the p-value and still provide meaningful results. 
Consequently,  I took the approach of looking for consistent findings across aChapter 11:  Discussion  242 
number of psychosocial outcomes and samples and tried not to read too much into 
a single significant result.
Samples
Power
Study 1   had large sample sizes and sufficient power to detect small effects. 
However, the subsequent studies in cancer patients all suffered from low power 
and consequently affected the conclusions that could be drawn from the analyses. 
Any analyses looking at interactions between SES and stressor on wellbeing were 
compromised by this as small effects may have remained undetected.  This 
means that larger studies will be needed in order to confirm or disprove the 
findings of this thesis.
However, the sample sizes used in this thesis were often as large as or 
larger than other studies that examine wellbeing in cancer patients.  Recruiting a 
clinical sample, such as cancer patients,  is often difficult and time consuming. 
Generally SES effects have been explored in terms of public health in larger, 
epidemiological settings rather than within smaller, clinical studies.  It is possible 
that effects of SES in terms of population health may be more important than the 
smaller effects of SES found in this thesis’ smaller, clinical samples.
Bias
The response rates for the research studies in this thesis were variable.
The post-FS sample in Study 1   had a response rate of 90.7%.  The samples for 
the other studies had response rates between 60.4% and 67%.  A review of 
response rates published in medical journals reports that the average responseChapter 11:  Discussion  243 
rate is about 60% (Asch et al  1997).  Response rates are usually taken to be an 
indication of how representative the sample is of the population.  A low response 
rate is only a problem if it is likely to have introduced bias.  Bias in response by 
SES is common in other research survey studies (Sheikh & Mattingly 1981, e.g. 
Turrell et al 2003).  Where possible I analysed SES differences in response rates.
In Study 2 there was no evidence of SES response bias in returning the 
research questionnaire.  In Study 1   there was some evidence that non-response 
was related to lower SES, as measured by the Townsend  Index.  However this 
sample had an extremely high response rate and this effect was likely to be small 
(partial eta squared = 0.004).  In Study 6,  lower SES groups were also less likely 
to respond to the second round of data collection,  based on a comparison with the 
baseline sample.  Unfortunately, the recruitment strategy of the longitudinal 
sample in Studies 4-6 (where research nurses approached patients) meant that I 
was unable to collect information about SES bias comparing baseline responders 
to non-responders.  Using a weighting to correct for SES bias found in a 
comparison with a baseline sample maybe inappropriate if the baseline sample 
itself is non-representative and so I did not use this route to correct for bias.  The 
bias by SES limits the generalisability of the research findings and questions the 
reliability of the findings in relation to SES and adjustment to stressors.
Design
The research studies in this thesis used a variety of research designs: 
longitudinal and cross-sectional, multi-centre and single centre, quantitative and 
qualitative, mixed-cancer sites and single cancer sites.  There are differentChapter 11:  Discussion  244 
strengths and weaknesses associated with the different strategies.  For example, 
the design of Study 2 used a single cancer site (bowel cancer) within a single 
hospital site and used cross-sectional data.  The use of a single type of cancer at 
one hospital meant the results were easier to interpret but limited the 
generalisability of the research.  The design in Studies 4-6 used mixed-cancer 
sites at multiple hospital centres and had longitudinal data collection.  This 
possibly makes the results more generalisable but produces difficulties in the 
analysis and  interpretation of the data e.g. taking account of clustering and 
differences in psychosocial wellbeing according to different types of cancer site.
The multi-centre,  longitudinal design also necessitated a change in recruitment 
strategy so that not all new cancer patients within each hospital were reached, 
whereas the single centre design and recruitment strategy in Study 2 meant that 
all new cancer patients in a one-year period were approached.  Using these 
different strategies may have caused some of the differences in results between 
the two datasets.
Lack of control sample
The research studies in this thesis did not make use of a healthy control 
sample.  This could have been useful for showing that cancer patients were 
experiencing greater levels of stress and for proving differential reactions to stress 
in relation to SES compared to healthy subjects.  I did  not choose to recruit a 
control sample for a number of reasons:
•  It was not clear what would constitute an appropriate control sample in 
terms of their demographic characteristics or how to recruit such a sample.Chapter 11:  Discussion  245
•  It is well known, and well researched, that there are SES differences in 
psychosocial wellbeing amongst the general population and so there was no 
need to replicate this effect.
•  Other studies and reviews have already shown that there are higher levels 
of distress amongst cancer patients compared to general population samples.
•  The psychosocial outcome variables were based on standardised 
questionnaires and so values in the present sample could easily be compared to 
those found in other studies.
•  The analytic strategy looked at interactions of SES with specific 
characteristics of the situation and adjustment over time and did not rely on an 
analysis of main effects.  Therefore it was possible to distinguish between what 
might have been population effects of SES and actual reactions to stressors.
Conclusions and directions for future work 
The overall picture of results in this thesis is that a vulnerability effect by 
SES in response to new stressors is not a striking effect.  If a vulnerability effect 
does exist, it is likely to be small.  Of course, the results from the studies need to 
be replicated to be certain of this.  Future research studies that aim to replicate or 
refute these findings would need to recruit larger sample sizes to achieve 
adequate power for sub-group and mediational analyses.
The results also raise the interesting possibility that exposure to new 
stressors reduces the gap in psychosocial wellbeing rather than  increases it. 
Additional research studies that use a longer follow-up period, with assessmentsChapter 11:  Discussion  246 
at additional time points, could help to establish whether SES differences re- 
emerge over time or whether these changes are permanent.
The results could be specific to the cancer-related stressors explored in this 
thesis.  Further work could explore SES differences in reactions to other types of 
illnesses such as multiple sclerosis or diabetes, and also among people 
experiencing sudden onset, acute illnesses, such as an unexpected cardiac event. 
Another issue with this series of studies is that because of the nature of the types 
of cancer that were studied, the research has been  restricted to an older age and 
retired population.  It could be useful to explore SES differences in a younger 
group as well, for example, those with a recent testicular cancer diagnosis.  The 
finding that experiencing an illness could reduce disparities in wellbeing is contrary 
to what might be expected.  Therefore, this kind of additional research is crucial for 
exploring the accuracy and generalisability of these results.
This thesis explored the relationships between SES and psychosocial 
outcomes and did not examine the processes that underlie these connections.
Clearly this is another important avenue of research that is needed in order to 
understand the mechanisms by which SES and wellbeing are linked.References  247
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Abstract
We assessed the relationship between socioeconomic status (SES) and trait 
optimism to test the hypotheses that i) there would be a socioeconomic gradient in 
optimism and ii) the SES gradient would be stronger for negative than positive optimism. 
Community samples of adults (55-64 years) from Scotland (N= 10,650) and England 
(N=5,099) were sent a questionnaire assessing optimism (Life Orientation Test) and SES. 
In both samples there was a strong SES gradient in optimism.  When negatively and 
positively worded items were analyzed separately, the gradient remained significant in 
both cases, although the effect was significantly stronger for the negatively worded items. 
Lower SES is associated with viewing the future as containing fewer positive and more 
negative events.  This bleak view on the future may have important implications for health.
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Introduction
The association between socioeconomic status (SES) and health has been well 
established for several decades (Adler et al., 1994; Lawlor, Smith, & Ebrahim, 2004; 
Marmot, Shipley, & Rose,  1984).  It has been observed across multiple different causes of 
morbidity and premature death, and using a variety of different measures of socioeconomic 
position (Bartley, 2004; Krieger, Chen, Waterman, Rehkopf, & Subramanian, 2005; 
Marmot, 2004; Mirowsky & Ross, 2003).  The effect is not just one of a difference 
between people living at the poverty level and the more prosperous sectors of society; 
rather there is a graded relationship with health across the whole spectrum of SES (Adler et 
al., 1994; Marmot et al.,  1984; Marmot et al., 1991).
Social epidemiologists have emphasized the role of psychosocial factors such as 
perceived control (Griffin, Fuhrer, Stansfeld, & Marmot, 2002; Marmot, Bosma, 
Hemingway, Brunner, & Stansfeld, 1997) and social affiliations (Mickelson & Kubzansky, 
2003; Stansfeld & Marmot,  1992; Turner & Marino,  1994) in mediating the relationship 
between SES and health, but health psychologists have paid limited attention to the 
investigation of SES disparities.  One potential candidate that could have widespread 
effects is so-called dispositional optimism: the generalized belief that more good than bad 
things will happen (Scheier & Carver,  1985).  There is a mass of evidence that an 
optimistic outlook on life is a relatively stable trait that is associated with a wide range of 
health behaviors and health outcomes (Giltay, Geleijnse, Zitman, Hoekstra, & Schouten, 
2004; Ironson et al., 2005; Lobel, DeVincent, Kaminer, & Meyer, 2000; Peterson &
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Related traits such as perceptions of control (Rothbaum, Weisz, & Snyder,  1982) 
have been shown to be related to SES, but there appears only to be one report on SES 
differences in optimism, and that was only a summary of the association (Taylor &
Seeman, 1999).  Taylor and Seeman described data on associations between optimism, as 
measured by the Life Orientation Test (LOT; Scheier & Carver,  1985) and SES in four 
unpublished datasets.  They included individuals having been through a hurricane (n=168); 
patients recovering from coronary artery bypass surgery (n=234); women at risk for HIV 
(n=256); and a study of the natural history of HIV in gay men (n=unknown).  In all four 
studies, total optimism scores were positively correlated with SES, but when the positively 
and negatively worded items were analyzed separately, the negative optimism items were 
significantly related to SES, while the positive optimism showed no association.  These 
results suggested that lower SES people expect more bad things to happen but not fewer 
good things, but the empirical data describing the association between SES and optimism 
has never been published.
The present study assessed the relationship between SES and optimism, also using 
the LOT, in two large samples of older British adults.  We hypothesized that i) total 
optimism score would be linearly associated with SES, and ii) when analyzed separately, 
negative but not positive optimism, would show an SES gradient.
Methods
Participants and procedures
Potential participants were all men and women aged 55-64 years, registered with 
participating Primary Care Practices taking part in the UK Flexible Sigmoidoscopy Trial 
(Atkin et al., 2001; UK Flexible Sigmoidoscopy Screening Trial Investigators, 2002),Appendices 295
excepting the 2% who were judged by their General Practitioner to be unsuitable for 
screening (e.g. already had bowel cancer, recently had sigmoidoscopy, very ill).  The data 
come from the baseline assessment in Glasgow, ‘the Scottish sample’ (N=l 0,650), and two 
centers in England, Welwyn Garden City and Leicester, ‘the English sample’ (N=5,099). 
Participants were mailed a letter, signed by their GP, informing them that a trial of 
colorectal cancer screening was being set up in their area and requesting that they complete 
an enclosed questionnaire and return it in the pre-paid reply envelope.  Non-respondents 
were sent a reminder questionnaire after two weeks.  Ethical approval was obtained at local 
Ethics Committees for each centre.
Measures
The Scottish and English samples received the same questionnaire items on the 
following measures.
Dispositional optimism.  Optimism was assessed using the LOT (Scheier & Carver, 
1985).  The LOT consists of four positively phrased items (e.g. ‘In uncertain times, I 
usually expect the best’) and four negatively phrased items (e.g. ‘I hardly ever expect 
things to go my way’).  Response options ranged from ‘strongly disagree’ to ‘strongly 
agree’ on a five-point Likert scale scored from zero to four.  Higher scores represent 
greater optimism.  Internal reliability was strong in both the Scottish sample (Cronbach’s 
a=0.79) and the English sample (Cronbach’s a=0.81).
Demographic characteristics. Age and gender were known from Health Authority 
records.  Simple items were used to assess ethnicity (‘White; Black; Asian; other; do not 
wish to answer’), marital status (‘married/living as married; divorced; separated; widowed; 
single’), occupational status (‘working full-time; working part-time; not working atAppendices 296
present; retired’), car ownership (‘no car; one car; two cars’), educational qualifications 
(passed public examinations within school or college; ‘yes; no’) and housing tenure 
(‘owning home; renting home’).  An individual-level score of socioeconomic deprivation 
was created by combining answers to questions on educational qualifications, housing 
tenure and car ownership ranging from zero (high SES) to four (low SES) (Wardle, 
McCaffery, Nadel, & Atkin, 2004).  In the present analysis, the two most deprived groups 
were combined to ensure sufficient numbers in each group, yielding four SES groups.  We 
opted to assess SES this way rather than with the more conventional markers of 
occupational status or income because the age group of our sample meant that many were 
retired or unemployed so did not have a current occupation, while some were working in 
post-retirement jobs that were different from their previous occupation.  Further, half the 
sample were women, whose SES is poorly indicated by occupation.  The individual-level 
index we employed is similar to the Townsend Material Deprivation Index (Townsend, 
Phillimore, & Beattie,  1988) or its Scottish equivalent ‘Neighborhood Type’ (Greater 
Glasgow Health Board,  1995) which are indices of neighborhood-level socioeconomic 
deprivation derived from census information on housing tenure, car ownership, 
unemployment, and overcrowding in the local area.  We used the individual-level index for 
the current analysis for greater precision in view of our use of an individual-level measure 
of optimism, but the associations between our individual-level marker of SES and the 
neighborhood-level measures suggested correspondence between the measures (Scottish 
sample: correlation between individual deprivation and Neighborhood Type score r=0.47, 
p<.001; English sample: correlation between individual deprivation and Townsend score 
r=0.44, p<.001).Appendices 297
Analysis of results
Results were analyzed using SPSS (Version 13).  The Scottish and English samples 
were analyzed separately because the Scottish sample used a different sampling frame, and 
over-sampled more socioeconomically deprived areas.  Chi square tests and independent- 
samples t-tests were used to examine differences between respondents and non­
respondents.  ANOVAs and chi square tests were employed to look at demographic 
differences across the SES groups.  The relationship between SES and dispositional 
optimism was assessed using linear one-way ANOVAs and Pearson correlations.
Results
The Scottish sample
In the Scottish sample, of the 10,650 people sent a questionnaire, 6,383 (60%) 
returned a completed questionnaire.  More women (62%) than men (58%) responded (x2(l, 
N= 10,650) =9.95, p<.001), and respondents were very slightly (mean age 60.2 years) older 
than non-respondents (mean age=60.0 years; t(10,648)=3.63, p<.001).  Previous analyses 
of the data from the Scottish centre have shown that response was lower among people 
living in more deprived neighborhoods (McCaffery, Wardle, Nadel, & Atkin, 2002).
Respondents in the highest SES category were younger (F(3, 5,869)=11.6, p<.001), 
more likely to be married (x2=(3, A=5,857)=312.2, p<.001), and more likely to be in full­
time employment (x2(9, vV=5,836)=551.3, p<.001), see Table  1.  There were no differences 
in gender or ethnicity across the SES groups, see Table 1.
The total optimism score showed a significant linear relationship with SES (r=0.23, 
p<.001), with higher optimism in the higher SES groups, see Table 2.  The pattern of 
results was the same when men and women were analyzed separately, and there was noAppendices 298
gender by SES interaction.  When negative items were considered separately, a strong 
positive association emerged, with higher SES groups showing a stronger belief that bad 
things were unlikely to happen (r=0.31, p<.01).  The relationship between positive 
optimism and SES was also linear, but the association was very much weaker than for the 
negative items (r=0.04, p<.01).
The English sample
In the English sample, 3,648 (71.5%) questionnaires were returned of the 5,099 
sent out.  Women (77%) were more likely to return the questionnaire than men (68%; x2(l, 
N=5,099)=392.9, p<.001).  Respondents were slightly older (mean age 60.1 years) than 
non-respondents (mean age 59.8 years; t(5,047)=2.84, p=.005).
Respondents in the higher SES groups were younger (F(3, 3,473)=7.60, p<.001), 
more likely to be male (x2(3, A=3,474)=37.0, p<.001), white (x2(3,7V=3,429)= 14.3, 
p=.003), married (x2(3, tV=3,436)=327.8, p<.001), and in full-time employment (x2(9, 
W=3,379)=159.2, p<.001), see Table 1.
SES was linearly associated with the total optimism score (r=0.22, p<.001), with 
higher SES groups reporting greater optimism, see Table 2.  Similar effects were seen in 
men and women when they were analyzed separately.  The relationship between negative 
optimism and SES was also significant and graded (r=0.29, p<.001).  Positive optimism 
was significantly related to SES (r=0.04, p<.01), indicating that higher SES groups 
reported a greater belief that positive things were likely to happen, however the 
relationship did not show a dose-response pattern, see Table 2.
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The aim of this study was to examine the relationship between SES and optimism 
in two community samples of older British adults.  As predicted, higher SES people were 
more optimistic.  Unlike previous reports, we found significant SES gradients for both 
positively and negatively-worded optimism scales, although the size of the association 
between SES and the positively worded items was very small, and the datasets described 
by Taylor and Seeman (1999) would have been underpowered to detect such a small effect.
Optimism is a psychosocial resource that could potentially contribute to the 
relationship between SES and health.  It may exert its influence on health through greater 
engagement and interest in health leading to successful uptake of health behaviors (Ironson 
et al., 2005; Lobel et al., 2000) or because people with an optimistic disposition would be 
more likely to believe that the impediments they face can be overcome (Scheier & Carver, 
1985).  Studies examining the relationship between optimism and health-promoting 
behaviors have found that more optimistic individuals have better dietary practices, lower 
alcohol consumption and lower smoking rates (Robbins, Spence, & Clark,  1991; Steptoe et 
al., 1994).
Optimists also appear to experience less distress during stressful events which 
provides another explanation of how optimism can have a positive impact on health.  Even 
when confronted with events as severe as a cancer diagnosis, optimists seem to fare better 
(Carver et al.,  1993; Epping-Jordan et al.,  1999; Schou, Ekeberg, Ruland, Sandvik, & 
Karesen, 2004; Stanton & Snider,  1993), perhaps because they tend to use more-problem- 
focused coping strategies or, when they are not appropriate (e.g. when the situation is 
uncontrollable), to turn to emotional coping strategies that are effective in the particular 
situation (Scheier, Weintraub, & Carver,  1986).Appendices 300
Generalization of these results is limited by several factors.  Our samples had a 
limited age range (55-64 years) and so it is possible that the relationship is a cohort effect 
and would not generalize to other age groups.  However, given that the pattern of results is 
similar to the datasets described by Taylor and Seeman (1999), we think that this is 
unlikely.  Our samples were predominantly white and we cannot assume that the same 
relationship would be seen in different ethnic groups.  The response rate was only 60% in 
the Scottish sample and only 72% in the English sample.  These response rates are typical 
of primary care surveys (e.g. Walsh,  1994), but it means that we do not know the responses 
of between 28-40% of potential participants.  Response rates to postal questionnaires tend 
to be lower among more socioeconomically disadvantaged groups (McCaffery et al., 2002) 
which suggests that our samples may not include the lowest SES groups.  However, given 
the graded relationship we found between SES and optimism, we would hypothesize that 
the non-responding group would report low levels of optimism.
The study is the first of its kind to present data on the relationship between SES and 
optimism, and our samples were sufficiently large for us to be confident of the reliability 
of the association.  The results suggest that lower SES people view the future as containing 
fewer positive and more negative events.  This bleaker view on the future may have 
implications for preventive health behaviors, resilience in the face of stress, or mental 
health.Appendices 301
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Differences in demographic characteristics between the four socioeconomic status groups in the Scottish and English samples
SES Group 1  
(n=l 293)
Scottish sample 
SES Group 2  SES Group 3 
(n=1846)  (n=l 891)
SES Group 4 
(n=840)
SES Group 1  
(n=1326)
English sample 
SES Group 2  SES Group 3 
(n=1409)  (n=523)
SES Group 4 
(n=216)
Mean age (SD) 59.7 (2.85) 60.3 (2.80) 60.2 (2.81) 60.3 (2.92)a 59.9 (2.86) 60.0 (2.98) 60.5 (2.85) 60.5 (2.91 )a
Gender %
Male 48.0 45.3 44.1 42.4 51.2 44.4 39.0 34.7
Female 52.0 54.7 55.9 57.6C 48.8 55.6 61.0 65.3b
Ethnicity %
White 96.6 96.9 96.6 97.0 96.3 98.4 97.1 95.3
Non White 3.4 3.1 3.4 3.0C 3.7 1.6 2.9 4.7b
Marital status %
Married/living 83.7 73.6 62.1 51.4 84.2 86.9 67.4 39.5
as married
Not married 16.3 26.4 37.9 48.6b 15.8 13.1 32.6 60.5b
Work status %
Employed full 35.1 25.2 14.3 8.1 35.3 38.5 28.3 16.4
time
Employed part 15.0 12.1 9.5 6.1 23.2 19.0 20.3 11.7
time
Retired 42.4 49.1 49.3 53.3 20.0 18.7 12.8 17.8
Unemployed 7.5 13.5 26.9 32.4b 21.6 23.8 38.6 54.0b
a F test for difference across SES Groups p<.01
bChi square test for difference across SES Groups p<.01
c Chi square test for difference across SES Groups p>.05Table 2
Differences in dispositional optimism across the four socioeconomic status groups in the Scottish and English samples (l=highest SES 
and 4= lowest SES)
SES Group 1  
(n=1293)
Scottish sample 
SES Group 2  SES Group 3 
(n=l 846)  (n=l 891)
SES Group 4 
(n=840)
SES Group 1  
(n=1326)
English sample 
SES Group 2  SES Group 3 
(n=1409)  (n=523)
SES Group 4 
(n=216)
Total
dispositional 
optimism 
score M  (SD)
21.0 (4.52) 20.2 (4.45) 18.8(4.54) 18.1 (4.36)a 20.6 (4.66) 19.2(4.52) 18.2 (4.64) 17.3 (4.55)a
Negative 
items score 
M  (SD)
11.0(2.67) 10.3 (2.82) 9.00 (3.01) 8.40 (2.93)a 10.8(2.89) 9.60 (2.97) 8.54 (3.12) 7.91 (3.10)a
Positive 
items score
M  (SD)
10.0 (2.60) 9.99 (2.60) 9.80 (2.63) 9.68 (2.62)b 9.81 (2.58) 9.56 (2.52) 9.65 (2.72) 9.36 (2.78)°
aTest for linear trend across SES Groups p<.001 
bTest for linear trend across SES Groups p= 001 
Test for linear trend across SES Groups p= 013Appendix II Chapter in press: Cancer and Depression
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Introduction
1   0 
Recent advances in the detection  and treatment of cancer  have led to longer
survival times 3. For example, the five year survival rate of localized breast cancer is
now 97% 4. As a result of this lengthened life expectancy, greater attention is now
being paid to quality of life and psychosocial care for cancer patients. In the short
term, this means ensuring that patients maintain their quality of life during diagnostic
and treatment phases. In the longer term, the aim is to ensure that psychological
problems are prevented or ameliorated so that cancer patients can rehabilitate and
resume functioning at the level they maintained before their cancer.
Cancer remains a life-threatening illness linked by many with fears about
incapacity, disfigurement, and death 5  6. Unsurprisingly, many individuals diagnosed
with cancer experience at least transient psychological distress. This recognition,
however, can lead to a dismissal of depression as a normative response to cancer and
missed opportunities to address a highly impairing, but readily treatable psychiatric
disorder when depression does occur. On the other hand, overestimation of the extent
to which cancer results in depression can misguide allocation of resources, leading to
an emphasis on strategies for aggressively detecting psychiatric disorders, at the
expense of follow-up care for patients who have already been identified, as well asAppendices 309
attention to more common problems and basic supportive needs that affect quality of 
life among cancer patients more generally.
In addition to concern about depression as an added disease burden, there is 
considerable speculation about depression as a cause of cancer and predictor of
n
disease progression and survival  . If depression can be shown to affect progression 
and survival, ensuring that it is detected and effectively treated becomes all the more 
important.  Yet, tying the value of treatment of depression to its effect on disease 
course and an extension of life can lead to a discrediting of quality of life as a 
valuable outcome for mental health and psychosocial interventions, particularly if 
stronger claims about effects on progression and survival are not substantiated.
The relationship between cancer and depression is the focus of a large and 
growing literature. A recent review identifies more than 3000 published abstracts in
o
the years 1966 to 2001  . In this chapter we will discuss three main areas: i) the 
prevalence of depression among cancer patients, ii) the identification and treatment of 
depression among cancer patients, and iii) the relationship between depression and 
cancer incidence, progression and survival. We propose that although the diagnosis 
and treatment of cancer is associated with depression for some, the prevalence of 
depression has been overestimated. Inaccurate estimates of the prevalence of 
depression impede the design of effective services and the rational allocation of 
clinical resources. A number of treatments for depression have been shown to be 
efficacious, but there remains a lack of demonstrated effectiveness in the delivery of 
these interventions in the routine care of cancer patients, in part because the 
competing demands of managing a life-threatening illness interfere with the delivery 
of quality care for depression. We will argue that the greatest challenge in the 
management of depression in cancer patients is ensuring the adequacy of the deliveryAppendices 310
of treatment within the confines of these competing demands, rather than the lack of 
efficacious treatments. Finally, available data suggest a lack of support for 
speculations that depression causes cancer or directly accelerates its progression, but 
depression remains an additional disease burden and threat to quality of life.
Prevalence of Depression among Cancer Patients 
Depression is widely believed to be a highly prevalent condition among 
cancer patients but estimates of its prevalence vary greatly. Massie’s 9 review of 
papers published up to 2002 cites a range of 0-38% for major depression and 0-58% 
for depression spectrum disorders (including more mild and moderate symptom 
reporting of depression), both estimates are far too imprecise to provide estimates of 
need for services. In studies published since 2002 this variability is still common. At 
the lower end, one study of a breast cancer waiting-room sample found that 29% of 
patients were in the distressed range. Follow-up interviews found that approximately 
9% met criteria for major depression, 7% met criteria for minor depression, and 6% 
met criteria for generalised anxiety disorder l0, quite consistent with other recent 
estimates n’13. One of the recent higher-end estimates is Burgess and colleagues’  1 4  
report that 48% of breast cancer patients experienced “clinically significant” 
depression or anxiety in the first year after diagnosis. However, this figure grouped 
individuals meeting full diagnostic criteria for M DD and generalized anxiety 
disorders with “borderline” cases of depression and anxiety for which the efficacy of 
intervention has not been established. Burgess and colleagues note that a year after 
diagnosis, the prevalence of “clinically significant” depression and anxiety was only 
15%, and thereafter the risk of anxiety and depression was no greater than in the 
general population, suggesting that the depression and anxiety being discussed is 
largely self-limiting and not an enduring clinical disorder.Appendices 311
There are a number of factors which contribute to the wide variation in 
reporting of depression in cancer patients. As already mentioned, levels of depression 
are likely to vary according to the length of time that has elapsed since diagnosis, and 
this may be particularly true where sub-clinical cases are concerned egl4. Higher 
estimates may also reflect use of self-report questionnaires of “depressive symptoms” 
rather than diagnostic interviews to ascertain formal clinical diagnoses 15, or the 
sampling of inpatients with more severe somatic disturbance or advanced stage of 
disease 16,17.
In UK older adults (60-74), the group most likely to experience a cancer 
diagnosis, the 1  -month prevalence for mixed anxiety and depressive disorder is 7%,
i o
3% for general anxiety disorder and 1% for depressive episodes  . Using an index of 
depressive symptoms and a wider age range (16-74), the one-month prevalence is 
10% for all adults in the UK 19. In the US, Kessler et al.20 find 16.6% lifetime 
prevalence of depression and 6.6% 12-month prevalence. Some studies of the 
prevalence of depression among cancer patients report levels comparable to or lower 
than these, suggesting that cancer itself may provide no additional risk for depression. 
This hypothesis was systematically tested in a meta-analysis of 58 studies comparing 
levels of anxiety and depression in cancer patients to the general population. This 
showed that levels of depression were higher in cancer patients than in the general 
population but levels of anxiety and general psychological distress were not21. Other 
reviews also conclude that depression is more common in cancer patients than among 
the general population 8  lx22. However, differences in sampling and assessment 
strategies, definitions of depression and diagnostic criteria, and handling of overlap 
between somatic symptoms of disease/treatment and depression make it difficult to 
draw definitive conclusions at this time.Appendices 312
Another useful comparison is between levels of depression in cancer patients 
and other patient groups. Rates in patients with neurological disorders appear to be 
more consistently higher (30-50%) than in those with cancer or other medical 
illnesses 9. Analyses of a longitudinal study of depressive symptoms in a sample of 
8387 adults (aged 51 to 61  years) suggested that cancer patients have more depressive 
symptoms than those with hypertension, arthritis, heart disease, diabetes or stroke in 
the first two years after diagnosis. Levels of depressive symptoms in cancer patients
J ^
were comparable to levels found in those with chronic lung disease  . However, the 
age range for this study is lower than the mean age of diagnosis of most cancers, and 
among cancer patients, lower age is associated with greater distress. More generally, 
estimates of the prevalence of major depressive disorder among cancer patients based 
on semi-structured diagnostic interviews with representative samples overlap with the 
5% to 13% range found in primary care patients 24'28
The best estimates of the prevalence of depression in cancer patients suggest 
that the disorder is more common than in the general population, but perhaps only as 
common as, or little more common, than, general medical patients, including primary 
care patients. Even accepting the higher estimates of prevalence in cancer patients, the 
majority will not develop major depression. As Raison and Miller’s 22 review 
concludes “cancer is a risk factor, rather than a mandate, for depression” (p283). This 
raises an interesting, but overlooked issue. If cancer does not raise the level of current 
depression as once thought what effect does it have on lifetime rates of depression? 
Depression is a recurrent, episodic condition with a mean first onset in the early 
twenties, long before the mean age at which most cancers are diagnosed. If most cases 
of depression during cancer treatment are recurrences, this would have importantAppendices 313
implications for efforts to detect and treat this depression, and perhaps even prevent it 
among cancer patients vulnerable on the basis of past history.
Dilemmas in the Diagnosis and Assessment of Depression in Cancer Patients 
Cancer poses many of the same challenges as other medical conditions in 
terms of accurate diagnosis of depression and the suitability of various strategies for 
detection and assessment. Symptoms that discriminate well between psychiatric and 
non-medical patients may prove less efficient in cancer patients, necessitating 
adjustment in diagnostic criteria. The overlap between depressive symptoms and the 
symptoms of cancer and side effects of treatment may pose problems in the 
interpretation of self-report and interview measures of depression 
Controversy in the Diagnosis of Depression
Many cancer patients report symptoms of fatigue, loss of appetite and 
cognitive impairment that could be attributed to either the illness, side effects of 
treatment, or depression. It has been particularly difficult to resolve the overlap 
between the fatigue that accompanies treatment for cancer and depression29. 
Confusion about the overlap between the symptoms of M DD and those of cancer and 
its treatment could result in invalid diagnoses, leading to inappropriate treatment of 
non-depressed individuals with antidepressants, in lieu of more appropriate supportive 
services or empirically supported interventions for other forms of symptom distress 30. 
The philosophy of the DSM-IV 3 1  definition of MDD is inclusive and non-etiological, 
and although the criteria for attributing a symptom to a medical illness are strict (i.e., 
the symptom must be the direct physiological consequence of a medical condition), 
the validity of this approach remains unsettled.
Studies provide contradictory suggestions as to whether overlapping 
symptoms should be given equal 28,32 or lesser weight33;34;34;35. Various strategiesAppendices 314
have been proposed for diagnosing MDD among cancer patients 36'38. Inclusive 
strategies count all symptoms, regardless of their aetiology and offer high sensitivity 
for MDD at the expense of low specificity and over diagnosis e  g  39. Exclusive 
strategies allow only symptoms clearly unrelated to the diagnosis and treatment of 
cancer to count toward an MDD diagnosis. However, this approach may require the
38 diagnostician to posses more knowledge than is readily available in the literature  . 
The substitutive approach40 replaces somatic symptoms with additional cognitive 
symptoms. However, there are currently no clear and agreed upon guidelines as to 
which symptoms to replace, the symptoms that should replace these, or whether and 
how to weigh various symptoms to arrive at an accurate diagnosis. Etiologic 
approaches count symptoms only if they are clearly not a result of physical illness, 
and thus can be the most restrictive of the classification schemes. Indeed, prevalence 
rates for depression among medical samples can vary as much as 210% when 
comparing inclusive and etiological strategies 41. The confusion over which strategy is 
most “accurate” in the sense of clinically useful  remains unresolved, and existing 
data  , though sparse, indicate that small changes in diagnostic strategies can 
substantially affect the nature and prevalence of MDD identified.
In the absence of conclusive data, the most prudent strategy may be to apply 
what is known about depression among other patient groups. Most cases of major 
depressive disorder among adults are recurrences. Among primary care patients, 
individuals with current depression are eight times more likely to have a history of 
depression than non-depressed individuals, and after taking history into account, the 
risk of depression proffered by other putative factors is substantially lowerede  g  42. 
Given this, it may be most reasonable for clinicians to have a variable threshold for 
counting symptoms, taking an inclusive approach among individuals with a history ofAppendices 315
depressive disorder and a more etiologic approach among those without such a 
history, but being prepared to revise a provisional diagnosis based on course or 
response to treatment. This resolution, while less than ideal, may allow for 
identification of those most likely to benefit from intervention while reducing the 
chance of introducing new treatment to individuals unlikely to benefit. Whether such 
a resolution can be readily implemented is unclear. It is somewhat reassuring that 
mental health professionals can be trained to discriminate between symptoms of 
depression and symptoms of physical illness and side effects of treatment when using 
structured interview protocols and formal diagnostic criteria 43. On the other hand, lay 
interviewers required to accept patient reports at face value without probing e  8 a s  m  44 
produce dubious diagnoses, rendering the conclusions of some research studies 
suspect45.
Prevalence of depression by cancer type, stage and treatment
Disease site
Cancer patients are not, of course, a homogeneous group in terms of the 
cancers they have and so for this reason alone differences exist in the levels of distress 
experienced by patients. Zabora et al 46 studied 5000 cancer patients, of whom 58% 
had received a diagnosis within the last 90 days.  The highest prevalence of distress 
was found in lung cancer patients, where 43.4% of the sample showed high levels of 
distress. Similarly high levels of distress were experienced by patients with brain, 
liver, pancreatic and head and neck cancer. Significantly lower levels of distress were 
experienced in patients with gynaecological, breast, colon and prostate cancers. This 
may be because of the better prognosis for these cancer sites. Other studies report 
similar findings, for example, Stommel et al 47 found higher levels of depression inAppendices 316
lung cancer patients compared to breast, colon or prostate patients in their sample of 
860 older (65 years+) patients.
Disease stage
Stage of disease at diagnosis is another factor that affects reporting of 
psychological adjustment. Being diagnosed with more advanced disease implies a 
poorer prognosis and understandably can be expected to pose a greater threat to 
psychological well-being. A number of studies show that more advanced disease is 
associated with increased psychological distress e  8 48’49 50 although other studies find
ci  o
little or no relationship between stage and psychological outcomes  '  . Studies that 
fail to find an effect often do not include patients with the most advanced disease 
stages 1 4 ;e  8 52?  or make a comparison between early and advanced stage patients in 
widely different time frames since diagnosis e  g  51.  These varied responses may also 
reflect the fact that patients are notoriously poor at understanding the precise 
implication of their diagnosis Mo7.
Treatments o f cancer
Some cancer treatments are also associated with increased levels of 
depression. Immunotherapeutic agents, such as interferon-alpha and interleukin, used 
to treat some cancers (e.g. kidney, melanoma), induce depressed mood as a direct 
side-effect58'60. Other more extreme treatments such as bone-marrow or stem-cell 
transplants appear to result in higher levels of distress than cancers with other 
treatment modalities indirectly because of the more severe trauma to the body and 
isolation of the patient61'63.  More widespread treatments such as chemotherapy, 
radiotherapy or surgery commonly cause symptoms of illness including fatigue, pain 
and sickness. These symptoms experienced at chronic levels are debilitating and are 
connected to psychological distress 47;64'66. The studies cited here fin d  that differentAppendices 317
treatments can increase levels of distress. Patients currently undergoing treatment may 
differ in terms of distress compared to those who have completed or who are still 
awaiting treatment. .
There are also other studies which conclude that type of treatment is not 
associated with distress e  8  14;47;53. Burgess et al’s 1 4  study of depression and anxiety in 
222 women with breast cancer concludes that risk factors such as younger age, past- 
history of depression and lack of social support, are more important risk factors for 
depression than cancer-related variables. This possibility cannot be discussed within 
the parameters of this review. These variables are risk-factors for depression in 
general population samples.
Detection and Treatment of Depression in Cancer Patients
Regardless of the prevalence of depression, its occurrence represents a burden 
to the patient. Nonetheless, the clinical significance of distress remains unclear.
Zabora et al. 46 suggest that 2/3 of distressed patients improve without intervention, 
but provide no supporting data. Others suggest that most patients experience a 
reduction in initial distress within weeks of diagnosis, and considerable improvement 
within 3-4 months14,67" 69. At least one effort to monitor intensively the emergence of 
any distress and to intervene quickly failed to demonstrate an effect, apparently 
because of the high rate of resolution without any intervention beyond routine care 70. 
Yet, there is a consensus that not all distress among cancer patients resolves so readily 
and that appropriately identifying and treating distressed patients is imperative. A 
more useful approach may be to identify groups of people who are most at risk for 
developing psychological problems and direct available services towards them. 
Unfortunately, there has not been much progress in identifying such patients.Appendices 318
It is well documented that depression is frequently overlooked by health care 
professionals, and that depression that goes undetected in routine medical care is  not 
likely to be addressed elsewhere 71. Cancer care professionals are often not well 
equipped to deal with depression in their patients, lacking the time, communication 
and diagnostic skills, and treatment and referral resources that are needed. Fallowfield 
and colleagues 72 assessed 143 cancer physicians’ ability to detect distress in their 
patients. Over 70% (595/827) of patients with probable psychiatric morbidity 
(measured by GHQ-12) were missed by their physicians. Physicians and nurses are 
able to recognize obvious signs of distress, such as crying, but miss symptoms such as 
suicidal thoughts or hopelessness, that would require more involved interviewing or 
direct inquiry to elicit13,14. Undetected depression in cancer patients represents a 
missed opportunity to reduce suffering and impairment. This has led to a growing 
chorus of calls for routine screening of cancer patients for psychological distress and 
depression75-77
Screening for depression in cancer patients
Screening for depression involves patients completing self-report 
questionnaires or computer touch screen measures with the results being passed on to 
doctors or allied health professionals for follow-up evaluation, and, if appropriate, 
treatment or referral. Screening instruments that have been proposed range from a 
simple distress thermometere  8 78 to the full range of standardized measures 
developed in other populations, such as the Center for Epidemologic Studies-
pec  ry  *7 0   on
Depression Scale  "   ’  , Brief Symptom Inventory  , Hospital Anxiety and 
Depression Scale HADS’8 1  and two 82 and .nine item 8 3  versions of the Patient Health 
Questionnaire (PHQ).
With appropriate cut-off points, as few as two screening items may prove asAppendices 319
valid and efficient as longer instruments 8\  reducing patient and staff burden. Yet, 
regardless of the length or other details of a screening instrument, a clinical interview 
is necessary to confirm a diagnosis. Conceptually, empirically, and clinically, there is 
a distinction between a score on a self-report measure and a clinical diagnosis of 
depression sufficient for decision making25. The imperfect fit between scores on a 
screening instrument and diagnosis dictates that efficient cut-points for a screening 
instrument inevitably involve a balance between sensitivity in identifying disorder and 
specificity for ruling out individuals without diagnosis. Lower cut-points ensure that 
fewer depressed patients are missed, but at the expense of requiring more follow-up 
interviews of patients who turn out not to be depressed. Resolution of these “false 
positive” cases is costly, and likely diverts resources from improving the treatment of 
individuals with known depression. In one large-scale study of depression screening
O f  #
in primary care settings, Spitzer et al.  estimated that an additional 8.4 minutes for 
resolution of a positive screen had to be added to what would have otherwise have 
been a 6 to 12 minute encounter . This observation was in the context of a research 
study with enriched resources and training for staff that is unlikely to be available in 
routine oncology settings. Other research has demonstrated that such resolution of 
positive screens can cost an additional US$60 per patient86.
A study conducted by two of the authors of this chapter 1 0  raised some issues 
about the efficiency of screening. Almost one-third of a sample of women recruited 
from the waiting room of a specialty breast cancer treatment setting screened positive 
for depression, despite many of them being long-term survivors reporting for a 
follow-up visit. This figure could be cited as evidence of the enduring distress 
associated with breast cancer, but it is actually almost identical to what would be 
obtained in a primary care waiting room 87. Furthermore, only 8% of the waiting roomAppendices 320
sample was subsequently found to have MDD and the odds that an individual 
screening positively having MDD was only 21%. Many of the depressed women had 
a recent or current prescription for an antidepressant, so that the probability of an 
interview with a woman who screened positive would yield an untreated case of MDD 
was only 7%. In short, two stage screening and interviewing in this sample, could 
provide little in terms of improved detection of untreated depression for a lot of effort.
There is some evidence that the introduction of screening with adequate 
feedback to medical staff can increase the number of cases of M DD that are identified 
1 3  and the number of patients who are referred for psychiatric care 88. This should 
presumably result in a reduction in the overall level of depression in the screened 
sample 89. However, there has yet been no demonstration that routine screening for 
depression reduces the rate of disorder or level of depressive symptoms among cancer 
patients on a clinic or population basis. The consistent finding in the general medical 
literature is that screening does not improve patient outcomes without the introduction 
of considerable resources, and it is exceedingly difficult to identify any enduring 
benefits after the enriched resources of a demonstration project are withdrawn 90. We 
know of no demonstration that screening by itself reduces depression on a population 
basis, despite an extensive review of the literature 90. The result of one pilot study 
with prostate cancer patients raises some issues that deserve more attention. Roth and 
colleagues 9 1  were able to get 77% (93/121) of a waiting room sample to complete 
questionnaires and 29 scored above a cut-point on one or both screening instruments. 
These 29 patients were referred for further evaluation, but 12 missed or refused an 
appointment. One recurrent issue in dealing with these patients was the difficulty of 
getting such an evaluation without requiring a return visit by the patient. O f the  17 
evaluated, three not currently receiving treatment were given a psychiatric diagnosis.Appendices 321
A re-evaluation was recommended to them, but there is no report of how many 
completed this. Consistent with some of the difficulties Roth and his colleagues 
encountered, Shimizu and colleagues 88 found that only 28% (19/67) of cancer 
patients who scored positive on a screening test for depression accepted a referral to a 
psychiatrist.
Screening is clearly not a panacea in the improvement of the outcome of 
depression on a cancer setting or population basis. We would urge caution before any 
commitment to screening as the sole or primary means to address depression in a 
cancer care setting, and careful consideration of its likely costs, benefits, and 
alternatives. Maguire 92 apparently shares our concerns and recommends training 
cancer care professionals in better detecting distress and depression in conversations 
with patients. We would also recommend strategies such as greater surveillance of 
cancer patients with histories of depression, given the importance of this background 
as a predictor of depression during cancer care 93-95; monitoring of the adequacy of 
existing treatment of patients identified as depressed; as well as lowering the barriers 
for cancer patients who are motivated to seek specialty mental health care.
Treatment for depression in cancer patients
In light of conventional assumptions that cancer is a strong risk factor for 
depression, it might seem ironic that there is a paucity of clinical trials examining 
treatment for depression in cancer patients. An expert scientific review and consensus 
conference commissioned by the Depression and Bipolar Support Alliance (DBSA)96 
> n  p re s s  conciucjecj that: “Available evidence strongly suggests that depression in the 
patient with cancer responds to TCAs, SSRIs, mirtazapine, and mianserin.” (p i6).
Yet, this statement is based on seven studies. Two were double blind, randomized 
placebo controlled trials supporting the efficacy of mianserin, a heterocyclicAppendices 322
antidepressant that is not commonly prescribed. Beyond that, none of these studies 
were double blind, randomized placebo controlled trials in which an antidepressant 
was shown to be superior to placebo. While one randomized placebo controlled trial 
obtained null effects for fluoxetine 97 the lack of evidence is mainly a matter of the 
paucity of research with adequate statistical power and other minimal methodological 
rigor. Pirl8  cites nine relevant studies, but his additions do not change our conclusion. 
Thus, currently, the strength of the recommendation of treatment of depression in 
cancer patients with antidepressants must come from studies of the treatment of 
depression with antidepressants more generally in the presence of co-morbid physical 
illness. However, the evidence is that depressed patients with co-morbid physical 
illness have worse treatment outcomes than those without physical co-morbidity98.
Evidence that psychotherapy is efficacious for depression in cancer patients is 
similarly limited. Sheard and Maguire 99 have provided what is becoming a widely 
cited meta-analysis of the effects of psychological interventions on depression in 
cancer patients. They initially identified twenty intervention trials in which depression 
was measured as an outcome, but only ten allowed assessment of an effect size.
Sheard and Maguire 99 found an effect size of .36, but the data were found to be 
highly heterogeneous, and elimination of three positive outliers with small sample 
sizes and other serious design flaws reduced the effect size by a half, .19. While these 
results can hardly be seen as demonstrating the efficacy of psychotherapy for 
depressed cancer patients, neither can they be taken as decisive evidence against the 
efficacy of treatment: particularly in this instance, absence of evidence of an effect is 
not evidence of an absence of effect. Sheard and Maguire 99 note that most of these 
studies did not involve recruitment of patients on the basis of them being depressed, 
and those that did so relied on self-reported distress as the criterion. What Sheard andAppendices 323
Maguire 99 do conclude for the studies in which patients were recruited without regard 
to level of depression is that there is no evidence that providing psychotherapy to non­
depressed patients prevents depression.
In the midst of what may seem a discouraging assessment of the literature, it 
would be useful to point to a promising recent study. The Nezus and colleagues 1 0 0  
randomized  132 cancer patients to either individual problem-solving therapy, problem 
solving therapy with the involvement of a significant other, or waiting list control. 
Patients were not recruited on the basis of a diagnosis of depression, but the 
requirement that they be experiencing a significant level of distress yielded a sample 
that had depressive symptoms of a mean severity typically seen in clinical trials with 
depressed outpatients. Both of the two problem-solving therapy conditions resulted in 
significant reductions in distress on most of a set of outcome measures, whereas 
baseline levels of distress were maintained in the waiting list control groups. The 
cancer patients who had the involvement of their significant others experienced 
greater gain than those receiving individual problem solving therapy. Improvements 
in the patients receiving active treatment were still evident at one year follow up.
Another promising, but preliminary study, supports patients’ use of anti­
depressant medication prior to receiving to treatment with interferon-a in order to 
prevent the development of depression, a side effect serious enough to require 
discontinuation of interferon in the treatment of melanoma. Musselman et a l59 
conducted a double-blind study using paroxetine in malignant melanoma (N = 40) 
patients prior to the start of interferon-a treatment. Only 2/18 patients receiving 
paroxetine developed depression compared to 9/20 in the placebo group. Further, only 
1   patient in the paroxetine group, compared to 7 in the placebo group, discontinued 
interferon treatment because of severe depression. This suggests that there may be aAppendices 324
role for anti-depressants as a preventative measure in patients receiving this type of 
treatment. These results need to be replicated and long-term effects are still unknown.
A third innovative study is more troubling in its implications, particularly 
given the investigators’ interpretation of their results. Fisch and colleagues  1 0 1  
randomized cancer patients in the community to receive by mail either fluoxetine or 
placebo, with the instructions that patients contact their oncologist if they experienced 
vomiting or nausea. Participants in this study had been screened for depression, but 
screening served as a basis for excluding patients who did not have at least some 
symptoms, rather than for insuring clinically significant levels of symptoms.  The 
authors concluded from their results that “our data may broaden the comfort zone of 
oncologists for prescribing antidepressants for some patients.” (p. 1942). However, 
there were numerous methodological problems with this study, starting with 
difficulties accruing patients despite a statewide recruitment effort. Moreover, the 
differences between their intervention and placebo groups were greater at baseline 
than at follow up, and in the follow-up assessment on which they base their claim of 
effectiveness; data were available for only 14 of the 81  intervention patients and  19 of 
their 78 placebo patients. Our major concerns with this study are threefold seeals0 
102,103. First, there is more generally a lack of evidence that antidepressants are 
effective for persons who have sub-threshold depression and the investigators’ 
encouragement of such use is counter to available evidence. Secondly, it is already 
difficult to get non-psychiatric physicians such as oncologists to adhere to diagnostic 
criteria and provide adequate patient education and follow up. Fisch and colleagues 
imply that neither is needed. Finally, from the point of view of policy, it would be 
unfortunate if inaccurate claims about the effectiveness of mailing antidepressants to 
patients who are not even depressed were used to argue against the provision ofAppendices 325
appropriate psychosocial services. Substantial rates of prescription of antidepressants
to cancer patients who are not depressed is already an important issue in quality and
1 0 2
economics of mental health care for cancer patients
In summary, the case for the efficacy of intervention for depression among 
cancer patients depends mainly on evidence derived from other populations. 
Demonstrations that such claims can be validly extended to cancer patients are sorely 
overdue. However, our earlier review of the prevalence of depression among cancer 
patients suggests a challenge in the mounting of methodologically adequate studies: if 
only 9% of breast cancer patients suffer from major depression and a substantial 
proportion are already receiving treatment, then a multi-site trial with massive 
amounts of screening may be necessary to accrue a sufficient sample.
Effectiveness of Delivery versus Efficacy of Treatment of Depression in Cancer 
Even if we provisionally accept that what is efficacious in the treatment of 
depression more generally should work for cancer patients as well, there is the 
question of the effectiveness with which care for depression can be delivered to 
cancer patients. Aside from the urgent and competing demands of treating a life- 
threatening illness, there are formidable issues concerning patient acceptance and 
access to quality care. A high proportion of patients reject psychological intervention 
88,104,105  Moynihan 104 reported that only 40% (73/184) of their sample of testicular 
cancer patients accepted psychological therapy. “We make a plea for caution with 
regard to the blind faith that counseling will be gratefully received and will be 
effective despite a dearth of sound evidence” (Moynihan et al.,  1999, p.  128). Sharpe 
and colleagues 1 0 5  report that 53% of patients rejected their problem-solving 
intervention but 37% also rejected the control condition where there was simply 
monitoring of depression and ‘usual care’. Sollner and colleagues 106 found that onlyAppendices 326
42% of breast cancer patients who screened positive on a measure of distress endorsed 
an interest in counselling, a proportion no greater than for non-distressed breast cancer 
patients. In the previously noted study by Roth and colleagues 9 1  one of the prostate 
patients refusing screening outright stated “This is a psychiatric evaluation? Right 
now I have my own problems and I don't want to get involved."
The data are mixed as to the extent to whether cancer care professionals 
influence patient uptake of mental health and psychosocial treatment.  Although most 
(68%) of a sample of prostate cancer patients reported that they would prefer not to 
take medication for depression, 75% indicated that they would do so if advised by 
their physician (Shapiro, et al., 2004). However, Eakin and Strycker 107 found that 
while clinicians reported referring 70% of cancer patients to support services, only 
24% of these patients recalled having services discussed the issue.
The problem of low uptake and even patient resistance to mental health and 
psychosocial services is often framed in terms of stigma, with the requisite solution
1  /"J D
being a destigmatization of help-seeking  . However, there is rather consistent 
evidence that offered a choice, cancer patients prefer more support and 
communication from oncologists and oncological nurses to interactions with mental 
health professionals, and interventions designed to increase their access to quality, 
understandable information about their condition and its treatment to counseling and 
psychotherapy ,09'113. Perhaps, not unreasonably, patients prefer to deal directly with 
the perceived source of their distress and depression 106. It remains an important, but 
unaddressed question whether improved access to care specialists and medical 
information is a more acceptable and effective means of preventing and ameliorating 
depression than formal mental health services, or, if not, such improved access and 
information might function as an effective first stage response, such that patients whoAppendices 327
do not sufficiently benefit are particularly appropriate for specialty mental health 
interventions.
Even when depressed cancer patients are interested in empirically supported 
treatments, they may have difficulty accessing such services. Cancer care tends to be 
provided in tertiary care settings to which patients travel many miles 10113. It may be 
logistically difficult or undesirable to coordinate mental health care with visits for 
chemotherapy or radiation, and unrealistic to expect that patients will make regular 
return visits expressly for care for depression.
Then there is the issue of the availability in cancer care settings of 
professionals trained in the effective treatment of depression. It has been argued that 
quality mental health and psychosocial care is an essential component of 
comprehensive cancer care, but psycho-oncology units, if they are present at all in 
routine cancer care, tend to be understaffed  . Pamphlets for the Memorial Sloane 
Kettering Cancer Center, which has been so instrumental in the development of 
psycho-oncology, flatly state that specialty psychosocial services are not available in 
their affiliated cancer care settings. Furthermore, the patient base needed for 
interventions targeting focused groups of cancer patients such as early breast or 
metastatic breast cancer patients has not usually been appreciated. Goodwin et al’s 1 1 4  
presentation of lessons learned in a randomized trial of supportive expressive therapy 
for metastatic breast cancer patients deserves careful consideration.
The unfortunate state of affairs for treatment of depression in routine care for 
cancer is that if depression is addressed at all, it is likely to be with peer or 
professionally led support groups with patients of varying cancer site, stage of cancer, 
and time since diagnosis; nonspecific individual counseling and psychotherapy; or, 
more predominately, prescription of antidepressants by non-psychiatric physiciansAppendices 328
and nurses that is both nonspecific and poorly followed up. The gap in outcome is 
likely to be great between what occurs with these treatments and what is obtained 
with empirically supported treatments in the context of a clinical trial.
The Relevance of Primary Medical Care
In closing our discussion of care for depression in cancer patients, there are 
three reasons for giving attention to primary medical care. First, the de factor mental 
health system for the treatment of depression in North America and the United 
Kingdom centers on primary medical care 115. Cancer patients who are suspected of 
being depressed are likely to be started by their oncology clinicians on antidepressants 
with expectations of follow up in primary care or to be referred directly to their 
primary care physicians for further evaluation for treatment with medication 116. The 
quality of care for depression in primary care is thus likely to be the quality of care 
available to depressed cancer patients.
Second, over 15 years of research on treatment of outcome of depression in 
primary care document well the difficulties in ensuring quality of care in non-
71.1  1 7
psychiatric medical settings  ’  .This large body of literature indicates that in routine 
primary care, treatments with established efficacy are delivered with effectiveness no 
greater than what is observed for placebo in clinical trials in specialty mental health 
settings, apparently due to the low quality of routine care. It is estimated that only 
20% of depressed primary care patients receive adequate care, and there are notable 
deficiencies in patient education, scheduling of follow-up visits, and a failure to adjust 
medications in the face of unacceptable side effects or lack of improvement7I;118. 
Approximately 40-50% of depressed patients will need such adjustments 119, but in 
the absence of adequate monitoring and follow up, problems with medication and 
nonadherence are not likely to be detected.Appendices 329
It has become clear that simply getting more depressed primary care patients 
identified will not improve patient outcomes on a practice or population basis, that
117120
physician education alone is insufficient to improve these outcomes  ’  , and that
more fundamental changes in the structure of practice are needed. In a comprehensive 
review, Brody 1 2 1  has identified some components that contribute to the effectiveness 
of multi-component strategies to improve the outcome of depression in primary care: 
“we have learned that improving the care and outcomes of depression in primary care 
requires some or all of the following: a systematic approach to the recognition and 
assessment of depression; evidence-based decision support; patient education and 
activation; ongoing monitoring and feedback regarding patient adherence and 
outcomes; integration of mental health specialists for patients who are not improving
1 9 1
as expected; and physician education” (p. 21).  Brody  notes, however, the serious 
difficulties that have been encountered in attempting to sustain these innovations 
beyond well funded demonstration projects.
Depression management specialists, who are usually masters level nurses or 
social workers who take responsibility for assessment and follow up, are coming to be 
a basic component of cost-effective strategies for improving the outcome of
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depression in general medical care  ’  . These managers can be trained to meet
patient preferences by offering either medication management or brief structured 
psychotherapies. One promising extension of this work is the utilization of centralized 
systems of telephone management of depressed patients, with regular direct contact of 
depression management specialists with patients and support and feedback to treating 
professionals 124;125.
The challenges of improving the effectiveness with which depression is 
managed in cancer care are undoubtedly even more overwhelming than what has beenAppendices 330
encountered in primary medical care. Yet, innovations developed in primary care are 
now being disseminated into cancer care, at least on a pilot and demonstration project 
basis. Strong et al 126 delivered a nurse-led intervention to cancer patients with a 
diagnosis of major depression, in which a cancer nurse was trained to deliver a 
problem-solving therapy and encourage the patient to consult with a primary care 
physician concerning antidepressants. Patients receiving the intervention showed 
significant reductions in depression compared to the control group. Strong et al 1 2 6  
noted a number of difficulties associated with patient rejection of participation in the 
program and primary care physicians rejecting the advice of the depression 
specialists, but this pilot project nonetheless shows the promise of depression 
management specialists in the context of cancer care. In effort having some 
similarities, but with the depression management specialist having more responsibility 
for promoting adherence to antidepressants, Dwight-Johnson, Ell and Lee  1 2 7  
randomized 55 low-income Latina patients from a public sector hospital with breast or 
cervical cancer and co-morbid depression to either collaborative care delivered by a 
depression management specialist or usual care. The usual care arm of the study 
involved informing the patient of her diagnosis of depression and encouraging her to 
seek treatment. The patients receiving the intervention experienced significantly 
greater reduction in depressive symptoms, which the investigators attributed to both 
the effectiveness of the intervention and the difficulties the control women 
experienced obtaining care for their depression.
Depression and cancer incidence, progression and survival: Death is not 
everything
The established rationale for improving the detection and treatment of 
depression is cancer care is that the toll of depression on the well being and quality ofAppendices 331
life of cancer patients is unnecessary in terms of the availability of efficacious 
treatments. However, considerable attention has been given to controversial claims 
that depression is implicated in the incidence and progression of cancer, and that as 
demonstrated in the effects of group psychotherapy on survival, treating depression 
can extend the lives of cancer patients 7,96. Indeed, the view that mood and morale 
affect the progression and outcome of cancer has become prevalent among the lay
128*129 public and even some oncology professionals  ’  .Yet, even the mechanism by 
which depression might influence development of cancer is highly speculative and 
controversial. Effects of depression on immune functioning is commonly cited as a 
plausible mechanism 1. Yet, there are a limited range of cancers for which immune 
functioning is conceivably relevant, and research have consistently failed to find 
effects of psychosocial interventions on the immune functioning of cancer patients l3°.
n
Spiegel and Giese-Davis  noted that the literature concerning depressed mood 
predicting cancer incidence is at best mixed, “although there is support in the 
literature for an association between lingering depression and faster cancer 
progression, the field has yet to sort out the overlapping symptoms of increased tumor 
burden and vegetative depression” (p.273). At the present time, there is considerable 
scepticism in the larger literature concerning whether a causal role for depression or 
emotional well-being in cancer progression can demonstrated when appropriate 
controls are introduced for known biological prognostic indicators, physical 
symptoms, and side effects of treatment1 3  *. Recent large scale observational studies 
have failed to find that emotional well-being predicts survival in metastatic  132or early 
breast cancer patients 133_134. jn a recent review of prospective studies Garssen, 1 3 5  
characterized depression as “'an influence that cannot be totally dismissed” (p.315), 
rather than being among the pool of the most promising psychosocial variables.Appendices 332
Some of the research interest in this topic stemmed from Greer, Pettingale and 
Morris' 136 study of survival in breast cancer patients which found an association 
between denial, helplessness/hopelessness, fighting spirit and survival in a group of 
early stage breast cancer patients. This group was followed for 15 years and the effect 
persisted over that time. However the sample size was relatively small (N=69).
Watson et al’s ongoing study of survival in breast cancer patients (N = 578) also 
shows that helplessness/hopelessness is related to decreased survival at both 5 years 
1 3 7  and 10 years follow-up 138. Watson et al’s study fails to replicate the findings for
1  1A  1  17
fighting spirit found in the Greer et al study  . Watson et al  did report a very
limited effect for depression at the five-year follow-up but this was no longer present
at the ten year follow-up (Watson et al 2005).
As regards the possibility that psychological interventions can improve
survival, Spiegel 7>,39’1 4 ° has argued that there is  evidence to support this possibility.
Spiegel cites 7,140 five studies that support this hypothesis ,39141'1 4 4  ancj f|ve studies
that do not 1 3 3  145_148. Since Spiegel and colleagues’ reviews, an additional negative
finding has been obtained 51. Palmer and Coyne 149 note that three of the studies cited
by Spiegel and his colleagues 142'1 4 4  involved a confounding of improved medical
surveillance and more intensive medical care with psychological intervention, so that
any improvement in survival cannot be unambiguously attributed to psychological
intervention. The remaining two studies 139’1 4 1  have serious statistical problems.
Survival data for cancer patients is highly skewed with a small number of patients
typically living much longer than the rest, making medians better summary statistics
1 1 0
than means. When the Spiegel et al  data are summarized in terms of median 
survival time, the advantage for the patients receiving the intervention is non­
significant, only a few months. Fawzy et a l1 4 1  dropped a number of patients fromAppendices 333
their analyses, including one because he was clinically depressed, and so does not 
provide the “intention  to treat” analyses that are standard in evaluating medical 
interventions. Not only do available studies not support an effect of psychological 
intervention on survival; their relevance to the question of a role for depression in 
cancer progression is quite unclear. Spiegel and Giese-Davis’s 7question: “What are 
the aspects of psychosocial intervention that seem to be most effective in reducing 
depression...?” (p. 275) seemed quite unanswerable. As noted, Fawzy et al 1 4 1  
dropped the one patient in his study found to be depressed, other studies do not target 
depression or assess it as an outcome, and, in general, these studies have recruited 
patients that are not notably depressed, even when suffering metastatic disease.
In summary, the evidence that depression causes cancer or accelerates its 
progression or that intervention for depression improves survival is largely absent or 
negative. This stands in sharp contrast to the robust prognostic value for depression in 
cardiovascular disease 15°. In the absence of credible evidence, continued claims for a 
role for depression in cancer and claims that psychological interventions promote 
survival can prove damaging to the field. “Although the prevention of death is a 
powerful tool to influence many of our medical colleagues who use it to justify the 
allocation of resources, death is not everything” 1 5 1  (p. 19). When strong claims about 
the role of depression in cancer ultimately need to be abandoned, it will seem to be an 
undignified retreat to claim that the usefulness of detecting and treating depression 
based on the “mere” benefits for wellbeing or quality of life. An unwarranted strong 
claim thus could rob the credibility of what had always been a reasonable claim.
Conclusions
Depression is unlikely to cause or accelerate cancer progression. This is in 
contrast to depression’s apparent role in other diseases, such as cardiac morbidity andAppendices 334
mortality discussed in chapters three and four of this book. The prevalence of 
depression in cancer patients is also relatively low but is an additional, and often 
unrecognised, problem for some patients. Difficulties assessing prevalence and 
identifying cases of depression in cancer patients have hampered efforts to provide 
appropriate clinical services. There are a number of effective treatments for 
depression but there is often limited availability of trained staff to deliver them and 
many cancer patients continue to reject interventions for psychological problems. 
Depression could be reduced in cancer patients by providing more effective symptom 
management or behavioural interventions. These forms of treatment could be more 
acceptable to patients and more easily delivered by existing oncology staff, but data 
concerning the potential of these methods are still limited.
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Appendix III -  Published paper: Socioeconomic Status differences in coping with a 
stressful medical procedure
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Appendix IV  Longitudinal questionnaire used in Study 1
FIRST,  SOME QUESTIONS ABOUT YOUR GENERAL HEALTH AND ATTITUDES
F/ease p h n v ,t f fcm (X ) in  th e  a p p ro p ria te  b o x
Would you say that for someone of your age your own health in general is:
Excellent  Good  fair  Poor
About how many times have you been to see your GP in the last 3 months?
Haven't been  Once  Twice  Three or more times
Do you
,,,srnoke cigarettes at all nowadays? 
...take regular exercise each week?
Yus N o
About how many servings of VEGETABLES do you eat (including safad, but 
excluding potatoesJ?  l or example, a handful of carrots counts as one serving.
Ictttten  j (> « < • giving  | ? -4 se *w ig v  | 5-6w rvuiqt j  O ru * vcm n g
wtewrwtig  ?   per week  [  pot week  {  ftcr week
pot week  ■   j  !
n  I   n i  ii  I  n
jk  i  d n y 3  s e rv in g *  \ 4 +  s e rv in g *  fief d a y  p e r d a y
About how many servings of FRUIT do you eat (fresh, frozen or canned)1 f or
example, one apple counts as one serving.
|  L e s t th a n   I cn c s e rv in g   j jictw e«k
O n e  s e rv in g  I I > 1  v e m riu s  
per week  ]  fier week b  is  s e rv in g * O n e  s e rv in g 1  v e rv m q s (  3  s e rv in g s
prf w e e k 
11
p e n  d a y
1 ..!
pci day 1   fii'r d a y s
i  ^   ^
f  p e r d a y
In general, how important do you feel the following health measures are?
Not ol  oil  Somewhat  M oder,H dy  Very  fxtrcniely
To avoid fatty  foods 
To eat plenty of fruit
To take regular exercise
Tor women to have a cervical 
smear test  at least  every h years
for women to have a breast screen 
(mammogram) at least every 3  yeais
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How worried are you about getting bowel cancer?
Not worried at all  A bit worried  Quito worried  Very worried
Compared with other men and women of your age, do you think your chances <  
getting bowel cancer are:
Much lower  A little lower  About the same  A little higher  Much higher
How worried are you about getting heart disease?
Not worried at all  A bit worried  Quite worried  Very worried
L i  I  1 .......................I...I  I  i
Compared with other men and women of your age, do you think your chances t 
getting heart disease are:
Much lower  A little lower  About  lhe same  A little higher  Much higSier
Please indicate how much you agree with each of the following items by 
marking the appropriate box:
Strongly  Disagree  Not  Agree  Strong! 
disagree  sure  agree
Ql all the diseases there are, I am  j— ;  i  i  i  i  i  *  i
most afraid of cancer  I  J   I  I  I__j........L...J   i  t
I I   i  i  I  }  I  I
I worry a lot about getting  cam er  i  .   ;   I  I  > 1
it maKes me uncomfortable  to  |  i  t  i  i  -  ;   i  r   ;
think about cancer  I  I  I I   I I -   I I   I  i
Many people who got canter can  i  t  r - i   t  ;  i  i  ;
be completely cured  I I   I I   I  I  I  I  i    i
In general, do you mind having medical tests?
Mind a lot  Mind a bit  Don't  mind at allAppendices 355
YOUR ATTITUDES TO THE TEST
Since the Flexi*Seope test is fairly new, we should like to learn more about 
people's attitudes to it. Please indicate how much you agree or disagree with the 
following statements:
Strongly  Disagree 
disagree
The test would give me peace of mind  CD  I  !
Having the lest would lake up too much time  I  ^   I  I
Having the test would be embarrassing  I  J  I  I
Having the test would reduce my chance  r   s   i t
of getting bowel cancer  j  |  |
The test would make me worry about cancer  I  I  L  I
If j say no 10 the test now, f might later  r  .  ,  (
wish I had been tested  I...  J  I___j
the test would he unamifor table  I f   I   \
The test would reassure me  [,  )  i
r
Having the test would be templing fate  l
Having the test would make me feci that I  i  i
was doing something positive about my health  !   i  !
Having the test would make me anxious  !  I  1
I would rather let nature take its course  ;   !  L
I don't feel that I need a test  !  j  f
I have other more important problems  .  *  .
to deal with right now  1   j  {
I would lather not know about problems  j  <
until I have to  I  !   j
I would not want to have a test in that  r—j  r
part of my body  I  j  {_
Not
sure
Agree  Strongly 
agree
1   *   ^  
J  LJ
It's not worth having the test because 
“what will be will Ire"Appendices 356
Please mark the box which best applies to you:
Not at all 
or rarely
Do you worry about your health?
If you have an ache or pain do you worry 
that it may be caused by a serious illness?
Do you tirid it difficult to keep worries 
about your health out of your mind?
When you read or hear about an illness on 
TV or  radio, does it  make you think you 
may be suffering from that  illness?
Sometimes  Often  Most of the 
lime
r~j  j  j
For each of the following statements, please mark the box which best applies to you
Completely  Somewhat  Somewhat  Completely
false false true true
If I were sick and needed someone to drive 
me to the dexter, t would  have trouble 
finding someone
There is at  least one person I know whose 
advice I really trust
There isn't anyone I feel comfortable talking 
to about personal problems
I regularly meet or talk with my friends 
or  members of  my family
|  Because we arc studying bowel screening, we would like to know how often people 
I  get these bowel symptoms and bowel problems. In the LAST THREE MONTHS have you...
No Occas ion ally  I' req vent ly
been constipated?  |  |  |  !
had haemorrhoids (piles)?  [  J  [  |
had diarrhoea?  [  f  [  |
been troubled with wind?  I  j  \ |
had pains in the abdomen (gut)?  i  ~ )  |  |
had bowel incontinence?  j  ]   |  J
noticed blood in your stools?  \  \  \  \  [
Please note: If you  have symptoms persistently, you  should go to your <iP for  .uivicc
1
i ~i
1  ...!Appendices 357
THESE ARE SOME GENERAL QUESTIONS ABOUT YOUR MOOD AND OUTLOOK ON LIFE, BECAUSE 
WE KNOW THESE CAN AFFECT PEOPLE'S ATTITUDES TO THEIR HEALTH AND TO SCREENING
Please read each statement, and then mark the appropriate box for each 
question to indicate how you feel right now, at this moment:
Not at all  Somewhat  Moderately  Very much 
I feel calm  !_J  I  I  I  I  I.  j
I am tense 
I feel upset 
I am relaxed 
I feel content 
I am worried
n  U
in
□
Please indicate how much you agree with each of the following items by 
marking the appropriate box:
Strongly  Disagree  Neutral  Agree  Strongly
disagree
I like to get all the medical information that I can
There are many things I care about more 
I ban my health
I do not wish to know what is going on inside 
my body
There is too much information around about 
health nowadays
I am never really convinced by what the 
doctor tells me
Good health is only of minor  importance 
in a happy life
There arc few things more important 
than good health
I am interested in hearing about important 
medical advances
I enjoy watching medical programmes 
on television
n
agree
IJ
1  L
n
i  i
if you don't have your health you don't have anything
! usually ask the doctor or  nurse lots of questions 
about the procedures duiing a medical examination
r >Appendices 358
FINALLY, A FEW QUESTIONS ABOUT YOURSELF AND YOUR FAMILY TO HELP US ANALYSt 
THE RESULTS OF THE SURVEY
Have any members of your family (BLOOD relatives, not relatives by 
marriage) had bowel cancer?
Y e s
mother
lather
mother's mother 
m other's father 
father's mother 
father's father
Mo  Don't 
know
□  n
□
N O t>i>n’t  Not 
know  applicable
What is your marital status?
Married/living  Divorced 
as married
son(s)
daug liter (s) 
sisterfs) 
iMolherfe)  I  I
ai/rtt(s), undefs)  r  i
(blood relatives)  I    I
If YES, number of aunts, 
and uncles affected
Separated  Widowed
Do you have any educational qualifications?
(e.g. School Certificate, GCE O' Levels, etc.)
Do you have a paid job or do any paid work?
No
Single
Yes
No, retired No, not working 
at present
Yes, part-time  Yes, full-time
Do you own or rent your home?  Own it/buying it
|  'j
Does your household have a car?  No
Rent it 
Yes,l
Which of these best describes your ethnic background?
White  Black  Asian  Other
Other
More Oran  1
Do not wish to 
answer
Did you find this questionnaire easy to complete? 
Did you mind completing this questionnaire?
Yes
□
No
Thank you very much fo r your helpAppendices 359
Appendix V Post-FS questionnaire used in Study 1
F i e X i f S C O p t ^ n a /
Your views on the 
Flexi-Scope Test
You recently had the new FlexFScope test. 
Here are a few questions about what you 
thought of it.
Your  answers  will  be  treated  in  strict 
confidence and will help  us improve the 
test and the information we give to others.
Please return the questionnaire in the *
enclosed envelope. No stamp needed.
If  you  have  any  questions  please 
contact:
Dr 
Tel: 
Imperial Cancer
Research FundAppendices 360
THE FLEXI-SCOPE TEST
(Please tick your answers)
How satisfied were you with the INFORMATION you were given before your test?
Very satisfied  Satisfied  Dissatisfied  Very dissatisfied
If you think the information could be improved, please tell us how.
How satisfied were you with the FACILITIES at the FfexhScope unit?
Very satisfied  Satisfied  Dissatisfied  Very dissatisfied
□  □  n  n
If you think the facilities could be improved, please teli us how;
How satisfied were you with the ATTITUDE of the staff at the unit?
Very satisfied  Satisfied  Dissatisfied  Very dissatisfied
□   □   □   □
If you think the attitude of the staff could be improved, pfease tell us how;
How satisfied were you with the way the results were EXPLAINED to you?
Very satisfied  Satisfied  Dissatisfied  Very dissatisfied
□   O
If we could improve the way we explain the results to you, please tell us how:
4
Did you have the opportunity to ask all the Yes No
questions you wanted to? □ 5
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DURING  THE FLEX!-SCOPE TEST
During your test, did you feel "in control" of what was happening to you?
Very much in control  Partly in control  Not in control
□   D u
How much embarrassment did you feel during your Flexi-Scope test?
None  Mild  Quite a lot of  Severe
embarrassment  embarrassment  embarrassment
How much pain did you feel during your Flexi-Scope test?
None  Mild pain  Quite a lot of pain  Severe pain r — *1  f-..|  j  f
\—..J   1 ....1   .— ?
How did you feel when you received the results of your Flexi-Scope test?
Did you feel anxious.,.?  at a||  somewhat  Moderately  Very
when you received the information r—i n  p i I—*»
about the Flexi-Scope test?
in the days before your Flexi-Scope test? : ...1   1  !
about administering the enema?
about the possible effects of the enema? L J   L.J
whilst waiting in the clinic for your test?
during the test? n n  □ C  ,
Compared to other men and women of your age, do you think your chances of getting bowel cancer are:
Much  A little About the A little Much
lower  lower same higher higher
□ □ □
Compared to other men and women of your age, do you think your chances of getting heart disease are:
Much  A little About the A little Much
lower  lower same higher higher
□  □ n □ ,   HH.il..
How worried are you about getting....
worried A bit  Quite Very
at all worried  worrtec worried
bowel cancer? n □  n
bowel polyps? □ a  n □
heart disease?
(for women) breast cancer? 1 1 !.]   i . . .T f.1
(for men) prostate cancer?
ill health in general?
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Please read each statem ent and then mark the appropriate box for each 
question to indicate how you feel right now, at this moment:
Not at all Somewhat Moderately Very much
1  feel calm 
1  am tense
I feel upset 
1  am relaxed i   L
1  feel content 
1  am worried 1 0
AFTER THE TEST
Did you have any problems after the test? 
If YES, what problems did you have?
Yes No
|
Immediately  Within 
a week
Within 
a month
After 
a month
When did the problems start? □
How long did they last in total?
Yes No
Do you still have problems?
If YES, what problems do you have?
i.j
1  ,........... „.................... ........................_ ...........j—   ..............'.i..'.j....  ....
Did you need to contact your GP or Hospital 
as a result of these problems?
Yes
□
No
n
GP Hospital
If so, which? n
Yes No
Did you have any treatment for these problems? 
If YES, what treatment did you have? C  J □
.........................  ...
« 1
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In the LAST 3 MONTHS have you.,.  N q   Occasionally Frequently
been constipated? L J I ]
f '"'""I
had haemorrhoids (piles)? □
had diarrhoea?
I been troubled with wind? i. . .i [   1
had pain in the abdomen (gut)?
had bowel incontinence? r. . i . -   Da
noticed blood in your stools?
i . . .1
LJ □
Please note: If you have symptoms persistently, you should go to your GP for advice  «
OTHER MEDICAL PROBLEMS
Yes No
Have you had any other medical problems since the test? n □ If YES, what medical problems have you had?
r . . . . . . . . .  .. . . .1
In
THESE QUESTIONS  ARE SIM ILAR TO SOME YOU  MAY  HAVE  BEEN  ASKED  BEFORE,
WE NEED  YOUR ANSWERS  NOW  THAT YOU HAVE  HAD  YOUR TEST.
Please indicate how much you agree or disagree with the following statements
Strongly  Disagree  Not  Agree  Strongly 
disagree  sure  agree
The test gave me peace of mind
Having the test took up too much time Li
r-.j □ □ □
Having the test reduced my chance of 
getting bowel cancer n o Cl □
The test made me worry about cancer o [ 3 u □
1  made the right decision to take the test in c :j n T.1 D
The test reassured me □ □
Having the test was tempting fate ! n LJ 0. ; D □
1  would rather have let nature take its course □ ) n :
Having the test made me feel that 1  was 
doing something positive about my health J :0 ' Q ‘:   Q □
Having the test made me anxious h
p i
1 ....i
1  regret having had a test in that part of my body □
c
™
^
l
_
J
o . n
A screening test for bowel cancer is important □ □ □  *
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In the LAST THREE MONTHS have you....
Better/more 
than usual
been able to concentrate on whatever you're doing? 
felt that you were playing a useful part in things? 
felt capable of making decisions about things? 
been able to enjoy your day to day activities? 
been able to face up to your problems? 
been feeling reasonably happy all things considered?
Same 
as usual
□
Less  Much less 
than usual  than usual
o
lost much sleep over worry?
felt constantly under strain?
felt you couldn't overcome your difficulties?
been feeling unhappy and depressed?
been losing confidence in yourself?
been thinking of yourself as a worthless person?
Not 
at all
□
n n
o
No more 
than usual
□
n  n
o  - o
Rather more  Much more 
than usual  than usual
,J   LJ
O   □
D
Do you think that your experience of having the Flexi-Scope
Not at all  A little bit
test Has....
Quite a bit  A great deal
given you a sense of reassurance that 
you do not have bowel cancer? ;   ; □ □
made you feel more able to do the 
things that you normally do? O H LJ I I - " n
made you feel more hopeful 
about the future? □ i;  □ □
made you feel less anxious 
about bowel cancer? n E i  r:l; ■ n
made you get on better with those 
around you?
given you a greater sense of well being? □ 'i.....  Ji  □ o » 6
On balance, were you glad you had the test?
Yes □
No Not sure
If a friend asked you If they should have  the Flexi-Scope test, would you 
encourage or discourage them?
Strongly
encourage
Encourage
□
Neither
□
Discourage Strongly
discourage
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FINALLY, SOME QUESTIONS ABOUT YOUR CURRENT HEALTH BEHAVIOURS AND ATTITUDES
About How many times have you been to see your GP in the last 3 months?
Haven't been  Once  Twice  Three or more times n  n  n  n
Would you say that for someone of your age your own health in general is:
Excellent  Good  Fair  Poor
j #
Do you....
smoke cigarettes at all nowadays? 
take regular exercise each week?
Yes No
About how many servings of VEGETABLES do you eat (including salad, but 
excluding potatoes)? For example, a handful of carrots counts as one serving.
Less ttian 
one serving 
par week
[ J
Orve serving 
per week
2-4 servings 
per week
5-6 serv nos 
per week
One serving 
per day
2 servings 
per day
3 servings 
per day
4+servings 
per day
□ □ □ □ □ □ ..j
About how many servings of FRUIT do you eat (fresh,  frozen or canned)?
For example, one apple counts as one serving.
less than 
ore serving 
per week
□
One serving 
per week
2-4 servings 
per week
!>-6se<v«qs 
per week
One serving 
per day
2 servings 
per day
3 servings 
per day
4* servings 
per day
LJ □ □ o D □ □   | 2 0
In general, how important do you feel the following health measures are?
Not at all  Somewhat  Moderately  Very  Extremely
To avoid fatty foods 
To eat plenty of fruit
To take regular exercise
For women to have a cervical 
smear test at least every 5 years
For women to have a breast screen 
(mammogram) at least every 3  years
LJ
17.1
i... 1
n
□
a:  0 z %
IF YOU HAVE ANY FURTHER COMMENTS REGARDING THE TEST OR THIS 
QUESTIONNAIRE PLEASE USE THE SPACE BELOW (and continue on the back if necessary)Appendices 366
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ABSTRACT
Background:  Disease stage is a strong predictor of cancer survival and therefore 
assumed to influence psychosocial outcomes.  However, existing findings are 
inconsistent, perhaps reflecting limited sample sizes, especially among patients with 
advanced disease.  There has also been an emphasis on breast cancer, resulting in a 
focus on outcomes among women.  The present study investigated associations 
between disease stage and psychosocial outcomes in 110 patients diagnosed with 
colorectal cancer.  Methods:  Patients diagnosed within the past year in a single 
hospital were invited to participate in a questionnaire study and give permission for 
staging information to be obtained from their medical records.  The questionnaire 
included measures of anxiety, depression, quality of life, social support, social 
difficulties, and quality of medical interactions.  Results:  Patients with more 
advanced disease were more anxious (/?<0.01) and depressed (p<0.001), perceived 
their social support as lower (p<0.01), and had a worse quality of life (/K0.01). 
Women with advanced disease had more severe colorectal symptoms (p<0.01), and 
worse physical (p<0.01) and emotional (p<0.05) quality-of-life than men.
Conclusions:  Patients with advanced colorectal cancer have unmet psychosocial 
needs. Women may be more strongly affected by advanced disease than men.Appendices 368
DISEASE STAGE AND PSYCHOSOCIAL OUTCOMES IN COLORECTAL
CANCER
Receiving a cancer diagnosis represents an enormous psychological challenge. 
Estimates vary as to the number of people with cancer who develop symptoms of 
anxiety (2%-25%) (Stark and House, 2000) or depression (20%-50%) (Bottomley, 
1998; McDaniel et al.,  1995), but it is likely that rates are higher than the 7% seen in 
the same age group in the general population (Evans et al., 2003).
Disease stage is widely assumed to be a determinant of psychosocial 
outcomes.  Its prognostic significance influences the magnitude of psychological 
threat posed by the disease.  Advanced disease stage is likely to be associated with 
increases in uncomfortable physical symptoms that could influence psychosocial 
wellbeing.  Patients with advanced disease are also are more likely to receive 
chemotherapy, which can be physically as well as psychologically difficult to deal 
with.  Most of the body of work on the psychosocial consequences of cancer has 
focused on psychosocial distress among women with breast cancer and the research 
findings have been mixed.  Some studies have shown advanced disease to be 
associated with poorer psychological wellbeing (Gallagher et al., 2002; Osborne et al., 
2003; Rosenfeld et al., 2004; Shimozuma et al., 1999), but others have found little or 
no relationship (Bleiker et al., 2000; Burgess et al., 2005; Kissane et al., 2004).
Very few studies have examined the psychosocial consequences of advanced 
colorectal cancer.  In one early study, (Norum,  1997) reported that colorectal cancer 
patients with Dukes’ C diagnosis (positive lymph nodes) were no more distressed than 
patients with a Dukes’ B (cancer contained within the bowel wall), but the sample size 
was small (N = 64) and groups with stage Cl  (positive lymph nodes, but cancerAppendices 369
contained within the bowel wall) and stage C2 disease (positive lymph nodes and 
cancer spread outside bowel wall) were combined, despite very different prognoses. 
Another study, designed to validate the Functional Assessment of Cancer Therapy -  
Colorectal version (FACT-C) (Ward et al.,  1999) explored disease stage in relation to 
quality of life in two separate samples.  In the Spanish sample (N = 93), patients with 
regional and distant metastases had worse quality of life compared to those with 
localized disease, but in the English sample (N = 63) the association was not 
significant, although the trends were in the same direction.
Another limitation to the literature on disease stage and psychosocial 
wellbeing is the focus on emotional distress (e.g. anxiety and depression) and quality 
of life.  The psychosocial effects of a diagnosis of cancer can extend beyond the 
psychological domain.  Cancer can affect social relationships (Northouse et al., 2000) 
which may in turn influence the support the patient receives during their illness 
(Reynolds and Perrin, 2004).  New relationships with medical staff have to be formed 
and the quality of these relationships is another significant factor in coping with the 
disease (Ong et al., 2000).  Cancer and its treatments can also impose a variety of 
physical and functional disabilities that compromise the patient’s ability to work or to 
maintain independence (Wright et al., 2002).  A recent qualitative study of colorectal 
cancer patients’ experiences found that a wide range of factors were important for 
determining wellbeing (Dunn et al., 2006).  These included satisfaction with the 
health system, social support from friends and family and impact on lifestyle; 
demonstrating that a broader conception of psychosocial wellbeing needs to be 
considered.
The present study was designed to examine the association between disease 
stage and a range of psychosocial outcomes in a mixed-sex sample of colorectalAppendices 370
cancer patients.  We hypothesized that patients with advanced disease would have 
poorer psychosocial outcomes across all domains.
METHOD
Design and Procedure
This was a cross-sectional survey sampling all patients who received a diagnosis of 
colorectal cancer at a single hospital in Southern England over a one-year period (July 2002- 
July 2003,N = 231).  Patients were sent an introductory letter with an information sheet and 
questionnaire.  Hospital staff sent out the letters which were returned anonymously to the 
research staff.  Questionnaires were numbered and linked to details in the hospital database to 
allow the hospital staff to send a reminder to non-responders after a month.  Return of the 
questionnaire was taken as consent to the questionnaire phase of the research but additional 
formal consent was sought for access to the medical records.
Ethical approval was obtained from the Isle of Wight, Portsmouth and South East 
Hampshire Local Research Ethics Committee.
Participants
290 patients with colorectal cancer had attended the participating hospital over the trial 
period, of which 231  were alive at the time of the survey.  Patients’ GPs were contacted one 
month prior to the survey to allow them to exclude patients who were too ill to participate; 
this resulted in 19 exclusions.  212 patients were therefore sent a postal questionnaire, of 
which 11  declined participation, citing reasons ranging from feeling too unwell, to feeling too 
well and not wanting to be reminded about cancer and a further 73 did not respond.  In total 
128/212 (60.4%) people completed and returned the questionnaire.Appendices 371
Measures
Diagnostic staging
Disease staging was based on the Dukes’ classification system with data taken 
from patients’ medical records: Dukes’ stage A: the tumor penetrates the mucosa of 
the bowel wall but no further, Stage B: the tumor penetrates into and/or through the 
muscular layer of the bowel wall, Stage C l: the tumor penetrates into, but not 
through, the muscular layer of the bowel wall and there is evidence of colon cancer in 
the lymph nodes, Stage C2: the tumor penetrates the muscular layer of the bowel wall 
and there is evidence of cancer in the lymph nodes, and Stage D: the cancer has 
spread throughout the body and there are distant metastases (e.g. in liver or lung).
Psychological Distress
Depression was measured with the Center for Epidemiological Studies 
Depression Scale (CES-D) (Radloff,  1977), which asks about feelings over the past 
week.  We used the shorter 10-item version (Kohout et al.,  1993) but retained the 
original response options (four options from ‘rarely, none of the time’ to ‘most or all 
of the time’) rather than the ‘yes/no’ format.  Items are summed to give scores from 0 
to 30, with higher scores indicating more depression.  The scale had good internal 
reliability in this sample (a = 0.83).
Anxiety was assessed using the anxiety scale from the Hospital Anxiety and 
Depression Scale (HADS-A, 7 items) (Zigmond and Snaith,  1983).  Participants rate 
how they have usually felt over the past week.  Each item has four response options 
that vary slightly according to the statement.  The scale range is from 0 to 21 with 
higher scores indicating more anxiety.  Reliability in this sample was good (a  =
0.87).
Quality o f  LifeAppendices 372
Quality of life was assessed using the Functional Assessment of Cancer 
Therapy Colorectal version (FACT-C) (Ward et al.,  1999).  This has five subscales: 
physical (7 items), functional (7 items), social/family (7 items), emotional well-being 
(6 items) and a colorectal-specific subscale (7 items) looking at colorectal symptoms 
such as control of bowels, appetite and digestion.  The items ask how true each 
statement has been during the past seven days.  The scale range is 0 to 24 for the 6- 
item scale and 0 to 28 for the 7-item scales, with higher scores indicating better 
quality of life.  A total score is computed from the sum of the physical, functional, 
social/family and emotional subscales, with a range from 0 to 108.
Social Support
Social support was measured with the Multidimensional Scale of Perceived 
Social Support (MSPSS) (Zimet et al.,  1988).  The MSPSS is a measure of the 
subjective assessment of social support adequacy.  It is a 12-item scale with three 
subscales (4 items each) examining support from family, friends, and significant 
other.  Respondents are asked how much they agree or disagree with each statement. 
The scale range is 1  to 60 with higher scores indicating better support.
Social Difficulties
The Social Difficulties Inventory (Wright et al., 2005) is a 21-item 
questionnaire covering problems in managing personal care, domestic chores and 
responsibilities, finances and benefits, employment, relationships, sexuality and body 
image, mobility and leisure activities.  Respondents indicate whether they have 
experienced any difficulties over the past month (using a range from ‘no difficulty’ to 
‘very much’).  The scale range is 0 to 63 with higher scores indicating more social 
difficulties.
Medical InteractionsAppendices 373
Communication with medical staff was assessed using the 4-item subscale 
from the Cancer Evaluation and Rehabilitation System -  Short Form (CARES-SF) 
(Schag and Heinrich, 1988).  The items refer to levels of information provided, 
understanding the information provided, levels of control over treatment, and 
difficulty asking questions.  Respondents are asked how much each statement applies 
to them during the past month (Schag and Heinrich,  1988).  Higher scores indicate 
poorer communication with medical staff.  The subscale has reasonable internal 
reliability (a = 0.67), good test-retest reliability (86% agreement) and good concurrent 
validity with related measures (Schag et al., 1991).
ANALYSES
Data were analyzed using analysis of covariance with disease stage as the 
independent variables and age and chemotherapy treatment as control variables. 
Outcomes included psychological distress, quality of life, social support, social 
difficulties and medical interactions.  Missing data on individual questionnaire items 
were replaced using the individual’s mean for each subscale if at least half the items 
had been completed (Fairclough and Celia,  1996).
RESULTS
128/212 (60.4%) questionnaires were returned.  Respondents were 52% male (N =
65) and 48% female (N= 60), with three having missing gender information, and all were 
white.  The mean age was 70.2 (SD = 10.7), with a range from 36 to 89.  The majority were 
married (N= 83), 29 were widowed, and 13 were either single or divorced.  Three participants 
did not provide information on marital status.  In terms of socioeconomic status (SES), nearly 
half the participants (46%, N= 59) had no formal educational qualifications, although 75% (NAppendices 374
= 96) were home owners and 75% (N= 95) owned one or more cars.  Using the limited data 
available on the full sample, there were no differences between responders and non­
responders in terms of age, gender or residential area deprivation (Townsend index;
Townsend et ah, 1988).
Disease stage was indexed using the Dukes’ classification system with data taken 
from medical records.  Ten participants did not give consent for their medical records to be 
examined.  Staging information was not obtained for two patients who had declined treatment 
and one who did not have surgery because of co-morbid disease.  Another four patients were 
excluded because they had anal squamous cancers and a further one because the diagnosis 
was appendiceal cancer.  Disease stage information was therefore available for 86%
(110/128) of participants (see Table 1).  The majority of participants (64%) had a Dukes’ 
stage B or Cl diagnosis, but 11  (10%) participants had a stage D diagnosis or were receiving 
palliative care and 12 (10.9%) participants had a stage C2 diagnosis; these two latter 
categories were combined to form the ‘advanced disease’ category in the subsequent analyses.
Age, gender, marital status, and SES (indexed by level of education, car and home- 
ownership) were not related to disease stage.  The average time between diagnosis and 
completing the questionnaire was 257 days (SD =112 days).  Time since diagnosis was not 
related to disease stage.
At the time of completing the questionnaire, 106/128 (83%) patients had undergone 
surgery, 34/128 (27%) had received chemotherapy and 22/128 (17%) had received 
radiotherapy.  There was no association between disease stage and undergoing surgery or 
radiotherapy, but patients with more advanced disease were more likely to receive 
chemotherapy Q f (1) = 12.64, p<0.001).
Patients with more advanced disease had poorer quality of life for all except one of 
the FACT-C subscales (see Table 2).  They had worse physical well-being (F (1,108) = 2.04 
/?<0.05), functional well-being (F(l,109) = 3.33 p<0.01), emotional well-being (F(l,109) = 
4.56p<0.01), and colorectal symptoms (F(1.109) = 2.18p<0.05), and a much lower overall 
score FACT-C score (Z7 (1,108) = 5.15 p<0.01).  The only scale that did not show differencesAppendices 375
was the social/family subscale.  More advanced disease stage was related to the perception of 
receiving less social support (overall MSPSS score: F (1,107) = 3.63 p<0.01) particularly 
from ‘significant others’ (F (1,106) = 4.16p<0.01) and ‘family’ (F (1,106) = 3.47,/?<0.05), 
although there was no difference in perceived support from friends.  Patients with more 
advanced disease were also more anxious (F(l,108) = 3.70p<0.01) and depressed (F(l,108) 
= 6.76 pO.OOl).  Quality of medical interactions and reporting of social difficulties did not 
differ significantly by disease stage.
Pairwise comparisons using the adjusted means showed that for the majority of the 
psychosocial outcomes, patients with stage A or B diagnoses significantly differed from those 
with stage C2/D.  There was one exception to this pattern: for perceived family support the 
difference was between patients with stage B and stage Cl  disease (mean difference = 2.22, 
/?<0.05).  The partial eta squared statistic (Table 1) indicates the proportion of variance in the 
dependent variable explained by the factor and is a measure of effect size.  Effect sizes ranged 
from small (from 0.01  to 0.08) to medium (from 0.09 to 0.24) on the basis of squaring 
Cohen’s r criteria for small, medium and large effect sizes (Cohen,  1988).
Men and women did not differ in age or treatments received and there were no simple 
associations between gender and psychosocial outcomes.  However there were some 
significant interactions between disease stage and gender for psychosocial outcomes.
Because men were more likely to be high SES (71%) than women (29%) ( j 2  (2) = 7.05, 
p<0.05) and more likely to be married (78% vs 52%) (x2  (2) = 9.43,/?<0.01), these factors 
were controlled for in the analyses of gender differences.  Among patients with C2/D 
diagnoses, women had worse quality of life for three of the subscales than men in terms of 
colorectal symptoms (F (3,101) = 4.00,/?<0.01, partial eta2 = 0.119)  (see Figure 1), physical 
(F (3,99) = 4.32,/?<0.01, partial eta2 = 0.130) (see Figure 2) and emotional (F(3,100) = 3.70, 
p<0.05, partial eta2 = 0.112)  (see Figure 3).  Effect sizes were in the medium range.
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The results of this study showed that patients with colorectal cancer in advanced 
stages (Dukes’ stage C2, D and those receiving palliative care) had worse outcomes than 
those with localized disease for almost every psychosocial outcome that we assessed.
Existing studies in this area have focused primarily on breast cancer patients and the 
conclusions have been inconsistent, perhaps because patients with advanced disease are often 
examined separately and not compared to patients with other disease stage diagnoses (Pinder 
et al., 1993).  There is also a general difficulty in recruiting patients with advanced disease 
into studies (Bleiker et ah, 2000).  In our study, patients with a C2 or D diagnosis -  those with 
metastatic disease or in palliative care - had incrementally poorer outcomes compared with 
the differences between the other stages.  These results highlight the importance of including 
patients with advanced disease in comparative research studies.
Because colorectal cancer is a disease affecting men and women we were able to 
examine gender differences in the relationship between disease stage and psychosocial 
outcomes.  Women’s physical wellbeing appeared to be more adversely affected by advanced 
disease stage than men, although because there are differences in symptoms and treatments by 
cancer site which could affect men and women differently, these results may not generalize 
beyond colorectal cancer patients.
The study had limitations.  The sample size, though larger than many, was still 
relatively small, and like other researchers, we had difficulties recruiting participants with 
advanced disease.  The proportion of patients with advanced disease (16%) is slightly lower 
than the overall colorectal cancer population, where as many as 2 0% of patients present with 
Dukes’ stage D (Hardcastle et al.,  1996).  Disease stage information was not available for 
non-responders because of patient confidentiality, but it is likely that more of them had 
advanced disease.  The overall response rate was only moderate (60%), although there were 
no differences between responders and non-responders in terms of age, gender or residential 
area deprivation, but it is hard to see that this is likely to bias the findings.  The sample lacked 
ethnic heterogeneity, reflecting the characteristics of the area around the hospital, which mayAppendices 377
limit the generalisability of the findings.  We acknowledge the need to replicate these results 
and recognize the need for longitudinal research designs to examine adjustment over time.
Despite the limitations, this study is one of the first to provide strong evidence that 
the psychosocial burden of colorectal cancer is significantly greater in those with more 
advanced disease and that the problem may be more severe for women. The implication of 
these results is that there may be significant unmet psychosocial needs in patients with 
advanced disease and future research should focus on the value of providing additional social 
and emotional support.Appendices 378
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Table 1   Disease stage and treatments received at the time of the survey
N (N =  128) %
Disease
stage
A 17 13.3
B 41 32.0
Cl 29 22.7
C2 12 9.4
D and palliative 11 8.6
Exclusions and refusals 18 14.1
Treatment Surgery 106 82.8
Radiotherapy 22 17.2
Chemotherapy 34 26.6Appendices 383
Table 2 The relationships between psychosocial outcomes and disease stage, controlling for age and chemotherapy treatment
Dependent Variables Disease Stage - Mean (95% Cl)
Linear Univariate 
ANOVA P-value
Partial eta 
squared
A
(n = 17)
B
(n = 41)
Cl
(n = 29)
C2/D/Palliative 
(n = 23)
Quality of Life
Physical 24.5 (22.2-26.8) 24.4 (23.0-26.0) 23.2 (21.4-25.1) 21.4(19.3-23.4) P = 0.039 0.057
Functional 22.1 (19.1-25.1) 21.3(19.4-23.3) 19.0(16.6-21.4) 16.6(14.0-19.2) P = 0.005 0.088
Emotional 20.5 (18.2-22.8) 20.7(19.2-22.2) 18.5(16.7-20.3) 16.2(14.2-18.2) P = 0.003 0.117
Social/Family 21.5(18.9-24.2) 23.4 (21.6-25.1) 19.6(17.5-21.7) 20.4(18.1-22.7) P = 0.212 0.072
Colorectal 22.2(19.5-24.8) 21.1  (19.4-22.9) 20.1 (18.0-22.2) 17.8(15.5-20.2) P = 0.018 0.059
Overall 88.6 (81.2-96.0) 89.8 (84.9-94.6) 80.2 (74.2-86.2) 74.5 (68.0-81.0) P = 0.002 0.131
Social Support
Family 18.8(17.2-20.5) 18.7(17.7-19.7) 16.4(15.2-17.6) 16.9(15.6-18.2) P = 0.019 0.094
Friends 17.3 (15.7-18.9) 17.6(16.6-18.6) 16.2(15.0-17.5) 16.0(14.6-17.2) P = 0.100 0.048
Significant Other 19.4(17.9-20.9) 19.1  (18.1-20.0) 17.5(16.4-18.7) 16.6(15.3-17.8) P = 0.002 0 .1 1 1
Overall 55.5 (51.5-59.6) 55.3 (52.7-57.8) 50.1  (47.0-53.3) 49.3 (46.0-52.7) P = 0.007 0.097
Psychological Distress
Anxiety 2.6 (0.6-4.5) 3.1  (1.8-4.3) 4.3 (2.8-5.8) 6.2 (4.6-7.9) P = 0.004 0.098
Depression 2.5 (0.0-5.0) 4.5 (3.0-6.1) 6.6 (4.7-8.5) 9.6 (7.4-11.7) P = 0.000 0.166
Medical Interactions 0.3 (0.0-0.7) 0.2 (0.0-0.4) 0.3 (0.1-0.6) 0.6 (0.3-0.9) P = 0.219 0.041
Social Difficulties 5.8 (2.3-9.2) 5.7 (3.5-8.0) 8.6 (5.9-11.4) 9.0 (6.0-12.1) P = 0.091 0.041C
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Figure 1
The relationship between disease stage, gender and colorectal symptoms, controlling 
for age, SES, marital status and chemotherapy treatment
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Figure 2
The relationship between disease stage, gender and physical quality-of- 
life, controlling for age, SES, marital status and chemotherapy treatment
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Appendix VII Questionnaire used in Study 2
Patient Identification Number: CONFIDENTIAL
Centre Number: C
Study Number:  1
Experiences of People 
With Colorectal Cancer
The aim  of this  research  is to find  out  more about how
you have coped after your diagnosis of cancer.
.  You can find more information about this study on the 
Patient Information Sheet.
.  Some  questions  appear to  have  been  repeated,  but 
they do differ in small ways, so we would appreciate it 
if you could answer them all.
•  Your answers will  be treated  in  strict confidence and 
will  help  us  to  identify ways  in  which  people  require 
help with this illness.
If you  are  willing  to  be  involved,  please fill  in this
questionnaire and return it in the freepost envelope.
We are very grateful for your help with this research.
If you have any questions please contact:
Alice Simon
Cancer Research UK Health Behaviour Unit 
Department of Epidemiology and Public Health 
University College London 
Tel: Appendices  3 3 3
b %
Male  Female
Are you male or female?
□   □
How old are you? Years
THIS SECTION ASKS ABOUT YOUR GENERAL HEALTH AND WELL-BEING.
Please circle t number per line to indicate how true each statement has been for you during the oast 7 davs
Not at all A little bit Somewhat Quite a bit Very m
1  have a lack of energy 0 1 2 3 4
1  have nausea 0 1 2 3 4
Because of my physical condition, 1  have  G  1  2  3  4 
trouble meeting the needs of my family
I have pain 0 1 2 3 4
I am bothered by side effects of treatment 0 1 2 3 4
I feel ill 0 1 2 3 4
I am foroed to spend time in bed 0 1 2 3 4
I feel close to my friends 0 1 2 3 4
I get emotional support from my family 0 1 2 3 4
I get support from my friends 0 1 2 3 4
My family has accepted my illness 0 1 2 3 4
I am satisfied with family communication 0 1 2 3 4
about my illness
I feel sad 0 1 2 3 4
I am satisfied with how I am coping with my 0 1 2 3 4
illness
I am losing hope in the fight against my illness 0 1 2 3 4
I feel nervous 0 1 2 3 4
I worry that my condition will get worse 0 1 2 3 4
I am able to work 0 1 2 3 4
My work (include work at home) is fulfilling 0 1 2 3 4
I am able to enjoy life 0 1 2 3 4Appendices  3 39
  ___________   64
Nst at ait A lim a bit Somewhat Quite a bit Very much
1  am sleeping well 0 1 2 3 4
1  am enjoying the things 1  usually do for fun 0 1 2 3 4
1  worry about dying 0 1 2 3 4
1  have accepted my illness 0 1 2 3 4
1  feel close to my partner (or the person who 
is my main support)
0 1 2 3 4
1  am content with the quality of my life right 
now
0 1 2 3 4
Regardless of your current level of sexual activity, please answer the following question.  If you 
prefer not to answer it, please check this box  Q  and go to the next question
1  am satisfied with my sex life 0 1 2 3 4
Please read each question carefully and tick the response that best describes your answer.  Please 
tick the *no difficulty* box if a question does not apply to you.
Ou ring the past month:  No difficulty  A tittle  Guiteabit  Very much
Have you had any difficulty in maintaining your 
independence?
Have you had any difficulty in carrying out your 
domestic chores? (e,g, cleaning, gardening, 
cooking, shopping)
Have you had any difficulty with managing your own 
personal care?
Have you had any difficulty with looking after those 
who depend on you? e.g. children, dependent 
adults, pets)
Have any of those close to you (e,g„ partner, children, 
parents) had any difficulty with the support available 
to them?
□ □ □ □
□ O □ □
□ □ □ □
□ □ □ □
□ □ □ □
THESE STATEMENTS ARE ABOUT YOUR EXPERIENCES WITH YOUR MEDICAL TEAM
Please read each statement and circle one number that best describes how much each statement applies to 
you during the past month, including today,
1  find that the medical team withholds information 
from me about the cancer 
I find that doctors dont explain what they are doing 
to me
I have difficulty asking doctors questions
I have difficulty expressing my feelings to the 
doctors and nurses
I have difficulty understanding what the doctors tell 
me about the cancer or its treatments 
I would like to have more control over what the 
doctors do to me
M O ) at all A little A fair amount M uch  Very rr
0 1 2 3  4
0 1 2 3  4
0 1 2 3  4
0 1 2 3  4
0 1 2 3  4
0 1 2 3  4Appendices  3 9Q
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THIS ASKS ABOUT OUT HOW YOUR ILtNESS HAS AFFECTED YOU FINANCIALLY AND AT WORK
At what age did you leave full-time education?  L-JLi
What is the highest level of educational or professional qualification you have obtained?
Q   GC5E/ School certificate/ O-level/CSE  Q   Masters/PhD/PGCE or equivalent
□   Vocational qualifications (e.g. NVQ1+2)  O   Other  (Specify.......................,„.)
Q   A-level/Higher school certificate or equivalent (e.g.  NVQ3)  □   No formal qualifications
□   Bachelor Degree or equivalent (e.g. NVQ4)  O   Still studying
A little  Quite a bit  Very much
Please read each question carefully and tick the response that best describes you answer.  Please
tick the 'no difficulty' box if a question does not apply to you.    _______________
During the past month:  No difficulty
Have you had any difficulties with benefits? (e.g. 
statutory sick pay, attendance allowance, disability 
living allowance)
Have you had any financial difficulties?
Have you had any difficulty with financial services?
(e.g. loans, mortgages, pensions, insurance)
Have you had any difficulty with your work? (or 
education if you are a student)
Have you had any difficulty with planning for your own 
or your family's future? (e.g. care of dependents, 
legal issues, business affairs) __________________ _
□ □ □ n
D □ □ □ n □ □
□ □ □ □
□ □ □ □
Are you currently:
□   Employed full-time
□   Employed part-time
□   Unemployed
□   Full-time homemaker
If you are working, what is the full title of your main |ob? 
Have you worked during the past month?  Yea  □
□   Retired
□   Student
□   Disabled or too ill to work
No  □
Please read each statement arid circle one number that best describes how much each statement applied to you during 
the past month, includtng today_______________
I have difficulty talking to the people who work 
with me about the cancer.
I have difficulty telling my employer that I 
cannot do something because of my illness.
I have difficulty asking for time off from work 
for medical treatments.
I have difficulty talking to my boss about the 
cancer
1  am worried about being fired.
Have not 
worked In 
the past 
month
Not at
alt
A little A fair 
amount
Much Very
m uch
0 1 2 3 4
0 1 2 3 4
0 1 2 3 4
0 1 2 3 4
0 1 2 3 4Appendices  391 
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Think about your family's income, which category would describe the total annual household 
income? (including your own and partner's salary and any benefits)
Less than  £10,000-  £20,000-  £30,000-  £40,000-  £50,000-  £60,000-  More than
£10,000 a  20,000 a  30,000 a  40,000 a  £50,000 a  60,000 a  70,000 a  £70,000 a
year  year  year  year  year  year  year  year
□  □  .  □  o  □  □  o  o
THE FOLLOWING SECTTON ASKS ABOUT YOUR MOOD AND GENERAL OUTLOOK ON LIFE
Jick the box which best describes how often you felt or behaved this way in the past week,_______
Rarely, noneof  Some or little  Occasionally or a  Most or all 
the time (less  of the time  moderate amount  of the time
than one day) (t-2 days) of time (3-4days) {S-7 days)
i was bothered by things that dont usually □ □ or u
bother me.
I did not feel like eating: my appetite was □ □ n □
poor.
I felt that I couM not shake off the blues | | □ □ □
even with help from my family or friends.
I had trouble keeping my mind on what I 0 □ 1   1 □
was doing.
I felt depressed. □ □ □ □
I felt that everything I did was an effort. □ □ □ □
I felt hopeful about the future □ □ □ □
1  thought my life had been a failure. □ □ □ □
1  felt tearful. □ □ □ □
My sleep was restless. □ □ □ □
1  was happy. □ □ i  1 □
1  talked less than usual. □ □ □ □
1  felt lonely. □ □ □ □
People were unfriendly. □ □ □ □
1  enjoyed life. □ □ □ □
1  had crying spells. □ □ □ □
1  felt sad. □ □ □ □
1  felt that people disliked me. □ □ □ □
i could not get 'going'. □ □ □ □Appendices  392
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pinacB mark one box for each statement to show how you have usually foft over the past week:
Worrying thoughts go through 
my mind;
A great deal of 
the time
□
A lot of the 
time
□
From time to time 
but not too often
O
Only
occasionally
□
1  get a sort of frightened 
feeling as if something 
awful is about to happen:
Very definitely 
and quite badly
0
Yes, but not 
too badly
□
A little, but it 
doesn't worry me
0
Not at all
0
1  feel restless as If 1  have to 
be on the move:
Very much 
indeed
a
Quite often 
□
Not very often 
□
Not at all
□
1  get sudden feelings of 
panic:
Very often indeed 
□
Quite often
O
Not very often 
n
Not at all
□
1  can sit at ease and feel 
relaxed:
Definitely
□
Usually
□
Not often
□
Not at ail
□
1  get a sort of frightened 
feeling like 'butterflies' in the 
stomach;
Very often 
□
Quite often
□
Occasionally
□
Not at ail
□
1  feel tense or wound up;
Most of the time
□
A lot of the 
time
□
From time to time, 
occasionally
□
Not at all
□
PEOPLE W ITH CANCER SOMETIMES FEEL THAT HAVING CANCER MAKES POSITIVE 
CONTRIBUTIONS TO THElft LIVES, AS WELL AS CAUSING PROBLEMS, IS  THIS TRUE FOR YOU?
Indicate how much you agree with each of the following, using these response options.
Having had cancer... Not at alt A little Moderately Quite a bit Extremely
has led me to be more accepting of things. □ 1   1 □ a □
has taught me how to adjust to things 1  cannot 
change.
□ □ □ □
□
has helped me take things as they come. □ □ □ □ □
has taught me that everyone has a purpose in 
life.
□ □ EJ □
has shown me that all people need to be loved. □ □ □ O □
has made me more aware and concerned for the 
future of all human beings.
□ □ □ □ □
has taught me to be patient. □ □ □ □ n
has led me to deal better with stress and 
problems.
□ □ □ □ □
has contributed to my overall emotional and 
spiritual growth. D
□ □ O □
has helped me become more focused on 
priorities, with a deeper sense of purpose ir* life
□ □ □ □ □
has helped me become a stronger person, more □ 0 □ n □
able to cope effectively with future life challenges.Appendices  393
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THESE ARE QUESTIONS ABOUT bIFFEftENT WAYS OF COPIN6 WITH YOl/ft ILLNESS 
There are many ways to deal with problems, people deal with things In different ways, please try to think about 
what you have been doing. Tick one box for each item and make your answers as true for you as you can,
1  haven’t
been 
doing this 
at all
rvebeen 
doing 
this a 
little bit
IVe been 
doing this 
a medium 
amount
IVe been 
doing 
this a lot
I’ve been turning to work or other activities to take my mind off □ □ □ □
things.
I've been concentrating my efforts on doing something about the □ O □ □
situation I'm in.
I've been saying to myself "this isn't real". □ n □ Q
1   I've been using alcohol or other drugs to make me feel better. □ □ □ □
! I've been giving up trying to deal with it. □ □ □ □
□ □ □ □
i I've been taking action to by to make the situation better.
I've been refusing to believe that it has happened. □ □ □ □
I've been saying things to let my unpleasant feelings escape □ □ □ □
fve been blaming myself for things that happened. ED □ □ □
I've been trying to see it in a different light, to make it seem more □ □ □
positive.
I’ve been criticising myself. □ □ □ □
I've been trying to come up with a strategy about what to do. □ □ □ □
I've been giving up the attempt to cope. □ □ □ Q
I've been looking for something good in what is happening. □ □ □ □
I’Ve been making Jokes about it. □ □ □ □
i've been doing something to think about it less, such as going to □ □ □ □
movies, watching TV, reading, daydreaming, sleeping or 
shopping.
I've been accepting the reality of the fact that it has happened. □ □ O □
I've been expressing my negative feelings. □ □ □ □
I've been praying or meditating, □ □ □ □
I've been trying to find comfort in my religion and spiritual beliefs, □ □ □ 1 ..!
I've been learning to live with it. □ □ □ 1   }
i've been thinking hard about what steps to take. □ □ □ Q
I've been using alcohol or drugs to help me get through it. □ □ O □
I've been making fun of the situation. □ □ □ □Appendices  3 9 4
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SOME QUESTIONS ABOUT YOU AND YOUR FAMILY
♦
What is your marital status?
Married/Living
with partner  Single Divorced Separated Widowed
□  0 0 □ □
How many children do you have?
i
None  1 2 3 More than 3
0   □ □ □ O
How many people live In your household? I T ]
Please tick the box which best describes your living arrangement:
Rent from local  Rent from private  Own/buying own 
authority  landlord  home
Live with 
parents/family
Other
□  0 □ □ □
Does your household have a car or van?
No
□
Yes, one  Yes, More than one 
□   □
Do you have access to the internet?
Yes No
□
Have you used the Internet to find out more about your disease?  □ □
JF you use tee internet,  Once or  Several times  About once  About 2-3 
how often do you  more a day  a week  a week  times a month 
usually use it?  □   □   □   □
Once a month 
or teas
□
These statements deal with discussion of your disease with your partner and/or your children. 
Please indicate for every statement whether you agree or disagree with it.  ______________
Strongly Agree Disagree Strongly
agree disagree
I talk as little as possible about my illness □ □ □ □
because 1  don't want to make my family uneasy.
If I talk about my illness, others gloss over it. □ □ □ □
My family always wants to hear from me that 1 □ □ □ □
am doing well.
Talking about my emotions related to my illness d □ □
upsets my family.
1  am mostly the one who starts a conversation in □ n n □
the family about mv disease.
If you do not have a partner or children please tick the 'NA' box for these statements.
Strongly Agree Disagree Strongly NA
agree disagree
My partner doesn’t like me to talk about my d □ ....O  " ...□ .n ~
problems.
My partner often doesn't know what to say or to d □ □ □ 1 1
do when I'm feeling down. i
My children don't like me to talk about my □ [  J -  Q
□ d
problems, i
My children often don't know what to say or to D □ n □ 0
do when I'm feeling down.Appendices  395
_______________ 70
Please read each question carefully and tick the response that best describes you answer.  Please tick the 'no 
difficulty’ box if a question does not apply to you.
During tho past month:  No difficulty  A little  Quite a bit  Very much
Have you had any difficulty w i t h   communicating with  O   E D   D   Q
those dose to you? (e.g. partner, children, parents)
Have you had any difficulty with communicating with  ED  O   D   ED
others? (e.g, friends, neighbours, colleagues, dates)
Have you had any difficulty concerning  sexual  □   □   □   ED
matters?
Have you had any difficulty concerning plans to have  O D D   O
a family?
Have you had any difficulty concerning  your  D   D   D   D
appearance or body image?
Have you fell 1  solated?  _________________________□   □ _______□ _______ 0 L „ ~
THIS SECTION ASKS A&OUT THE SUPPORT YOU DECEIVE FROM THE OTHER PEOPLE............
Please circle one response to indicate how much you agree with each statement.______________________
Strongly  Disagree  Neither agree  Agreo  Strongly 
disagree  or disagree  agree
There is a special person who is around when I am  ^  2   3   4  5
in need.
There is a special person with whom I can share my  ^   ^  3   4 5
joys and sorrows.
My family really tries to help me.  1  2  3  4  5
I get the emotional help and support I need from my  ^   ^  ^  4 5
family.
I have a special person who is a real source of  1 0   **  a  k
comfort to me.
My friends really try to help me.  1  2  3  4  5
I can count on my friends when things go wrong.  1   2   3   4   5
I can talk about my problems with my family.  1   2   3   4   5
I have friends with whom I can share my joys and  1   2   3   4   5
sorrows.
There is a special person in my life who cares about  1 0   -a   a  k
my feelings.
My family is willing to help me make decisions,  1 2   3  4  5
I can talk about my problems with my friends.  1   2  3  4  5
HAVE YOU HAD ANY EVERYDAY DIFFICULTIES FOLLOWIHS YOUR DrA&MQSIS?________________ _
Please read each question carefully and tick the response that best describes you answer.  Please tick the 'no 
difficulty' box if a question does not apply to you.
During the past month:  No difficulty  A little  Quite a bit  Very much
Have you had any difficulty with getting around? (e.g.  □   □   □   D
transport, car parking, your mobility)
Have you had any difficulty with where you live? (e.g.  O D D   D
space, access, damp, heating, neighbours, security)
Have you had any difficulty in carrying out our  '  .   ;   O   O   D   □
recreational activities? (e.g. hobbies, pastimes, social 
pursuits)
Have you had any difficulty with your plans to travel  O   Q   Q   D
or take a holiday?
Have you had any difficulty with any other area of  . O D D   □
your everyday life?_______________________________ _______________________ _____________Appendices  3 95
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t h e s e q u e s t io n s  are a b o u t s y m p t o m s a sso c ia t e d  w it h  c o lo r ec ta l can c e r _________
Please circle 1 number per line to indicate how true each sfatemenl has been for you during the past 7 days.
Not at all  A little bit  Somewhat  Quite a bit  Very mucti
1  have swelling or cramps in my stomach area 0 1 2 3 4
1  am losing weight 0 1 2 3 4
1  have control of my bowels 0 1 2 3 4
1  can digest food well 0 1 2 3 4
1  have diarrhoea 0 1 2 3 4
1  have a good appetite 0 1 2 3 4
1  like the appearance of my body 0 1 2 3 4
Do you have an ostomy appliance? 0 No □ Yes
If yes, please answer the next two items:
1  am embarrassed by my ostomy appliance 0 1 2 3 4
Caring for my ostomy appliance is difficult 0 1 2 3 4
MEDICAL INFORMATION:
Have you already received any of the following treatments? (tick AIL that apply)
Surgery Radiotherapy Chemotherapy Hormone 
therapy (e g. 
Tamoxifen)
Any other treatments?
■ ..............u ~ ...... CL n   i  □ □
Please specify............
Have your lymph glands have been affected by cancer?..........................................................
What is your ethnic group? Please tick as appropriate.  If you are descended from more than one ethnic 
group, please tick the group to which you consider that you belong, or lick 'any other ethnic group* and then 
describe your background in the space provided.
White □ Indian □
Black-Caribbean □ Pakistani □
Black-African □ Bangladeshi □
Black other □ Chinese □
Please specify........... Any other ethnic group □
Please specifyAppendices  3 9 7
MEDICAL CONSENT:  Please reed and sign b e l o w ___________________________
We would like to obtain your permission for the medical team to review your notes and 
share some of this information with us.  We will be looking for information about your 
diagnosis and treatment*  If you are happy for us to do this, please read and sign the 
statement below.
I understand that setions of any of my medical notes may be looked at by responsible 
individuals from the Cancer Research UK Health Behaviour Unit at University College 
London,  I give permission for these individuals to have access to my records.
Signed.....................................        ,....        Bate...................................
FUTURE CONTACT?____________________________ ___
In the future we may be carrying out more surveys like this.  If you would be willing to be contacted 
again, please tick this box  0
we ARE VERY INTERESTED IN HEARING YOUR THOUGHTS ABOUT THIS 
QUESTIONNAIRE: SO PLEASE WRITE ANY COMMENTS YOU HAVE IN THE BOX BELOW:
Thank you very much for taking the time to fill in this questionnaire.Appendix VIII -  Ethical approval for Study 2
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Isle of Wight, Portsmouth & SE Hants 
Local Research Ethics Committee
Professor J Wardle 
Director 
Cancer Research UK Health Behaviour Unit
Department of Epidemiology and Public  12 June 2003
Health
Dear Prof Wardle
REC Prop No:  04/03/1480
Title:  Socio-economic status and coping with cancer • examining the
experiences of people diagnosed with colorectal cancer
The Chair of the Local Research Ethics Committee has considered your response to the 
issues the committee raised and is satisfied your response has fulfilled their requirements. 
The Chair, acting under delegated authority, has therefore approved the above study. 
Approval for the study is only granted until the end of 31s t December 2003. If your study 
continues after this date further Ethics Committee approval will be required.
The following documents were reviewed:
Protocol
Patient information sheet 
Letter to patient and reminder letter 
Questionnaire 
Application Form
Data Protection Questionnaire (v2)
Curriculum Vitae - Frances Jane Wardle 
Letter of thanks to patient after questionnaire 
received
The Ethics Committee will require a copy of the completed study for its records, you are 
therefore requested to submit a copy of the completed study to the address above.
The Committee must be informed of any untoward or adverse events, which occur during the 
course of the study.
Please inform the Committee if the study is withdrawn, or does not take place.
The Ethics Committee must also be informed of, and approve, any proposed amendments to 
your initial application.
Undated
Version 1, dated 14th  April 2003
Undated
Undated
dated 16/04/03
dated 14/04/03
Undated
Undated
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Please note it is the policy of the Committee NOT to deal direct with sponsoring companies. 
All correspondence (including telephone enquiries) MUST be from the first named 
researcher.  Enquiries from other sources will be refused.
Ethics Committee approval means that the proposal is ethically sound. It does not mean 
approval of resources, access to data or any other requirement relating to the project. These 
must be agreed with the organisation where the research / project is to take place.
If you have any further questions please do not hesitate to contact me quoting the Research 
Ethics Committee Proposal Number given above.
Yours sincerely
Administrator to the Research Ethics Committee
E-mail 
cc  Alice Simon
NB:  The Committee endorses the Royal College of Physicians Report on 'Fraud & Misconduct in 
Medical Research Practice 1991'.  This states that all original data (eg questionnaires, lab books, 
hard copies of any computer data) are kept for a minimum often years in a retrievable form.  If 
storage is to be outside either Portsmouth Hospitals or Portsmouth Healthcare NHS Trusts' 
premises, the Committee must be informed of the site of storage.  It is a condition of any approval 
that such storage occurs.
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Interview Topic Guide
Questions will be set within the topics listed below, however respondents will be 
encouraged to express any additional views which lie outside the topics specified to 
allow a patient-centred approach.
Interview topics:
1.  Open-ended invitation to relate cancer 'story'.
2.  Access to care, comprehensibility of medical information and doctor- 
patient relationship.
3.  Coping strategies employed and their success or failure.
4.  Issues surrounding social support (perceived need versus received 
support and effect on personal relationships).
5.  Issues of disclosure of illness to family and workplace and effect on 
relationships.
6.  Recent emotional and physical well-being
7.  Social expectations and norms within family/friend groups regarding 
cancer and illness.
8.  Issues in everyday life that have changed as result of illness, e.g. 
finances, social roles, employment, travel etc.Appendices  401
SAMPLE QUESTIONS
Open-ended invitation to relate cancer 'story'.
e.g. Could you start by describing when you first realised that you might have 
cancer? 
PERSONAL WELL-BEING & BENEFIT FINDING
•  Has this illness changed  how you feel about yourself?
•  Has this illness changed  how you think about your future?
•  How have you been feeling in yourself since you received your diagnosis?
•  How stressful would you  say it has been to have this illness?
•  What sort of things do you do to cope?
STRESS & LIFESTYLE
•  Has this illness had any effect on your usual lifestyle?
•  Have you made changes in your life because of your illness?
•  Are there other stressful things going on in your life?
•  How do you balance these?
•  Are there any financial implications for you that result from having  cancer?
•  Are you employed or retired (get info about last job if retired)? What effect
has your illness had in this area of your life?
•  Do you think that your experience with this illness has been different 
compared to other people who have a different background or lifestyle?  AND 2) 
compared to people of a different age?
•  Do you think that people from a different area or social background would 
have coped with this illness differently to vou?AND 2) people of a different age?
MEDICAL TEAM & Information/comprehension
•  What has your experience been like with the medical care at this hospital?
•  Could you tell me something about the doctors and nurses that you’ve come 
across?
•  Do you find it easy to understand what the doctor  says?
•  Do you find it easy to understand what the nurses  says?
•  Do you prefer speaking to nurses or doctors?
•  What sources/where have you gained information  about this disease from?
Is it enough information? Were you able to understand it?
TRAVEL
•  How easy is it for you to reach the hospital?
•  Have you made any changes in how you get around since your diagnosis?
•  Has it had an effect on any of your travel plans?
SOCIAL SUPPORT
•  Among people you know and spend time with do you talk about cancer 
generally?
•  If you wanted to could you talk about your own illness with these  people?
•  How has your family reacted to your illness?Appendix X -  Questionnaire used in Studies 3, 4, and 5
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Patient Identification Number: CONFIDENTIAL
Centre Number: B
Study Number:  1
Experiences of People 
Recently Diagnosed with Cancer
The  aim  of this  research  is  to  find  out  more  about the 
difficulties you  have had  and  how you  have coped  after 
your diagnosis of cancer.
.  You can find more information about this study on the 
Patient Information Sheet.
.  Some  questions  appear  to  have  been  repeated,  but 
they do differ in smafl ways, so we would appreciate it 
if you could answer them all,
.  Your answers will  be treated  in  strict confidence and 
will  help  us to  identify ways  in  which  people  require 
help with this illness.
if you  are  willing  to  be  involved,  please  fill  In  this 
questionnaire and return it with your Consent Form 
and Address Sheet in the freepost envelope.
We are very grateful for your help with this research.
If you have any questions please contact:
Alice Simon
Cancer Research UK Health Behaviour Unit 
Department of Epidemiology and Public Health 
University College London 
Tel: Appendices  403
How old are you?  [~T~I Years
THIS SECTION ASKS ABOUT YOUft GENERAL HEALTH AND WELL-BEING._ "
Please circle 1  number per line to indicate how true each statement has been for you during the past 7 days.
Not at all  A little bit  Somewhat  Quite 0 bit  Very much
I have a lack of energy 0 1 2 3 4
) have nausea 0 1 2 3 4
Because of my physical condition, I have  ri  1  2  3  4 
trouble meeting the needs of my family
1  have pain 0 1 2 3 4
1  am bothered by side effects of treatment 0 1 2 3 4
1  feel ill 0 1 2 3 4
1  am forced to spend time in bed 0 1 2 3 4
1  feel close to my friends 0 1 2 3 4
1  get emotional support from my family 0 1 2 3 4
1  get support from my friends 0 1 2 3 4
My family has accepted my illness 0 1 2 3 4
1  am satisfied with family communication 0 1 2 3 4
about my illness
1  feel sad 0 1 2 3 4
1  am satisfied with how 1  am coping with my 0 1 2 3 4
illness
1  am losing hope in the fight against my illness 0 1 2 3 4
1  feel nervous 0 1 2 3 4
1  worry that my condition will get worse 0 1 2 3 4
1  am able to work 0 1 2 3 4
My work (include work at home) is fulfilling 0 1 2 3 4
1  am able to enjoy life 0 1 2 3 4
1  am sleeping well 0 1 2 3 4
1  am enjoying the things 1  usually do for fun 0 1 2 3 4Appendices  404
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Neftatal A little bit Somewhat Quite a bit Very much
1  worry about dying 0 1 2 3 4
1  have accepted my illness 0 1 2 3 4
1  feel close to my partner (or the person who 
is my main support)
D 1 2 3 4
1  am content with the quality of my life right 
now
0 1 2 3 4
Regardless of your current level of sexual activity, phase answer the following question.  If you 
prefer not to answer ft, phase check this box  Q   and go to the next question
1  am satisfied with my sex life 0 1 2 3 4
1   lease read each question carefully and tick die response that best describes your answer.  Please 
Jick the  no difficulty1  box if a question does not apply to you.
During the past month:  No difficulty  A little  Quiteabii  Verymuch
Have you had any difficulty in maintaining your 
independence?
Have you had any difficulty in carrying out your 
domestic chores? {e.g. cleaning, gardening, 
cooking, shopping)
Have you had any difficulty with managing your own 
personal care?
Have you had any difficulty with looking after those 
who depend on you? e.g. children, dependent 
adults, pets)
Have any of those close to you (e.g. partner, children,  □   O  O  D
parents) had any difficulty with the support available 
to them?
□
a □ □
□ □ □ □
□ □ □ □
□ n D □
TH€se STATEMENTS ARE ABOUT YOUR: EXPERIENCES W ITH YOUR MEDICAL TEAM
Please read each statement and circle one number that best describes how much each statement applies to 
you during the past month, including today.
I find that the medical team withholds information 
from me about the cancer 
I find that doctors don't explain what they are doing 
to me
I have difficulty asking doctors questions
I have difficulty expressing my feelings to the 
doctors and nurses
I have difficulty understanding what the doctors tell 
me about the cancer or its treatments 
I would like to have more control over what the 
doctors do to me
Net at alt Alittte A fair amount Much Very rr
0 1 2 3 4
0 1 2 3 4
0 1 2 3 4
0 1 2 3 4
0 1 2 3 4
0 1 2 3 4Appendices  495
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THIS ASKS ABOUT OUT HOW YOUR ILLNESS HAS AFFECTED YOU FINANCIALLY AND AT WORK
At what age did you leave full-time education?
What is the highest level of educational or professional qualification you have obtained?
0   GCSE/ School certificate/ O-levet/CSE  0   MastersyPhD/PGCE or equivalent
0   Vocational qualifications (e,g. NVQ1+2)  0   Other  (Specify..,.....
Q   A-ieveI/Higher school certificate or equivalent (e.g. NVQ3)  Q  No formal qualifications
0   Bachelor Degree or equivalent (e.g. NVQ4}  0   Still studying
Please read each question carefully and tick the response that best describes you answer.  Please 
tick the 'no difficulty' box if a question does not apply to you.
During the past month:
Have you had any difficulties with benefits? (e.g. 
statutory sick pay, attendance allowance, disability 
living allowance)
Have you had any financial difficulties?
Have you had any difficulty with financial services?
(e.g. loans, mortgages, pensions, insurance)
Have you had any difficulty with your work? (or 
education if you are a student)
Have you had any difficulty with planning far your own 
or your family’s future? (e.g. care of dependents, 
legal issues, business affairs)  _________ _
No difficulty
□
□
A little Quite a bit Very ms
□ 0 □
□ □ 0
0 □ 0
□ □ □
0 □ 0
Are you currently:
□   Employed full-time 
0   Employed parMime 
0   Unemployed 
0   Full-time homemaker
If you are working, what Is the full title of your main job? 
Have you worked during the past month?  Yes  0
0   Retired 
0   Student
0   Disabled or too ill to work
No  0
Please read each statement and circle one number that best describes how much each statement 
applied to you during the past month, including t o d a y . ___________________________
I have difficulty talking to the people who work 
with me about the cancer.
I have difficulty telling my employer that I 
cannot do something because of my illness.
I have difficulty asking for time off from work 
for medical treatments.
I have difficulty talking to my boss about the 
cancer
I am worried about being fired.
Have not 
worked in 
the pest 
month
Not at 
ell
A little A fair 
amount
Much Very
much
□ 0 1 2 3 4
□ 0 1 2 3 4
□ 0 1 2 3 4
□ 0 1 2 3 4
□ 0 1 2 3 4Appendices  495
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Think about your family's income, which category woutd describe the total annual household  j 
income? (including your own and partner’s salary and any benefits)
Less than  £10,000-  £20,000-  £30,000-  £40,000-  £50,000-  £60,000-  More than
£10,000 a  20,000 a  30,000 a  40,000 a  £50,000 a  60,000 a  70,000 a  £70,000 a
year  year  year  year  year  year  year  year
a  o  □  □  □  □  □  □
THE FOLLOWING SECTION ASK5 ABOUT HOW YOU HAVE BEEN FEELING RECENTLY
Tick the box which best describes how often you feit or behaved this wav in the cast week.
Rarely, none of  Some or little Occasionally or a Most or all
the lime (less  at the time moderate amount of me lime
one flay}  (1*2 days) of lima (3-4days) (5*7 days)
I was bothered by things that don't usually □  □ C D
bother me.
I did not feel like eating: my appetite was □  □ □ □
poor.
I felt that I could not shake off the blues □  □ □ □
even with help from my family or friends.
I had trouble keeping my mind on what I □  □ □ □
was doing.
□ □ I feit depressed. □ □
I felt that everything I did was an effort. □ □ □ C D
I felt hopeful about die future □ a C D D
I thought my life had been a failure. □ □ C D □
1  felt tearful. □ □ □ □
My sleep was restless. c C D □ □
1  was happy. c C D □
1  talked less than usual. C D □ □
1  felt lonely. □ □
People were unfriendly. t □ □ □
1  enjoyed life. c □ □ □
1  had crying spells. □ □ □
1  felt sad. c □ □ □
1  felt that people disliked me. c □ □
C D
□
1  could not get 'going*. r □ □Appendices  4Q 7
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Please mark one box for each statement to show how vou have usually felt over the oast week'
Worrying thoughts go through 
my mind:
A great deal of 
the time
n
A lot of the 
time 
□
From time to time 
but not too often
Only
occasionally
1  get a sort of frightened 
feeling as if something 
awful is about to happen:
Very definitely 
and quite badly 
□
Yes, but not 
too badly 
□
A little, but it 
doesn't worry me
□
Not at all
□
1  feel restless as if 1  have to 
be on the move:
Very much 
indeed
n
Quite often 
□
Not very often 
□
Not at alt 
□
1  get sudden feelings of 
panic:
Very often indeec Quite often Not very often
□
Not at all
□
1  can sit at ease and feel 
relaxed:
Definitely
□
Usually
□
Not often 
□
Not at all
□
i get a sort of frightened 
feeling like 'butterflies' in the 
stomach:
Very often 
□
Quite often
EH
Occasionally
□
Not at all 
□
1  feel tense or wound up:
Most of the time 
□ .
A lot of the 
time
□
From time to time, 
occasionally 
□
Not at all
Please answer according to your own feelings and how you generally feel, rather than how you think 'most  ! 
people* would answer. Please tick one box for each statement.
1  agree 1  agree 1  neither 1 1
a lot a little agree nor 
disagree
disagree 
a little
disagree 
3 lot
I’m always optimistic about my future. □ □ □ □ □
1  hardly ever expect things to go my way. □ □ □ □ □
In uncertain times, 1  usually expect the best. CD □ □ D C D
If something can go wrong for me, it will. □ □ a □ □
1  rarely count on good things happening to me. □ □ □ □ O
Overall, 1  expect more good things to happen to me □ □ □ □ □
than bad.
1  have little control over the things that happen to me □ □ □ □ □
There is really no way 1  can solve some of the ED □ □ □ □
problems 1  have
There is little 1  can do to change many of the important □ n □ □ □
things in my life
1  often feel helpless in dealing with the problems of life □ □ □ □ □
Sometimes 1  feel that I'm being pushed around in life □ □ □
What happens to me in the future mostly depends on
mR
□ □ □ □ □
1 1  IQ
1  can do iust about anything 1  really set mv mind to do □ n n □ — L »J__Appendices  4 08
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NEXT, SOME QUESTIONS ABOUT THE WAY YOU THINK AND FEEL ABOUT HAVING 
CANCER
These questions ask about how you think and feel about having cancer.  Please circle the 
number that best describes your response;
Hot at all  Somewhat  Definitely yes
Would you describe this illness as harmful? 0 1 2 3 4 5 6
Would you describe this illness as threatening? 0 1 2 3 4 5 6
Would you describe this illness as a loss? 0 1 2 3 4 5 6
Would you describe this illness as a challenge? 0 1 2 3 4 5 6
Would you rate the experience of this illness as stressful or 
worrying?
0 1 2 3 4 5 6
Do you feel you have the energy and stamina to get 
through this? 0 1 2 3 4 5 6
Are you pleased with your outlook on things? 0 1 2 3 4 5 6
Are you pleased with the way you are handling things? 0 1 2 3 4 5 6
PEOPLE W ITH CANCER SOMETIMES FEEL THAT HAVING CANCER MAKES POSITIVE 
CONTRIBUTIONS TO THEIR LIVES, AS WELL AS CAUSING PROBLEMS, IS  THIS TRUE FOR YOU?
Indicate how much you agree with each of the following, using these response options.
Having had cancer... Hot at oil A Little Moderately Quite a bit Extremely
has led me to be more accepting of things. □ □ □ □ □
has taught me how to adjust to things I cannot 
change.
□ □ □ □ D
has helped me take things as they come. □ □ □ □ □
has taught me that everyone has a purpose in 
life.
□ □ □ □ □
has shown me that all people need to be loved. □ □ □ □ □
has made me more aware and concerned for the 
future of all human beings.
□ □ □ □ □
has taught me to be patient. □ O □ □ □
has led me to deal better with stress and 
problems. n
Q
□ □ □
has contributed to my overall emotional and 
spiritual growth.
□ O □ □ n
has helped me become more focused on 
priorities, with a deeper sense of purpose in life
□ □ □ □
has helped me become a stronger person, more □ □ □ □ □
able to cope effectively with future life challenges.Appendices  499
THESE ARE QUESTIONS ABOUT DIFFERENT WAVS OF COPING WITH YOUR ILLNESS____________________
There are many ways to deal with problems, people deal with things in different way's, please try to think about 
what you have been doing. Tick one box for each item and make your answers as true for you as you can.
1  haven't I've been IVe been l ve been
been doing doing m is dosng
doing this 
at all
this a 
little t»t
a medium
amount
this a tot
IVe been turning to work or Qtber activities to take my mind □ □ □ □
off things.
I've been concentrating my efforts on doing something D □ □
about the situation I'm in.
I've been saying to myself "this isn’t real". □ □ □ □
i've been using alcohol or other drugs to make me feel better. □ □ □ □
IVe been giving up trying to deaf with it. □ □ O □
□ □ □ □
I've been taking action to try to make the situation better.
I've been refusing to believe that K has happened. □ □ □ □
I’ve been saying things to let my unpleasant feelings □ □ □ □
escape.
I've been blaming myself for things that happened. □ □ □ LD
I've been trying to see it in a different light, to make it seem □ □ □ n
more positive.
IVe been criticising myself. □ □ O □
I've been trying to come up with a strategy about what to do. □ □ □ □
I've been giving up the attempt to  cope. □ □ □ □
I've been looking for something good in what is happening. □ □ □ □
I've been making jokes about it □ □ □ 0
I've been doing something to think about it less, such as going to □ □ □ □
movies, watching TV, reading, daydreaming, sleeping or 
shopping.
I’ve been accepting the reality of the fact that it has happened. □ O □ □
I’ve been expressing my negative feelings. □ □ D □
I’ve been praying or meditating . □ □ □ 0
I've been trying to find comfort in my religion and spiritual beliefs. □ □ O □
IVe been learning to live with It. □ Q 0 □
I've been thinking hard about what steps to take. □ □ □ p i
IVe been using alcohol or drugs to help me get through it. □ □ □ □
IVe been making fun of the situation. □ □ □ □Appendices  4 1 0
SOME QUESTIONS ABOUT YOU AND YOUR FAMILY
What is your marital status?
Mamed/Living
with partner  Single Divorced Separated Widowed
□   □ □ LJ □
How many children do you have?
None  1 2 3 More than 3
□   □ n D □
How many people live in your household?  J^J J
Please tick the box which best describes your living arrangement:
Rent from local  Rent from private Own/buying own Live with Other
authority  landlord home parents/family
□
□ □ □ □
No Yes, one  Yes, More than one
Does your household have a car or van?  Q □ □
Yes No
Do you have access to the internet? □ □
Have you used the Internet to find out more about your disease?  □ □
IF you use the internet,  Once or Several times  About once  About 2-3 Once a month
how often do you  <™re a day a week  a week  times a month or less
usually use It?  £] □   c ]  □ □
These statements deal with discussion of your disease with your partner and/or your children.
Please indicate for every statement whether you agree or disagree with it.
Strongly Agree Disagree Strongly
agree disagree
I talk as little as possible about my illness D □ n □
because I don't want to make my family uneasy.
If I talk about my Illness, others gloss over it. □ □ □ □
My family always wants to hear from me that I □ □ |  | □
am doing well.
Talking about my emotions related to my illness □ □ □ □
upsets my family.
I am mostly the one who starts a conversation in O □ □ □
the family about my disease.
if you do not have a partner or children please tick the 'NA' box for these statements.
Strongly Agree Disagree Strongly NA  1
agree disagree
My partner doesn't like me to talk about my □ □
.   |“ j □ T T   ]
problems. 1
My partner often doesn't know what to say or to □ |..| □ □ □
do when I'm feeling down.
My children don't like me to talk about my □ I | (   1
“  □ □
problems.
My children often donl know what to say or to □ □ □ □
do when I'm feeling down.Appendices  41 j
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No difficulty  A little  Quite a bit  Very much
Please read eich question carefully and tick the response that best describes you answer.  Please tick the 'no
difficulty' box if a question does not apply to you  _____
During the past month:
Have you had any difficulty with communicating with 
those close to you? (e.g. partner, children, parents)
Have you had any difficulty with communicating with 
others? (e.g. friends, neighbours, colleagues, dates)
Have you had any difficulty concerning sexual 
matters?
Have you had any difficulty concerning plans to have 
a family?
Have you had any difficulty concerning your 
appearance or body image?
Have you felt Isolated?
□ □ O □
□ □ □ □
n □ O n
□ □ □ □
□ I"***! □ 0
□ ...._£]_ □ n
THIS SECTION ASKS A8QUT THE SUPPORT YOU RECEIVE FROM THE OTHER PEOPLE 
Please circle one response to indicate how much you agree with each statement.
Strongly  Disagree  Neither agree  Agree  Strongly
There is a special person who is around when 1  am 
in need.
There is a special person with whom i can share my 
joys and sorrows.
My family really tries to help me,
I get the emotional help and support I need from my 
family.
I have a special person who is a real source of 
comfort to me.
My friends really try to help me.
I can count on my friends when things go wrong,
I can talk about my problems with my family.
I have friends with whom I can share my joys and 
sorrows,
There is a special person in my life who cares about 
my feelings.
My family is willing to help me make decisions.
I can talk about my problems with my friends.
agree
1 2
or disagree
3 4
agree
5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 S
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
HAVE YOU HAD ANY EVERYDAY DIFFICULTIES FOLLOWING YOUR DIAGNOSIS?
Please read each question carefully and tick the response that beat describes you answer.  Please tick the 'no
During the past month: No difficulty A little Quite a bit Very much
Have you had any difficulty with getting around? (e.g. 
transport, car parking, your mobility)
□ n 0 □
Have you had any difficulty with where you live? (e.g. 
space, access, damp, heating, neighbours, security)
□ □ 0
□
□
Have you had any difficulty in carrying out our 
recreational activities? (e.g. hobbies, pastimes, social 
pursuits)
□ □ □
Have you had any difficulty with your plans to travel 
or take a holiday?
□ □ O □
Have you had any difficulty with any other area of 
your everyday life? O □ □ □Appendices  4 1 2  
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THESE QUESTIONS ARE AgOUT SYMPTOMS /IMP CONCERNS ASSOCIATED WTTR gRE^ST CANCER_______
Please circle 1  number per line to indicate hew true each statement has been for you during the past 7 days.
Not at all  A little bit  Somewhat  Quite a bit  Very much
1  have been short of breath 0 1 2 3 4
1  am self-conscious about the way i dress 0 1 2 3 4
One or bolh of my arms are swollen or lender 0 1 2 3 4
1  feel sexually attractive 0 1 2 3 4
1  am bothered by hair toss 0 1 2 3 4
1  worry that other members of my family might 
someday get the same illness 1  have
0 1 2 3 4
1  worry about the effect of stress on my illness 0 1 2 3 4
1  am bothered by a change in weight 0 1 2 3 4
1  am able to feel like a woman 0 1 2 3 4
1  have certain parts of my body where 1 0 1 2 3 4
experience significant pain
MEDICAL INFORMATION:
On what date did you receive your cancer diagnosis?  (dd/mmfyy)  [ i n / n n / D f l
Have you already received any of the following treatments? {tick ALL that apply)
Surgery Radiotherapy Chemotherapy Hormone 
therapy (e.g. 
Tamoxifen)
Any other treatments?
0 □ □ □ O
Please specify................................
Have your lymph glands been affected by cancer?.........................................................
What is your ethnic group? Please tick as appropriate,  if you ere descended from more than one ethnic 
group, please tick the group to which you consider that you belong, or tick 'any other ethnic group' and then 
describe your background In the space provided,
White □ Indian □
Black-Caribbean □ Pakistani □
Black-African □ Bangladeshi □
Black other □ Chinese □
Please specify........................ Any other ethnic group □
Please specify.Appendices  413
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WE ARE VERY INTERESTED IN  HEARING YOUR THOUGHTS ABOUT THIS 
QUESTIONNAIRE: SO PLEASE WRITE ANY COMMENTS YOU HAVE IN  THE BOX BELOW:
Thank you very much for taking the time to fill in th is questionnaire.Appendices  414
Appendix XI -  Ethical Approval for Studies 3, 4, 5 and 6
mm
The London Multi-Centre Research Ethics Committee
7th  August 2002
1  Tel: 020 8453 2336
pw/lc/02-6  fax: 020 8961 0012
„ 
Professor Jane Wardle
Director of CRUK Health Behaviour Unit
Department o f Epidemiology &  Public Health
University College London
Dear Professor Wardle
Application Reference Number  MREC/02/2/61
Title  Socio-economic status and coping with cancer -  examining the experiences of people 
recently diagnosed with cancer
The Chairman of the London Multicentre Research Ethics Committee has considered the 
amendments submitted in response to the Committee’s earlier review o f your application on 26"’
June 2002 as set out in our letter dated 5lh July 2002.  The documents considered were as follows:
Letter  from Professor Wardle  (dated 15* July 2002)
MREC Application Form  (dated 2Sh May 2002)
Protocol  (Version 1, dated 15* May 2002)
Patient Information Sheet  (Version 2, dated I f f  July 2002)
List of  Cancer Support Services  (Version 1, dated 1 ( f  July 2002)
Consent Form  (Version I, dated I5'h  May 2002)
Questionnaire  (Version 1, dated 15* May 2002)
Interview Topic Guide  (Version 1, dated 15* May 2002)
Principle Researcher‘s Curriculum Vitae
The Chairman, acting under delegated authority, is satisfied that these accord with the decision of 
the Committee and has agreed that there is no objection on ethical grounds to the proposed study.
I am, therefore, happy to give you our approval on the understanding that you will follow the 
conditions of the approval set out below.  A full record o f the review undertaken by the M REC is 
contained in the attached M REC Response Form.  The project must be started within three years 
of the date on which M REC approval is given.
While  undertaking  the  review  of your  application  the  M R EC   noted  the  research  involves  the 
establishment of a  new disease or  patient database for  research  purposes / the  use of an  existing 
database collected  for  previous  research or other purposes  with  subsequent  patient contact.  For 
this reason you are  asked  to  read carefully  the sections  concerning  LR EC   involvement and 
local  NHS  management  set  out  below  as  there  arc  specific  requirement  involved  when 
undertaking such research.Appendices  415
M R E C  Conditions of Approval
•  No research procedures are undertaken until the appropriate local research ethics committees 
is informed o f the research including the name o f the local clinician involved.
•  The local clinician must inform his/her NHS organisation o f their co-operation in the research 
project.
•  The protocol approved by the MREC is followed and any changes to the protocol are 
undertaken only after M REC approval.
•   If  projects are approved before funding is received, the MREC must see, and approve, any 
major changes made by the funding body. The M REC would expect to see a copy o f the final 
questionnaire before it is used.
•  You must promptly inform the MREC of:
(i)  any changes that increase the risk to subjects and/or affect significantly the conduct of 
the research;
(ii)  any new information that may affect adversely the safety or welfare of the subjects or 
the conduct of the trial.
•  You must complete and return to the MREC the annual review form that will be sent to you 
once a year, and the final report form when your research is completed.
LR E C  involvement
When undertaking the review of your project the M REC observed that there is/ limited patient contact 
involving the performance o f a technical procedures or additional data collection as described in the 
M REC approved protocol/ initial contact by a local clinician for purposes o f recruitment.  It is felt that 
these tasks appear well within his/her routine professional competence and adequate facilities for such 
procedure are available as part of his/her normal professional practice.
For this reason you are asked to only inform the appropriate LREC of the project by sending a copy of 
this letter and also giving the name and contact details of the local clinician involved and what 
procedures w ill be undertaken by this person.  If (unusually) the LREC has any reason to doubt that 
the local clinician is competent to carry out the tasks required,  it will inform the clinician and the 
MREC that gave ethical approval giving full reasons.
When such tasks are performed by centrally based researchers it should be assumed that the MREC 
lias reviewed their competence to undertake the tasks and it is not necessary to inform the LREC of the 
contact details but only that the research will take place.
You are not required to wait for confirmation from the LREC before starting your research.Appendices  4 1 5
Local NHS Management
The local clinician must inform his/her NHS organisation o f their co-operation in the research 
project and the nature o f their involvement.  Care should be taken to ensure with the NHS 
organisation that local indemnity arrangements are adequate.
Legal and Regulatory Requirements
It remains your responsibility to ensure in the subsequent collection, storage or use o f data or 
research sample you are not contravening the legal or regulatory requirements of any part of the 
UK in which the research material is collected, stored or used. If  data is transferred outside the 
UK you should be aware o f the requirements of the Data Protection Act  1998.
ICH GCP Compliance
The MRECs are fully compliant with the International Conference on Harmonisation/Good 
Clinical Practice (IC H  GCP) Guidelines for the Conduct o f Trials Involving the Participation of 
Human Subjects as they relate to the responsibilities, composition, function, operations and 
records of an Independent Ethics Committee/Independent Review Board. To this end it 
undertakes to adhere as far as is consistent with its Constitution, to the relevant clauses o f the IC H  
Harmonised Tripartite Guideline for Good Clinical Practice, adopted by the Commission of the 
European Union on  17 January  1997. The Standing Orders and a Statement o f Compliance were 
included on the computer disk containing the guidelines and application form and are available on 
request or on the Internet at www.corec.ore.uk
Yours sincerely
Administrator
H v  f   tJrnn  A V . London Multicentre Research Ethics Committee
EncAppendices  4 1 7
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The London Multi-Centre Research Ethics Committee
%  
RESPONSE FORM 
      —  
DETAILS OF APPLICANT: 
1.  Name and address of Principal Researcher:
Professor Jane Wardle
Director o f CRUK Health Behaviour Unit
Department o f Epidemiology &  Public Health
University College London
2.  Title of Project:
Socio-economic status and coping with cancer -  examining the experiences of people 
recently diagnosed with cancer
3.  Name and address of Sponsor:
Cancer Research UK 
DETAILS OF MREC:
4.  Name and address of MREC:
^  London Multicentre Research Ethics Committee
5.  MREC Reference Number:Appendices  41 g
Listed below is a complete record of the review undertaken by the MREC with the decisions 
made, dates of decisions and the requirements at each stage of the review:
The London Multicentre Research Ethics Committee at its meeting on Wednesday 26* June 2002
approved the study subject to the following:
a)  Could the researcher clarify what support would be available should a patient become 
distressed during an interview?  Would patients be referred to a counsellor or 
psychologist?
b)  Could the researcher clarify what training would the interviewer receive?
c)  Could the researcher provide patients with details o f  cancer support groups?
d)  Could a maximum time limit be set on the interviews (for example, one hour),  to prevent
patients  from becoming tired?
e)  It was noted that the sample size is based on a medium size effect of 0.25.  Could the 
researcher explain the meaning of  0.25?  Could the researcher explain how this is 
recognised as clinically significant by those working in this  field?
j)  Could the researchers explain why the  first sage of  the survey is not stratified by social
class, given that it is important to obtain a similar sample size in each group to optimise 
the efficiency of  the study?
g)  Could the researcher clarify what definitions would be used to identify the three social 
classes?
h)  Does the researcher  feel that by excluding  patients  for whom English is not a  first 
language, the research will miss important cultural  factors?
i)  Could the researcher confirm if the questionnaire has been validated?
The Committee delegated authority to the Chairman to approve the study,  if the responses to the
above were satisfactory.
Professor Wardle responded on  15lh July 2002.Appendices  4 1 9
T H E  F IN A L  D O C U M E N TS  A N D  A R R A N G EM EN TS A PPR O VED  B Y  T H E  M R E C  
The London Multicentre Research Ethics Committee has approved the following items:
Letter  from Professor Wardle 
MREC Application Form 
Protocol
Patient Information Sheet
List of  Cancer Support Services
Consent Form
Questionnaire
Interview Topic Guide
Methods of  Initial Recruitment to Study
(dated i f  July 2002) 
(dated 2f  May 2002) 
(Version 1, dated 15* May 2002) 
(Version 2, dated JO* Jtdy2002) 
(Version I, dated i f  July 2002) 
(Version 1, dated 15* May 2002) 
(Version I, dated i f  May 2002) 
(Version 1, dated i f  May 2002)
Date of approval:  29* July 2002
Signature of Administrator:  Date:  7* August 2002
Name (please print) 
List of Members in Attendance at the Meeting on 26th June 2002
(Chairman) Lay Member, Retired Engineer
General Practitioner
Psychologist
Nurse
Statistician
Clinical Scientist
Pharmacist
Consultant Paediatrician 
Lay Member, Editor 
Qualitative Researcher 
Consultant  Haematologist
Administrator420 Appendices
Appendix X II Codebook used in Study 3
Content analysis code book
ID Number................................................................
1. Quality of medical care/satisfaction with care
Medical care Yes No Personality Expertise Explicit System General
Drs specialist Positive □ □ □ □ □ □ □
Negative □ □ □ □ □ □ □
Nurses
specialist
Positive □ □ □ □ □ □ □
Negative □ □ □ □ □ □ □
Dr other Positive □ □ □ □ □ □ □
Negative □ □ □ □ □ □ □
Nurse other Positive □ □ □ □ □ □ □
Negative □ □ □ □ □ □ □
GP Positive □ □ □ □ □ □ □
Negative □ □ □ □ □ □Appendices  421
2. Administration difficulties
Administration
Appointments Difficulties □ No difficulties □
Bed availability Difficulties □ No difficulties □
Scans/medical procedures Difficulties □ No difficulties O
Short-staffed Difficulties □ No difficulties □
Agency nurses Difficulties □ No difficulties O
Other
administration.......................................
Difficulties □ No difficulties O
3. Treatments, side effects and medical history
Time to diagnosis (after referral from GP)  ...........................................................................
Diagnostic tests Received Planned Not having
Flexible sigmoidoscopy □ □ □
Colonoscopy □ □ □
CT scan □ □ □
Barium enema □ □ □
Pathology □ □ □
Endoscopy (other) □ □ □
MRI scan □ □ □
Other test............................... □ □ □
Treatments Received Planned Not having
Surgery □ □ □
Chemotherapy □ □ □
Radiotherapy □ □ □
Other............................ □ □ □Appendices 422
Satisfaction with treatment Yes □ N o D
Side effects
Incontinence Yes □ N oD
Hospital infection Yes □ N oD
Sexual problems Yes □ N oD
Weight loss Yes □ N oD
Painful arms/veins due to chemo Yes □ N oD
Fatigue Yes □ N oD
Loss of appetite Yes □ N oD
Other..................................................... Yes □ N oD
Co-morbid health problems Yes □ N o D
Details.......................................................................................................................
Stage of disease A  □ B  □ C1  □   C2 □
Colostomy Yes  □ N o D
If  ‘yes’ Temporary □ Permanent □
Embarassment/difficulties 
with colostomy
Yes  □ N o D
Symptoms prior to 
diagnosis
Yes □ N o D
Delay in seeking medical 
care regarding symptoms
Yes □ N o D
If ‘yes’ Up to 1  wk □ Up to 2 wk n Up to  1mth □
Up to 3mth □ Up to 12mth □Appendices 423
Appendix XIII -  Questionnaire used in Study 6
Patient Identification Number: CONFIDENTIAL
Centre Number:  B
Study Number:  2
Experiences of People Who 
Have had a Diagnosis of Cancer
A few months ago you filled in a survey for us.  Thank you 
very much for taking part.
We  are  now  asking  you  to  complete  a  similar  survey  to 
find out if your illness has continued to affect your life and 
to see if your views have changed over time.
.  You  can  find  more  information  about  this  study on  the 
Patient Information Sheet.
.  Your answers will be treated in strict confidence and will 
help  us  to  identify  ways  in  which  people  require  help 
with this illness.
.  Some  questions  have  been  repeated  but  this  is 
because we want to see if your opinions have changed 
compared to when you first answered these questions.
If  you  are  willing  to  be  involved,  please  fill  in  this 
questionnaire and return it in the freepost envelope.
We are very grateful for your help with this research.
If you have any questions please contact:
Alice Simon
Cancer Research UK Health Behaviour Unit 
Department of Epidemiology and Public Health 
University College London Appendices
THIS SECTION ASKS ABOUT YOUR GENERAL HEALTH AND WELL-BEING.
Please circle 1  number per line to indicate how true each statement has been for you during the past 7 days  j
Not at all  A littfe bit  Somewhat  Quite a bat  Very much  j
I have a tack of energy 0 1 2 3 4
I have nausea 0 1 2 3 4
Because of my physical condition, 1  have n 1 A
trouble meeting the needs of my family
1  have pain 0 1 2 3 4
1  am bothered by side effects of treatment 0 1 2 3 4
1  feel ill 0 1 2 3 4
1  am forced to spend time in bed 0 1 2 3 4
1  feel close to my friends 0 1 2 3 4
1  get emotional support from my family 0 1 2 3 4
1  get support from my Friends 0 1 2 3 4
My family has accepted my illness 0 1 2 3 4
1  am satisfied with family communication 0 1 2 3 4
about my illness
1  fee) sad 0 1 2 3 4
1  am satisfied with how 1  am coping with my 0 1 2 3 4
illness
1  am losing hope in the fight against my illness 0 1 2 3 4
1  feel nervous 0 1 2 3 4
1  worry that my condition will get worse 0 1 2 3 4
1  am able to work 0 1 2 3 4
My work (Include work at home) is fulfilling 0 1 2 3 4
1  am able to enjoy life 0 1 2 3 4
I am sleeping well 0 1 2 3 4
1  am enjoying the things 1  usually do for fun 0 1 2 3 4
1  worry about dying 0 1 2 3 4
1  have accepted my illness 0 1 2 3 4Appendices
Notalafl  Alititobft  Somewhat  Quite a bit Very much
1  feel close to my partner (or the person who  0  1  2  3 
is my main support)
4
I am content with the quality of my life right 
now
0  1 2   3 4
Regardless of  your current level of sexual activity, please answer the following question.  If you prefer
not to answer it, please check this box  ° and go to the next question
I am satisfied with my sex life 0   1 2  3 4
THESE STATEMENTS ARE ABOUT YOUR EXPERIENCES W ITH YOUR MEDICAL TEAM
Please read each statement and circle one number that best describes how much each statement applies to 
you d u r i n g   the p a s t   m o n t h ,   including today.
Not al all  A little  A fair amount  Much  Very much
I find that the medical team withholds information 
from me about the cancer 
I find that doctors don’t explain what they are doing  * 
to me
0
I have difficulty asking doctors questions  0
! have difficulty expressing my feelings to the  q
doctors and nurses 
I have difficulty understanding what the doctors tell  «
me about the cancer or its treatments
would like to have more control over what the 
doctors do to me 0
2   3   4
2   3   4
2 3   4
2   3   4
2   3   4
2   3   4
THIS SECTION IS ABOUT HOW YOUR ILLNESS HAS AFFECTED YOU FINANCIALLY AND AT WORK
Are you currently:
□   Employed full-time  □   Retired
□   Employed part-time  □   Student
□   Unemployed  Q   Disabled or too ifl to work
D   Full-time homemaker
What Is the full tide of your main job, or If you are retired or unemployed what was the full 
title of your last job?    .......................................................................................... .
Do (did) you work as an employee or are (were) you self-employed?
Employee  Self-employed with employees  Setf-emptoyed/freelance without
□   □   employees  □
For employees; Indicate how many people work (worked) for your employer  ^10 24  □
For self-employed: Indicate how many people you employ (employed)  25 or more  □
Do (did) you supervise any other employees?  Yes  □   No  □Appendices
The following questions refer to your current main job, or to your last main lob.  Please tick 
one box only.
Please tick one box to show which best describes the sort or work you do {did):
Modem professional occupations
such as: teacher - nurse - physiotherapist - social worker - welfare officer - artist - musician -
police officer (sergeant or above) - software designer
Clerical and intermediate occupations  ,— ,
such as: secretary - personal assistant - clerical worker - office clerk - call centre agent -  |___|
nursing auxiliary - nursery nurse
Senior managers or administrators  ,— ,
(usually responsible for planning, organising and co-ordinating work and for finance)  |  |
such as: finance manager - chief executive
Technical and craft occupations  ,— . 
such as: motor mechanic - fitter - inspector - plumber - printer - tool maker - electrician -
gardener - train driver
Semi-routine manual and service occupations  ,— ,
such as: postal worker - machine operative - security guard - caretaker - farm worker -  j  |
catering assistant - receptionist - sales assistant
Routine manual and service occupations 
such as: HGV driver - van driver - cleaner - porter - packer - sewing machinist - messenger -
labourer - waiter / waitress - bar staff
Middle or junior managers
such as: office manager - retail manager - bank manager - restaurant manager - warehouse
manager -  publican
Traditional professional occupations
such as: accountant - solicitor - medical practitioner - scientist - civil I mechanical engineer
Please read circle one number that best describes how much each statement applied to you 
during the oast month, including today.___________  _________________
I have difficulty talking to the people who 
work with me about the cancer,
I have difficulty telling my employer that I 
cannot do something because of my illness. 
I have difficulty asking for time off from work 
for medical treatments.
I have difficulty talking to my boss about the 
cancer
I am worried about being fired.
Have not 
worked in (lie 
past month
Not 
at el!
A litUe A fair 
amount
Much Very
much
□ 0 1 2 3 4
□ 0 1 2 3 4
□ 0 1 2 3 4
□ 0 1 2 3 4
□ 0 1 2 3 4Appendices
think of this ladder as representing where people stand in the 
UK.
At the top of the ladder are the people who are the best off, those with 
the most money , most education and most respected jobs.  Those at the 
bottom are the people who are worst off with the least money, least 
education and the least respected jobs or no job,  The higher up you ore 
on the ladder, the closer you are to the people at the top, the lower you 
ore the closer you are to the people at the bottom.
Please place a large X  on the rung where you think you stand at 
this time in your life relative to other people in die UK
THE FOLLOWING SECTION ASKS ABOUTHOW YOU HAVE BEEN FEELING RECENTLY
Tick the box which best describes how often
I was bothered by things that don't usually 
bother me.
1  did not feel like eating: my appetite was 
poor.
i felt that I could not shake off the blues 
even with help from my family or friends. 
I had trouble keeping my mind on what I 
was doing.
I felt depressed.
I felt that everything I did was an effort.
I thought my life had been a failure.
I fell tearful.
My sleep was restless.
I was happy,
I talked less than usual.
I felt lonely.
People were unfriendly.
I enjoyed life,
I had crying spells.
I felt sad.
I felt that people disliked me.
I could not get 'going*.
you felt or behaved this wav in the oast w e e k ,______
Rarely, none of  Some or little  Occasionally or s  Most or all
Ihe time (less  of the time  moderate amount  of the time
than one day)____(1-2 days)  of time (3-4d»y$;i  (S-7 days)
□ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ d
□ □ □ □
□ □ □ □
□ □ □ □
□ D □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ O □
n □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □Appendices  428
Please mark one box for each statement to show how vou have usually felt over the oast week:
Worrying thoughts go through 
my mind:
A great deal of 
the time
A lot of the 
lime
From time to time 
but not too often
Only
occasionally
□
1  get a sort of frightened 
feeling as if something 
awful is about to happen:
Very definitely 
and quite badly 
□
Yes, but not 
too badly 
□
A little, but it 
doesn't worry me 
□
Not at ali
□
1  feel restless as if 1  have to 
be on the move:
Very much 
indeed
n
Quite often 
□
Not very often
o
Not at all
□
1  get sudden feelings of 
panic:
Very often indeed
□
Quite often
□
Not very often 
□
Not at ali
□
1  can sit at ease and feel 
relaxed:
Definitely
□
Usually
D
Not often 
□
Not at all 
□
1  get a sort of frightened 
feeling like ‘butterflies' in the 
stomach:
Very often 
□
Quite often 
□
Occasionally
□
Not at all
□
1  feel tense or wound up:
Most of the time 
□
A lot of the
time
From time to time, 
occasionally 
□
Not at all
THIS SECTION ASKS ABOUT THE SUPPORT YOU RECEIVE FROM THE OTHER PEOPLE 
Please circle one response to indicate how much you agree with each statement,  ___________
There is a special person who is around when 1  am 
in need.
There is a special person with whom 1  can share my 
joys and sorrows.
My family really trie® to help me,
Strongly
disagree
1
1
1
Disagree
2
2
2
Neither agree 
or disagree
3
3
3
Agree
4
4
4
Strongly
agree
5
5
5
I gel the emotional help and support 1  need from my 
family.
1  have a special person who is a real source of 
comfort to me.
My friends really try to help me.
1
1
1
2
2
2
3
3
3
4
4
4
5
5
5
1  can count on my friends when things go wrong.
1 2 3 4 5
1  can talk about my problems with my family.
1 2 3 4 5
I have friends with whom 1  can share my joys and 
sorrows.
There is a special person in my life who cares about 
my feelings.
My family is willing to help me make decisions.
1
1
1
2
2
2
3
3
3
4
4
4
5
5
5
1  can talk about my problems with my friends.
1 2 3 4 5Appendices 429
HAS YOUR ILLNESS AFFECTED YOUR  EVERYDAY UPE?
Please read each question carefully and tick the response that best describes your answer,  Please
tick the 'no difficulty* box if a question does not apply to you.  _________________________
During the oast month:  No difficulty  A little  Quite a bit  Very much
Have you had any difficulty In maintaining your 
independence?
Have you had any difficulty in carrying out your 
domestic chores? (e.g. cleaning, gardening, 
cooking, shopping)
Have you had any difficulty with managing your own 
personal care?
Have you had any difficulty with looking after those 
who depend on you? e.g. children, dependent 
adults, pets)
Have any of those dose to you (e.g. partner, 
children, parents) had any difficulty with the 
support available to them?
Have you had any difficulties with benefits? (e.g. 
statutory sick pay, attendance allowance, disability 
living allowance)
Have you had any financial difficulties?
Have you had any difficulty with financial services?
(e.g. loans, mortgages, pensions, insurance)
Have you had any difficulty with your work? (or 
education if you are a student)
Have you had any difficulty with planning for your 
own or your family's future? (e.g. care of 
dependents, legal issues, business affairs)
Have you had any difficulty with communicating with 
those close to you? (e.g. partner, children, parents) 
Have you had any difficulty with communicating with 
others? (e.g. friends, neighbours, colleagues, 
dates)
Have you had any difficulty concerning sexual 
matters?
Have you had any difficulty concerning plans to have 
a family?
Have you had any difficulty concerning your 
appearance or body Image?
Have you felt isolated?
Have you had any difficulty with getting around?
(e.g. transport, car parking, your mobility)
Have you had any difficulty with where you live?
(e.g. space, access, damp, heating, neighbours, 
security)
Have you had any difficulty in carrying out your 
recreational activities? (e.g. hobbies, pastimes, 
social pursuits)
Have you had any difficulty with your plans to travel 
or take a holiday?
Have you had any difficulty with any other area of 
your everyday life?
Please give details        ............................................
D □ □ □
□ □ □ n
□ □ □ □
□ □ □ □
□ O □ □
□ □ □ □
□ □ □ □
E D □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ ED n
□ □ □ □Appendices  430
THESE AkE QUESTIONS 4BOUT DIFFERENT W*V5 OF COPIN& WITH YOUR XU.NE55________________ ___
There are many ways lo deal with problems, people deal with things in different ways, please try to think about 
what you have been doing. Tick one box for each item and make your answers as true for you as you can.
i haven't
been 
doing this 
at alt
IVe been 
doing this 
a tittle bit
I’ve been 
doing this 
a medium 
amount
I'Ve been 
doing 
this a lot
I've been turning to work or other activities to take my mind 
off things. □ □ □ □
I've been concentrating my efforts on doing something 
about the situation I'm in. □ □ □ □
I've been saying to myself "this isn't reaf. □ □ □ □
I've been using alcohol or other drugs to make me feel 
better. □ □ □ □
I've been giving up trying to deal with it. □ □ □ □
1 ‘ve been taking action to try to make toe situation better.
□ □ □ □
I've been refusing to believe that it has happened. □ □ □ □
I've been saying things to let my unpleasant feelings 
escape. □ □ □ □
I've been blaming myself for things that happened. □ □ □ □
i've been trying to see it in a different light, to make it seem 
more positive. □ □ □ □
I've been criticising myself, □ [D □ □
I've been trying to come up with a strategy about what to 
do. □ □ □ □
I’ve been giving up the attempt to cope. □ □ □ □
I’ve been looking for something good in what is happening. □ □ □ □
i've been making jokes about it. □
J-J D □
I've been doing something to think about it less, such as 
going to movies, watching TV, reading, daydreaming, 
sleeping or shopping.
□ □ □ □
I've been accepting the reality of toe fact that it has 
happened. □ □ □ □
I'Ve been expressing my negative feelings. □ □ □ □
I've been praying or meditating. □ f~ ~ l 1   I □
I’ve been trying to find comfort in my religion and spiritual 
beliefs. □ □ □ □
I've been learning to live with it. □ □ □ □
I’ve been thinking hard about what steps to take. D □ □ □
I've been using alcohol or drugs to help me get through it □ □ □ □
I've been making fun of the situation. a □ □ □Appendices
SOfAE QUESTIONS ABOUT THE WAY YOU THINK AND FEEl ABOUT CANCER NOW
These questions ask about how you think and feel about cancer now.  Please circle the
number that best describes your response:
Not at all Somewhat Definitely yes
Would you describe this illness as harmful? 0 1 2 3 4 5 6
Would you describe this illness as threatening? 0 1 2 3 4 5 6
Would you describe this Illness as a loss? 0 1 2 3 4 5 6
Would you describe this illness as a challenge? 0 1 2 3 4 5 6
Would you rate the experience of this illness as stressful or 0 1 3 A 5 ft
worrying?
Do you feel you have the energy and stamina to get n 2 3 A 5 R
through this?
Are you pleased with your outlook on things? 0 1 2 3 4 5 6
Are you pleased with the way you are handling things? 0 1 2 3 4 5 6
PEOPLE WHO HAVE HAD CANCER SOMETIMES FEEL THAT IT  HAS MADE POSITIVE 
CONTRIBUTIONS TO THEIR LIVES, AS WELL AS CAUSING PROBLEMS, IS THIS TRUE FOR YOU?
Indicate how much you agree with each of the following, using these response options.
Having had cancer...
has ted me to be more accepting of things.
has taught me how to adjust to things I cannot
change.
has helped me take things as they come.
has taught me that everyone has a purpose in 
life.
has shown me that ail people need to be loved.
has made me more aware and concerned for the 
future of ail human beings.
has taught me to be patient.
has led me to deal better with stress and 
problems.
has contributed to my overall emotional and 
spiritual growth.
has helped me become more focused on 
priorities, with a deeper sense of purpose in life
has helped me become a stronger person, more
able to cope effectively with future life challenges.
Not at all A Little Moderately Quite a bit Extremely
□ □ □ □ □
□ □ o □ □
□ □ □ □ □
□ □ □ □ □
□ □ □ □ □
□ □ □ □ □
□ □ D □ □
□ □ □ □ □
□ □ □ □ □
□ □ □ □ □
□ □ □ n ElAppendices  432
SOME QUESTIONS ABOUT YOU AND YOUR FAMILY
These statements deal with discussion of your disease with your partner andtor your children. Please 
indicate for every statement whether you agree or disagree with it.
1  talk as little as poss&le about my illness 
because 1  don't want to make my family uneasy. 
If 1  talk about my illness, others gloss over it
My family always wants to hear from me that 1  
am doing well.
Talking about my emotions related to my illness 
upsets my family.
1  am mostly the one who starts a conversation in 
the family about mv disease.
Strongly
agree
□
o
□
□
Agree
□
□
□
□
Disagree
□
n
□
Strongly
disagree
□
1 ..1
□
□
if you do not have a partner or children please tick the ’NA* box for these statements.
Strongly
agree
Agree Disagree Strongly
disaqree
NA
My partner doesn't like me to talk about my 
problems. □ Q □ □ □
My partner often doesn't know what to say or to 
do when I'm feeling down. Q n □ □ □
My children don’t like me to talk about my 
problems. □ □ □ □ □
My children often don’t know what to say or to 
do when I’m feeling down. □ □ □ □ □
THESE QUESTIONS ARE ABOUT SYMPTOMS AND CONCERNS ASSOCIATED W ITH BREAST
CANCER  ____ ________________________________________   _______________________
Please circle 1   number per line to indicate how true each statement has been for you during the oast 7 davs.
Not at all  A Ifttte bit  Somewhat  Quite a bit  Very much
1 have been short of breath 0 1 2 3 4
1  am self-conscious about the way 1  dress 0 1 2 3 4
One or both of my arms are swollen or tender 0 1 2 3 4
1 feel sexually attractive 0 1 2 3 4
1 am bothered by hair loss 0 1 2 3 4
1 worry that other members of my family might 
someday get the same illness 1  have
0 1 2 3 4
I worry about the effect of stress on my illness 0 1 2 3 4
1  am bothered by a change in weight 0 1 2 3 4
1 am able to fee! like a woman 0 1 2 3 4
1 have certain parts of my body where 1  
experience significant pain
0 1 2 3 4Appendices
IN  WHAT WAYS HAVE YOUR VIEWS ABOUT YOUR ILLNESS CHANGED FROM WHEN YOU 
WERE FIRST DIAGNOSED TO NOW?
WE ARE VERY INTERESTED IN  HEARING YOUR THOUGHTS, SO PLEASE WRITE ANY 
COMMENTS YOU HAVE IN  THE BOX BELOW-
Thank you very much fo r taking the time to fill in this questionnaire.